Sentence,class,file
Available from: http://globalsurg.org/ .,OADS,/arxiv_data1/oa_pdf/9a/b0/main.PMC4430705.pdf
Available from: http://www.surgicalcollaborative.com/ .,Non-OADS,/arxiv_data1/oa_pdf/9a/b0/main.PMC4430705.pdf
Available from: http://metrics.stanford.edu/ .,OADS,/arxiv_data1/oa_pdf/9a/b0/main.PMC4430705.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/15694529 .,Non-OADS,/arxiv_data1/oa_pdf/9a/b0/main.PMC4430705.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/e9/main.PMC4430706.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.04.006 2049-0801/ ©2015 Published by Elsevier Ltd on behalf of IJS Publishing Group Limited.,Non-OADS,/arxiv_data1/oa_pdf/ba/e9/main.PMC4430706.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.02.003,Non-OADS,/arxiv_data1/oa_pdf/f6/f0/main.PMC4430707.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,1–4 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f6/f0/main.PMC4430707.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,1–4 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f6/f0/main.PMC4430707.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,6,1–4 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/f6/f0/main.PMC4430707.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/55/1d/main.PMC4430708.pdf
http://dx.doi.org/10.1016/j.csbj.2015.03.006 2001-0370/© 2015 Ibrahim.,Non-OADS,/arxiv_data1/oa_pdf/55/1d/main.PMC4430708.pdf
This is an ope n access article under the CC BY-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/55/1d/main.PMC4430708.pdf
Available at: http://www.mssanz.org.au/modsim09/B6/kunkle_B6a.pdf.,Non-OADS,/arxiv_data1/oa_pdf/79/a6/bjc2014586a.PMC4430710.pdf
"Carlson M, Falcon S, Pages H, Li N (2014) hgu133plus2.db: Affymetrix Human Genome U133 Plus 2.0 Array annotation data (chip hgu133plus2), v2.14.0, http://www.bioconductor.org/packages/release/data/annotation/ html/hgu133plus2.db.html.",OADS,/arxiv_data1/oa_pdf/56/b8/bjc2014665a.PMC4430711.pdf
"Gentleman R (2014) annotate: Annotation for microarrays, v1.42.1, http://www.bioconductor.org/packages/release/bioc/html/annotate.html.",Non-OADS,/arxiv_data1/oa_pdf/56/b8/bjc2014665a.PMC4430711.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Primary tumour and nodal metastasis transcriptomes 1674 www.bjcancer.com | DOI:10.1038/bjc.2014.665,Non-OADS,/arxiv_data1/oa_pdf/56/b8/bjc2014665a.PMC4430711.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER MED12 mutations in phyllodes tumour 1708 www.bjcancer.com | DOI:10.1038/bjc.2015.116,Non-OADS,/arxiv_data1/oa_pdf/2a/e5/bjc2015116a.PMC4430713.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)DNA ploidy in endometrial cancer curettage specimens BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2015.123 1663,Non-OADS,/arxiv_data1/oa_pdf/69/b9/bjc2015123a.PMC4430715.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Circulating ARandCYP17A1 CNVs and abiraterone 1724 www.bjcancer.com | DOI:10.1038/bjc.2015.128,Non-OADS,/arxiv_data1/oa_pdf/ec/9d/bjc2015128a.PMC4430717.pdf
http://www.figo.org/publications.,Non-OADS,/arxiv_data1/oa_pdf/ec/fd/bjc2015137a.PMC4430720.pdf
http://ctep.cancer.gov.,Non-OADS,/arxiv_data1/oa_pdf/ec/fd/bjc2015137a.PMC4430720.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Optimizing CIGB-300 intralesional delivery 1642 www.bjcancer.com | DOI:10.1038/bjc.2015.137,Non-OADS,/arxiv_data1/oa_pdf/ec/fd/bjc2015137a.PMC4430720.pdf
IKNL (2014) Available at http://www.cijfersoverkanker.nl (accessed 6 October 2014).,Non-OADS,/arxiv_data1/oa_pdf/8f/40/bjc2015138a.PMC4430721.pdf
NCCN Guidelines Version 3 (2014) Available at http://www.NCCN.com (accessed 25 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/8f/40/bjc2015138a.PMC4430721.pdf
"NZA (2014) Available at http://www.nza.nl (accessed 17 June 2014).Pennant M, Takwoingi Y, Pennant L, Davenport C, Fry-Smith A, Eisinga A, Andronis L, Arvanitis T, Deeks J, Hyde C (2010) A systematic review ofpositron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancerrecurrence.",Non-OADS,/arxiv_data1/oa_pdf/8f/40/bjc2015138a.PMC4430721.pdf
RIVM report (2012) Available at http://www.gezondheidszorgbalans.nl/ kosten/zorguitgaven/totale-zorguitgaven/ (accessed January 2013).,OADS,/arxiv_data1/oa_pdf/8f/40/bjc2015138a.PMC4430721.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/08/main.PMC4430722.pdf
Direct link to deposited data The deposited data can be found at: http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE64215 .Genomics Data 4 (2015) 148 –149 ⁎Corresponding author at: Div.,OADS,/arxiv_data1/oa_pdf/02/08/main.PMC4430722.pdf
The Encore Biotin Module (NuGEN) chemically fragmented http://dx.doi.org/10.1016/j.gdata.2015.04.011 2213-5960/© 2015 The Authors.,OADS,/arxiv_data1/oa_pdf/02/08/main.PMC4430722.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/08/main.PMC4430722.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/02/08/main.PMC4430722.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/dc/main.PMC4430723.pdf
"Methods Survey data Data were drawn from the 2010 Behavioral Risk Factor Surveillance System (BRFSS), a national survey conducted by the Centers for Disease Control ( http://www.cds.gov/brfss ).",OADS,/arxiv_data1/oa_pdf/82/dc/main.PMC4430723.pdf
http://dx.doi.org/10.1016/j.pmedr.2015.04.004 2211-3355/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/82/dc/main.PMC4430723.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/dc/main.PMC4430723.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/82/dc/main.PMC4430723.pdf
"1Epidemiology and HealthEpidemiology and Health Volume: 37, Article ID: e2015006, 7 pages  http://dx.doi.org/10.4178/epih/e2015006   HEALTH STATISTICS Open Access Stomach cancer incidence rates among Americans, Asian  Americans and Native Asians from 1988 to 2011 Yeerae Kim*, Jinju Park*, Byung-Ho Nam, Moran Ki Department of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea Stomach cancer is the second most common cancer in Eastern Asia, accounting for approximately 50% of all  new cases of stomach cancer worldwide.",Non-OADS,/arxiv_data1/oa_pdf/be/34/epih-37-e2015006.PMC4430761.pdf
"Received:  Jan 8, 2015, Accepted:  Feb 16, 2015, Published:  Feb 16, 2015 This article is available from: http://e-epih.org/  2015, Korean Society of Epidemiology  This is an open-access article distributed under the terms of the Creative Commons  Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits  unrestricted use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/34/epih-37-e2015006.PMC4430761.pdf
Available from: http://www.cancerre - searchuk.org/cancer-info/cancerstats/world/incidence/.,Non-OADS,/arxiv_data1/oa_pdf/be/34/epih-37-e2015006.PMC4430761.pdf
Available from: http://www.cdc.gov/mi - norityhealth/populations/REMP/asian.html.,Non-OADS,/arxiv_data1/oa_pdf/be/34/epih-37-e2015006.PMC4430761.pdf
"Available from: http://kosis.kr/statHtml/statHt - ml.do?orgId=117&tblId=DT_117N_A00022&conn_path=I3 (Kore - an, author’s translation).",OADS,/arxiv_data1/oa_pdf/be/34/epih-37-e2015006.PMC4430761.pdf
Available from: http://newsoffice.mit.,Non-OADS,/arxiv_data1/oa_pdf/be/34/epih-37-e2015006.PMC4430761.pdf
Available  from: http://www.nosmokeguide.or.kr/mbs/nosmokeguide/subview.,Non-OADS,/arxiv_data1/oa_pdf/be/34/epih-37-e2015006.PMC4430761.pdf
Available from:  http://www.jt.com/media/press_releases/2014/0730_01.html.,Non-OADS,/arxiv_data1/oa_pdf/be/34/epih-37-e2015006.PMC4430761.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/be/34/epih-37-e2015006.PMC4430761.pdf
Available  from: http://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_ data/cig_smoking/.,OADS,/arxiv_data1/oa_pdf/be/34/epih-37-e2015006.PMC4430761.pdf
Available from: http://www.wpro.who.int/china/mediacentre/ factsheets/tobacco/en/.,Non-OADS,/arxiv_data1/oa_pdf/be/34/epih-37-e2015006.PMC4430761.pdf
"1Epidemiology and HealthEpidemiology and Health Volume: 37, Article ID: e2015013, 10 pages  http://dx.doi.org/10.4178/epih/e2015013   LECTUREOpen Access Calculation of smoking rates by dong/eup/myeon unit using  small-area estimation in the Community Health Survey Kay O Lee1, Jong Seok Byun2, Yang Wha Kang3, Yun Sil Ko3, Hyo Jin Kim3 1Gallup Korea, Seoul; 2Department of Applied Statistics, Hanshin University, Osan; 3Division of Chronic Disease Control, Korea Centers for  Disease Control and Prevention, Cheongju, Korea Correspondence:  Kay O Lee Gallup Korea, 70 Sajik-ro, Jongno-gu, Seoul 110-054, Korea Tel: +82-2-3702-2582, Fax: +82-2-3702-2628, Email: kolee575@hanmail.net Received:  Jan 22, 2015, Accepted:  Mar 2, 2015, Published:  Mar 2, 2015 This article is available from: http://e-epih.org/  2015, Korean Society of Epidemiology  This is an open-access article distributed under the terms of the Creative Commons  Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits  unrestricted use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION  The Korean Community Health Survey (CHS), a community- based nationwide annual survey with the objective of provid - ing important health indicators, is conducted through stratified  cluster sampling and computer-assisted personal interviewing.",Non-OADS,/arxiv_data1/oa_pdf/a7/19/epih-37-e2015013.PMC4430763.pdf
CONFLICT OF INTEREST The authors have no conflicts of interest to declare for this  study.SUPPLEMENTARY MATERIAL Supplementary material is available at http://www.e-epih.org/.,Non-OADS,/arxiv_data1/oa_pdf/a7/19/epih-37-e2015013.PMC4430763.pdf
"ACKNOWLEDGMENTS This work was supported by National Basic Research Program of China  (grant numbers 2013CB967401; http://www.most.gov.cn) and the National  Nature Science Foundation of China (grant numbers 81370675, 81200472  and 81421061; http://www.nsfc.gov.cn), and Shanghai Jiao Tong University  Medicine-Engineering Fund (grant numberYG2013ZD04; http://www.sjtu.",Non-OADS,/arxiv_data1/oa_pdf/29/32/AJA-17-347.PMC4430931.pdf
Available from: http://www.cancergenome.nih.gov/.,Non-OADS,/arxiv_data1/oa_pdf/c0/34/AJA-17-373.PMC4430935.pdf
"Because of diurnal variation, blood samples for measuring T are  taken before 10:00 am.27,34 Based on levels of total T and SHBG, free and  bioavailable T can be calculated (http://www.issam.ch/freetesto.htm).",Non-OADS,/arxiv_data1/oa_pdf/fd/6c/AJA-17-459.PMC4430952.pdf
"Men with NOA have a mean of 0–3 mature spermatids per  seminiferous tubule, thus explaining why rare sperm are occasionally  found in ejaculates.5,11 The technical details of how we perform micro- TESE can be found elsewhere (http://www.brazjurol.com.br/videos/ may_june_2013/Esteves_440_441video.htm).42 LABORATORY HANDLING OF RETRIEVED GAMETES AND  EMBRYOS After SR, testicular parenchyma is transferred to the IVF laboratory  for tissue processing and sperm search.",Non-OADS,/arxiv_data1/oa_pdf/fd/6c/AJA-17-459.PMC4430952.pdf
Available from: http://www.ClinicalTrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/c0/ed/AJA-17-471.PMC4430953.pdf
Available from: http://www.ClinicalTrials.,Non-OADS,/arxiv_data1/oa_pdf/c0/ed/AJA-17-471.PMC4430953.pdf
Available from: http://www.ClinicalTrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/c0/ed/AJA-17-471.PMC4430953.pdf
Available from:  http://www.ClinicalTrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/c0/ed/AJA-17-471.PMC4430953.pdf
Available from: http://www.ClinicalTrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/c0/ed/AJA-17-471.PMC4430953.pdf
Average fluorescent intensity was measured  for every nucleus in the field and averaged for the field with an image  analyzer system (National Institutes of Health Image J 1.34; Internet:  http://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/a3/ef/AJA-17-487.PMC4430956.pdf
SOPMA (http://npsa-pbil.ibcp.fr/cgi-bin/npsa_ automat.pl?page = npsa_sopma.html) and Polyphen (http://genetics.,Non-OADS,/arxiv_data1/oa_pdf/bc/90/AJA-17-509.PMC4430961.pdf
"Until date, more than 1000 AR mutations have been annotated  in the AR gene mutation database (http://www.androgendb.mcgill.",OADS,/arxiv_data1/oa_pdf/bc/90/AJA-17-509.PMC4430961.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/3b/main.PMC4431027.pdf
An oesophagectomy was performed via a vertical midline inci- sion with bilateral subcostal extensions for the abdominal phase.A postero-lateral thoracotomy was carried out for the thoracic http://dx.doi.org/10.1016/j.ijscr.2015.02.023 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/58/3b/main.PMC4431027.pdf
"7 (1) (2009)61, http://dx.doi.org/10.1186/1477 7819-7-61 .",Non-OADS,/arxiv_data1/oa_pdf/58/3b/main.PMC4431027.pdf
"Cancer 97 (March (3)) (2010) E16–E22,http://dx.doi.org/10.1684/bdc.2010.1041 .",Non-OADS,/arxiv_data1/oa_pdf/58/3b/main.PMC4431027.pdf
"(2013),http://dx.doi.org/10.1111/ans.12429 , December 11.",Non-OADS,/arxiv_data1/oa_pdf/58/3b/main.PMC4431027.pdf
"20 (September (9)) (2013) 2937–2943,http://dx.doi.org/10.1245/s10434-013-3013-7 , Epub 2013 June 13.",Non-OADS,/arxiv_data1/oa_pdf/58/3b/main.PMC4431027.pdf
"88(August (2)) (2010) 69–80, http://dx.doi.org/10.1016/j.ciresp.2010.01.007 , Epub 2010 May 24.",OADS,/arxiv_data1/oa_pdf/58/3b/main.PMC4431027.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S164Preliminary documentation of the comparable efficacy of vitoss  versus NanOss bioactive as bone graft expanders for posterior  cervical fusion Nancy E. Epstein Chief of Neurosurgical Spine and Education, Department of Neuro Science, Winthrop University Hospital, Mineola, NY 11501, USA E‑mail: *Nancy E. Epstein ‑ nancy.epsteinmd@gmail.com   *Corresponding author Received: 18 January 15   Accepted: 19 January 15  Published: 07 May 15 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.156559  Quick Response Code: Abstract Background:  Laminectomies with posterior cervical instrumented fusions  often utilize bone graft expanders to supplement cervical lamina/iliac crest  autograft/bone marrow aspirate (BMA).",Non-OADS,/arxiv_data1/oa_pdf/3b/9a/SNI-6-164.PMC4431045.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/5/164/156559 Copyright: © 2015 Epstein NE.,Non-OADS,/arxiv_data1/oa_pdf/3b/9a/SNI-6-164.PMC4431045.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S140Diagnosis and management of traumatic cervical central spinal  cord injury: A  review Nancy E. Epstein, Renee Hollingsworth Department of NeuroScience, Winthrop University Hospital, Mineola, NY 11501, USA E‑mail: *Nancy E. Epstein ‑ nancy.epsteinmd@gmail.com; Renee.",Non-OADS,/arxiv_data1/oa_pdf/ec/df/SNI-6-140.PMC4431046.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/5/140/156552 Copyright: © 2015 Epstein NE.,Non-OADS,/arxiv_data1/oa_pdf/ec/df/SNI-6-140.PMC4431046.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S244Posterior atlantoaxial fixation: A cadaveric and fluoroscopic  step‑by‑step technical guide Kamran Sattarov , Jesse Skoch, Salman Abbasifard, Apar S. Patel, Mauricio J. Avila,   Christina M. Walter, Ali A. Baaj Department of Surgery, Division of Neurosurgery, University of Arizona Medical Center, 1501 N. Campbell Ave. Tucson, Arizona, 85724, USA  E‑mail:  Kamran Sattarov ‑ dr.sattarov@gmail.com; Jesse Skoch ‑ jesse@seekaltroute.com; Salman Abbasifard ‑ abbasifard@email.arizona.edu;   Apar S. Patel ‑ apatel80@jhu.edu; Mauricio J. Avila ‑ avila.mao@gmail.com; Christina M. Walter ‑ chrismw@surgery.arizona.edu;   *Ali A. Baaj ‑ abaaj@surgery.arizona.edu   *Corresponding author Received: 22 January 15  Accepted: 23 February 15  Published: 07 May 15 INTRODUCTION Atlantoaxial fixation is an effective treatment  modality for instability caused by trauma, rheumatoid  arthritis, congenital anomalies, and a myriad of other  pathologies.",Non-OADS,/arxiv_data1/oa_pdf/aa/2a/SNI-6-244.PMC4431047.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/5/244/156611 Copyright: © 2015 Sattarov K. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,   distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/aa/2a/SNI-6-244.PMC4431047.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S186Operative costs, reasons for operative waste, and vendor credit  replacement in spinal surgery Nancy E. Epstein, Rita Roberts1, John Collins2 Department of NeuroScience, Chief of Neurosurgical Spine and Education, 1Vice President Operative Services, 2Chief Executive Officer, Winthrop University  Hospital, Mineola, NY 11501, USA E‑mail: *Nancy E. Epstein ‑ nancy.epsteinmd@gmail.com; Rita Roberts ‑ rroberts@winthrop.org; John Collins ‑ jcollins@winthrop.org   *Corresponding author Received: 28 November 14   Accepted: 02 December 14   Published: 07 May 15 Abstract Background: In 2012, Epstein et al.",Non-OADS,/arxiv_data1/oa_pdf/34/6e/SNI-6-186.PMC4431048.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/5/186/156574 Copyright: © 2015 Epstein NE.,Non-OADS,/arxiv_data1/oa_pdf/34/6e/SNI-6-186.PMC4431048.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S240Does lumbar paraspinal muscle fatty degeneration correlate with  aerobic index and Oswestry disability index?",Non-OADS,/arxiv_data1/oa_pdf/42/61/SNI-6-240.PMC4431049.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/5/240/156606 Copyright: © 2015 Prasarn ML.,Non-OADS,/arxiv_data1/oa_pdf/42/61/SNI-6-240.PMC4431049.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S172Tisseel does not reduce postoperative drainage, length of stay,  and transfusion requirements for lumbar laminectomy with  noninstrumented fusion versus laminectomy alone Nancy E. Epstein Chief of Neurosurgical Spine and Education, Department of Neuro Science, Winthrop University Hospital, Mineola, NY 11501, USA E‑mail: *Nancy E. Epstein ‑ nancy.epsteinmd@gmail.com   *Corresponding author Received: 17 February 15  Accepted: 19 February 15  Published: 07 May 15 Abstract Background:  Typically, fibrin sealants (FSs) and fibrin glues (FGs) are used to  strengthen dural repairs during spinal surgery.",Non-OADS,/arxiv_data1/oa_pdf/4d/54/SNI-6-172.PMC4431050.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/5/172/156561 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.156561  Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/4d/54/SNI-6-172.PMC4431050.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S177Resection of an Occipital–Cervical Junction Schwannoma  through a modified minimally invasive approach: Technical Note Michael Feldman, Kristopher T .",Non-OADS,/arxiv_data1/oa_pdf/6e/1e/SNI-6-177.PMC4431051.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/5/177/156566 Copyright: © 2015 Feldman M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/6e/1e/SNI-6-177.PMC4431051.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S236CT‑based morphometric analysis of C1 laminar dimensions: C1  translaminar screw fixation is a feasible technique for salvage of  atlantoaxial fusions Andrew Yew, Derek Lu, Daniel C. Lu Department of Neurosurgery, University of California, Los Angeles, CA, USA E‑mail: Andrew Yew ‑ andrewyew@mednet.ucla.edu; Derek Lu ‑ DSLu@mednet.ucla.edu; *Daniel C. Lu ‑ dclu@mednet.ucla.edu   *Corresponding author Received: 20 October 14  Accepted: 20 December 14  Published: 07 May 15 Abstract Background:  Translaminar screw fixation has become an alternative in the fixation  of the axial and subaxial cervical spine.",Non-OADS,/arxiv_data1/oa_pdf/d2/26/SNI-6-236.PMC4431052.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/5/236/156603 Copyright: © 2015 Yew A.,Non-OADS,/arxiv_data1/oa_pdf/d2/26/SNI-6-236.PMC4431052.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S190Clinical and surgical outcomes after lumbar laminectomy: An  analysis of 500 patients Mohamad Bydon1,2,*, Mohamed Macki1,2,*, Nicholas B. Abt1,2, Daniel M. Sciubba1,  Jean‑Paul Wolinsky1, Timothy F .",Non-OADS,/arxiv_data1/oa_pdf/f4/ba/SNI-6-190.PMC4431053.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/5/190/156578 Copyright: © 2015 Bydon M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/f4/ba/SNI-6-190.PMC4431053.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S154C5 Nerve root palsies following cervical spine surgery:  A review Nancy E. Epstein, Renee Hollingsworth Department of NeuroScience, Winthrop University Hospital, Mineola, NY 11501, USA E‑mail: *Nancy E. Epstein ‑  nancy.epsteinmd@gmail.com; Renee Hollingsworth ‑ rhollingsworth@winthrop.org   *Corresponding author Received: 29 December 14  Accepted: 31 December 14  Published: 07 May 15 Abstract Background: Cervical C5 nerve root palsies may occur in between 0% and  30% of routine anterior or posterior cervical spine operations.",Non-OADS,/arxiv_data1/oa_pdf/4d/1e/SNI-6-154.PMC4431054.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/5/154/156556 Copyright: © 2015 Epstein NE.,Non-OADS,/arxiv_data1/oa_pdf/4d/1e/SNI-6-154.PMC4431054.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S182Solid variant of aneurysmal bone cyst presenting as a giant  cervical mass: A clinical, radiological, histopathological dilemma Amey R. Savardekar, Deviprasad Patra, Debajyoti Chatterjee1, Chirag K. Ahuja2, Pravin Salunke Departments of Neurosurgery, 1Pathology, and 2Radiology, Post‑graduate Institute of Medical Education and Research, Chandigarh, India E‑mail: *Amey R. Savardekar ‑  ameysavardekar@gmail.com; Deviprasad Patra ‑  devosy4ever@gmail.com; Debajyoti Chatterjee ‑  devchat1984@gmail.com;   Chirag K Ahuja ‑  chiragkahuja@gmail.com; Pravin Salunke ‑  drpravinsalunke@yahoo.co.uk   *Corresponding author Received: 05 November 14  Accepted: 28 November 14  Published: 07 May 15 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.156570  Quick Response Code: Abstract Background: Typical aneurysmal bone cysts (ABCs) are osteolytic, multicystic  lesions with parietal sclerosis and blood‑filled cysts.",Non-OADS,/arxiv_data1/oa_pdf/01/c9/SNI-6-182.PMC4431055.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/5/182/156570 Copyright: © 2015 Savardekar AR.,Non-OADS,/arxiv_data1/oa_pdf/01/c9/SNI-6-182.PMC4431055.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S137Complications corner: Anterior thoracic disc surgery with dural  tear/CSF fistula and low‑pressure pleural drain led to severe  intracranial hypotension Eline A. Oudeman1,2, Rishi D. S. Nandoe Tewarie1,3, G. Joost Jöbsis4, Mark P .",Non-OADS,/arxiv_data1/oa_pdf/b1/a4/SNI-6-137.PMC4431056.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/5/137/156544,Non-OADS,/arxiv_data1/oa_pdf/b1/a4/SNI-6-137.PMC4431056.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S194Comparison of the efficacy of saline, local anesthetics, and  steroids in epidural and facet joint injections for the management  of spinal pain: A  systematic review of randomized controlled trials Laxmaiah Manchikanti, Devi E. Nampiaparampil1, Kavita N. Manchikanti2, Frank J.E.",Non-OADS,/arxiv_data1/oa_pdf/e2/4e/SNI-6-194.PMC4431057.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/5/194/156598 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.156598  Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/e2/4e/SNI-6-194.PMC4431057.pdf
Available from: http://canadiantaskforce.ca/wp‑content/ uploads/2014/03/Procedure‑Manual‑2014‑v2‑0FINAL.pdf/?414ed1 [Last  accessed on 2015 Jan 27].,Non-OADS,/arxiv_data1/oa_pdf/e2/4e/SNI-6-194.PMC4431057.pdf
Available  from: http://www.americanpainsociety.org/uploads/pdfs/LBPEvidRev.pdf [Last  accessed on 2015 Jan 27].,Non-OADS,/arxiv_data1/oa_pdf/e2/4e/SNI-6-194.PMC4431057.pdf
Available from: http://www.fda.gov/downloads/Drugs/DrugSafety/ UCM394286.pdf [Last accessed on   2015 Jan 27].,Non-OADS,/arxiv_data1/oa_pdf/e2/4e/SNI-6-194.PMC4431057.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 007378).,Non-OADS,/arxiv_data1/oa_pdf/a8/ef/bmjopen-2014-007378.PMC4431058.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a8/ef/bmjopen-2014-007378.PMC4431058.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7a/39/bmjopen-2014-007428.PMC4431060.pdf
http://www.acg.jhsph.edu 35.,Non-OADS,/arxiv_data1/oa_pdf/7a/39/bmjopen-2014-007428.PMC4431060.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-007387).,Non-OADS,/arxiv_data1/oa_pdf/4c/5f/bmjopen-2014-007387.PMC4431062.pdf
Data sharing statement Additional data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.hr7k2.,OADS,/arxiv_data1/oa_pdf/4c/5f/bmjopen-2014-007387.PMC4431062.pdf
"Cochrane handbook for systematic reviews of interventions Version 5.1.0 [Updated March 2011] .T h e Cochrane Collaboration, 2011. http://www.cochrane-handbook.org 31.",OADS,/arxiv_data1/oa_pdf/4c/5f/bmjopen-2014-007387.PMC4431062.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-006814).,Non-OADS,/arxiv_data1/oa_pdf/ad/d8/bmjopen-2014-006814.PMC4431064.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006539).,Non-OADS,/arxiv_data1/oa_pdf/88/7e/bmjopen-2014-006539.PMC4431065.pdf
2004. http://www.hc-sc.gc.ca/hcs-sss/home-domicile/longdur/index-eng.php 25.,Non-OADS,/arxiv_data1/oa_pdf/88/7e/bmjopen-2014-006539.PMC4431065.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006816).,Non-OADS,/arxiv_data1/oa_pdf/fa/00/bmjopen-2014-006816.PMC4431066.pdf
http://publications.gc.ca/collections/collection_2007/hc-sc/H164-9-2006E.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/fa/00/bmjopen-2014-006816.PMC4431066.pdf
http://www.prescrire.org/docus/HowReviewsProduced.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/fa/00/bmjopen-2014-006816.PMC4431066.pdf
http://www.pmprb-cepmb.gc.ca/view.asp?ccid=492-1637 6 Lexchin J. BMJ Open 2015; 5:e006816.,Non-OADS,/arxiv_data1/oa_pdf/fa/00/bmjopen-2014-006816.PMC4431066.pdf
http://english.prescrire.org/en/81/168/46800/0/NewsDetails.aspx 8.,Non-OADS,/arxiv_data1/oa_pdf/fa/00/bmjopen-2014-006816.PMC4431066.pdf
http://www.whocc.no/atcddd/ 11.,Non-OADS,/arxiv_data1/oa_pdf/fa/00/bmjopen-2014-006816.PMC4431066.pdf
http://www.hc-sc.gc.,Non-OADS,/arxiv_data1/oa_pdf/fa/00/bmjopen-2014-006816.PMC4431066.pdf
http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/DrugandBiologicApprovalReports/NDAandBLAApprovalReports/ucm373420.htm 15.,Non-OADS,/arxiv_data1/oa_pdf/fa/00/bmjopen-2014-006816.PMC4431066.pdf
http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/DrugandBiologicApprovalReports/UCM123959.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/fa/00/bmjopen-2014-006816.PMC4431066.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008097).,Non-OADS,/arxiv_data1/oa_pdf/d9/de/bmjopen-2015-008097.PMC4431067.pdf
"Participants in both groups will complete food records for 3 days (two weekdays and one weekend day) which will be analysed to assess for dietary de ﬁciencies or imbal- ances, using a nutritional database software program(ESHA, http://www.esha.com), as well as gluten content.",Non-OADS,/arxiv_data1/oa_pdf/d9/de/bmjopen-2015-008097.PMC4431067.pdf
This article provides guidance towards the design of the CD-DIET study (http://www.celiacanddiabetes.com)with detailed descriptions of outcome measurements and instruments that will be used at each step of screening and dietary intervention phases.,Non-OADS,/arxiv_data1/oa_pdf/d9/de/bmjopen-2015-008097.PMC4431067.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-007413).,Non-OADS,/arxiv_data1/oa_pdf/db/1b/bmjopen-2014-007413.PMC4431068.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 007375).,Non-OADS,/arxiv_data1/oa_pdf/c3/c7/bmjopen-2014-007375.PMC4431069.pdf
"Atlanta, GA: US Department of Health and Human Services, 2014. http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf (accessed 15 Aug 2014).",Non-OADS,/arxiv_data1/oa_pdf/c3/c7/bmjopen-2014-007375.PMC4431069.pdf
Comparing medications for adults with type 2 diabetes.http://www.effectivehealthcare.ahrq.gov/ehc/products/155/720/ECBCM_Oral%20Meds%20T2%20Diab_Clinician06282011.pdf(accessed 7 Oct 2014).,Non-OADS,/arxiv_data1/oa_pdf/c3/c7/bmjopen-2014-007375.PMC4431069.pdf
http://www.ngsp.org/ADA.asp (accessed10 Oct 2014).,OADS,/arxiv_data1/oa_pdf/c3/c7/bmjopen-2014-007375.PMC4431069.pdf
http://care.diabetesjournals.org/content/37/Supplement_1/S14.full (accessed 17 Sep 2014).,Non-OADS,/arxiv_data1/oa_pdf/c3/c7/bmjopen-2014-007375.PMC4431069.pdf
http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html#Interpreted(accessed 29 Oct 2014).,Non-OADS,/arxiv_data1/oa_pdf/c3/c7/bmjopen-2014-007375.PMC4431069.pdf
Updated July 2014. https://www.icsi.org/_asset/ 3rrm36/diabetes-interactive0412.pdf (accessed 2 Oct 2014).,Non-OADS,/arxiv_data1/oa_pdf/c3/c7/bmjopen-2014-007375.PMC4431069.pdf
http://meps.ahrq.gov/mepsweb/data_files/publications/rf30/rf30.pdf (accessed 14 Aug 2014).,OADS,/arxiv_data1/oa_pdf/c3/c7/bmjopen-2014-007375.PMC4431069.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007249).,Non-OADS,/arxiv_data1/oa_pdf/8e/58/bmjopen-2014-007249.PMC4431071.pdf
"Secondary health effects of cigarette smoking , 2013. http://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoking/index.htm 2.",Non-OADS,/arxiv_data1/oa_pdf/8e/58/bmjopen-2014-007249.PMC4431071.pdf
"Secondary health benefits of cessation , 2013. http://www.cdc.gov/tobacco/data_statistics/fact_sheets/cessation/quitting/index.",Non-OADS,/arxiv_data1/oa_pdf/8e/58/bmjopen-2014-007249.PMC4431071.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-007590).,Non-OADS,/arxiv_data1/oa_pdf/f3/ee/bmjopen-2015-007590.PMC4431123.pdf
http://dx.doi.org/ 10.1002/0470867922.ch3 59.,Non-OADS,/arxiv_data1/oa_pdf/f3/ee/bmjopen-2015-007590.PMC4431123.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006588).,Non-OADS,/arxiv_data1/oa_pdf/60/c4/bmjopen-2014-006588.PMC4431124.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006798).,Non-OADS,/arxiv_data1/oa_pdf/54/b2/bmjopen-2014-006798.PMC4431125.pdf
doi:10.1136/ bmjopen-2015-007884 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-007884).,Non-OADS,/arxiv_data1/oa_pdf/98/e7/bmjopen-2015-007884.PMC4431126.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007533).,Non-OADS,/arxiv_data1/oa_pdf/e7/e7/bmjopen-2014-007533.PMC4431129.pdf
Secondary why A&E departments are fighting for their life 2014.http://www.theguardian.com/commentisfree/2014/jan/14/emergency- departments-fighting-for-life-nhs-marketisation 6.,Non-OADS,/arxiv_data1/oa_pdf/e7/e7/bmjopen-2014-007533.PMC4431129.pdf
Secondary Facts and figures 2011. http://www.nhsdirect.nhs.uk/News/FactsAndFigures?name=FactsAndFiguresAboutNHSDirect 8.,Non-OADS,/arxiv_data1/oa_pdf/e7/e7/bmjopen-2014-007533.PMC4431129.pdf
2008. http://www.nlm.nih.gov/mesh/ 18.,OADS,/arxiv_data1/oa_pdf/e7/e7/bmjopen-2014-007533.PMC4431129.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 006666).,Non-OADS,/arxiv_data1/oa_pdf/f9/f5/bmjopen-2014-006666.PMC4431130.pdf
The generation of evi-dence is made possible because patientsStrengths and limitations of this study ▪Comprehensive set of evidence-informed recom- mendations aimed at reducing disseminationbias based on work conducted as part of European Union FP7 project (Overcome failure to Publish nEgative fiNdings (OPEN) project; http://www.open-project.eu).,Non-OADS,/arxiv_data1/oa_pdf/f9/f5/bmjopen-2014-006666.PMC4431130.pdf
"3This problem has been called ‘publication bias ’,4or—as more recently sug- gested —‘dissemination bias ’,t or e ﬂect the multiple facets of this problem.56Dissemination bias has recently received attention due to initiatives such as the AllTrials campaign (http://www.alltrials.net7) and the RIAT pro- posal,8the discussion of oseltamivir in the context of avian in ﬂuenza,9and announcements from companies, for example, GlaxoSmithKline, to grant access to patient-level data from all company trials.10However, general awareness of this problem and, even more importantly, the necessity to address and resolve it, has presumably not yet been fully recognised by manystakeholders.",Non-OADS,/arxiv_data1/oa_pdf/f9/f5/bmjopen-2014-006666.PMC4431130.pdf
"The European Union has committed funds to two pro-jects, Overcome failure to Publish nEgative ﬁNdings (OPEN; http://www.open-project.eu) 11and UNCOVER (http://www.ait.ac.at/uncover), supported within theSeventh Framework Program.",Non-OADS,/arxiv_data1/oa_pdf/f9/f5/bmjopen-2014-006666.PMC4431130.pdf
"Different work packages of OPEN have sur-veyed representatives of funding agencies, the pharma- ceutical industry, research ethics committees, research institutions, researchers, 15trial registers,16medical jour- nals,17regulatory agencies and bene ﬁt (health technol- ogy) assessment agencies such as NICE in the UK (http://www.nice.org.uk) and IQWiG in Germany(http://www.iqwig.de).",Non-OADS,/arxiv_data1/oa_pdf/f9/f5/bmjopen-2014-006666.PMC4431130.pdf
More detailed rationales as well as related assessments based on ourdecision tables for these targeted recommendations will be discussed more extensively in forthcoming articles and will be made available through the OPEN website(http://www.open-project.eu).,Non-OADS,/arxiv_data1/oa_pdf/f9/f5/bmjopen-2014-006666.PMC4431130.pdf
As recently raised by Doshi et al 8as well as by the AllTrials campaign (http://www.alltrials.,Non-OADS,/arxiv_data1/oa_pdf/f9/f5/bmjopen-2014-006666.PMC4431130.pdf
"Competing interests All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi_disclosure.pdf and declare: the OPEN project has received funding from the European Union under grantagreement number 285453; Davina Ghersi reports being the Chair of the WHO Advisory Panel on the International Clinical Trials Registry Platform; JK reports grants from Amgen, GSK, Sanofi, Biomarin, MSD, Roche and Bayer outside the submitted work; JJM reports being a member of the WHO Advisory Panel on the International Clinical Trials Registry Platform; AR is astaff member of the WHO - the author alone is responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the WHO; EW reports training and consultancy activities for various companies and publishers, and training activities for various universities; Robert Wolff reports grants from Amgen, GSK, Sanofi, Biomarin,MSD, Roche and Bayer outside the submitted work.",Non-OADS,/arxiv_data1/oa_pdf/f9/f5/bmjopen-2014-006666.PMC4431130.pdf
"Chichester, UK: John Wiley & Sons, Ltd, 2011. http://www.cochrane-handbook.org 26.",Non-OADS,/arxiv_data1/oa_pdf/f9/f5/bmjopen-2014-006666.PMC4431130.pdf
2014. http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32014R0536&from=EN (accessed 5 Jun 2014).,Non-OADS,/arxiv_data1/oa_pdf/f9/f5/bmjopen-2014-006666.PMC4431130.pdf
"http://www.who.int/ictrp/en/ Meerpohl JJ, et al.BMJ Open 2015; 5:e006666.",OADS,/arxiv_data1/oa_pdf/f9/f5/bmjopen-2014-006666.PMC4431130.pdf
doi:10.1136/ bmjopen-2014-006840 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006840).,Non-OADS,/arxiv_data1/oa_pdf/13/3f/bmjopen-2014-006840.PMC4431131.pdf
2004. http://www.nice.org.uk/guidance/csgsp 5.,Non-OADS,/arxiv_data1/oa_pdf/13/3f/bmjopen-2014-006840.PMC4431131.pdf
http://www.ncbi.nlm.nih.gov/pubmed/11769298 17.,Non-OADS,/arxiv_data1/oa_pdf/13/3f/bmjopen-2014-006840.PMC4431131.pdf
2009. http://www.ncsi.org.uk/wp-content/uploads/Outcome-Measures-for-Evaluating-Cancer-Aftercare.pdf 18.,Non-OADS,/arxiv_data1/oa_pdf/13/3f/bmjopen-2014-006840.PMC4431131.pdf
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3906697&tool=pmcentrez&rendertype=abstract 25.,OADS,/arxiv_data1/oa_pdf/13/3f/bmjopen-2014-006840.PMC4431131.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006995).,Non-OADS,/arxiv_data1/oa_pdf/2f/de/bmjopen-2014-006995.PMC4431132.pdf
"For more information about the European collaborative INFECT project, please visit http://www.fp7infect.",Non-OADS,/arxiv_data1/oa_pdf/2f/de/bmjopen-2014-006995.PMC4431132.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/2f/de/bmjopen-2014-006995.PMC4431132.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006900).,Non-OADS,/arxiv_data1/oa_pdf/06/8f/bmjopen-2014-006900.PMC4431133.pdf
There are limits imposed on some services as described in the TAC treatment payment and other policy (avail-able via http://www.tac.vic.gov.au).,Non-OADS,/arxiv_data1/oa_pdf/06/8f/bmjopen-2014-006900.PMC4431133.pdf
2010. http://webarchive.nationalarchives.gov.uk/20101011032547/http://www.iegmp.org.uk/ report/clarification.htm (accessed 12 Oct 2014).,Non-OADS,/arxiv_data1/oa_pdf/e0/a0/bmjopen-2014-007302.PMC4431134.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-007220).,Non-OADS,/arxiv_data1/oa_pdf/f0/9d/bmjopen-2014-007220.PMC4431135.pdf
Information is available at http://www.checkpointLX.com.,OADS,/arxiv_data1/oa_pdf/f0/9d/bmjopen-2014-007220.PMC4431135.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f0/9d/bmjopen-2014-007220.PMC4431135.pdf
http://www.eurosurveillance.org/ ViewArticle.aspx?ArticleId=19414 23.,Non-OADS,/arxiv_data1/oa_pdf/f0/9d/bmjopen-2014-007220.PMC4431135.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 007553).,Non-OADS,/arxiv_data1/oa_pdf/b3/38/bmjopen-2014-007553.PMC4431136.pdf
"TRACE was available 4 nights per week through the secure platform of http://www.abilityonline.org, a website designed foryouth and young adults with chronic conditions and dis- abilities.",Non-OADS,/arxiv_data1/oa_pdf/b3/38/bmjopen-2014-007553.PMC4431136.pdf
Funding This work was supported by the Japan Society for the Promotion of Science ( JSPS) KAKENHI grant number 24390399 (https://kaken.nii.ac.jp/d/p/ 24390399.en.html).,Non-OADS,/arxiv_data1/oa_pdf/95/42/bmjopen-2015-007733.PMC4431137.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-006505).,Non-OADS,/arxiv_data1/oa_pdf/cc/c7/bmjopen-2014-006505.PMC4431138.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/cc/c7/bmjopen-2014-006505.PMC4431138.pdf
22 March 2013. http://www.fhi.no/artikler/?id=105586 25.,Non-OADS,/arxiv_data1/oa_pdf/7f/88/bmjopen-2014-007139.PMC4431139.pdf
Secondary Information for researchers and professionals about the Strengths & DifficultiesQuestionnaires 1 January 2012. http://www.sdqinfo.com/ 28.,Non-OADS,/arxiv_data1/oa_pdf/7f/88/bmjopen-2014-007139.PMC4431139.pdf
1 January 2008. http://www.ssb.no/english/subjects/04/90/nos_c751_en/nos_c751_en.pdf 31.,Non-OADS,/arxiv_data1/oa_pdf/7f/88/bmjopen-2014-007139.PMC4431139.pdf
2 January 2008. http://www.ssb.no/emner/05/01/nos_inntektformue/nos_d310/nos_d310.pdf 32.,Non-OADS,/arxiv_data1/oa_pdf/7f/88/bmjopen-2014-007139.PMC4431139.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-007930).,Non-OADS,/arxiv_data1/oa_pdf/d0/09/bmjopen-2015-007930.PMC4431140.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d0/09/bmjopen-2015-007930.PMC4431140.pdf
http://www.who.int/blindness/ GLOBALDATAFINALforweb.pdf 22.,Non-OADS,/arxiv_data1/oa_pdf/d0/09/bmjopen-2015-007930.PMC4431140.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007512).,Non-OADS,/arxiv_data1/oa_pdf/a9/c2/bmjopen-2014-007512.PMC4431142.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 007456).,Non-OADS,/arxiv_data1/oa_pdf/07/7d/bmjopen-2014-007456.PMC4431143.pdf
http://www.zorgstandaarddiabetes.nl/ (accessed 24 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/07/7d/bmjopen-2014-007456.PMC4431143.pdf
"Klomp MLF, Romeijnders ACM, de Braal E, et al.Transparent chain care, diabetes mellitus, COPD, CVRM reports of care groupsconcerning 2013, towards nuanced reporting of care [in Dutch]http://ineen.nl/wp-content/uploads/2014/11/1378392013wpdm_LOK-Landelijke-benchmark-DM-COPD-VRM-september-2013.pdf (accessed 1 Jun 2014).",Non-OADS,/arxiv_data1/oa_pdf/07/7d/bmjopen-2014-007456.PMC4431143.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007328).,Non-OADS,/arxiv_data1/oa_pdf/ce/62/bmjopen-2014-007328.PMC4431167.pdf
"We are unable to share the study database, but information related to it is available at (https://www.dur.ac.uk/wolfson.institute/geohealth/).",Non-OADS,/arxiv_data1/oa_pdf/ce/62/bmjopen-2014-007328.PMC4431167.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ce/62/bmjopen-2014-007328.PMC4431167.pdf
"London: The Marmot Review, 2010. http://www.instituteofhealthequity.org/projects/fair-society-healthy-lives-themarmot-review (accessed 13 Feb 2015).",Non-OADS,/arxiv_data1/oa_pdf/ce/62/bmjopen-2014-007328.PMC4431167.pdf
"Office for National Statistics, 2010. http://www.ons.gov.uk/ons/dcp171778_254061.pdf(accessed 13 Feb 2015).",Non-OADS,/arxiv_data1/oa_pdf/ce/62/bmjopen-2014-007328.PMC4431167.pdf
"The NHS Information Centre for Health and Social Care, 2011. http://www.ic.nhs.uk/pubs/smoking11(accessed 13 Feb 2015).",Non-OADS,/arxiv_data1/oa_pdf/ce/62/bmjopen-2014-007328.PMC4431167.pdf
"Department of Health, 2008. http://image.guardian.",Non-OADS,/arxiv_data1/oa_pdf/ce/62/bmjopen-2014-007328.PMC4431167.pdf
"London: The King ’s Fund, 2010. http://www.kingsfund.org.uk/sites/files/kf/field/ field_document/health-inequalities-general-practice-gp-inquiry- research-paper-mar11.pdf (accessed 13 Feb 2015).",Non-OADS,/arxiv_data1/oa_pdf/ce/62/bmjopen-2014-007328.PMC4431167.pdf
http://www.pharmacyregulation.org/ (accessed 13 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/ce/62/bmjopen-2014-007328.PMC4431167.pdf
http://www.ons.gov.uk/ons/ guide-method/geography/products/area-classifications/rural-urban-definition-and-la/rural-urban-definition —england-and-wales-/index.,Non-OADS,/arxiv_data1/oa_pdf/ce/62/bmjopen-2014-007328.PMC4431167.pdf
https://www.dur.ac.,Non-OADS,/arxiv_data1/oa_pdf/ce/62/bmjopen-2014-007328.PMC4431167.pdf
Duffin C. Two-week wait for GP appointments to become the norm in many practices ‘within a year ’.Pulse Today Published Online First: 20 May 2014. http://www.pulsetoday.co.uk/your-practice/practice-topics/access/two-week-wait-for-gp-appointments-to-become-the-norm-in-many-practices-within-a-year/20006739.article(accessed 13 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/ce/62/bmjopen-2014-007328.PMC4431167.pdf
http://www.pharmaceutical-journal.,Non-OADS,/arxiv_data1/oa_pdf/ce/62/bmjopen-2014-007328.PMC4431167.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006818).,Non-OADS,/arxiv_data1/oa_pdf/92/e9/bmjopen-2014-006818.PMC4431168.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/92/e9/bmjopen-2014-006818.PMC4431168.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-006920).,Non-OADS,/arxiv_data1/oa_pdf/94/d2/bmjopen-2014-006920.PMC4431169.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-007589).,Non-OADS,/arxiv_data1/oa_pdf/6e/cd/bmjopen-2015-007589.PMC4431170.pdf
Further details of data collection and man- agement procedures are available on the survey website(http://www.censusindia.gov.in/2011-Common/AHSurvey.,OADS,/arxiv_data1/oa_pdf/6e/cd/bmjopen-2015-007589.PMC4431170.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 007397).,Non-OADS,/arxiv_data1/oa_pdf/b6/9f/bmjopen-2014-007397.PMC4431171.pdf
used the RAST web pipeline (http://rast.nmpdr.org/)14 and the PHAST tools.15 Resequencing of DNA from 46 K. pneumoniae isolates was performed by applying Illumina technology (see online supplementary methods).,OADS,/arxiv_data1/oa_pdf/b6/9f/bmjopen-2014-007397.PMC4431171.pdf
Sequence data were submittedto the Sequence Read Archive at NCBI (BioProject PRJNA 235888; http://www.ncbi.nlm.nih.gov/sra).,OADS,/arxiv_data1/oa_pdf/b6/9f/bmjopen-2014-007397.PMC4431171.pdf
"We then estimated evolutionary rates and diver- gence dates from an alignment of genome sequence dates with the isolates ’recovery dates, by using BEAST V .1.7.4 (http://beast.bio.ed.ac.uk; see online supplemen- tary methods).",OADS,/arxiv_data1/oa_pdf/b6/9f/bmjopen-2014-007397.PMC4431171.pdf
"Materials and methods Vector monitoring programmes in Austria andSwitzerland In both countries, Austria and Switzerland, the national vector monitoring programmes were established in accordance with EUregulation 1266/2007 (http://eurlex.europa.eu) to investigate the occurrence and geographical distribution of midges in Europeancountries.",Non-OADS,/arxiv_data1/oa_pdf/67/a1/vetrec-2014-102979.PMC4431321.pdf
To view please visit the journal (http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/67/a1/vetrec-2014-102979.PMC4431321.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ References ANDER, M., MEISWINKEL, R. & CHIRICO, J.",Non-OADS,/arxiv_data1/oa_pdf/67/a1/vetrec-2014-102979.PMC4431321.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2013-205060).,OADS,/arxiv_data1/oa_pdf/3e/cc/annrheumdis-2013-205060.PMC4431324.pdf
"Presentation of Results : Results were presented in abstract form in an oralpresentation at the EuropeanLeague Against Rheumatism annual conference in Madrid, 13 June, 2013 (presentationnumber OP0094; available athttp://www.abstracts2view.",Non-OADS,/arxiv_data1/oa_pdf/3e/cc/annrheumdis-2013-205060.PMC4431324.pdf
"12Costs were calculated using the diagnostic-related group-coding system, a weighted average of costs per disease group, from 2011 (http://www.socialstyrelsen.se).",OADS,/arxiv_data1/oa_pdf/3e/cc/annrheumdis-2013-205060.PMC4431324.pdf
Costs were calculated using 2011 drugprices in Sweden (http://www.tlv.se).,OADS,/arxiv_data1/oa_pdf/3e/cc/annrheumdis-2013-205060.PMC4431324.pdf
"14Productivity losses were estimated as the accumulated days of sick leave anddisability pension multiplied with the mean average salary perday, including social fees, in Sweden 2011 (http://www.scb.se).",Non-OADS,/arxiv_data1/oa_pdf/3e/cc/annrheumdis-2013-205060.PMC4431324.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/REFERENCES 1 Lauer MS, D ’Agostino RB Sr.",Non-OADS,/arxiv_data1/oa_pdf/3e/cc/annrheumdis-2013-205060.PMC4431324.pdf
"http://publications.nice.org.uk/methods-for-the-development-of-nice-public-health-guidance-third-edition-pmg4 22 Shiroiwa T, Sung YK, Fukuda T, et al.",Non-OADS,/arxiv_data1/oa_pdf/3e/cc/annrheumdis-2013-205060.PMC4431324.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2013-204816).,OADS,/arxiv_data1/oa_pdf/4d/4c/annrheumdis-2013-204816.PMC4431325.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Furst DE, Pangan AL, Harrold LR, et al.",Non-OADS,/arxiv_data1/oa_pdf/4d/4c/annrheumdis-2013-204816.PMC4431325.pdf
"The challenge of crafting policy for do-it-yourself brain stimulation Nicholas S Fitz, Peter B Reiner National Core for Neuroethics, University of British Columbia,Vancouver, British Columbia,Canada Correspondence to Professor Peter B Reiner, National Core for Neuroethics,University of British Columbia,2211 Wesbrook Mall, Vancouver, BC, Canada V6J 2B5; peter.reiner@ubc.ca Received 8 March 2013 Revised 22 April 2013 Accepted 30 April 2013 Published Online First3 June 2013 ▸http://dx.doi.org/10.1136/ medethics-2013-101692 To cite: Fitz NS, Reiner PB.",Non-OADS,/arxiv_data1/oa_pdf/35/05/medethics-2013-101458.PMC4431326.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Nitsche MA, Paulus W. Transcranial direct current stimulation —update 2011.",Non-OADS,/arxiv_data1/oa_pdf/35/05/medethics-2013-101458.PMC4431326.pdf
"5 http://www.diytdcs.com6 Fitz NS, Reiner PB.",Non-OADS,/arxiv_data1/oa_pdf/35/05/medethics-2013-101458.PMC4431326.pdf
"In Press, Corrected Proof available online 23 November 2012. http://www.sciencedirect.com/science/article/pii/S0924933812001149 13 Boggio PS, Zaghi S, Villani AB, et al .",Non-OADS,/arxiv_data1/oa_pdf/35/05/medethics-2013-101458.PMC4431326.pdf
"‘Petitions to request change in classi ﬁcation for cranial electrotherapy stimulators ’(FDA executive summary, prepared for the February 10, 2012 meeting of the Neurologic Devices Panel, 2012. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/ MedicalDevicesAdvisoryCommittee/NeurologicalDevicesPanel/UCM290787.pdf 16 European Commission.",Non-OADS,/arxiv_data1/oa_pdf/35/05/medethics-2013-101458.PMC4431326.pdf
"Proposal for a regulation of the European parliament and of the council on medical devices and amending directive 2001/83/EC, regulation (EC)No 178/2002 and Regulation (EC) No 1223/2009 (EC Publication 2012/0266) , 2012. http://ec.europa.eu/health/medical-devices/ ﬁles/revision_docs/proposal_2012_ 542_en.pdf 17 http://www.tdcsdevicekit.com18 http://www.foc.us 19 National Science Advisory Board for Biosecurity.",Non-OADS,/arxiv_data1/oa_pdf/35/05/medethics-2013-101458.PMC4431326.pdf
2011. http://oba.od.nih.gov/biosecurity/pdf/ﬁnalnsabbreport-amateurbiologist-nonlifescientists_june-2011.pdf 20 Presidential Commission for the Study of Bioethical Issues.,Non-OADS,/arxiv_data1/oa_pdf/35/05/medethics-2013-101458.PMC4431326.pdf
2010. http://www.bioethics.,Non-OADS,/arxiv_data1/oa_pdf/35/05/medethics-2013-101458.PMC4431326.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2013-204986).,OADS,/arxiv_data1/oa_pdf/b3/49/annrheumdis-2013-204986.PMC4431327.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Mclnnes IB, Schett G. The pathogenesis of rheumatoid arthritis.",Non-OADS,/arxiv_data1/oa_pdf/b3/49/annrheumdis-2013-204986.PMC4431327.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ heartjnl-2014-307007).,Non-OADS,/arxiv_data1/oa_pdf/f4/2e/heartjnl-2014-307007.PMC4431328.pdf
"Correspondence to Dr Teruo Noguchi, Department of CardiovascularMedicine, National Cerebraland Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan;tnoguchi@hsp.ncvc.go.jp Received 25 October 2014 Accepted 11 February 2015 Published Online First 11 March 2015 ▸http://dx.doi.org/10.1136/ heartjnl-2014-307426 To cite: Tateishi E, Noguchi T, Goto Y, et al.",Non-OADS,/arxiv_data1/oa_pdf/f4/2e/heartjnl-2014-307007.PMC4431328.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 McCrohon JA, Moon JC, Prasad SK, et al.",Non-OADS,/arxiv_data1/oa_pdf/f4/2e/heartjnl-2014-307007.PMC4431328.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2013-205095).,Non-OADS,/arxiv_data1/oa_pdf/e0/2c/annrheumdis-2013-205095.PMC4431329.pdf
Ethics approval The study was approved by the Mayo Clinic Institutional Review Board.Data sharing statement The copyright transfer agreement is subject to applicable Mayo terms located on the following page: (http://www.mayo.edu/copyright/).,Non-OADS,/arxiv_data1/oa_pdf/e0/2c/annrheumdis-2013-205095.PMC4431329.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Zhu Y, Pandya BJ, Choi HK.",Non-OADS,/arxiv_data1/oa_pdf/e0/2c/annrheumdis-2013-205095.PMC4431329.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2013-203993).,OADS,/arxiv_data1/oa_pdf/7a/f2/annrheumdis-2013-203993.PMC4431330.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Mewar D, Wilson AG.",Non-OADS,/arxiv_data1/oa_pdf/7a/f2/annrheumdis-2013-203993.PMC4431330.pdf
http://www.das28.nl/das28/en/difference-between-the-das-and-das28/ how-to-measure-the-das28/how-to-calculate-the-das28.html (accessed 3 Apr 2013).,OADS,/arxiv_data1/oa_pdf/7a/f2/annrheumdis-2013-203993.PMC4431330.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2014-206176).,OADS,/arxiv_data1/oa_pdf/af/78/annrheumdis-2014-206176.PMC4431331.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Altman R, Asch E, Bloch D, et al .",Non-OADS,/arxiv_data1/oa_pdf/af/78/annrheumdis-2014-206176.PMC4431331.pdf
"Geneva: World Health Organization, 2002; Retrieved 2 May 2010. http://www.who.int/whr/2002/en/whr02_en.pdf 5 Lineker SC, Husted JA.",Non-OADS,/arxiv_data1/oa_pdf/af/78/annrheumdis-2014-206176.PMC4431331.pdf
"2009; Leitlinie Koxarthrose.Retrieved 2 May 2010. http://www.awmf.org/uploads/tx_szleitlinien/033-001_S3_ Koxarthrose_11-2009_11-2014.pdf 16 Zhang W, Nuki G, Moskowitz RW, et al .",Non-OADS,/arxiv_data1/oa_pdf/af/78/annrheumdis-2014-206176.PMC4431331.pdf
"London: Royal College of Physicians, 2008; Retrieved 1 January 2012. http://www.nice.org.uk/nicemedia/live/11926/ 39720/39720.pdf 18 Fernandes L, Hagen KB, Bijlsma JWJ, et al .",Non-OADS,/arxiv_data1/oa_pdf/af/78/annrheumdis-2014-206176.PMC4431331.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 RJ Reynolds.,Non-OADS,/arxiv_data1/oa_pdf/b3/12/tobaccocontrol-2013-051209.PMC4431332.pdf
http://www.bat.com/group/sites/UK__ 8GLKJF.nsf/vwPagesWebLive/3FF4B58C81321BC8C12578880056EF37/$FILE/14_Mark%20Cobben%20-%20Capsule%20Rollout.pdf?openelement (accessed 2 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/b3/12/tobaccocontrol-2013-051209.PMC4431332.pdf
http://www.ic.gc.ca/app/opic-cipo/trdmrks/srch/ vwTrdmrk.do?lang=eng&status=& ﬁleNumber=1534247&extension=0&starting DocumentIndexOnPage=1 (accessed 4 May 2013).,OADS,/arxiv_data1/oa_pdf/b3/12/tobaccocontrol-2013-051209.PMC4431332.pdf
Packaging Digest 2007 Jan. http://www.packagingdigest.com/article/ 341456-Kent_cigarette_multipacks_carton_lights_up_with_integrated_electronics.php (accessed 2 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/b3/12/tobaccocontrol-2013-051209.PMC4431332.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Malone RE.,Non-OADS,/arxiv_data1/oa_pdf/fe/f5/tobaccocontrol-2013-051125.PMC4431333.pdf
2012. http://www.abc.,Non-OADS,/arxiv_data1/oa_pdf/fe/f5/tobaccocontrol-2013-051125.PMC4431333.pdf
2012. http://www.thisisguernsey.com/news/2012/08/29/guernsey-may-adopt-similar- cigarette-ban-to-tasmania/ (accessed 23 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/fe/f5/tobaccocontrol-2013-051125.PMC4431333.pdf
2010. http://www.stm.,Non-OADS,/arxiv_data1/oa_pdf/fe/f5/tobaccocontrol-2013-051125.PMC4431333.pdf
2011. http://smokefree.org.nz/ smokefree-2025 (accessed 24 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/fe/f5/tobaccocontrol-2013-051125.PMC4431333.pdf
1948. http://www.un.,Non-OADS,/arxiv_data1/oa_pdf/fe/f5/tobaccocontrol-2013-051125.PMC4431333.pdf
1976. http://www2.ohchr.org/english/law/cescr.htm (accessed 7 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/fe/f5/tobaccocontrol-2013-051125.PMC4431333.pdf
1990. http://www2.ohchr.,Non-OADS,/arxiv_data1/oa_pdf/fe/f5/tobaccocontrol-2013-051125.PMC4431333.pdf
2012. http://www.telegraph.co.uk/news/worldnews/australiaandthepaci ﬁc/australia/ 9492504/Tasmania-considers-cigarette-ban-for-anyone-born-after-2000.html (accessed 7 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/fe/f5/tobaccocontrol-2013-051125.PMC4431333.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2013-204769).,OADS,/arxiv_data1/oa_pdf/c0/2b/annrheumdis-2013-204769.PMC4431334.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Smolen JS, Landewe R, Breedveld FC, et al.",Non-OADS,/arxiv_data1/oa_pdf/c0/2b/annrheumdis-2013-204769.PMC4431334.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Aletaha D, Smolen J, Ward MM.",Non-OADS,/arxiv_data1/oa_pdf/20/d5/annrheumdis-2014-206359.PMC4431335.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/d4/main.PMC4431336.pdf
The complement system which is composed of more than 50 plasma and membrane http://dx.doi.org/10.1016/j.fob.2015.04.007 2211-5463/ /C2112015 The Authors.,OADS,/arxiv_data1/oa_pdf/d7/d4/main.PMC4431336.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: IgG, immunoglobulin G; ATP, adenosine triphosphate; NAD+, nicotinamide adenine dinucleotide; CNBr, cyanogens bromide; PNGase F, peptideN-glycosidase F; BHI, Brain–Heart Infusion; ANTS, 8-aminonaphthalene-1,3,6-trisulfonate; BCIP, 5-Bromo 4-Chloro 3 0indolylphosphate; NBT, nitro-blue tetra- zolium chloride; G6PDH, glucose-6-phosphate dehydrogenase; BSA, bovine serumalbumin; EDTA, ethylenediamine tetra acetic acid; EGTA, ethylene glycol tetra acetic acid ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/d7/d4/main.PMC4431336.pdf
"The MS/MS of the most intense chymotryptic peptide mass ion were searched against Swissprot and NCBI database using Mascot (Matrix Science Ltd., London, U.K; http://www.matrixscience.",OADS,/arxiv_data1/oa_pdf/d7/d4/main.PMC4431336.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2013-204963).,OADS,/arxiv_data1/oa_pdf/ac/69/annrheumdis-2013-204963.PMC4431338.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Braun J, Bollow M, Remlinger G, et al.",Non-OADS,/arxiv_data1/oa_pdf/ac/69/annrheumdis-2013-204963.PMC4431338.pdf
2010. http://www.gene.com/gene/products/ information/actemra/pdf/pi.pdf (accessed July 2012).,OADS,/arxiv_data1/oa_pdf/ac/69/annrheumdis-2013-204963.PMC4431338.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ References ATKINS, C., BONAGURA, J., ETTINGER, S., FOX, P ., GORDON, S., HAGGSTROM, J., HAMLIN, R., KEENE, B., LUIS-FUENTES, V .",Non-OADS,/arxiv_data1/oa_pdf/3b/04/vetrec-2014-102818.PMC4431339.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Ripamonti C, Mercadante S. Pathophysiology and management of malignant bowel obstruction.",Non-OADS,/arxiv_data1/oa_pdf/d8/f8/ejhpharm-2014-000555.PMC4431342.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2013-204948).,Non-OADS,/arxiv_data1/oa_pdf/9d/27/annrheumdis-2013-204948.PMC4431343.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1O ’Dell JR, Leff R, Paulsen G, et al.",Non-OADS,/arxiv_data1/oa_pdf/9d/27/annrheumdis-2013-204948.PMC4431343.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ References DA VIES, M. (2011) Internet users ’perception of the importance of signs com- monly seen in old animals with age-related diseases.",Non-OADS,/arxiv_data1/oa_pdf/dc/98/vetrec-2014-102751.PMC4431344.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2014-206028).,OADS,/arxiv_data1/oa_pdf/8d/7e/annrheumdis-2014-206028.PMC4431345.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 McInnes I, Schett G. The pathogenesis of rheumatoid arthritis.",Non-OADS,/arxiv_data1/oa_pdf/8d/7e/annrheumdis-2014-206028.PMC4431345.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ annrheumdis-2014-205351) For numbered af ﬁliations see end of article.,Non-OADS,/arxiv_data1/oa_pdf/85/b1/annrheumdis-2014-205351.PMC4431348.pdf
"Competing interests HIB has in the past three years received honoraria and speaker bureau fees from AbbVie, P ﬁzer, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Novartis, Roche and Janssen; the CCHMC, where she holds a full-time position, has received contributions to support the research activities of the PRCSG network (http://www.prcsg.org) from Roche, Abbott, AstraZeneca,Bristol-Myers Squibb, Janssen, P ﬁzer Inc. and Wyeth Pharmaceuticals Inc. NR has in the past three years received honoraria and speaker bureau fees from AbbVie, Alter, Medac, Novo Nordisk, P ﬁzer, Astellas, AstraZeneca, Bristol-Myers Squibb, CD-Pharma, GlaxoSmithKline, Italfarmaco, MedImmune, Novartis, Roche, Sano ﬁ Aventis and Vertex Pharmaceuticals; the GASLINI Hospital, where he works as afull-time employee, has received contributions to support the research activities of PRINTO (http://www.printo.it) from Abbott, AstraZeneca, Bristol-Myers Squibb, Janssen Biologics B.V., Eli Lilly and Company, ‘Francesco Angelini ’, GlaxoSmithKline, Italfarmaco, Novartis, P ﬁzer Inc., Roche, Sano ﬁAventis, Schwarz Biosciences GmbH, Xoma and Wyeth Pharmaceuticals Inc. ZZ declares no con ﬂicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/85/b1/annrheumdis-2014-205351.PMC4431348.pdf
"AM has in the past three years receivedhonoraria and speaker bureau fees from Novartis, GlaxoSmithKline, BoehringerIngelheim, AstraZeneca, BMS, Sano ﬁ, MedImmune and Novo Nordisk; the GASLINIHospital, where he works as a full-time employee, has received contributions to support the research activities of PRINTO (http://www.printo.it) from Abbott,AstraZeneca, Bristol-Myers Squibb, Janssen Biologics B.V., Eli Lilly and Company, ‘Francesco Angelini ’, GlaxoSmithKline, Italfarmaco, Novartis, P ﬁzer Inc., Roche, Sano ﬁAventis, Schwarz Biosciences GmbH, Xoma and Wyeth Pharmaceuticals Inc. FDB has received an unrestricted grant and travel grants from Hoffmann-La Roche.",Non-OADS,/arxiv_data1/oa_pdf/85/b1/annrheumdis-2014-205351.PMC4431348.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Prakken B, Albani S, Martini A.",Non-OADS,/arxiv_data1/oa_pdf/85/b1/annrheumdis-2014-205351.PMC4431348.pdf
ICH Topic E 2 A: Clinical safety data management: deﬁnitions and standards for expedited reporting: step 5. http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/85/b1/annrheumdis-2014-205351.PMC4431348.pdf
Review Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/9d/9c/MJIRI-29-168.PMC4431356.pdf
"29.168.28 January 2015http://mjiri.iums.ac.irpopulation over 70 years of age (8).The causes of PD are still unknown, however a number of researchers believe that it devel- ops in response to a combination of certain genetic and non -genetic factors (9).",Non-OADS,/arxiv_data1/oa_pdf/9d/9c/MJIRI-29-168.PMC4431356.pdf
"29.168.28 January 2015 http://mjiri.iums.ac.irbe avoided by cell sorting, prolonged di f- ferentiation and subsequently exhaustion in vitro before transplantation (11,39-42).",Non-OADS,/arxiv_data1/oa_pdf/9d/9c/MJIRI-29-168.PMC4431356.pdf
29.168.28 January 2015http://mjiri.iums.ac.irshowed partial improvement with no tumor formation or other side effects.,Non-OADS,/arxiv_data1/oa_pdf/9d/9c/MJIRI-29-168.PMC4431356.pdf
"29.168.28 January 2015 http://mjiri.iums.ac.irhigher mental functions (84)and also a minimum of 7 years of treatment, the pre s- ence of intractable problems (more a d- vanced stages), taking L -dopa for several years and established L -dopainduced dy s- kinesia(8).",Non-OADS,/arxiv_data1/oa_pdf/9d/9c/MJIRI-29-168.PMC4431356.pdf
"29.168.28 January 2015http://mjiri.iums.ac.irby two different paths; 1) in vitro pre - differentiation of stem cells toward dop a- minergic neurons prior to transplantation, 2) In vivo differentiation toward dopami n- ergic neurons after implantation into the PD patient’s brain (86).",Non-OADS,/arxiv_data1/oa_pdf/9d/9c/MJIRI-29-168.PMC4431356.pdf
"29.168.28 January 2015 http://mjiri.iums.ac.ir6.Hughes AJ, Daniel SE, Kilford L, Lees AJ.",Non-OADS,/arxiv_data1/oa_pdf/9d/9c/MJIRI-29-168.PMC4431356.pdf
29.168.28 January 2015http://mjiri.iums.ac.irpancreatic islets.,Non-OADS,/arxiv_data1/oa_pdf/9d/9c/MJIRI-29-168.PMC4431356.pdf
29.168.28 January 2015 http://mjiri.iums.ac.irand application for autologous transplantation.,Non-OADS,/arxiv_data1/oa_pdf/9d/9c/MJIRI-29-168.PMC4431356.pdf
"29.168.28 January 2015http://mjiri.iums.ac.ir81.Perlmutter JS, Mink JW.",Non-OADS,/arxiv_data1/oa_pdf/9d/9c/MJIRI-29-168.PMC4431356.pdf
2013.Available from: http://www.clinicaltr ials.,Non-OADS,/arxiv_data1/oa_pdf/9d/9c/MJIRI-29-168.PMC4431356.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/c8/48/MJIRI-29-166.PMC4431357.pdf
29.166.27 January 2015http://mjiri.iums.ac.irthe situation (7).,Non-OADS,/arxiv_data1/oa_pdf/c8/48/MJIRI-29-166.PMC4431357.pdf
"29.166.27 January 2015 http://mjiri.iums.ac.irand effectiveness were 3.85 and 4.36, r e- spectively (Ta ble 2).",OADS,/arxiv_data1/oa_pdf/c8/48/MJIRI-29-166.PMC4431357.pdf
29.166.27 January 2015http://mjiri.iums.ac.ir(26).,Non-OADS,/arxiv_data1/oa_pdf/c8/48/MJIRI-29-166.PMC4431357.pdf
Retrieved from http://www.mindgarden.com 17.Mhoon-Walker EJ.,Non-OADS,/arxiv_data1/oa_pdf/c8/48/MJIRI-29-166.PMC4431357.pdf
"29.166.27 January 2015 http://mjiri.iums.ac.ir20.Shakour M, Bazrafkan L, Alizadeh M, Ghasemi M. Assessing the Leade rship Styles and Effectiveness of Administrators in Isfahan Unive r- sity of Medical Sciences in 1388.",Non-OADS,/arxiv_data1/oa_pdf/c8/48/MJIRI-29-166.PMC4431357.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/6b/20/MJIRI-29-161.PMC4431358.pdf
"29.161.26January2015http://mjiri.iums.ac.iring Iran, was reported as 4.1% years (4).",OADS,/arxiv_data1/oa_pdf/6b/20/MJIRI-29-161.PMC4431358.pdf
29.161.26January2015 http://mjiri.iums.ac.irfied accordingly.,Non-OADS,/arxiv_data1/oa_pdf/6b/20/MJIRI-29-161.PMC4431358.pdf
"29.161.26January2015http://mjiri.iums.ac.irrelated services' 23 (11%), 'my spouse' 8(3.8%), and 'only my father' 2 (0.9%) st u- dents.",Non-OADS,/arxiv_data1/oa_pdf/6b/20/MJIRI-29-161.PMC4431358.pdf
"29.161.26January2015 http://mjiri.iums.ac.irtions similar to that of the person intr o- duced in the vignette, 102 (59%) stated they had not taken any professional help or treatment.",Non-OADS,/arxiv_data1/oa_pdf/6b/20/MJIRI-29-161.PMC4431358.pdf
"29.161.26January2015http://mjiri.iums.ac.irtions, through which public awareness about the psychiatric disorders treatment would be improved considerably (20).",Non-OADS,/arxiv_data1/oa_pdf/6b/20/MJIRI-29-161.PMC4431358.pdf
29.161.26January2015 http://mjiri.iums.ac.ircreating negative attitude toward person which indicates necessity for intervention for reducing stigma.,Non-OADS,/arxiv_data1/oa_pdf/6b/20/MJIRI-29-161.PMC4431358.pdf
29.161.26January2015http://mjiri.iums.ac.irand TV were mentioned as the main sources of obtaining information about mental health diseases.,Non-OADS,/arxiv_data1/oa_pdf/6b/20/MJIRI-29-161.PMC4431358.pdf
"3.Investing in Global Health, A Regional Spo t- light on the Middle East and North Africa Region, The 10 Leading Causes of Burden of Disease, 2006, Available from:          http://siteresources.world bank.org/INTMNAREGTOPHEALTH/Resources/D CPP-15-MENA.pdf 4.Mathers CD ,Lopez AD ,Murray CJL .The bur- den of disease and mortality by condition; data, methods and results for 2001, In: Lopez AD,Mathers CD ,Ezzati M ,Jamison DT ,Murray CJL, editors.",Non-OADS,/arxiv_data1/oa_pdf/6b/20/MJIRI-29-161.PMC4431358.pdf
"Iran J Psychiatry 2007; 2:137 -150, Available from: http://ijps.tums.ac.ir/index.php/ ijps/article/view/253.pdf 6.Mohammadi M.R,Rahgozar M,BagheriYazdi S.A,Mesgarpour B,Khalkhali M.R,FarsiM.R, Sharafati M.Anepidemiological studyofpsychiat- ricdisorders inGuilanprovince (year2001),Journal ofGuilan university ofmedical sciences 2004;13(51); 55 -66.",Non-OADS,/arxiv_data1/oa_pdf/6b/20/MJIRI-29-161.PMC4431358.pdf
"An epidemi o- logical study of psychiatric disorders in Semnan province in year 2001, Koomesh Journal of Semnan University of Medical Sciences, 1382; 2 -1(5);17-7, Available from: http://www.koomeshjournal.ir/ browse.php?a_code=A -10-4-182&slc_lang=en& sid=1 9.",Non-OADS,/arxiv_data1/oa_pdf/6b/20/MJIRI-29-161.PMC4431358.pdf
29.161.26January2015 http://mjiri.iums.ac.irInterv Psychiatry 2012 Feb; 6(1):45 -52.,Non-OADS,/arxiv_data1/oa_pdf/6b/20/MJIRI-29-161.PMC4431358.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/51/4a/MJIRI-29-167.PMC4431359.pdf
29.167.27 January 2015http://mjiri.iums.ac.irdisease are substantially greater in ESRD patients(6).,Non-OADS,/arxiv_data1/oa_pdf/51/4a/MJIRI-29-167.PMC4431359.pdf
29.167.27 January 2015 http://mjiri.iums.ac.irAny disagreements between the reviewers were resolved by discussion until conse n- sus was reached.,Non-OADS,/arxiv_data1/oa_pdf/51/4a/MJIRI-29-167.PMC4431359.pdf
"29.167.27 January 2015http://mjiri.iums.ac.irfore, it was not appropriate to synthesize the results for a meta -analysis.",Non-OADS,/arxiv_data1/oa_pdf/51/4a/MJIRI-29-167.PMC4431359.pdf
29.167.27 January 2015 http://mjiri.iums.ac.ircreased tHcy in both groups and the d e- crease was genotype -dependant.,Non-OADS,/arxiv_data1/oa_pdf/51/4a/MJIRI-29-167.PMC4431359.pdf
"29.167.27 January 2015http://mjiri.iums.ac.irmin II, which is necessary for the entry of vitamin B12 into tissues, may be impaired in ESRD (6, 14-15).",Non-OADS,/arxiv_data1/oa_pdf/51/4a/MJIRI-29-167.PMC4431359.pdf
29.167.27 January 2015 http://mjiri.iums.ac.irseems that the essential role of cobalamin in remethylation of tHcy was the reason behind the simultaneous reduction of h o- mocysteine and folate levels.,Non-OADS,/arxiv_data1/oa_pdf/51/4a/MJIRI-29-167.PMC4431359.pdf
29.167.27 January 2015http://mjiri.iums.ac.irrenal disease.,Non-OADS,/arxiv_data1/oa_pdf/51/4a/MJIRI-29-167.PMC4431359.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.PhDStudent in Nursing, Student Researches Committee, Faculty Member, School of Nursing and Midwifery, Mashhad University of Medi cal Sciences, Mashhad, Iran.",Non-OADS,/arxiv_data1/oa_pdf/ae/27/MJIRI-29-162.PMC4431360.pdf
"29.162.25 January 2015http://mjiri.iums.ac.irern teaching meth ods like problem -solving approach and the availability of computers and the Internet, lectures are still used to exchange information due to their nume r- ous benefits including cost -effectiveness for large populations (7).",Non-OADS,/arxiv_data1/oa_pdf/ae/27/MJIRI-29-162.PMC4431360.pdf
"29.162.25 January 2015 http://mjiri.iums.ac.irMethods In a quasi -experimental study, 60 nursing students in their fourth semester were s e- lected from the School of Nursing and Midwifery (Mashhad University of Medical Sciences, Iran).",Non-OADS,/arxiv_data1/oa_pdf/ae/27/MJIRI-29-162.PMC4431360.pdf
"29.162.25 January 2015http://mjiri.iums.ac.irthe two groups in terms of age, gender, and baseline level of knowledge.",Non-OADS,/arxiv_data1/oa_pdf/ae/27/MJIRI-29-162.PMC4431360.pdf
"29.162.25 January 2015 http://mjiri.iums.ac.iring skills of students (22).This difference might be justified by the fact that theoret i- cal topics and multiple -choice questions deal with cognitive aspects, but role pla y- ing involves emotional, mental, and motor domains.",Non-OADS,/arxiv_data1/oa_pdf/ae/27/MJIRI-29-162.PMC4431360.pdf
29.162.25 January 2015http://mjiri.iums.ac.irmentioned facts.,Non-OADS,/arxiv_data1/oa_pdf/ae/27/MJIRI-29-162.PMC4431360.pdf
29.162.25 January 2015 http://mjiri.iums.ac.irnursing students.,Non-OADS,/arxiv_data1/oa_pdf/ae/27/MJIRI-29-162.PMC4431360.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________ _____________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/ea/e1/MJIRI-29-159.PMC4431361.pdf
29.159.13 January 2015http://mjiri.iums.ac.irtherapycould be promising efficacious treatments for this type of cancer (7).,Non-OADS,/arxiv_data1/oa_pdf/ea/e1/MJIRI-29-159.PMC4431361.pdf
29.159.13 January 2015  http://mjiri.iums.ac.ir20µl with the following sequence: one c y- cle of pre -denaturation for 5 min at 95 °C and 45 amplification cycles (5s of denatur a- tion at 95°C and 35s of annealing a nd ex- tension at 57°C and 72°C).,Non-OADS,/arxiv_data1/oa_pdf/ea/e1/MJIRI-29-159.PMC4431361.pdf
"29.159.13 January 2015 http://mjiri.iums.ac.irAs illustrated in Fig .2, flow cytometric analysis of the LNCaP line with anti NGEP-p1 and-p2 antibodies against NGEP showed that only 8% and 5% of the cells were stained with these two antibodies, r e- spectively.",Non-OADS,/arxiv_data1/oa_pdf/ea/e1/MJIRI-29-159.PMC4431361.pdf
29.159.13 January 2015 http://mjiri.iums.ac.irgreen fluorescence signals but in DU145 cells there were very weak or no signal of fluorescence and observed ghost of cells as shown at Fg .3 by anti-NGEP-p2 antibody.,Non-OADS,/arxiv_data1/oa_pdf/ea/e1/MJIRI-29-159.PMC4431361.pdf
29.159.13 January 2015http://mjiri.iums.ac.ircondition could not be a good target for immunotherapy.,Non-OADS,/arxiv_data1/oa_pdf/ea/e1/MJIRI-29-159.PMC4431361.pdf
29.159.13 January 2015 http://mjiri.iums.ac.ir11.,Non-OADS,/arxiv_data1/oa_pdf/ea/e1/MJIRI-29-159.PMC4431361.pdf
Brief Communication http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/9b/22/MJIRI-29-163.PMC4431362.pdf
29.163.25 January 2015http://mjiri.iums.ac.irto complete the third section of the que s- tionnaire.,Non-OADS,/arxiv_data1/oa_pdf/9b/22/MJIRI-29-163.PMC4431362.pdf
"29.163.25 January 2015 http://mjiri.iums.ac.irfrom humans, domestic fowls, sheep, goats, chickens and ducks (16 -19).",Non-OADS,/arxiv_data1/oa_pdf/9b/22/MJIRI-29-163.PMC4431362.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________ ________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/e8/e6/MJIRI-29-165.PMC4431363.pdf
29.165.27 January 2015http://mjiri.iums.ac.irdependent.,Non-OADS,/arxiv_data1/oa_pdf/e8/e6/MJIRI-29-165.PMC4431363.pdf
"29.165.27 January 2015  http://mjiri.iums.ac.irand 0.5μM of the HBV primers, with the same primers as those used for PCR ampl i- fication of pre -S region.",Non-OADS,/arxiv_data1/oa_pdf/e8/e6/MJIRI-29-165.PMC4431363.pdf
"29.165.27 January 2015 http://mjiri.iums.ac.ir(4,5,31).",Non-OADS,/arxiv_data1/oa_pdf/e8/e6/MJIRI-29-165.PMC4431363.pdf
29.165.27 January 2015 http://mjiri.iums.ac.irtypes have largely been conducted among patients with chronic hepatitis B (CHB) from Iran (26).,Non-OADS,/arxiv_data1/oa_pdf/e8/e6/MJIRI-29-165.PMC4431363.pdf
29.165.27 January 2015http://mjiri.iums.ac.irtion: genotypes and mutants.,Non-OADS,/arxiv_data1/oa_pdf/e8/e6/MJIRI-29-165.PMC4431363.pdf
29.165.27 January 2015 http://mjiri.iums.ac.ir30.,Non-OADS,/arxiv_data1/oa_pdf/e8/e6/MJIRI-29-165.PMC4431363.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/58/7b/MJIRI-29-160.PMC4431366.pdf
"29.160.13 January 2015http://mjiri.iums.ac.ircounts for 7.3 million deaths, about 12.8% of all deaths(1).",Non-OADS,/arxiv_data1/oa_pdf/58/7b/MJIRI-29-160.PMC4431366.pdf
29.160.13 January 2015 http://mjiri.iums.ac.irtime of study conduct was considered as a hypertensive case (17).Body mass index (BMI) was calculated using the formula weight (kg)/height (m2).,OADS,/arxiv_data1/oa_pdf/58/7b/MJIRI-29-160.PMC4431366.pdf
29.160.13 January 2015http://mjiri.iums.ac.irgroups.,Non-OADS,/arxiv_data1/oa_pdf/58/7b/MJIRI-29-160.PMC4431366.pdf
"29.160.13 January 2015 http://mjiri.iums.ac.irof anon-fatal MI than university educated group (p= 0.011).Graph 1 indicates that overall, as the level of education increased, the odds of non-fatal MI decreased (p for trend<0.001).",Non-OADS,/arxiv_data1/oa_pdf/58/7b/MJIRI-29-160.PMC4431366.pdf
29.160.13 January 2015http://mjiri.iums.ac.irthe controls.,Non-OADS,/arxiv_data1/oa_pdf/58/7b/MJIRI-29-160.PMC4431366.pdf
29.160.13 January 2015 http://mjiri.iums.ac.irLimitations Our study is subject to several limitations.,Non-OADS,/arxiv_data1/oa_pdf/58/7b/MJIRI-29-160.PMC4431366.pdf
29.160.13 January 2015http://mjiri.iums.ac.irpopulation -based study (Urban HEART -2).,Non-OADS,/arxiv_data1/oa_pdf/58/7b/MJIRI-29-160.PMC4431366.pdf
"Therefore, the role played by  PTP1B in the activation of RPE cells needs to be clarified.Molecular Vision  2015; 21:523-531 <http://www.molvis.org/molvis/v 21/523> Received 13 November 2014 | Accepted 29 April 2015 | Published 1 May 2015© 2015 Molecular Vision 523Protein tyrosine phosphatase 1B regulates the activity of retinal  pigment epithelial cells Zhao-dong Du,1 Li-ting Hu,1 Gui-qiu Zhao,1 Ying Li,2 Zhi-zhong Ma2 (The first two authors contributed equally to this work.)",Non-OADS,/arxiv_data1/oa_pdf/2b/f6/mv-v21-523.PMC4431406.pdf
"Molecular Vision  2015; 21:523-531 <http://www.molvis.org/molvis/v 21/523> © 2015 Molecular Vision  524This study was the first to investigate the expression of  PTP1B in RPE cells and the role of PTP1B in regulating cell  proliferation, differentiation, and migration using TCS-401,  a selective inhibitor of PTP1B.",Non-OADS,/arxiv_data1/oa_pdf/2b/f6/mv-v21-523.PMC4431406.pdf
Molecular Vision  2015; 21:523-531 <http://www.molvis.org/molvis/v 21/523> © 2015 Molecular Vision  525per chamber.,Non-OADS,/arxiv_data1/oa_pdf/2b/f6/mv-v21-523.PMC4431406.pdf
Molecular Vision  2015; 21:523-531 <http://www.molvis.org/molvis/v 21/523> © 2015 Molecular Vision  526and 2 μM) and incubated for 24 h. The results demonstrate  that the basal levels of cyclin A and cyclin D1 were minimal.,Non-OADS,/arxiv_data1/oa_pdf/2b/f6/mv-v21-523.PMC4431406.pdf
"Molecular Vision  2015; 21:523-531 <http://www.molvis.org/molvis/v 21/523> © 2015 Molecular Vision  527release of cell-cell contacts, resulting in the appearance of  gaps between cells and a gradual loss of monolayer integrity.",Non-OADS,/arxiv_data1/oa_pdf/2b/f6/mv-v21-523.PMC4431406.pdf
Molecular Vision  2015; 21:523-531 <http://www.molvis.org/molvis/v 21/523> © 2015 Molecular Vision  528MEK/Erk and PI3K/Akt signaling pathways played a vital  role in TCS-401-induced activation of RPE cells.,Non-OADS,/arxiv_data1/oa_pdf/2b/f6/mv-v21-523.PMC4431406.pdf
"Molecular Vision  2015; 21:523-531 <http://www.molvis.org/molvis/v 21/523> © 2015 Molecular Vision  529resistance to apoptosis [ 23,24].",Non-OADS,/arxiv_data1/oa_pdf/2b/f6/mv-v21-523.PMC4431406.pdf
Molecular Vision  2015; 21:523-531 <http://www.molvis.org/molvis/v 21/523> © 2015 Molecular Vision  530α-SMA contributes to fibrous membrane contractility [ 3].,Non-OADS,/arxiv_data1/oa_pdf/2b/f6/mv-v21-523.PMC4431406.pdf
Molecular Vision  2015; 21:523-531 <http://www.molvis.org/molvis/v 21/523> © 2015 Molecular Vision  531PTP1B is a negative regulator of CD40 and BAFF-R signaling  and controls B cell autoimmunity.,Non-OADS,/arxiv_data1/oa_pdf/2b/f6/mv-v21-523.PMC4431406.pdf
"Because  it seemed odd that the alleles associated with IOP elevation  were preferentially associated with increased susceptibility to  NTG with normal IOP rather than HTG with high IOP [ 4,8],  these variants were examined to replicate the associations  with HTG susceptibility, as well as with IOP, and CAV1  and  CAV2  expression.Molecular Vision  2015; 21:548-554 <http://www.molvis.org/molvis/v 21/548> Received 11 February 2015 | Accepted 8 May 2015 | Published 11 May 2015© 2015 Molecular Vision 548Expression-associated polymorphisms of CAV1 -CAV2  affect  intraocular pressure and high-tension glaucoma risk Sewon Kim,1 Kyunglan Kim,1 Dong Won Heo,2 Jong-Sung Kim,3 Chan Kee Park,4 Chang-sik Kim,2 Changwon  Kang1 1Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Korea; 2Department of  Ophthalmology, Chungnam National University Hospital, Daejeon, Korea; 3Department of Family Medicine, Chungnam National  University Hospital, Daejeon, Korea; 4Department of Ophthalmology and Visual Science, Seoul St. Mary’ s Hospital, College of  Medicine, the Catholic University of Korea, Seoul, Korea Purpose:  The human CAV1 -CAV2  locus has been associated with susceptibility to primary open-angle glaucoma in four  studies of Caucasian, Chinese, and Pakistani populations, although not in several other studies of non-Korean popula - tions.",Non-OADS,/arxiv_data1/oa_pdf/d8/31/mv-v21-548.PMC4431411.pdf
"Molecular Vision  2015; 21:548-554 <http://www.molvis.org/molvis/v 21/548> © 2015 Molecular Vision  549METHODS Study samples:  Adhering to the ARVO statement on human  subjects, this study followed the tenets of the Declaration  of Helsinki.",Non-OADS,/arxiv_data1/oa_pdf/d8/31/mv-v21-548.PMC4431411.pdf
"Molecular Vision  2015; 21:548-554 <http://www.molvis.org/molvis/v 21/548> © 2015 Molecular Vision  550IOP association of CAV1-CAV2  SNPs: Next, the two SNPs  were examined for association with IOP.",Non-OADS,/arxiv_data1/oa_pdf/d8/31/mv-v21-548.PMC4431411.pdf
"Molecular Vision  2015; 21:548-554 <http://www.molvis.org/molvis/v 21/548> © 2015 Molecular Vision  55187 kb region encompassing CAV1  and CAV2 , the possible  effects on the two gene expression levels were examined  using cis-eQTL analysis with two data sets from the Genevar   database [ 20].",OADS,/arxiv_data1/oa_pdf/d8/31/mv-v21-548.PMC4431411.pdf
Molecular Vision  2015; 21:548-554 <http://www.molvis.org/molvis/v 21/548> © 2015 Molecular Vision  552decreased the outflow rate possibly leading to IOP elevation  [27].,Non-OADS,/arxiv_data1/oa_pdf/d8/31/mv-v21-548.PMC4431411.pdf
Molecular Vision  2015; 21:548-554 <http://www.molvis.org/molvis/v 21/548> © 2015 Molecular Vision  553variants near CAV1 and CAV2 are associated with primary  open-angle glaucoma in Caucasians from the USA.,Non-OADS,/arxiv_data1/oa_pdf/d8/31/mv-v21-548.PMC4431411.pdf
"Molecular Vision  2015; 21:548-554 <http://www.molvis.org/molvis/v 21/548> © 2015 Molecular Vision  554Stefansson K, Smith GD, McCarthy MI, Deloukas P, Dermit - zakis ET, Spector TD.",Non-OADS,/arxiv_data1/oa_pdf/d8/31/mv-v21-548.PMC4431411.pdf
Research is  ongoing worldwide to identify genes and molecules involved  in DES and to design new pharmacological strategies for  treating DES and improving the vision-related quality of life  for patients with DES.Molecular Vision  2015; 21:555-567 <http://www.molvis.org/molvis/v 21/555> Received 17 December 2014 | Accepted 8 May 2015 | Published 11 May 2015© 2015 Molecular Vision 555A metabolomic approach to dry eye disorders.,Non-OADS,/arxiv_data1/oa_pdf/6c/78/mv-v21-555.PMC4431415.pdf
Molecular Vision  2015; 21:555-567 <http://www.molvis.org/molvis/v 21/555> © 2015 Molecular Vision  556AOXs and anti-inflammatory compounds such as  essential polyunsaturated fatty acids (EPUFAs) have been  reported to be potentially useful for treating eye diseases  [13].,Non-OADS,/arxiv_data1/oa_pdf/6c/78/mv-v21-555.PMC4431415.pdf
"Molecular Vision  2015; 21:555-567 <http://www.molvis.org/molvis/v 21/555> © 2015 Molecular Vision  557Specific ophthalmologic examination was performed  for the study candidates, including detailed inspection of the  anterior eye segment and adnexal structures, as well as the  presence (or not) of lid disease.",Non-OADS,/arxiv_data1/oa_pdf/6c/78/mv-v21-555.PMC4431415.pdf
Molecular Vision  2015; 21:555-567 <http://www.molvis.org/molvis/v 21/555> © 2015 Molecular Vision  558are always free to decline to participate in any aspect of the  study at any time.,Non-OADS,/arxiv_data1/oa_pdf/6c/78/mv-v21-555.PMC4431415.pdf
"Molecular Vision  2015; 21:555-567 <http://www.molvis.org/molvis/v 21/555> © 2015 Molecular Vision  559glutathione (2 mg), zinc (1.6 mg), copper (0.16 mg), manga - nese (0.33 mg), and selenium (9.17 mg).",Non-OADS,/arxiv_data1/oa_pdf/6c/78/mv-v21-555.PMC4431415.pdf
"Molecular Vision  2015; 21:555-567 <http://www.molvis.org/molvis/v 21/555> © 2015 Molecular Vision  560Wenatchee, WA) and MATLAB in-house routines for all  spectra.",OADS,/arxiv_data1/oa_pdf/6c/78/mv-v21-555.PMC4431415.pdf
Molecular Vision  2015; 21:555-567 <http://www.molvis.org/molvis/v 21/555> © 2015 Molecular Vision  561Table  2. c lInIcal probes  for dry eye dIsease  dIagnos Is and manag Ing.,Non-OADS,/arxiv_data1/oa_pdf/6c/78/mv-v21-555.PMC4431415.pdf
Molecular Vision  2015; 21:555-567 <http://www.molvis.org/molvis/v 21/555> © 2015 Molecular Vision  562Table  3. m eTabol ITes presen T In mIld-desg and modera Te-desg Tears  prIor/afTer To supplemen TaTIon.,Non-OADS,/arxiv_data1/oa_pdf/6c/78/mv-v21-555.PMC4431415.pdf
Molecular Vision  2015; 21:555-567 <http://www.molvis.org/molvis/v 21/555> © 2015 Molecular Vision  563a variety of diagnostic clinical signs and symptoms.,Non-OADS,/arxiv_data1/oa_pdf/6c/78/mv-v21-555.PMC4431415.pdf
"Molecular Vision  2015; 21:555-567 <http://www.molvis.org/molvis/v 21/555> © 2015 Molecular Vision  564The 1H NMR S analysis of the tear samples from our  participants showed significantly different metabolite peaks,  according to previous assignment.",Non-OADS,/arxiv_data1/oa_pdf/6c/78/mv-v21-555.PMC4431415.pdf
Molecular Vision  2015; 21:555-567 <http://www.molvis.org/molvis/v 21/555> © 2015 Molecular Vision  565Supplementation with AOX/EPUFAs induced a decrease  in the baseline metabolic differential profile between groups  (Figure 5B).,Non-OADS,/arxiv_data1/oa_pdf/6c/78/mv-v21-555.PMC4431415.pdf
Molecular Vision  2015; 21:555-567 <http://www.molvis.org/molvis/v 21/555> © 2015 Molecular Vision  566docosahexaenoic and eicosapentaenoic acids.,Non-OADS,/arxiv_data1/oa_pdf/6c/78/mv-v21-555.PMC4431415.pdf
Molecular Vision  2015; 21:555-567 <http://www.molvis.org/molvis/v 21/555> © 2015 Molecular Vision  56739.,Non-OADS,/arxiv_data1/oa_pdf/6c/78/mv-v21-555.PMC4431415.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/55/41/MJIRI-29-169.PMC4431422.pdf
"29.169.28 January 2015 http://mjiri.iums.ac.irthese literatures are from white population yielded mainly from cadaveric or imaging studies (7 -9, 11, 12).",Non-OADS,/arxiv_data1/oa_pdf/55/41/MJIRI-29-169.PMC4431422.pdf
29.169.28 January 2015 http://mjiri.iums.ac.irthem (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/55/41/MJIRI-29-169.PMC4431422.pdf
29.169.28 January 2015http://mjiri.iums.ac.irgest similar profile among Iranian popul a- tion and reported v alues form most of Asian and Caucasian ethnicities.,Non-OADS,/arxiv_data1/oa_pdf/55/41/MJIRI-29-169.PMC4431422.pdf
29.169.28 January 2015 http://mjiri.iums.ac.irreasonable.,Non-OADS,/arxiv_data1/oa_pdf/55/41/MJIRI-29-169.PMC4431422.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/bf/77/MJIRI-29-187.PMC4431423.pdf
29.187.9March2015http://mjiri.iums.ac.irso it is revealed to be a potential sourc e of naturalantioxidant (3).,Non-OADS,/arxiv_data1/oa_pdf/bf/77/MJIRI-29-187.PMC4431423.pdf
29.187.9March2015 http://mjiri.iums.ac.iras a single da ily dose for twelve weeks.,Non-OADS,/arxiv_data1/oa_pdf/bf/77/MJIRI-29-187.PMC4431423.pdf
29.187.9March2015http://mjiri.iums.ac.irSuperoxide Dismutase (SOD) Activity SOD activity was determined by method of Misra and Fridovich (18).,OADS,/arxiv_data1/oa_pdf/bf/77/MJIRI-29-187.PMC4431423.pdf
29.187.9March2015  http://mjiri.iums.ac.irrat to find the target platform.,Non-OADS,/arxiv_data1/oa_pdf/bf/77/MJIRI-29-187.PMC4431423.pdf
"29.187.9March2015 http://mjiri.iums.ac.irof variance: ANOVA) more time in the ta r- get quadrant compared to the normalgroup (*p< 0.05), (Fig .3).",Non-OADS,/arxiv_data1/oa_pdf/bf/77/MJIRI-29-187.PMC4431423.pdf
"29.187.9March2015  http://mjiri.iums.ac.ir(p< 0.01), respectively (Fig .6B).",Non-OADS,/arxiv_data1/oa_pdf/bf/77/MJIRI-29-187.PMC4431423.pdf
"29.187.9March2015 http://mjiri.iums.ac.irDiscussion The aim of this study was to examine the effect of administration of different doses (50, 100 and 200mg/kg) of RE on spatial memory and learning scores, density of neurons in the CA1 area of hippocampus, theoxidative stress status and level of lipid peroxidation in hippocampus in middle - aged rat.",Non-OADS,/arxiv_data1/oa_pdf/bf/77/MJIRI-29-187.PMC4431423.pdf
29.187.9March2015 http://mjiri.iums.ac.ircampus(27).,Non-OADS,/arxiv_data1/oa_pdf/bf/77/MJIRI-29-187.PMC4431423.pdf
29.187.9March2015http://mjiri.iums.ac.irmals in the ER (200mg) group compared to the normal group.,Non-OADS,/arxiv_data1/oa_pdf/bf/77/MJIRI-29-187.PMC4431423.pdf
"29.187.9March2015 http://mjiri.iums.ac.ir19.Wheeler C.R, Salzman J.",Non-OADS,/arxiv_data1/oa_pdf/bf/77/MJIRI-29-187.PMC4431423.pdf
Original Article http://mjiri.iums.ac.ir MedicalJournal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _____________________________________________________________________ _______________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/74/de/MJIRI-29-186.PMC4431424.pdf
29.186.25 February 2015http://mjiri.iums.ac.irto achieve this goal (6).,Non-OADS,/arxiv_data1/oa_pdf/74/de/MJIRI-29-186.PMC4431424.pdf
29.186.25 February 2015 http://mjiri.iums.ac.irtook anaerobic exercises in combination took anaerobic exercises in combination with acupuncture and physical modalities (Figs.1-6 of Appendix 3).,Non-OADS,/arxiv_data1/oa_pdf/74/de/MJIRI-29-186.PMC4431424.pdf
"29.186.25 February 2015http://mjiri.iums.ac.irtherapy group, 3 were not accessible due to changed address and phone number.",Non-OADS,/arxiv_data1/oa_pdf/74/de/MJIRI-29-186.PMC4431424.pdf
29.186.25 February 2015 http://mjiri.iums.ac.irtoo.,Non-OADS,/arxiv_data1/oa_pdf/74/de/MJIRI-29-186.PMC4431424.pdf
29.186.25 February 2015http://mjiri.iums.ac.irterm.,Non-OADS,/arxiv_data1/oa_pdf/74/de/MJIRI-29-186.PMC4431424.pdf
"29.186.25 February 2015 http://mjiri.iums.ac.irduring 12 months, better results would be obtained for effect of exercise.",Non-OADS,/arxiv_data1/oa_pdf/74/de/MJIRI-29-186.PMC4431424.pdf
29.186.25 February 2015http://mjiri.iums.ac.ir18.,Non-OADS,/arxiv_data1/oa_pdf/74/de/MJIRI-29-186.PMC4431424.pdf
"29.186.25 February 2015  http://mjiri.iums.ac.irAppendix 1 Diagnostic criteria of ACR (American college of rheum a- tology) for knee OA (1986) -knee pain + 5 of 9 1-Age >50 6-bony enlargement 2-Stiffness< 30 min 7-ESR < 40 mmol/hour 3-Crepitus 8-RF<1/40 4-Bony tenderness 9-synovial fluid signs of osteoarthritis 5-No palpable warmthAppendix 2 Kellgren Lawrence scale: Grade I: normal ,Grade II: uncertain joint space, possible osteophyte ,Grade III: Decreased certain joint space, mild sclerosis, certain osteophyte ,Grade III: Significant redu c- tion in joint space, moderate sclerosis, moderate osteophyte , possible cysts, possible d eformity,Grade IV :Total redu c- tion in joint space, severe sclerosis, great osteophyte , cer- tain deformity Appendix 3 Figures of exercises according to knee pamphlet",Non-OADS,/arxiv_data1/oa_pdf/74/de/MJIRI-29-186.PMC4431424.pdf
Review Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/c8/e3/MJIRI-29-189.PMC4431425.pdf
"29.189.10 March 2015http://mjiri.iums.ac.irdioversion, in this case, a controlled electric shock is administered to the heart to return it to its normal rhythm.",Non-OADS,/arxiv_data1/oa_pdf/c8/e3/MJIRI-29-189.PMC4431425.pdf
29.189.10 March 2015 http://mjiri.iums.ac.irfluoroscopic mapping system (Ensite NavX).,Non-OADS,/arxiv_data1/oa_pdf/c8/e3/MJIRI-29-189.PMC4431425.pdf
29.189.10 March 2015http://mjiri.iums.ac.ircluding safety and effectiveness.,Non-OADS,/arxiv_data1/oa_pdf/c8/e3/MJIRI-29-189.PMC4431425.pdf
29.189.10 March 2015 http://mjiri.iums.ac.irradioactivity(3).,Non-OADS,/arxiv_data1/oa_pdf/c8/e3/MJIRI-29-189.PMC4431425.pdf
29.189.10 March 2015http://mjiri.iums.ac.irload and needing for anti -arrhythmia drugs and visual representation ( Table 4).,Non-OADS,/arxiv_data1/oa_pdf/c8/e3/MJIRI-29-189.PMC4431425.pdf
29.189.10 March 2015 http://mjiri.iums.ac.irtechnologies (95.7% and 95.9% respectiv e- ly)(8).,Non-OADS,/arxiv_data1/oa_pdf/c8/e3/MJIRI-29-189.PMC4431425.pdf
29.189.10 March 2015http://mjiri.iums.ac.irfor anti-arrhythmic medicines in patients with advanced arrhythmia whom the gui d- ed ablation by fluoroscopy wasn’t effective (3).,Non-OADS,/arxiv_data1/oa_pdf/c8/e3/MJIRI-29-189.PMC4431425.pdf
29.189.10 March 2015 http://mjiri.iums.ac.ir9.,Non-OADS,/arxiv_data1/oa_pdf/c8/e3/MJIRI-29-189.PMC4431425.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/f2/24/MJIRI-29-173.PMC4431426.pdf
29.173.4 February 2015http://mjiri.iums.ac.irprofessionalization (2)and prepare the m- selves for practice in future workplaces.,Non-OADS,/arxiv_data1/oa_pdf/f2/24/MJIRI-29-173.PMC4431426.pdf
29.173.4 February 2015 http://mjiri.iums.ac.irwith 7 items per each scale.,Non-OADS,/arxiv_data1/oa_pdf/f2/24/MJIRI-29-173.PMC4431426.pdf
29.173.4 February 2015http://mjiri.iums.ac.irhighest (23.65 ±5.393) and the lowest means (17.20 ±5.09) (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/f2/24/MJIRI-29-173.PMC4431426.pdf
29.173.4 February 2015 http://mjiri.iums.ac.irsame(21).,Non-OADS,/arxiv_data1/oa_pdf/f2/24/MJIRI-29-173.PMC4431426.pdf
29.173.4 February 2015http://mjiri.iums.ac.irward staff are supposed to present clear d e- tailed directions for students’ safe pra ctice.,Non-OADS,/arxiv_data1/oa_pdf/f2/24/MJIRI-29-173.PMC4431426.pdf
"29.173.4 February 2015 http://mjiri.iums.ac.irresults showed that students’ expectation of their involvement in c linical practice is near to the actual status, but to fulfill their e x- pectations in this regard there is a need to take specific steps.",Non-OADS,/arxiv_data1/oa_pdf/f2/24/MJIRI-29-173.PMC4431426.pdf
29.173.4 February 2015http://mjiri.iums.ac.irwork with clinical educators in Turkey.,Non-OADS,/arxiv_data1/oa_pdf/f2/24/MJIRI-29-173.PMC4431426.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________ ________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/ad/80/MJIRI-29-177.PMC4431427.pdf
"29.177.10 February 2015http://mjiri.iums.ac.irMethods This qualitative study was conducted in three stages: first, a narrative review of the literature was conducted to identify the list of organizational quality indicators for health centers; second, the Delphi process was used to select the main quality indic a- tors for immediate assessing the organiz a- tional quality of Iranian health cen ters.",Non-OADS,/arxiv_data1/oa_pdf/ad/80/MJIRI-29-177.PMC4431427.pdf
29.177.10 February 2015 http://mjiri.iums.ac.irformance ( 14).,Non-OADS,/arxiv_data1/oa_pdf/ad/80/MJIRI-29-177.PMC4431427.pdf
"29.177.10 February 2015 http://mjiri.iums.ac.irlar interest in quality assessment, both in healthca re services and in healthcare o r- ganizations.",Non-OADS,/arxiv_data1/oa_pdf/ad/80/MJIRI-29-177.PMC4431427.pdf
29.177.10 February 2015 http://mjiri.iums.ac.irtem of Management Effectiveness on Hospital H u- man Resource Based on Balanced Scorecard.,Non-OADS,/arxiv_data1/oa_pdf/ad/80/MJIRI-29-177.PMC4431427.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.PhD in Health Education & Promotion, Department of Public Health ,School of Health ,Shahrekord University of Medical Science, Shahrekord, Iran.",Non-OADS,/arxiv_data1/oa_pdf/ec/27/MJIRI-29-183.PMC4431428.pdf
29.183.18 February 2015http://mjiri.iums.ac.irmostglobally pervasive change among th e- se health transitions has been the rising burden of non -communicable diseases (NCDs).,Non-OADS,/arxiv_data1/oa_pdf/ec/27/MJIRI-29-183.PMC4431428.pdf
29.183.18 February 2015 http://mjiri.iums.ac.irhealth.,Non-OADS,/arxiv_data1/oa_pdf/ec/27/MJIRI-29-183.PMC4431428.pdf
29.183.18 February 2015http://mjiri.iums.ac.irchronic diseases.,Non-OADS,/arxiv_data1/oa_pdf/ec/27/MJIRI-29-183.PMC4431428.pdf
"29.183.18 February 2015 http://mjiri.iums.ac.irsusceptibility, severity, barriers and ben e- fits and adoption of prevention -oriented behavior.",Non-OADS,/arxiv_data1/oa_pdf/ec/27/MJIRI-29-183.PMC4431428.pdf
"29.183.18 February 2015http://mjiri.iums.ac.irregards to the important role of girls and women in the foundation of families and the cost effectiveness of educational pr o- grams compared to treatment services (17), utilizing health education theories and models by the experts in schools is highly recommended to promote public health and well-being.",Non-OADS,/arxiv_data1/oa_pdf/ec/27/MJIRI-29-183.PMC4431428.pdf
Review Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
29.171.31 January 2015http://mjiri.iums.ac.irAnatomy of Rectum The rectum is final portion of the large i n- testine between the sigmoid colon and the anal canal.,Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
29.171.31 January 2015 http://mjiri.iums.ac.irhas increased by 1.8% annually for rectal cancers among adults younger than 50 years.,Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
29.171.31 January 2015http://mjiri.iums.ac.iris another r isk factor of rectal cancer (15).,Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
29.171.31 January 2015 http://mjiri.iums.ac.iring are available.,Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
29.171.31 January 2015http://mjiri.iums.ac.irest relative's diagnosis; and it needs to be repeated every five years (31).,Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
29.171.31 January 2015 http://mjiri.iums.ac.irComputed tomographic colonography (CTC) (also known as virtual colonoscopy) is another non -invasice and sa fe diagnostic tool.,Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
29.171.31 January 2015http://mjiri.iums.ac.ir75% for the size and 71% for the nodal st a- tus.,Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
29.171.31 January 2015 http://mjiri.iums.ac.irTreatment Different types of treatment modalities have been proposed for patients with rectal cancer.,Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
"29.171.31 January 2015http://mjiri.iums.ac.irLocal Excision Distal rectal tumors with nonaggressive features can be resected by local excision; however, it is not recommended for tumors located in proximal part of rectum.",Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
"29.171.31 January 2015 http://mjiri.iums.ac.irproctoscopic testing, preoperative chem o- radiation, or history of immunosuppressive medication.",Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
29.171.31 January 2015http://mjiri.iums.ac.irIII or high -risk stage II rectal cancer.,Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
29.171.31 January 2015 http://mjiri.iums.ac.irtures and circumferential margins can be assessed u sing MRI.,Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
Available from: http://globocan.iarc.fr/Pa ges/fact_sheets_cancer.asp,Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
29.171.31 January 2015http://mjiri.iums.ac.irx.,Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
29.171.31 January 2015 http://mjiri.iums.ac.irMedicine.,Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
29.171.31 January 2015http://mjiri.iums.ac.ir10.1097/DCR.0b013e3182781668.,Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
29.171.31 January 2015 http://mjiri.iums.ac.ircancer with curative intent.,Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
29.171.31 January 2015http://mjiri.iums.ac.irfor rectal cancer: results from the ACS NSQIP.,Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
"29.171.31 January 2015 http://mjiri.iums.ac.irNogueras JJ, Wexner SD.",Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
"29.171.31 January 2015http://mjiri.iums.ac.irrectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07.",Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
29.171.31 January 2015 http://mjiri.iums.ac.ir15.4138.,Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
29.171.31 January 2015http://mjiri.iums.ac.iradvanced rectal cancer: CT or high -resolution MRI?,Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
29.171.31 January 2015 http://mjiri.iums.ac.irAbdominosacral resection for locally advanced and recurrent rectal cancer.,Non-OADS,/arxiv_data1/oa_pdf/ad/0c/MJIRI-29-171.PMC4431429.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ________________________________ ____________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/e0/f1/MJIRI-29-172.PMC4431430.pdf
"29.172.2 February 2015 http://mjiri.iums.ac.irwith several anaerobic bacteria like Ba c- teroides,Clostridium perfringens and Baci l- lus fragilis.",Non-OADS,/arxiv_data1/oa_pdf/e0/f1/MJIRI-29-172.PMC4431430.pdf
29.172.2 February 2015 http://mjiri.iums.ac.irColostomy was carried out for fecal d i- version when the source of infection orig i- nated from the anorectum and the sphincter wasinfected.,Non-OADS,/arxiv_data1/oa_pdf/e0/f1/MJIRI-29-172.PMC4431430.pdf
29.172.2 February 2015 http://mjiri.iums.ac.irand Clostridium perfringens.,Non-OADS,/arxiv_data1/oa_pdf/e0/f1/MJIRI-29-172.PMC4431430.pdf
"29.172.2 February 2015 http://mjiri.iums.ac.irsuitable antibiotic administration, and ex- tensive operation could significantly reduce mortality as well as morbidity.",Non-OADS,/arxiv_data1/oa_pdf/e0/f1/MJIRI-29-172.PMC4431430.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/67/e7/MJIRI-29-184.PMC4431431.pdf
29.184.23February 2015http://mjiri.iums.ac.irdifferent classifications (6).,Non-OADS,/arxiv_data1/oa_pdf/67/e7/MJIRI-29-184.PMC4431431.pdf
29.184.23February 2015 http://mjiri.iums.ac.irdren (29) and may notably make them m o- tivated once experimenters try to evaluate their cogn itive skills.,Non-OADS,/arxiv_data1/oa_pdf/67/e7/MJIRI-29-184.PMC4431431.pdf
29.184.23February 2015http://mjiri.iums.ac.irthe visual field effect on attention alloc a- tion).,Non-OADS,/arxiv_data1/oa_pdf/67/e7/MJIRI-29-184.PMC4431431.pdf
29.184.23February 2015 http://mjiri.iums.ac.irComputerized Stroop C olor-Word Test was determined.,Non-OADS,/arxiv_data1/oa_pdf/67/e7/MJIRI-29-184.PMC4431431.pdf
"29.184.23February 2015http://mjiri.iums.ac.irlected from10 first -grade participants, the test was perceived to be attractive (n=10, 100%), the time duration for each trial was sufficient (n=8, 80%) and the task was si m- ple (n=8, 80%).",Non-OADS,/arxiv_data1/oa_pdf/67/e7/MJIRI-29-184.PMC4431431.pdf
"29.184.23February 2015 http://mjiri.iums.ac.irDiscussion Theaim of this study was to develop and validate an instrument, which is interesting to children, to test their selective attention.",Non-OADS,/arxiv_data1/oa_pdf/67/e7/MJIRI-29-184.PMC4431431.pdf
"29.184.23February 2015http://mjiri.iums.ac.iradult is 7 ±2 , or by letting the target stim u- lus remain displayed on the screen until the end of the replication.",Non-OADS,/arxiv_data1/oa_pdf/67/e7/MJIRI-29-184.PMC4431431.pdf
29.184.23February 2015 http://mjiri.iums.ac.irConclusion The computer -based Selective Visual A t- tention Test is an easily administered i n- strument to assess selective attention in children who were not literate.,Non-OADS,/arxiv_data1/oa_pdf/67/e7/MJIRI-29-184.PMC4431431.pdf
29.184.23February 2015http://mjiri.iums.ac.irNimmo-Smith I.,Non-OADS,/arxiv_data1/oa_pdf/67/e7/MJIRI-29-184.PMC4431431.pdf
(cited 2010 Jun20]; Available from: http://www.animaldream guide.com.,Non-OADS,/arxiv_data1/oa_pdf/67/e7/MJIRI-29-184.PMC4431431.pdf
2011 (cited 2011 Dec 14]; Available from: http://fin6.com.,OADS,/arxiv_data1/oa_pdf/67/e7/MJIRI-29-184.PMC4431431.pdf
"29.184.23February 2015 http://mjiri.iums.ac.ir55.De Luca M, Borrelli M, Judica A, Spinelli D, Zoccolotti P. Reading words and pseudowords: an eye movement study of developmental dyslexia.",Non-OADS,/arxiv_data1/oa_pdf/67/e7/MJIRI-29-184.PMC4431431.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/29/12/MJIRI-29-181.PMC4431432.pdf
"29.181.17 February 2015http://mjiri.iums.ac.irteinuriaand during the neonatal per iod as weight gain disorder, polyuric dehydration and urinary tract infection (7).",Non-OADS,/arxiv_data1/oa_pdf/29/12/MJIRI-29-181.PMC4431432.pdf
"29.181.17 February 2015 http://mjiri.iums.ac.ir(GFR=30 -59cc/min/1.73m2) and kidney damage with severely decreased GFR (GFR=15 -29 cc/min/1.73m2) ,respectively (25).",Non-OADS,/arxiv_data1/oa_pdf/29/12/MJIRI-29-181.PMC4431432.pdf
"29.181.17 February 2015http://mjiri.iums.ac.irconsidering the exclusion/inclusion criteria and obtaining informed consent from chi l- dren’s parents for participating in the study, basic information (age, sex) was recorded.",Non-OADS,/arxiv_data1/oa_pdf/29/12/MJIRI-29-181.PMC4431432.pdf
29.181.17 February 2015 http://mjiri.iums.ac.irmixed type (p= 0.189) and the gender di s- tribution of children in the two groups (T a- ble 2).,Non-OADS,/arxiv_data1/oa_pdf/29/12/MJIRI-29-181.PMC4431432.pdf
"29.181.17 February 2015http://mjiri.iums.ac.irthe importance of the relationships between different types of psychiatric disorders and CKD and lack of enough evidence concer n- ing the relationship between ADHD and different stages of CKD in children, co n- ducting further studies in this field is re c- ommended.",Non-OADS,/arxiv_data1/oa_pdf/29/12/MJIRI-29-181.PMC4431432.pdf
"29.181.17 February 2015 http://mjiri.iums.ac.irpractice guidelines for chronic kidney disease: eva l- uation, classification, andstratification.",Non-OADS,/arxiv_data1/oa_pdf/29/12/MJIRI-29-181.PMC4431432.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.Postdoctoral Researcher, Clinical Epidemiology Unit, Orthopaedics, Department of Clinical Sciences -Lund, Lund University, Lund, Sweden .",Non-OADS,/arxiv_data1/oa_pdf/3d/5a/MJIRI-29-178.PMC4431433.pdf
29.178.14 February 2015http://mjiri.iums.ac.irdeaths and 12 million life -years of ill health each year (4).,Non-OADS,/arxiv_data1/oa_pdf/3d/5a/MJIRI-29-178.PMC4431433.pdf
"29.178.14 February 2015 http://mjiri.iums.ac.irandalso individual data about mental health, health -related quality of life, pain, physical activity, social capital and oral health, through a multi -stage cluster ra n- dom sampling proportional to population size at neighborhood level.",Non-OADS,/arxiv_data1/oa_pdf/3d/5a/MJIRI-29-178.PMC4431433.pdf
"29.178.14 February 2015 http://mjiri.iums.ac.irhighest prevalence of overweight and ob e- sity were obse rved in people in the age groups of 15 -24 and 45 -54 years old, r e- spectively.",Non-OADS,/arxiv_data1/oa_pdf/3d/5a/MJIRI-29-178.PMC4431433.pdf
29.178.14 February 2015 http://mjiri.iums.ac.irparities in distribution of overweight and obesity across sociodemographic strata and the districts in Tehran.,Non-OADS,/arxiv_data1/oa_pdf/3d/5a/MJIRI-29-178.PMC4431433.pdf
"29.178.14 February 2015 http://mjiri.iums.ac.iristics living in the districts such as attitudes, beliefs, socioeconomic status, and physical activity; second, it might be due to diffe r- ences in environmental features of the di s- trictssuch as availability of places for physical activity, access to health care; third, differences in implemented policies by health authorities or municipalities which support healthy life style.While overweight was less common among females, they were m ore obese than males in all districts of Tehran.",Non-OADS,/arxiv_data1/oa_pdf/3d/5a/MJIRI-29-178.PMC4431433.pdf
"29.178.14 February 2015  http://mjiri.iums.ac.irConsistent with some previous studies in Iran(5, 13), the results showed that ove r- weight and obesity rose with age until age 54 and decrease later on.",Non-OADS,/arxiv_data1/oa_pdf/3d/5a/MJIRI-29-178.PMC4431433.pdf
29.178.14 February 2015http://mjiri.iums.ac.irplying considerable economic bur den for health system which needs to be considered by health authorities and policy -makers in Iran.,Non-OADS,/arxiv_data1/oa_pdf/3d/5a/MJIRI-29-178.PMC4431433.pdf
"29.178.14 February 2015 http://mjiri.iums.ac.irtionship between the body mass index and body fat: cross -sectional, population -based data.",OADS,/arxiv_data1/oa_pdf/3d/5a/MJIRI-29-178.PMC4431433.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________ _____________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/a3/e1/MJIRI-29-174.PMC4431434.pdf
29.174.7February 2015http://mjiri.iums.ac.irhalf (55.5%) endorsed a history of IPV and the majority (86.0%) endorsed a hist ory of sexual violence (2).,Non-OADS,/arxiv_data1/oa_pdf/a3/e1/MJIRI-29-174.PMC4431434.pdf
"29.174.7February 2015 http://mjiri.iums.ac.irthe last 12 months, 2) lifetime exposure to IPV by a husband or intimate partner, and 3) ability to provid e informed consent.",Non-OADS,/arxiv_data1/oa_pdf/a3/e1/MJIRI-29-174.PMC4431434.pdf
29.174.7February 2015http://mjiri.iums.ac.irStatistical Analysis Our main goal in the analysis was to d e- termine whether higher levels of IPV were associated with higher -risk sexual beha v- iors in the studied women.,Non-OADS,/arxiv_data1/oa_pdf/a3/e1/MJIRI-29-174.PMC4431434.pdf
29.174.7February 2015 http://mjiri.iums.ac.irAll women were classified as IPV victims and none of them were classified as IPV perpetrators.,Non-OADS,/arxiv_data1/oa_pdf/a3/e1/MJIRI-29-174.PMC4431434.pdf
"29.174.7February 2015http://mjiri.iums.ac.irIn Table 4, we present the associations between specific abuse domains and co n- dom use.",Non-OADS,/arxiv_data1/oa_pdf/a3/e1/MJIRI-29-174.PMC4431434.pdf
29.174.7February 2015 http://mjiri.iums.ac.irvariable associated with higher risk of IPV amongst women (21).,Non-OADS,/arxiv_data1/oa_pdf/a3/e1/MJIRI-29-174.PMC4431434.pdf
29.174.7February 2015http://mjiri.iums.ac.irwe worked to minimize recall bias by e n- couraging the participants to respond to all questions as accurately as they could.,Non-OADS,/arxiv_data1/oa_pdf/a3/e1/MJIRI-29-174.PMC4431434.pdf
"29.174.7February 2015 http://mjiri.iums.ac.irAS, Azadmehr H, Assari S, Lankarani MM.",Non-OADS,/arxiv_data1/oa_pdf/a3/e1/MJIRI-29-174.PMC4431434.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/f0/94/MJIRI-29-182.PMC4431435.pdf
29.182.17 February 2015http://mjiri.iums.ac.irdefined as a person’s ability to appreciate the funny side of a situation (7).,Non-OADS,/arxiv_data1/oa_pdf/f0/94/MJIRI-29-182.PMC4431435.pdf
"29.182.17 February 2015 http://mjiri.iums.ac.ir‘What are your experiences of humour?’, ‘As a nurse, what do you do to make your working shift more pleasa nt?’, and ‘What factors make you use or not use humor?’ Depending on the participants’ preferences, interviews were conducted in the researc h- er’s room in the nursing department.",Non-OADS,/arxiv_data1/oa_pdf/f0/94/MJIRI-29-182.PMC4431435.pdf
"29.182.17 February 2015http://mjiri.iums.ac.irA nurse said, “Humor calls for being able to relate well to the patients; however, b e- cause I am a Muslim, I cannot behave too friendly with the male patients.” Understanding Humour: Participants b e- lieved that it was important to consider p a- tients and their companions, as their unde r- standing of nurse's humor would help r e- solve any misunderstandings; and the p a- tient would be less cautious around th e nurse and this would minimise patients’ harsh reactions toward nurses.",Non-OADS,/arxiv_data1/oa_pdf/f0/94/MJIRI-29-182.PMC4431435.pdf
"29.182.17 February 2015 http://mjiri.iums.ac.irsulted in her detesting me and not talking to me for a long time.” Consideration of Unique Per sonal Cha r- acteristics: Most nurses believed that u n- derstanding and analysing  a patient or co l- league’s personality and their demographic characteristics such as age, gender, soci o- economic level, personality and mood is necessary when using humour.",Non-OADS,/arxiv_data1/oa_pdf/f0/94/MJIRI-29-182.PMC4431435.pdf
"29.182.17 February 2015http://mjiri.iums.ac.irOne nurse commented, “In my organis a- tion, humour and laughter are considered unethical behaviour for nurses.",Non-OADS,/arxiv_data1/oa_pdf/f0/94/MJIRI-29-182.PMC4431435.pdf
"29.182.17 February 2015 http://mjiri.iums.ac.irwas a means to assess the situation, ope n- ing them up to psychological, emotional, and physical ab use.",Non-OADS,/arxiv_data1/oa_pdf/f0/94/MJIRI-29-182.PMC4431435.pdf
29.182.17 February 2015http://mjiri.iums.ac.irempathy.,Non-OADS,/arxiv_data1/oa_pdf/f0/94/MJIRI-29-182.PMC4431435.pdf
"29.182.17 February 2015 http://mjiri.iums.ac.irgious Iranian culture, humour is considered a pleasant attribute, recommended to a ce r- tain extent by religious leaders.",Non-OADS,/arxiv_data1/oa_pdf/f0/94/MJIRI-29-182.PMC4431435.pdf
29.182.17 February 2015http://mjiri.iums.ac.irand sorrow (32).,Non-OADS,/arxiv_data1/oa_pdf/f0/94/MJIRI-29-182.PMC4431435.pdf
29.182.17 February 2015 http://mjiri.iums.ac.irmodels.,Non-OADS,/arxiv_data1/oa_pdf/f0/94/MJIRI-29-182.PMC4431435.pdf
Available at: http://clearinghouse.missouriwestern.edu/manuscrip ts/153.asp.,Non-OADS,/arxiv_data1/oa_pdf/f0/94/MJIRI-29-182.PMC4431435.pdf
"Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.MD, M.P.H, Associate Professor, Occupational Medicine Research Center (OMRC), Iran University of Medical Sciences and Health Se r- vices (IUMS), Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/55/6f/MJIRI-29-190.PMC4431440.pdf
29.190.10 March2015http://mjiri.iums.ac.irimportant causes of disability and morbid i- ty in workers.,Non-OADS,/arxiv_data1/oa_pdf/55/6f/MJIRI-29-190.PMC4431440.pdf
29.190.10 March2015 http://mjiri.iums.ac.irtomobile factory in Tehran.,Non-OADS,/arxiv_data1/oa_pdf/55/6f/MJIRI-29-190.PMC4431440.pdf
"29.190.10 March2015http://mjiri.iums.ac.irpain or discomfort in the soft tissue of the neck or shoulder regions, which had o c- curred at least for 2 -3 work days during the past week or year.",Non-OADS,/arxiv_data1/oa_pdf/55/6f/MJIRI-29-190.PMC4431440.pdf
29.190.10 March2015 http://mjiri.iums.ac.irhad been described in ergonomic training methods.,Non-OADS,/arxiv_data1/oa_pdf/55/6f/MJIRI-29-190.PMC4431440.pdf
29.190.10 March2015http://mjiri.iums.ac.irmobile factory.,Non-OADS,/arxiv_data1/oa_pdf/55/6f/MJIRI-29-190.PMC4431440.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/be/21/MJIRI-29-179.PMC4431441.pdf
29.179.15 February 2015http://mjiri.iums.ac.irerty and social exclusion (16).,Non-OADS,/arxiv_data1/oa_pdf/be/21/MJIRI-29-179.PMC4431441.pdf
29.179.15 February 2015 http://mjiri.iums.ac.irsome participants could not stand long i n- terview.,Non-OADS,/arxiv_data1/oa_pdf/be/21/MJIRI-29-179.PMC4431441.pdf
29.179.15 February 2015http://mjiri.iums.ac.irParticipants believed that work was effe c- tive for management of their mental sym p- toms.,Non-OADS,/arxiv_data1/oa_pdf/be/21/MJIRI-29-179.PMC4431441.pdf
"29.179.15 February 2015 http://mjiri.iums.ac.irEscaping from boring routines and having fun times Escaping from boring routines Being inactive made participant feel bored, thus they tried to find a way to ma n- age their time better.",Non-OADS,/arxiv_data1/oa_pdf/be/21/MJIRI-29-179.PMC4431441.pdf
29.179.15 February 2015http://mjiri.iums.ac.irdolence.,Non-OADS,/arxiv_data1/oa_pdf/be/21/MJIRI-29-179.PMC4431441.pdf
29.179.15 February 2015 http://mjiri.iums.ac.irency”.,Non-OADS,/arxiv_data1/oa_pdf/be/21/MJIRI-29-179.PMC4431441.pdf
29.179.15 February 2015http://mjiri.iums.ac.irpsychiatric disabilities and employment service pr o- viders.,Non-OADS,/arxiv_data1/oa_pdf/be/21/MJIRI-29-179.PMC4431441.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/f9/76/MJIRI-29-180.PMC4431442.pdf
"29.180.16 February 2015http://mjiri.iums.ac.irfy the pathogen linked molecular pattern (PAMPs) of the microbes, including viruses and induce immune responses including gnicotinamide adenine dinucleotide pho s- phate(NADPH) oxidase activation (6), mi- gration(7), phagocytosis (8)and inflamm a- tory cytokine expression (9).TLRsaccom- plishthediscussed topics throughthe mye- loid differentiation primary response 88 (MYD88) and the TIR-domain-containing adapter-inducing interferon -β(TRIF) d e- pendent pathways (10).",Non-OADS,/arxiv_data1/oa_pdf/f9/76/MJIRI-29-180.PMC4431442.pdf
"29.180.16 February 2015 http://mjiri.iums.ac.irkit (Cinnaclon, Tehran, Iran) in accordance with the manufacturer’s information.",Non-OADS,/arxiv_data1/oa_pdf/f9/76/MJIRI-29-180.PMC4431442.pdf
"29.180.16 February 2015http://mjiri.iums.ac.irDiscussion Previous studies demonstrated that CHB patients suffer from psychiatry disorders including depression and anxiety (Keskin et al., 2012) .",Non-OADS,/arxiv_data1/oa_pdf/f9/76/MJIRI-29-180.PMC4431442.pdf
29.180.16 February 2015 http://mjiri.iums.ac.irAcknowledgments The authors would like to thank all the participants of the study.,Non-OADS,/arxiv_data1/oa_pdf/f9/76/MJIRI-29-180.PMC4431442.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ______________________________ ______________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/24/2e/MJIRI-29-176.PMC4431443.pdf
29.176.9 February 2015http://mjiri.iums.ac.irtervention.,Non-OADS,/arxiv_data1/oa_pdf/24/2e/MJIRI-29-176.PMC4431443.pdf
29.176.9 February 2015 http://mjiri.iums.ac.irMethods Hazrat Rasoul -e-Akram Hospital is a 426 - bed Hospital in Tehran.,Non-OADS,/arxiv_data1/oa_pdf/24/2e/MJIRI-29-176.PMC4431443.pdf
29.176.9 February 2015http://mjiri.iums.ac.irequal results to the initial test run.,Non-OADS,/arxiv_data1/oa_pdf/24/2e/MJIRI-29-176.PMC4431443.pdf
"29.176.9 February 2015 http://mjiri.iums.ac.irvalues, the repeat values of 52 specimens (63.4%) had equal results to the initial test run.",Non-OADS,/arxiv_data1/oa_pdf/24/2e/MJIRI-29-176.PMC4431443.pdf
"29.176.9 February 2015http://mjiri.iums.ac.ir0.8 to 1, and the mean values in the range of 5.6 to 6.5.",OADS,/arxiv_data1/oa_pdf/24/2e/MJIRI-29-176.PMC4431443.pdf
29.176.9 February 2015 http://mjiri.iums.ac.irred blood cells is important to the laborat o- ry because it can have an effect on labor a- tory results by increasing them falsely.,Non-OADS,/arxiv_data1/oa_pdf/24/2e/MJIRI-29-176.PMC4431443.pdf
Available at: http://www.jcaho.org/ accredit- ed+organizations/patient+safety/npsg.htm.,Non-OADS,/arxiv_data1/oa_pdf/24/2e/MJIRI-29-176.PMC4431443.pdf
29.176.9 February 2015http://mjiri.iums.ac.ir19.,Non-OADS,/arxiv_data1/oa_pdf/24/2e/MJIRI-29-176.PMC4431443.pdf
"2009 National patient safety goals, laboratory services Program (NPSGs).http://www.jointcommission.org/patientsaf ety/nationalpatientsafetygoals.Accessed April 1, 2010.",OADS,/arxiv_data1/oa_pdf/24/2e/MJIRI-29-176.PMC4431443.pdf
http://www.cap .,Non-OADS,/arxiv_data1/oa_pdf/24/2e/MJIRI-29-176.PMC4431443.pdf
Original Article http://mjiri.iums.ac.ir MedicalJournal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/cd/a6/MJIRI-29-170.PMC4431444.pdf
"29.170.28 January 2015http://mjiri.iums.ac.iran activated Factor VII (FVIIa) conce n- trate, prepared from human plasma on a largescale became available for clinical use for haemophiliacs with antibodies against FVIII and FIX (5).",Non-OADS,/arxiv_data1/oa_pdf/cd/a6/MJIRI-29-170.PMC4431444.pdf
29.170.28 January 2015 http://mjiri.iums.ac.irpeak of FVII (Fractions 48 -50) and the m i- nor peak of FIX (Fractions 46 -51) has been shown; activity of other coagulation factors was lower.,OADS,/arxiv_data1/oa_pdf/cd/a6/MJIRI-29-170.PMC4431444.pdf
"29.170.28 January 2015 http://mjiri.iums.ac.ir2) indicated that factor VII concentrate co n- tained approximately 89% alpha -2 proteins, providing evidence of its improved purity as compared with PPSB which contains three major bands of alpha -1, alpha-2 and beta proteins.",Non-OADS,/arxiv_data1/oa_pdf/cd/a6/MJIRI-29-170.PMC4431444.pdf
29.170.28 January 2015 http://mjiri.iums.ac.irHaematol1980; 45: 107 -18.,Non-OADS,/arxiv_data1/oa_pdf/cd/a6/MJIRI-29-170.PMC4431444.pdf
29.170.28 January 2015http://mjiri.iums.ac.ir51.,Non-OADS,/arxiv_data1/oa_pdf/cd/a6/MJIRI-29-170.PMC4431444.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences _______________________________________________________________________________ _____________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/39/88/MJIRI-29-185.PMC4431445.pdf
"29.185.23 February 2015http://mjiri.iums.ac.irprotect against such I/R injury in tissues (7- 9) To counteract ROS formation, ROS sca v- engers/antioxidants are of prime i m- portance to prevent and control human di s- eases.",Non-OADS,/arxiv_data1/oa_pdf/39/88/MJIRI-29-185.PMC4431445.pdf
29.185.23 February 2015  http://mjiri.iums.ac.ircyanidin) dissolved in water was admini s- tered by orogastric tube in the intervention group and the same amount of normal s a- line was given to other groups by orogas tric tube at the same time (Fig .1).,Non-OADS,/arxiv_data1/oa_pdf/39/88/MJIRI-29-185.PMC4431445.pdf
"29.185.23 February 2015http://mjiri.iums.ac.irhemorrhage (p< 0.001), edema (p=0.001) and vascular dilatation (p< 0.001) (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/39/88/MJIRI-29-185.PMC4431445.pdf
29.185.23 February 2015 http://mjiri.iums.ac.iromyocytes and limited the infarct size in I/R damage.,Non-OADS,/arxiv_data1/oa_pdf/39/88/MJIRI-29-185.PMC4431445.pdf
16.http://comudam.comu.edu.tr/index.,Non-OADS,/arxiv_data1/oa_pdf/39/88/MJIRI-29-185.PMC4431445.pdf
29.185.23 February 2015http://mjiri.iums.ac.ircol Reprod Biol.,Non-OADS,/arxiv_data1/oa_pdf/39/88/MJIRI-29-185.PMC4431445.pdf
Original Article http://mjiri.iums.ac.ir MedicalJournal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/e3/6a/MJIRI-29-164.PMC4431446.pdf
29.164.26 January 2015http://mjiri.iums.ac.irthe cerebellum.,Non-OADS,/arxiv_data1/oa_pdf/e3/6a/MJIRI-29-164.PMC4431446.pdf
26 January 2015  http://mjiri.iums.ac.irtheir jaw against the hand -held inflated cuff to generate a 40 millimeter of mercury cuff pressure(14).,Non-OADS,/arxiv_data1/oa_pdf/e3/6a/MJIRI-29-164.PMC4431446.pdf
29.164.26 January 2015http://mjiri.iums.ac.irright and left side (p>0.05).,Non-OADS,/arxiv_data1/oa_pdf/e3/6a/MJIRI-29-164.PMC4431446.pdf
26 January 2015 http://mjiri.iums.ac.irpatients and not recorded in 52.59% (n=9) of patients.,Non-OADS,/arxiv_data1/oa_pdf/e3/6a/MJIRI-29-164.PMC4431446.pdf
29.164.26 January 2015http://mjiri.iums.ac.irFindings of the current study showed that abnormality of both cVEMP and oVEMP in MS patient with infratentorial plaque are more than that of MS patient without in- fratentorial plaque.,Non-OADS,/arxiv_data1/oa_pdf/e3/6a/MJIRI-29-164.PMC4431446.pdf
"26 January 2015 http://mjiri.iums.ac.ir24.Su CH, Young YH.",Non-OADS,/arxiv_data1/oa_pdf/e3/6a/MJIRI-29-164.PMC4431446.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/df/86/MJIRI-29-188.PMC4431447.pdf
"29.188.9 March2015http://mjiri.iums.ac.ir(outlet dysfunction) could be as high as 36.5%(1).Significant healthcare resources are often spent on chronic constipation, and it imposes a large socio -economic burden to the society (2).",Non-OADS,/arxiv_data1/oa_pdf/df/86/MJIRI-29-188.PMC4431447.pdf
"29.188.9 March2015  http://mjiri.iums.ac.iraxis, which is significantly disturbed bi - directionally, and thereby improves bo wel function.",Non-OADS,/arxiv_data1/oa_pdf/df/86/MJIRI-29-188.PMC4431447.pdf
29.188.9 March2015http://mjiri.iums.ac.irdigital rectal examination (DRE) (20).,Non-OADS,/arxiv_data1/oa_pdf/df/86/MJIRI-29-188.PMC4431447.pdf
"29.188.9 March2015 http://mjiri.iums.ac.irtion by a 4 -element phased -array coil, which was placed around the pelvis of the patient.",Non-OADS,/arxiv_data1/oa_pdf/df/86/MJIRI-29-188.PMC4431447.pdf
29.188.9 March2015http://mjiri.iums.ac.irwere consulted to avoid straining m ore than 5 minutes during defecation).The patients were advised not to use digital maneuvers to facilitate defecation.,Non-OADS,/arxiv_data1/oa_pdf/df/86/MJIRI-29-188.PMC4431447.pdf
29.188.9 March2015  http://mjiri.iums.ac.irand dyssynergic defecation were included in the study.,Non-OADS,/arxiv_data1/oa_pdf/df/86/MJIRI-29-188.PMC4431447.pdf
"29.188.9 March2015http://mjiri.iums.ac.irQOL and Depression, within and between Group Analysis :Based on the results of the paired t -tests , depression and the fo l- lowing three out of eight QOL subscales significantly improved in the BFT:   fun c- tioning (p= 0.020), vitality ( p=0.006) and role emotion ( p= 0.007).",Non-OADS,/arxiv_data1/oa_pdf/df/86/MJIRI-29-188.PMC4431447.pdf
29.188.9 March2015 http://mjiri.iums.ac.irdetermine the improvement of pelvic floor motion dysfunction after BFT.,Non-OADS,/arxiv_data1/oa_pdf/df/86/MJIRI-29-188.PMC4431447.pdf
"29.188.9 March2015http://mjiri.iums.ac.irtreatment plan for dyssenergic patients, b e- sides BFT; however, no obvious change was observed in the success rate compared to the previous studies.",Non-OADS,/arxiv_data1/oa_pdf/df/86/MJIRI-29-188.PMC4431447.pdf
29.188.9 March2015 http://mjiri.iums.ac.irsuitable treatments and achi eving better clinical outcome.,Non-OADS,/arxiv_data1/oa_pdf/df/86/MJIRI-29-188.PMC4431447.pdf
"29.188.9 March2015http://mjiri.iums.ac.ir22.Chu WC,Tam YH,Lam WW ,Ng AW,Sit F, Yeung CK .Dynamic MR assessment of the anore c- tal angle and puborectalis muscle in pediatric p a- tients with anismus: technique and feasibility.",Non-OADS,/arxiv_data1/oa_pdf/df/86/MJIRI-29-188.PMC4431447.pdf
Original Article http://mjiri.iums.ac.ir Medical Journal of the Islamic Republic of Iran (MJIRI) Iran University of Medical Sciences ____________________________________________________________________________________________________________________ 1.,Non-OADS,/arxiv_data1/oa_pdf/87/aa/MJIRI-29-175.PMC4431452.pdf
29.175.8 February 2015http://mjiri.iums.ac.iremotional needs of these patients are mos t- ly ignored (4).,Non-OADS,/arxiv_data1/oa_pdf/87/aa/MJIRI-29-175.PMC4431452.pdf
"29.175.8 February 2015 http://mjiri.iums.ac.irwhich women with  breast cancer face and evidences related to the mindfulness -based stress reduction program on different ps y- chological variables, this study was d e- signed with the aim of examining the effect of the mindfulness -based stress reduction program on improving global and specific life quality of the patients.",Non-OADS,/arxiv_data1/oa_pdf/87/aa/MJIRI-29-175.PMC4431452.pdf
"29.175.8 February 2015http://mjiri.iums.ac.irdisturbances, constipation and diarrhea) and economic problems caused by the di s- ease and the treatment (an overall domain of life quality) (31).",Non-OADS,/arxiv_data1/oa_pdf/87/aa/MJIRI-29-175.PMC4431452.pdf
29.175.8 February 2015 http://mjiri.iums.ac.irvention.,Non-OADS,/arxiv_data1/oa_pdf/87/aa/MJIRI-29-175.PMC4431452.pdf
"29.175.8 February 2015 http://mjiri.iums.ac.irtest, post-test and follow -up in the  exper i- mental and control groups are reported in Table3.",OADS,/arxiv_data1/oa_pdf/87/aa/MJIRI-29-175.PMC4431452.pdf
29.175.8 February 2015  http://mjiri.iums.ac.irfollow-up in the experimental and control groups are reported in Table3.,OADS,/arxiv_data1/oa_pdf/87/aa/MJIRI-29-175.PMC4431452.pdf
"29.175.8 February 2015http://mjiri.iums.ac.irtoms scale, but it was significant in the  d i- mension of sadness due to hair loss (p>0.05).",Non-OADS,/arxiv_data1/oa_pdf/87/aa/MJIRI-29-175.PMC4431452.pdf
29.175.8 February 2015 http://mjiri.iums.ac.irwhich suggest that the intervention effect in this dimension was not consistent.,Non-OADS,/arxiv_data1/oa_pdf/87/aa/MJIRI-29-175.PMC4431452.pdf
29.175.8 February 2015http://mjiri.iums.ac.irorientation.,Non-OADS,/arxiv_data1/oa_pdf/87/aa/MJIRI-29-175.PMC4431452.pdf
29.175.8 February 2015 http://mjiri.iums.ac.irkara-Turkey: Publisher New hope in health found a- tion.,Non-OADS,/arxiv_data1/oa_pdf/87/aa/MJIRI-29-175.PMC4431452.pdf
"Fang C, Reibel D, Longacre M, Rosenzweig S, Campbell D, Douglas S. Enhanced psychosocial well-being following participation in a mindfulness - based stress reduction programis associated wit h increased natural killer cell activity.2010.J Altern Complement Med, 16, 531 -38.http://dx.doi.org/ 10.1089/acm.2009.0018.",Non-OADS,/arxiv_data1/oa_pdf/87/aa/MJIRI-29-175.PMC4431452.pdf
29.175.8 February 2015http://mjiri.iums.ac.ir32.,Non-OADS,/arxiv_data1/oa_pdf/87/aa/MJIRI-29-175.PMC4431452.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6d/99/tcrm-11-759.PMC4431469.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pTherapeutics and Clinical Risk Management 2015:11 759–766Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  759Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S6912 3Profile of PEGylated interferon beta in the  treatment of relapsing-remitting multiple sclerosis eleonora Cocco Maria Giovanna Marrosu Multiple Sclerosis Center, Department  of Public Health, Clinical and  Molecular Medicine, University of  Cagliari, Cagliari, ItalyAbstract:  Several treatments are currently available for relapsing-remitting multiple sclerosis.",Non-OADS,/arxiv_data1/oa_pdf/6d/99/tcrm-11-759.PMC4431469.pdf
"No definitive therapies exist to cure MS, but a set of  drugs is used to reduce the inflammatory activity (relapses and magnetic resonance imaging  [MRI] parameters) and to delay the progression of disability over time.1 Interferon (IFN) beta has immunomodulatory properties, antiviral and antiprolif - erative effects, promotes cell differentiation, and exerts a pleiotropic mechanism of  action in MS.2 Among other effects, IFN beta: •	Downregulates the expression of major histocompatibility complex class II mol - ecules on various antigen-presenting cells •	Reduces the migration of T-cells across the brain barriers by decreasing the secre - tion of proteolytic matrix metalloproteinases and surface-expressed adhesion Correspondence: eleonora Cocco Multiple Sclerosis Center, Department  of Public Health, Clinical and Molecular  Medicine, University of Cagliari/Binaghi  Hospital, Via Is Guadazzonis,   2, 09126 Cagliari, Italy Tel +39 070 609 3027 Fax +39 070 609 2929 email ecocco@unica.i t Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Cocco and Marrosu Running head recto: PEGylated interferon beta in multiple sclerosis DOI: http://dx.doi.org/10.2147/TCRM.S69123",Non-OADS,/arxiv_data1/oa_pdf/6d/99/tcrm-11-759.PMC4431469.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/6d/99/tcrm-11-759.PMC4431469.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/99/tcrm-11-759.PMC4431469.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/50/c2/clep-7-305.PMC4431470.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Epidemiology 2015:7 305–312Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  305Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S7335 5The Danish national Prescription registry   in studies of a biological pharmaceutical:   palivizumab – validation against two external   data sources ann haerskjold1,2 lonny henriksen2 susanne Way1 Mikkel Malham3 Jesper hallas4 lars Pedersen5 lone graff stensballe1 1The Child and adolescent Clinic  4072, Copenhagen University  hospital rigshospitalet, Copenhagen,  Denmark; 2The research Unit  Women’s and Children’s health,  The Juliane Marie Centre for  Women, Children and reproduction,  Copenhagen University hospital  rigshospitalet, Copenhagen,  Denmark; 3Department of Pediatrics,  hvidovre University hospital,  hvidovre, Denmark; 4Department of  Clinical Pharmacology, institute of  Public health, University of southern  Denmark, Denmark; 5Department  of Clinical Epidemiology, aarhus  University hospital, aarhus n,  Denmark Correspondence: ann haerskjold   The research Unit Women’s and  Children’s health, The Juliane Marie  Centre for Women, Children and  reproduction, Copenhagen University  hospital, rigshospitalet, Tagensvej 22,  2100 Copenhagen, Denmark   Tel +45 2720 9792   Email ann.haerskjold@regionh.d kBackground:  National prescription databases are important tools in pharmacoepidemiologi - cal studies investigating potential long-term adverse events after drug use.",Non-OADS,/arxiv_data1/oa_pdf/50/c2/clep-7-305.PMC4431470.pdf
"Available at: http://www.paediatri.dk/images/ pdf_filer/dps_vejl/001kar.pd f. Accessed January 30, 2014.",Non-OADS,/arxiv_data1/oa_pdf/50/c2/clep-7-305.PMC4431470.pdf
Avail - able at: http://www.paediatri.dk/images/pdf_filer/dps_vejl/neo/013neo.,Non-OADS,/arxiv_data1/oa_pdf/50/c2/clep-7-305.PMC4431470.pdf
2013 Available at: http://e-dok.rm.dk/ edok/Admin/GUI.nsf/Desktop.html?open&openlink=http://e-dok.,Non-OADS,/arxiv_data1/oa_pdf/50/c2/clep-7-305.PMC4431470.pdf
"Available from: https://sundhedsstyrelsen.dk/da/medicin/tilsku d.  Accessed January 4, 2015.",Non-OADS,/arxiv_data1/oa_pdf/50/c2/clep-7-305.PMC4431470.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/50/c2/clep-7-305.PMC4431470.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a9/32/tcrm-11-767.PMC4431471.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 767–777Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  767ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S7742 8T o what extent is clinical and laboratory  information used to perform medication reviews  in the nursing home setting?,Non-OADS,/arxiv_data1/oa_pdf/a9/32/tcrm-11-767.PMC4431471.pdf
"For patients under  40, 41–64, 65–69, 70–74, and over 75 years, the percentage who were polymedicated  was found to be 0%, 8%, 20%, 25%, and 33%, respectively.5  Polymedicated patients are at increased risk of experiencing adverse drug reactions  and possibly undertreatment.6 Frail and disabled nursing home patients on polypharmacy Correspondence: Carlota Mestres  gonzalvo Department of Clinical Pharmacology  and Toxicology, Orbis Medical Centre,   Dr h van der hoffplein 1, 6162 Bg   sittard-geleen, the netherlands Tel +31 88 459 7708 Fax +31 88 459 7179 email c.mestresgonzalvo@orbisconcern.nlJournal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Gonzalvo et al Running head recto: Medication review in the nursing home setting DOI: http://dx.doi.org/10.2147/TCRM.S77428",Non-OADS,/arxiv_data1/oa_pdf/a9/32/tcrm-11-767.PMC4431471.pdf
Available from: https://www.nhg.org/sites/default/files/content/ nhg_org/uploads/polyfarmacie_bij_ouderen.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a9/32/tcrm-11-767.PMC4431471.pdf
Available from:  http://www.sfk.nl/nieuws-publicaties/PW/2012/polyfarmacie-voor-1- op-de-10-apotheekbezoekers.,Non-OADS,/arxiv_data1/oa_pdf/a9/32/tcrm-11-767.PMC4431471.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/a9/32/tcrm-11-767.PMC4431471.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/32/tcrm-11-767.PMC4431471.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/82/52/copd-10-899.PMC4431472.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 899–908International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  899OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7571 0seasonality, ambient temperatures and  hospitalizations for acute exacerbation of COPD:  a population-based study in a metropolitan area Pere almagro1 Carme hernandez2,3,7 Pable Martinez-Cambor4,5 ricard Tresserras2,6 Joan escarrabill2,7 1acute geriatric Care Unit, Internal  Medicine, University hospital Mútua  de T errasa, University of Barcelona,   Barcelona, spain; 2respiratory Disease  Management Plan, Department  of health of the autonomous  government of Catalonia,   Observatory of respiratory Therapy,   3Integrated Care Unit, Medical and  nursing Management, hospital  Clínic Barcelona, Barcelona, 4Oficina  de Investigación Biosanitaria de  Oviedo, asturias, spain; 5Universidad  autonoma de Chile, santiago,   Chile; 6health Department,   7Chronic Diseases Care Program,   hospital  Clinic, hospital Clínic &  reDIsseC (health services research  on Chronic Patients network),   Barcelona, spainBackground:  Excluding the tropics, exacerbations of chronic obstructive pulmonary disease  (COPD) are more frequent in winter.",Non-OADS,/arxiv_data1/oa_pdf/82/52/copd-10-899.PMC4431472.pdf
"According to the World Health  Organization, in 2005, COPD affected 210 million people, of whom 3 million died  from the disease.1 More recently, the Global Burden of Disease Study estimated that,  in 2010, COPD was the third leading cause of death globally and ninth in disability- adjusted life years.2,3 A great part of this mortality in COPD occurs during exacerbations and the  subsequent weeks, especially in patients hospitalized for severe exacerbations.4,5  Recent studies show that up to one third of patients with COPD require hospitalization Correspondence: Pere almagro acute geriatric Care Unit, Internal  Medicine, hospital Mútua de Terrassa,  Pza Dr robert 5, Terrassa 08221,  Barcelona, spain Tel +349 3736 5050  Fax +349 3736 5550 email 19908pam@comb.e s Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Almagro et al Running head recto: Temperature and hospitalizations for COPD DOI: http://dx.doi.org/10.2147/COPD.S75710",Non-OADS,/arxiv_data1/oa_pdf/82/52/copd-10-899.PMC4431472.pdf
"Available from: http://www.gencat.cat/salut/ depsalut/html/ca/dir3157/plapidirac.pd f. Accessed June 20, 2014.",Non-OADS,/arxiv_data1/oa_pdf/82/52/copd-10-899.PMC4431472.pdf
"Available from:  http://ecdc.europa.e u. Accessed June 20, 2014.",Non-OADS,/arxiv_data1/oa_pdf/82/52/copd-10-899.PMC4431472.pdf
"Available from: http://www20.gencat.cat/ portal/site/mediambient/menuite m. Accessed June 20, 2014.",Non-OADS,/arxiv_data1/oa_pdf/82/52/copd-10-899.PMC4431472.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/82/52/copd-10-899.PMC4431472.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/52/copd-10-899.PMC4431472.pdf
Available  from: http://mediambient.gencat.cat/ca/05_ambits_dactuacio/atmosfera/ qualitat_de_laire/avaluacio/icqa/que_es_lindex_catala_de_qualitat_de_ laire/.,OADS,/arxiv_data1/oa_pdf/82/52/copd-10-899.PMC4431472.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d9/d7/tcrm-11-751.PMC4431473.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 751–757Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  751ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S7937 4Refractory cachexia is associated with increased  plasma concentrations of fentanyl in cancer  patients Manabu suno1,* Yuriko endo1,* hiroyuki nishie2 Makoto Kajizono3 T oshiaki sendo3 Junji Matsuoka4 1Department of Oncology  Pharmaceutical Care and science,   graduate school of Medicine,   Dentistry and Pharmaceutical  sciences, 2Department of  anesthesiology and Resuscitology,   graduate school of Medicine,   Dentistry and Pharmaceutical  sciences, Okayama University,   3Department of Pharmacy, Okayama  University hospital, 4Faculty of health  sciences, Okayama University Medical  school, Okayama, Japan *These authors contributed equally  to this workBackground:  An appropriate plasma concentration of fentanyl is the key to achieving good  pain control in cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d9/d7/tcrm-11-751.PMC4431473.pdf
"Individual differences have been reported in analgesic  effects obtained by cancer patients administered fentanyl.2,3 Individual variations, in  either metabolizing enzymes or skin absorption from the fentanyl transdermal patches,  may affect blood fentanyl concentrations.4,5 However, information on individual Correspondence: Manabu suno Department of Oncology Pharmaceutical  Care and sciences, graduate school of  Medicine, Dentistry and Pharmaceutical  sciences Okayama University,  2-5-1, shikata-cho, Kita-ku,  Okayama 700-8558, Japan Tel +81 86 235 6597 Fax +81 86 235 6597 email sunoma@pharm.okayama-u.ac.j pJournal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Suno et al Running head recto: Impact of cachexia on plasma fentanyl concentrations DOI: http://dx.doi.org/10.2147/TCRM.S79374",Non-OADS,/arxiv_data1/oa_pdf/d9/d7/tcrm-11-751.PMC4431473.pdf
"Available from: http://www.epcrc.org/guidelines.php?p =cachexi a.  Accessed February 15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d9/d7/tcrm-11-751.PMC4431473.pdf
"[updated 2014 Feb; cited 2014 Sep 10]  Available from: http://www.fda.gov/downloads/Drugs/GuidanceCom - plianceRegulatoryInformation/Guidances/UCM386366.pd f. Accessed  September 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d9/d7/tcrm-11-751.PMC4431473.pdf
"[updated 2010 Jun 14; cited 2014 Sep 10] Available  from: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_ QuickReference_8.5x11.pd f. Accessed September 10, 2014.",OADS,/arxiv_data1/oa_pdf/d9/d7/tcrm-11-751.PMC4431473.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/d9/d7/tcrm-11-751.PMC4431473.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/d7/tcrm-11-751.PMC4431473.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b9/56/ndt-11-1161.PMC4431492.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 1161–1167Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1161OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7236 7high relapse rate and poor medication adherence  in the chinese population with schizophrenia:  results from an observational survey in the  People’s republic of china correspondence: hongyan Zhang Department of Psychiatry,  Peking University sixth hospital, Peking  University institute of Mental health, Key  laboratory of Mental health, Ministry  of health, Peking University, 51 huayuan  North road, Beijing 100191, People’s  republic of china  Tel +86 136 0123 7138 Fax +86 010 6206 4549 email hongyanzhang@bjmu.edu.c n Jingbo Xiao Weifeng Mi lingzhi li Ying shi hongyan Zhang Department of Psychiatry,   Peking  University sixth hospital,   Peking University institute of Mental  health, Key laboratory of Mental  health, Ministry of health, Peking  University, Beijing, People’s republic  of china Background:  Relapse is common in schizophrenia, and seriously impacts patients’ quality  of life and social functioning.",Non-OADS,/arxiv_data1/oa_pdf/b9/56/ndt-11-1161.PMC4431492.pdf
"The majority of patients with schizophrenia  typically experience acute symptomatic relapses alternating with periods of full or  partial remission over a period of many years.1 Frequent relapses are associated with  exacerbated psychopathology, a worsened clinical prognosis, and impaired function, Journal name: Neuropsychiatric Disease and Treatmen t Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Xiao et al Running head recto: Relapse rate and medication adherence in Chinese patients with schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S72367",Non-OADS,/arxiv_data1/oa_pdf/b9/56/ndt-11-1161.PMC4431492.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b9/56/ndt-11-1161.PMC4431492.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/56/ndt-11-1161.PMC4431492.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/68/18/jbm-6-143.PMC4431493.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Blood Medicine 2015:6 143–150Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  143Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S7733 2Acquired hemophilia A: emerging   treatment options Maissaa Janbain1 Cindy A Leissinger1 Rebecca Kruse-Jarres2 1Louisiana Center for Bleeding and  Clotting Disorders, Tulane University  Medical Center, New Orleans,  LA, USA;  2washington Center for  Bleeding Disorders, Blood works  Nw, Seattle, wA, USA Correspondence: Rebecca Kruse-Jarres   washington Center for Bleeding  Disorders, Blood works Nw ,   921 Terry Ave, Seattle, wA 98104, USA   Tel +1 206 689 6570  email r ebeccakr@psbc.or gAbstract:  Acquired hemophilia A is a rare autoimmune disorder caused by an autoantibody  (inhibitor) to factor VIII (FVIII) that interferes with its coagulant function and predisposes  to severe, potentially life-threatening hemorrhage.",Non-OADS,/arxiv_data1/oa_pdf/68/18/jbm-6-143.PMC4431493.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/68/18/jbm-6-143.PMC4431493.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/68/18/jbm-6-143.PMC4431493.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ea/d9/ndt-11-1169.PMC4431494.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 1169–1174Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1169OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7986 6evaluation of acute cardiovascular effects  of immediate-release methylphenidate in  children  and adolescents with attention-deficit hyperactivity  disorder correspondence: Marco lamberti Division of child Neurology and  Psychiatry, Department of Pediatrics  and  Department of clinical and experimental  Medicine, Policlinico Universitario  g. Martino, Via consolare Valeria 1,  98125 Messina, italy Tel +39 090 221 2910 Fax +39 090 293 0414 email mlamberti@unime.i t; marcolb@ yahoo.i t Marco lamberti1,2 Domenico italiano2 laura guerriero1 gessica D’amico3 rosamaria siracusano1,4 Massimo ingrassia5 eva germanò1 Maria Pia calabrò3 edoardo spina2 antonella gagliano1 1Division of child Neurology and  Psychiatry, Department of Pediatrics,   2Department of clinical and  experimental Medicine, 3Division of  Pediatric cardiology, Department  of Pediatrics, University of Messina,   Messina, italy; 4institution of clinical  Physiology, cNr, Pisa, 5Division  of Psychology, Department of  humanities and social sciences,   University of Messina, Messina, italyAbstract:  Attention-deficit hyperactivity disorder is a frequent condition in children and often  extends into adulthood.",Non-OADS,/arxiv_data1/oa_pdf/ea/d9/ndt-11-1169.PMC4431494.pdf
"Stimu - lants, such as amphetamines and methylphenidate (MPH), represent the mainstay of  pharmacological treatment for ADHD.5 Amphetamines act by increasing presynaptic  release of dopamine and other biogenic amines in the brain while MPH, a substituted  phenethylamine, inhibits the reuptake of dopamine and norepinephrine and therefore  its pharmacology is identical to that of amphetamines.6Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Lamberti et al Running head recto: Evaluation of acute cardiovascular effects of IR-MPH in ADHD patients DOI: http://dx.doi.org/10.2147/NDT.S79866",Non-OADS,/arxiv_data1/oa_pdf/ea/d9/ndt-11-1169.PMC4431494.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ea/d9/ndt-11-1169.PMC4431494.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/d9/ndt-11-1169.PMC4431494.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d9/15/jpr-8-229.PMC4431495.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 229–238Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  229ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S8349 0Tapentadol prolonged release for patients with  multiple myeloma suffering from moderate-to- severe cancer pain due to bone disease Flaminia coluzzi1,2 Robert B Raffa3 Joseph Pergolizzi4 alessandra Rocco1 Pamela locarini1 natalia cenfra5 giuseppe cimino5 consalvo Mattia1,2 1Department of Medical and surgical  sciences and Biotechnologies,  Faculty of Pharmacy and Medicine,  Unit of anaesthesiology, intensive  care Medicine and Pain Therapy,  Polo Pontino, sapienza University  of Rome, latina, italy;  2siaa RTi  study group on acute and chronic  Pain, Rome, italy;  3Department of  Pharmaceutical sciences, Temple  University school of Pharmacy,  Philadelphia, P a, Usa;  4Department  of Medicine, Johns hopkins University  school of Medicine, Baltimore,  MD, Usa;  5Department of cellular  Biotechnology and hematology,  sapienza University of Rome, Rome,  italy correspondence: Flaminia coluzzi   Department of Medical and surgical  sciences and Biotechnologies,   Faculty of Pharmacy and Medicine,   Unit of anaesthesia, intensive care   and Pain Medicine, sapienza University   of Rome, corso Della Repubblica  79,  04100 latina, italy   Tel +39 0773 6513 334  Fax +39 0773 6513 333  email flaminia.coluzzi@uniroma1.i tContext:  Myeloma bone disease (MBD) is a devastating complication of multiple myeloma  that leads to severe pain.",Non-OADS,/arxiv_data1/oa_pdf/d9/15/jpr-8-229.PMC4431495.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/d9/15/jpr-8-229.PMC4431495.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/15/jpr-8-229.PMC4431495.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3c/d9/rru-7-081.PMC4431496.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pResearch and Reports in Urology 2015:7 81–83Research and Reports in Urology Dove press submit your manuscript | www.dovepress.co m Dove press  81ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/RRU.S8330 9a pilot study of acotiamide hydrochloride   hydrate in patients with detrusor underactivity Koichi sugimoto1 Takahiro akiyama2 nobutaka shimizu3 naoki Matsumura1 Taiji hayashi1 Tsukasa nishioka1 hirotsugu Uemura3 1Department of Urology, sakai  hospital, Kinki University Faculty  of Medicine, sakai, Osaka, Japan;   2Department of Urology, sakai- Onshinkai hospital, sakai, Osaka,  Japan;  3Department of Urology,  Kinki University Faculty of Medicine,  Osaka-sayama, Osaka, Japan correspondence: Koichi sugimoto   Department of Urology, sakai hospital,  Kinki University Faculty of Medicine,   2-7-1 harayamadai, Minami-ku, sakai,  Osaka  590-0132, Japan   email sugimo51@med.kindai.ac.j pAim:  To investigate the clinical efficacy of acotiamide hydrochloride hydrate in patients with  detrusor underactivity.",Non-OADS,/arxiv_data1/oa_pdf/3c/d9/rru-7-081.PMC4431496.pdf
"Research and Reports in Urology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/research-and-reports-in-urology-journa lResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of adult and pediatric urology  in the clinic and laboratory including the following topics: Pathology,  pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of  urological disease.",Non-OADS,/arxiv_data1/oa_pdf/3c/d9/rru-7-081.PMC4431496.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/d9/rru-7-081.PMC4431496.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/a8/ijwh-7-511.PMC4431497.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2015:7 511–515International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  511Case serIesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S8287 9Lichen sclerosus: a potpourri of misdiagnosed  cases based on atypical clinical presentations Gary Ventolini ravi Patel robert Vasquez T exas T ech University Health  sciences  Center Permian Basin,   Odessa, TX, UsaObjective:  Lichen sclerosus (LS) is a chronic progressive inflammatory autoimmune-induced  disease that primarily affects the epidermis and dermis of the external genital-anal region.",Non-OADS,/arxiv_data1/oa_pdf/6e/a8/ijwh-7-511.PMC4431497.pdf
"Correspondence:  Gary Ventolini  Texas Tech University Health sciences  Center Permian Basin, 800 West street,  Odessa, TX 79763, Usa Tel +1 432 703 5134 email gary.ventolini@ttuhsc.ed uJournal name: International Journal of Women’s Health Article Designation: Case Series Y ear: 2015 Volume: 7 Running head verso: Ventolini et al Running head recto: Lichen sclerosus: a potpourri of misdiagnosed cases DOI: http://dx.doi.org/10.2147/IJWH.S82879",Non-OADS,/arxiv_data1/oa_pdf/6e/a8/ijwh-7-511.PMC4431497.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/6e/a8/ijwh-7-511.PMC4431497.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/a8/ijwh-7-511.PMC4431497.pdf
2 http://repository.academyhealth.org/egems/vol3/iss2/2 DOI: 10.13063/2327-9214.1133,Non-OADS,/arxiv_data1/oa_pdf/72/09/egems1133.PMC4431498.pdf
2 http://repository.academyhealth.org/egems/vol3/iss2/2 DOI: 10.13063/2327-9214.1133,Non-OADS,/arxiv_data1/oa_pdf/72/09/egems1133.PMC4431498.pdf
2 http://repository.academyhealth.org/egems/vol3/iss2/2 DOI: 10.13063/2327-9214.1133,Non-OADS,/arxiv_data1/oa_pdf/72/09/egems1133.PMC4431498.pdf
2 http://repository.academyhealth.org/egems/vol3/iss2/2 DOI: 10.13063/2327-9214.1133,Non-OADS,/arxiv_data1/oa_pdf/72/09/egems1133.PMC4431498.pdf
2 http://repository.academyhealth.org/egems/vol3/iss2/2 DOI: 10.13063/2327-9214.1133,Non-OADS,/arxiv_data1/oa_pdf/72/09/egems1133.PMC4431498.pdf
"Accessed Feb 19, 2015 from http://www.healthit.gov/sites/default/files/pghd_brief_final122013.pdf.",Non-OADS,/arxiv_data1/oa_pdf/72/09/egems1133.PMC4431498.pdf
2 http://repository.academyhealth.org/egems/vol3/iss2/2 DOI: 10.13063/2327-9214.1133,Non-OADS,/arxiv_data1/oa_pdf/72/09/egems1133.PMC4431498.pdf
"Accessed Feb 19, 2015 from: http://www.becer- tain.org/patients/spine/spine_scoap  22.",Non-OADS,/arxiv_data1/oa_pdf/72/09/egems1133.PMC4431498.pdf
Retrieved Feb 19 2015 from: http://www.iso.org/iso/cata- logue_detail.htm?csnumber=52075.,OADS,/arxiv_data1/oa_pdf/72/09/egems1133.PMC4431498.pdf
"Retrieved Feb 19, 2015 from: http://www.axure.com/ 41.",Non-OADS,/arxiv_data1/oa_pdf/72/09/egems1133.PMC4431498.pdf
"This mock-up mimics a tablet or smart phone touch inter-face for users to select data categories, and then swipe through a slideshow of predefined views.https://www.QIDashboard/StandardReports Lumbar Cervical Burbank Hospital NRS 10 8 6 4 2 0 Baseline        30 daysODI 100 80 60 40 20 0 Baseline        30 days All sitesReadmission rate: 3%  Reason 1 Reason 2 Reason 310 8 6 4 2 0 Baseline    30 days     6 months     12 monthsNo treatment Treatment 1Treatment 2NRS 30 day outcomes-ODI  Appalachian Hospital Burbank HospitalBack ClinicEinstein Clinic Forsythe Clinic Groveton Lane HospitalNorbertPresbyterian Clinic Rochester Bernard  The Soul InstituteVeterans Institute Zion Clinic 0    10    20   30   40   50   60   70   80   90  100Readmission rates Appalachian Hospital 1% Burbank Hospital 3% Back Clinic 0.3% Einstein Clinic 1% Forsythe Clinic` 0.2% Groveton 0.9% Lane Hospital 13% Norbert 3% Presbyterian Clinic 3.7% Rochester 2% Bernard 6% The Soul Institute 1% Veterans Institute 0.2%Zion Clinic 4% All sites (mean +/- se) 2.6% +/- 0.9%10 8 6 4 2 0Baseline            30 days           6 months        12 monthsBurbank All other  sitesNRSQI Dashboards for         as of Burbank Hospital February 28, 2013 Click to enlarge h t t p s: / / / / ww w .",Non-OADS,/arxiv_data1/oa_pdf/72/09/egems1133.PMC4431498.pdf
https://www.QIDashboard/InteractiveReports Hospital Name All Hospitals compared to All Hospitals Surgical Types Lumbar Outcome Measurement NRS ODI/NDI Satisfaction Time Points Cervical 30 day Comparison Average 6 monthMake selections on the left to  generate a data view 1 year Interactive dashboard: Let me dig into the data and generate views.,Non-OADS,/arxiv_data1/oa_pdf/72/09/egems1133.PMC4431498.pdf
2 http://repository.academyhealth.org/egems/vol3/iss2/2 DOI: 10.13063/2327-9214.1133,Non-OADS,/arxiv_data1/oa_pdf/72/09/egems1133.PMC4431498.pdf
2 http://repository.academyhealth.org/egems/vol3/iss2/2 DOI: 10.13063/2327-9214.1133,Non-OADS,/arxiv_data1/oa_pdf/72/09/egems1133.PMC4431498.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b2/50/ijn-10-3447.PMC4431504.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2015:10 3447–3458International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3447OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7602 3amino-functionalized poly( l-lactide) lamellar single  crystals as a valuable substrate for delivery of  hPV16-e7 tumor antigen in vaccine development Paola Di Bonito1 linda Petrone1 gabriele casini2 Iolanda Francolini2 Maria grazia ammendolia3 luisa accardi1 antonella Piozzi2 lucio D’Ilario2 andrea Martinelli2 1Department of Infectious, Parasitic  and Immune-mediated Diseases,   Italian National Institute of health,   2Department of chemistry, sapienza  University of rome, rome, Italy;   3Department of T echnology and  health, Italian National Institute of  health, rome, ItalyBackground:  Poly( l-lactide) (PLLA) is a biodegradable polymer currently used in many bio - medical applications, including the production of resorbable surgical devices, porous scaffolds  for tissue engineering, nanoparticles and microparticles for the controlled release of drugs or  antigens.",Non-OADS,/arxiv_data1/oa_pdf/b2/50/ijn-10-3447.PMC4431504.pdf
"The intrinsic adjuvant properties  of antigens in the form of microparticles and nanoparticles have been shown in sev - eral studies.1,2 One of the primary roles of particulate antigens in vaccination is their correspondence: Paola Di Bonito Department of Infectious, Parasitic  and Immune-mediated Diseases, Istituto  superiore di sanità, Viale regina   elena 288, 00161 rome, Italy Tel +39 06 4990 2956 email paola.dibonito@iss.i t  andrea Martinelli Department of chemistry, sapienza  University of rome, Ple a Moro 5,  00185 rome, Italy Tel +39 06 4991 3950 email andrea.martinelli@uniroma1.i t Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Di Bonito et al Running head recto: Vaccine based on HPV16-E7-loaded amino-PLLA DOI: http://dx.doi.org/10.2147/IJN.S76023",Non-OADS,/arxiv_data1/oa_pdf/b2/50/ijn-10-3447.PMC4431504.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b2/50/ijn-10-3447.PMC4431504.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/50/ijn-10-3447.PMC4431504.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/da/89/ijn-10-3403.PMC4431505.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2015:10 3403–3416International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3403OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8241 3reduction-responsive cross-linked stearyl peptide  for effective delivery of plasmid DNa correspondence: shen gao; Yuan gao Department of Pharmaceutics,  changhai hospital, second Military  Medical University, No.",Non-OADS,/arxiv_data1/oa_pdf/da/89/ijn-10-3403.PMC4431505.pdf
"Polyarginine, as a  cell-penetrating peptide, can help enhance intracellular uptake through interactions of  the guanidine group with the sulfate, carbonate, and phosphate of the proteoglycans on  the cellular surface.7,8 In particular, its ability to condense DNA with the positive charge  and control DNA release make it possible to use polyarginine as an intracellular delivery  vector for plasmid DNA (pDNA).9 In addition, histidine has a proton sponge effect, thus  making it possible to enhance the endosomal escape rate by increasing the pH of the  endosomes, leading to osmotic swelling and bursting.10,11 It was reported that stearyla - tion could improve intracellular uptake and endosomal escape.12–14 A stearyl moiety  could increase the buffering capacity of histidine, thus increasing the efficiency of  transfection by the hydrophobic moiety of stearylation on the N-terminus of the peptide  and facilitating absorption of the complex through the membrane.15,16 Additionally, Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Y ao et al Running head recto: Cross-linked stearyl peptide for delivery of pDNA DOI: http://dx.doi.org/10.2147/IJN.S82413",Non-OADS,/arxiv_data1/oa_pdf/da/89/ijn-10-3403.PMC4431505.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/da/89/ijn-10-3403.PMC4431505.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/da/89/ijn-10-3403.PMC4431505.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0c/09/ijn-10-3429.PMC4431506.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 3429–3445International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3429OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7593 6effects of PV a coated nanoparticles on human  immune cells cindy strehl1,2 Timo gaber1–3 lionel Maurizi4 Martin hahne1,2 roman rauch1,2 Paula hoff1–3 Thomas häupl1 Margarethe hofmann- amtenbrink5 a robin Poole6 heinrich hofmann4 Frank Buttgereit1–3 1Department of rheumatology  and clinical Immunology, charité  Universitätsmedizin Berlin, Berlin,   germany; 2german rheumatism  research centre (DrFZ), Berlin,   germany; 3Berlin-Brandenburg center  for regenerative Therapies (Bcr T),   Berlin, germany; 4Powder T echnology  laboratory, ecole Polytechnique  Federale de lausanne (ePFl),   lausanne, switzerland; 5Matsearch  consulting hofmann, Pully-lausanne,   switzerland; 6Department of surgery,   Mcgill University, Montreal, Qc ,   canadaAbstract:  Nanotechnology provides new opportunities in human medicine, mainly for  diagnostic and therapeutic purposes.",Non-OADS,/arxiv_data1/oa_pdf/0c/09/ijn-10-3429.PMC4431506.pdf
"Additionally, imaging techniques like X-ray, ultrasound and magnetic  resonance imaging (MRI) as well as laboratory tests (such as inflammatory markers,  rheumatoid factors, and anti-citrullinated protein antibodies) complete the diagnosis  and permit surveillance of disease activity, progress and therapy success.15–18 There is  no cure for RA, but the treatment can improve symptoms and quality of life, and can correspondence: cindy strehl Department of rheumatology and  clinical Immunology, charité University  hospital, charitéplatz 1, 10117 Berlin,  germany Tel +49 30 450 513364 Fax +49 30 450 513917 email cindy.strehl@charite.d e Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Strehl et al Running head recto: Effects of PVA coated nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S75936",Non-OADS,/arxiv_data1/oa_pdf/0c/09/ijn-10-3429.PMC4431506.pdf
Available from: http://usa.healthcare.,Non-OADS,/arxiv_data1/oa_pdf/0c/09/ijn-10-3429.PMC4431506.pdf
"2010;6029. available from: http://www.bio-rad.com/webroot/web/pdf/ lsr/literature/Bulletin_6029.pd f. accessed January 29, 2015.2 Abbreviations:  nd, not detectable; ctrl, control; ra, rheumatoid arthritis; lPs, lipopolysaccharide; Pha, Phaseolus vulgaris ; a-PVa-sPION, amino-polyvinyl alcohol coated  superparamagnetic iron oxide nanoparticles.Supplementary materials Table S1  characteristics of patients with ra at screening visit Characteristics RA patients (n =19) Female:male 16:3 age (years)* 56.42 (24/75) Duration of ra (years)* 10.3 (0.2/37.6) rF* 231 (1/1,600) acPa* 241.7 (0/1,000) Das28* 4.81 (2.72/6.86) esr (mm/h)* 22.68 (2/60) crP (mg/dl)* 0.98 (0.03/6.56) glucocorticoid treatment 13 (68%) DMarDs 19 (100%) NsaIDs 11 (58%) Note:  Data are given as *mean (minimum/maximum) or number (%).",Non-OADS,/arxiv_data1/oa_pdf/0c/09/ijn-10-3429.PMC4431506.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/0c/09/ijn-10-3429.PMC4431506.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/09/ijn-10-3429.PMC4431506.pdf
2010;6029. available from: http://www.bio-rad.com/webroot/web/pdf/ lsr/literature/Bulletin_6029.pdf .,Non-OADS,/arxiv_data1/oa_pdf/0c/09/ijn-10-3429.PMC4431506.pdf
"Available from: http://www.bio-rad.com/webroot/web/pdf/ lsr/literature/Bulletin_6029.pd f. Accessed January 29, 2015.",Non-OADS,/arxiv_data1/oa_pdf/0c/09/ijn-10-3429.PMC4431506.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4a/7a/ijn-10-3417.PMC4431508.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2015:10 3417–3427International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3417Methodologyopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/IJN.S8209 1Novel stable cytokine delivery system  in  physiological ph solution: chitosan oligosaccharide/ heparin nanoparticles Bin Wang ling tan dengpu deng ting lu Changwei Zhou Zhongkui li Zhenjie tang Zhongshi Wu hao tang department of Cardiovascular  Surgery, the Second Xiangya hospital  of Central South University, Changsha,   People’s Republic of ChinaBackground:  Cell therapy is a promising strategy for tissue regeneration.",Non-OADS,/arxiv_data1/oa_pdf/4a/7a/ijn-10-3417.PMC4431508.pdf
"Keywords:  cytokine delivery system, nanoparticles, chitosan oligosaccharide, physiological  pH, stromal cell-derived factor-1 α, vascular endothelial growth factor Introduction Tissue damage occurs in many diseases, including diabetes, acute graft-versus-host  disease, and cardiovascular disease.1 Of these diseases, myocardial infarction, one of  the leading causes of mortality, is the most common and difficult to treat in the clinic,  because cardiomyocytes are not able to regenerate.2 Tissue regeneration through stem/ progenitor cells has been studied extensively in a wide range of tissue repair applica - tions, especially for regeneration of cardiomyocytes, owing to the unique pluripotency  and regenerative properties of these cells.3,4 However, tissue regeneration involves a  series of biological processes, including mobilization of stem cells, angiogenesis, and Correspondence: hao tang department of Cardiovascular Surgery,  the Second Xiangya hospital of Central  South University, No 139 Renmin Road,  Changsha, hunan Province, 410011,  People’s Republic of China tel +86 139 7493 9669 Fax +86 0731 8529 2133 email tanghao3168@sina.co mJournal name: International Journal of Nanomedicine Article Designation: Methodology Y ear: 2015 Volume: 10 Running head verso: Wang et al Running head recto: CSO/H nanoparticles for cytokine delivery DOI: http://dx.doi.org/10.2147/IJN.S82091",Non-OADS,/arxiv_data1/oa_pdf/4a/7a/ijn-10-3417.PMC4431508.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international­journal­of­nanomedicine­journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/4a/7a/ijn-10-3417.PMC4431508.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/7a/ijn-10-3417.PMC4431508.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/30/main.PMC4431638.pdf
Success- ful neutrophil differentiation was assessed by increased CEBPE mRNAContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2015.04.002 2213-0489/ &2015 The Authors.,OADS,/arxiv_data1/oa_pdf/31/30/main.PMC4431638.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/30/main.PMC4431638.pdf
http://dx.doi.org/10.1002/cncr.22233 .,Non-OADS,/arxiv_data1/oa_pdf/31/30/main.PMC4431638.pdf
http://dx.doi.org/ 10.1038/nrc2943 .,Non-OADS,/arxiv_data1/oa_pdf/31/30/main.PMC4431638.pdf
Nat Cell Biol 2008;10:538 –46.http://dx.doi.org/ 10.1038/ncb1716 .,OADS,/arxiv_data1/oa_pdf/31/30/main.PMC4431638.pdf
Nat Cell Biol 2008;10:547 –55.http://dx.doi.org/ 10.1038/ncb1717 .,OADS,/arxiv_data1/oa_pdf/31/30/main.PMC4431638.pdf
Nat Med 2008;14:1333 –42.http://dx.doi.org/10.1038/nm.1891 .,OADS,/arxiv_data1/oa_pdf/31/30/main.PMC4431638.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/31/30/main.PMC4431638.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/31/30/main.PMC4431638.pdf
http://dx.doi.org/10.1189/jlb.0606400 .,OADS,/arxiv_data1/oa_pdf/31/30/main.PMC4431638.pdf
http://dx.doi.org/10.1182/ blood-2011-09-378117 .,Non-OADS,/arxiv_data1/oa_pdf/31/30/main.PMC4431638.pdf
J Biol Chem 2006;281:15869 –77.http://dx.doi.org/10.1074/jbc.M511658200 .E.A.,OADS,/arxiv_data1/oa_pdf/31/30/main.PMC4431638.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/2a/cvv103.PMC4431663.pdf
"Moore et al., 2015, Cell Reports 11, 689–696 May 5, 2015 ª2015 The Authors http://dx.doi.org/10.1016/j.celrep.2015.03.068",OADS,/arxiv_data1/oa_pdf/80/be/main.PMC4431668.pdf
"Evans,1Therese Andersson,2Erik Portelius,3James Smith,1Tatyana B. Dias,1 Nathalie Saurat,1Amelia McGlade,1Peter Kirwan,1Kaj Blennow,3John Hardy,4Henrik Zetterberg,3,4 and Frederick J. Livesey1,* 1The Gurdon Institute, Cambridge Stem Cell Institute and Department of Biochemistry, University of Cambridge, Cambridge CB2 1QN, UK 2Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, 106 91 Stockholm, Sweden 3Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, 431 80 Molndal, Sweden 4Department of Molecular Neuroscience, Institute of Neurology, University College London, Queen Square, London WC1N 1PJ, UK *Correspondence: rick@gurdon.cam.ac.uk http://dx.doi.org/10.1016/j.celrep.2015.03.068 This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/80/be/main.PMC4431668.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and two movies and can be found with this article online at http://dx.doi.org/10.1016/j.celrep.2015.03.068 .",Non-OADS,/arxiv_data1/oa_pdf/80/be/main.PMC4431668.pdf
"Stage group IV had further shorter survival time than stage group III ( P=1 e/C06) (Supplementary Figure 1a, Supplemental Digital Content 2, http://links.lww.com/AIMM/A48).",Non-OADS,/arxiv_data1/oa_pdf/89/df/pai-23-334.PMC4431677.pdf
"Grade 4 tumors presented shorter survival time than grade 3 ( P= 0.0003), whereas no dif- ference was found between grade 3 and 2 or grade 2 and 1(Supplementary Figure 1b, Supplemental Digital Content 2, http://links.lww.com/AIMM/A48).",Non-OADS,/arxiv_data1/oa_pdf/89/df/pai-23-334.PMC4431677.pdf
Available at: http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/89/df/pai-23-334.PMC4431677.pdf
"http://dx.doi.org/10.1016/j.gendis.2014.10.004 2352-3042/Copyright ª2014, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/31/23/main.PMC4431759.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes &Diseases (2015) 2,1 3e25",Non-OADS,/arxiv_data1/oa_pdf/31/23/main.PMC4431759.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/23/main.PMC4431759.pdf
http://seer.cancer.,Non-OADS,/arxiv_data1/oa_pdf/31/23/main.PMC4431759.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/c6/main.PMC4431773.pdf
"http://dx.doi.org/10.1016/j.gendis.2015.01.001 2352-3042/Copyright ª2015, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/1c/c6/main.PMC4431773.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes &Diseases (2015) 2,3 5e45",Non-OADS,/arxiv_data1/oa_pdf/1c/c6/main.PMC4431773.pdf
2014. http://dx.doi.or- g/10.1111/liv.12698 [Epub ahead of print].44 S. Shrivastava et al.,Non-OADS,/arxiv_data1/oa_pdf/1c/c6/main.PMC4431773.pdf
Graphical Abstract © 2015 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/90/nihms678675.PMC4431957.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four figures, one table, and four movies and can be found  with this article online at http://dx.doi.org/10.1016/j.celrep.2015.04.006 .",OADS,/arxiv_data1/oa_pdf/0e/90/nihms678675.PMC4431957.pdf
"2013;14:e592-e599, available at http://neoreviews.aappublica- tions.org/content/14/12/e592 (accessed December 12, 2013) (intestinal microbiota could alter brain function; cesarian section versus vaginal delivery could co ntribute to enterocolitis, late- onset sepsis, and altered brain motor activity and anxiety-like behavior).",Non-OADS,/arxiv_data1/oa_pdf/b7/3a/10.1177_0883073814543306.PMC4431995.pdf
"J. Biomed Informatics (2014), http://dx.doi.org/10.1016/j.jbi.2014.04.010 (accessed 5 June 2014); Clark SL Nageotte MP Garite TJ et al.",OADS,/arxiv_data1/oa_pdf/b7/3a/10.1177_0883073814543306.PMC4431995.pdf
2014;41:105-117; available at http://dx.doi.org/10.1016/j.clp.,OADS,/arxiv_data1/oa_pdf/b7/3a/10.1177_0883073814543306.PMC4431995.pdf
"Available at http://www.women- shealthsection.com/content/heal/heal020.0hp3 (accessed Septem- ber 7, 2013).",Non-OADS,/arxiv_data1/oa_pdf/b7/3a/10.1177_0883073814543306.PMC4431995.pdf
"Available at http://www.hpm.org/survey/jp/a14/4 (accessed October 12, 2013); Kennedys Law LLP.",Non-OADS,/arxiv_data1/oa_pdf/b7/3a/10.1177_0883073814543306.PMC4431995.pdf
"Feb. 22, 2013, available at http://www.Kennedys-law.com/article/ nofaultcompensationforscotland/ (accessed December 3, 2013).",Non-OADS,/arxiv_data1/oa_pdf/b7/3a/10.1177_0883073814543306.PMC4431995.pdf
"NHS NICE, Anetanatal Care, Routine Care for the Healthy Preg- nant Woman, NICE Clinical Guideline 62 at 36, available at http://www.nice.org.uk/cg62 (accessed September 15, 2013).",Non-OADS,/arxiv_data1/oa_pdf/b7/3a/10.1177_0883073814543306.PMC4431995.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.References 1.",Non-OADS,/arxiv_data1/oa_pdf/27/47/10549_2015_Article_3408.PMC4432026.pdf
"The Korean Academy of Conservative Dentistry.104This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Effect of intracanal medicaments used in endodontic regeneration procedures on microhardness and chemical structure of dentin Objectives: This study was performed to investigate the effects of different intracanal  medicaments on chemical structure and microhardness of dentin.",Non-OADS,/arxiv_data1/oa_pdf/8e/82/rde-40-104.PMC4432252.pdf
"1Yassen GH; Platt JA, Department  of Restorative Dentistry, Division of Dental Biomaterials, Indiana University School of Dentistry,  Indianapolis, IN, USA 2Eckert GJ, Department of  Biostatistics, Indiana University  School of Medicine, Indianapolis, IN, USA*Correspondence to Ghaeth Hamdon Yassen, BDS, MSD, PhD.Assistant Professor, Department of Restorative Dentistry, Division of Dental Biomaterials, Indiana University School of Dentistry, 1121 W. Michigan St., Indianapolis, IN, 46202, USATEL, +1-317-437-2240; FAX, +1-317-278-7462; E-mail, gyassen@iupui.eduResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.2.104",Non-OADS,/arxiv_data1/oa_pdf/8e/82/rde-40-104.PMC4432252.pdf
The Effect of intracanal medicaments on dentin http://dx.doi.org/10.5395/rde.2015.40.2.104,Non-OADS,/arxiv_data1/oa_pdf/8e/82/rde-40-104.PMC4432252.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.104,Non-OADS,/arxiv_data1/oa_pdf/8e/82/rde-40-104.PMC4432252.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.104,Non-OADS,/arxiv_data1/oa_pdf/8e/82/rde-40-104.PMC4432252.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.104,Non-OADS,/arxiv_data1/oa_pdf/8e/82/rde-40-104.PMC4432252.pdf
"NaOCl, sodium hypochlorite;  EDTA, ethylenediaminetetraacetic acid; DTAP, methylcellulose-based triple antibiotic paste; TAP, triple antibiotic paste.Control              NaOCl + EDTA               DTAP            Calcium hydroxide                   TAP 0                     10                    20                    30                   40                    50                   60 Microhardness (VHN)Phosphate/Amide I ratio9 876 5 4 3 2 1 0 http://dx.doi.org/10.5395/rde.2015.40.2.104",Non-OADS,/arxiv_data1/oa_pdf/8e/82/rde-40-104.PMC4432252.pdf
"27 However, the  recommended low concentrations of TAP are usually in a  http://dx.doi.org/10.5395/rde.2015.40.2.104",Non-OADS,/arxiv_data1/oa_pdf/8e/82/rde-40-104.PMC4432252.pdf
Mahidol study 1: comparison of radiographic and survival outcomes of immature teeth treated with either regenerative  http://dx.doi.org/10.5395/rde.2015.40.2.104,Non-OADS,/arxiv_data1/oa_pdf/8e/82/rde-40-104.PMC4432252.pdf
Available from: http://www.aae.org/clinical-resources/regenerative-endodontics/ considerations-for-regenerative-procedures.aspx (updated 2014 Aug 12).,Non-OADS,/arxiv_data1/oa_pdf/8e/82/rde-40-104.PMC4432252.pdf
J Prosthet Dent 2010;103:352-361. http://dx.doi.org/10.5395/rde.2015.40.2.104,Non-OADS,/arxiv_data1/oa_pdf/8e/82/rde-40-104.PMC4432252.pdf
"The Korean Academy of Conservative Dentistry.113This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Evaluation of electrical impedance ratio measurements in accuracy of electronic apex locators Objectives:  The aim of this paper was evaluating the ratios of electrical impedance  measurements reported in previous studies through a correlation analysis in order to explicit it as the contributing factor to the accuracy of electronic apex locator (EAL).",Non-OADS,/arxiv_data1/oa_pdf/f8/9c/rde-40-113.PMC4432253.pdf
"1Kim PJ; Kim HG, Biomedical  Knowledge Engineering Laboratory, Seoul National University School of Dentistry, Seoul, Korea  2Cho BH, Department of  Conservative Dentistry, Seoul National University School of Dentistry and Dental Research Institute, Seoul, Korea*Correspondence to Byeong-Hoon Cho, DDS, MSD, PhD.Professor, Department of Conservative Dentistry, Seoul National University School of Dentistry and Dental Research Institute, 101 Daehag-ro, Jongro-gu, Seoul, Korea 110-749TEL: +82-2-2072-3514; FAX: +82-2-764-3514; E-mail, chobh@snu.ac.krResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.2.113",Non-OADS,/arxiv_data1/oa_pdf/f8/9c/rde-40-113.PMC4432253.pdf
"Search terms for electrical apex locator with electrical data used  Search engine Search term Pubmed((impedance[TIAB] or impedances[TIAB] or voltage[TIAB] or measure[TIAB] or measurement[TIAB]  or 'electronic device'[TIAB]) and ((tooth[TIAB] or teeth[TIAB]) and 'root canal'[TIAB] or 'foramen locator'[TIAB] or 'root canal treatment'[TIAB] or 'apex locator'[TIAB])) Embase((impedance:ab,ti or impedances:ab,ti or voltage:ab,ti or measure:ab,ti or measurement:ab,ti or 'electronic device':ab,ti) and ((tooth:ab,ti or teeth:ab,ti) and 'root canal':ab,ti or 'foramen locator':ab,ti or 'root canal treatment':ab,ti or 'apex locator':ab,ti)) http://dx.doi.org/10.5395/rde.2015.40.2.113",OADS,/arxiv_data1/oa_pdf/f8/9c/rde-40-113.PMC4432253.pdf
First and second order polynomials were estimated  http://dx.doi.org/10.5395/rde.2015.40.2.113,OADS,/arxiv_data1/oa_pdf/f8/9c/rde-40-113.PMC4432253.pdf
"(a) Three-dimensional plot of a grouped data set from Pilot and Pitts, in which the inputs were the distance from the apical constriction and the frequency, and the outputs were the absolute impedance values (Z abs);19 (b) Plot of the log-scaled frequency and the Zabs  from a sample data set from Krizaj et al.15(a) (b) 9000 8000700060005000400030002000 -1.5-1 -0.5 0 0.5 500040003000200010000|Impedance| ( Ω) Distance from Apical Constriction (mm) Frequency (Hz)5000 450040003500300025002000|Impedance| ( Ω) 100                       1000                       10000                   100000  Frequency (Hz) http://dx.doi.org/10.5395/rde.2015.40.2.113",OADS,/arxiv_data1/oa_pdf/f8/9c/rde-40-113.PMC4432253.pdf
(a) (b) (c) (d) (e)Impedance ratio2.9 2.72.52.32.11.91.7 -3                                                   0                                                  3 Distance from apical constriction (mm) Rambo 2010 Jan 2009Huang 2008Rambo 2007Krizaj 2004Lee 1997Pilot 1997-1Pilot 1997-2Pilot 1997-3Pilot 1997-4Pilot 1997-5Pilot 1997-6Pilot 1997-7Kobayashi 1994-1Kobayashi 1994-2Kobayashi 1994-3Levinkind 1994 left horizontal sectionlinear sectionright horizontal sectionImpedance ratio 0  Distance from apical constriction (mm) Impedance ratio 0  Distance from apical constriction (mm)1 1Impedance ratio 0  Distance from apical constriction (mm)12A 2B Impedance ratio 0  Distance from apical constriction (mm)3B3A http://dx.doi.org/10.5395/rde.2015.40.2.113,Non-OADS,/arxiv_data1/oa_pdf/f8/9c/rde-40-113.PMC4432253.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.113,Non-OADS,/arxiv_data1/oa_pdf/f8/9c/rde-40-113.PMC4432253.pdf
Relative approximate resistance from distance 0 (no unit)3 2.5 2 1.5 1 0.5 0Lee 1997 Levinkind 1994Krizaj 2004Pilot 1997-1Pilot 1997-2Pilot 1997-3Pilot 1997-4Pilot 1997-5Pilot 1997-6Pilot 1997-7Huang 2008 http://dx.doi.org/10.5395/rde.2015.40.2.113,Non-OADS,/arxiv_data1/oa_pdf/f8/9c/rde-40-113.PMC4432253.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.113,Non-OADS,/arxiv_data1/oa_pdf/f8/9c/rde-40-113.PMC4432253.pdf
"Stöber EK, Duran-Sindreu F, Mercadé M, Vera J, Bueno Electrical impedance ratios on EAL accuracy http://dx.doi.org/10.5395/rde.2015.40.2.113",OADS,/arxiv_data1/oa_pdf/f8/9c/rde-40-113.PMC4432253.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.113,Non-OADS,/arxiv_data1/oa_pdf/f8/9c/rde-40-113.PMC4432253.pdf
"The Korean Academy of Conservative Dentistry.123This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Effect of repetitive pecking at working length for glide path preparation using G-file Objectives:  Glide path preparation is recommended to reduce torsional failure of nickel- titanium (NiTi) rotary instruments and to prevent root canal transportation.",Non-OADS,/arxiv_data1/oa_pdf/2b/7d/rde-40-123.PMC4432254.pdf
"1Ha JH; Kim SK, Department of  Conservative Dentistry, School of Dentistry, Kyungpook National University, Daegu, Korea 2Jeon HJ; Kim HC, Department of  Conservative Dentistry, Pusan National University School of Dentistry and Dental Research Institute, Yangsan, Korea 3Abed RE, Department of Dentistry,  Endodontic Unit, Dubai Health Authority, Dubai, UAE 4Chang SW, Department of Conservative  Dentistry, School of Dentistry, Kyung Hee University, Seoul, Korea*Correspondence to Hyeon-Cheol Kim, DDS, MS, PhD.Associate Professor, Department of Conservative Dentistry, Pusan National University School of Dentistry, 20, Geumo-ro, Mulgeum-eup, Yangsan, Korea 626-787TEL, +82-55-360-5222; FAX, +82-55-360-5214; E-mail, golddent@pusan.ac.krResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.2.123",Non-OADS,/arxiv_data1/oa_pdf/2b/7d/rde-40-123.PMC4432254.pdf
(a) (b) (c) http://dx.doi.org/10.5395/rde.2015.40.2.123,Non-OADS,/arxiv_data1/oa_pdf/2b/7d/rde-40-123.PMC4432254.pdf
(a) (b)213 µm 1.00 mm 183 µm http://dx.doi.org/10.5395/rde.2015.40.2.123,Non-OADS,/arxiv_data1/oa_pdf/2b/7d/rde-40-123.PMC4432254.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.123,Non-OADS,/arxiv_data1/oa_pdf/2b/7d/rde-40-123.PMC4432254.pdf
Glide path preparation using NiTi rotary file http://dx.doi.org/10.5395/rde.2015.40.2.123,Non-OADS,/arxiv_data1/oa_pdf/2b/7d/rde-40-123.PMC4432254.pdf
"The Korean Academy of Conservative Dentistry.128This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Effect of resin thickness on the microhardness and optical properties of bulk-fill resin composites Objectives:  This study evaluated the effects of the resin thickness on the  microhardness and optical properties of bulk-fill resin composites.",Non-OADS,/arxiv_data1/oa_pdf/44/d1/rde-40-128.PMC4432255.pdf
"1Kim EH; Jung KH; Son SA; Hur B;  Park JK, Department of Conservative Dentistry, School of Dentistry, Pusan National University, Yangsan, Korea 2Kwon YH, Department of Dental  Materials, School of Dentistry, Pusan National University, Yangsan, Korea*Correspondence to Jeong-Kil Park, DDS, MSD, PhD.Associate Professor, Department of Conservative Dentistry, School of Dentistry, Pusan National University, 20, Geumo-ro, Mulgeum-eup, Yangsan, Korea 626-787TEL, +82-55-360-5221; FAX, +82-55-360-5214; E-mail, jeongkil@pusan.ac.krResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.2.128",Non-OADS,/arxiv_data1/oa_pdf/44/d1/rde-40-128.PMC4432255.pdf
ΔE23 and ΔE24 Microhardness and color of bulk-fill resins http://dx.doi.org/10.5395/rde.2015.40.2.128,Non-OADS,/arxiv_data1/oa_pdf/44/d1/rde-40-128.PMC4432255.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.128,Non-OADS,/arxiv_data1/oa_pdf/44/d1/rde-40-128.PMC4432255.pdf
Microhardness values (Hv)90 8070605040302010 0 0 mm 2 mm3 mm4 mm VB         SR          CF          TB          SO         TN http://dx.doi.org/10.5395/rde.2015.40.2.128,Non-OADS,/arxiv_data1/oa_pdf/44/d1/rde-40-128.PMC4432255.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.128,Non-OADS,/arxiv_data1/oa_pdf/44/d1/rde-40-128.PMC4432255.pdf
"Translucency parameter40 353025201510 5VB R: 0.43, p  = 0.71 SR R: 1.00, p  = 0.05 CF R: 0.89, p  = 0.31 TB R: 0.94, p  = 0.22 SO R: 0.95, p  = 0.21 TN R: 0.92, p  = 0.26 15     20     25     30     35     40     45     50     55     60     65     70 Microhardness values (Hv) http://dx.doi.org/10.5395/rde.2015.40.2.128",Non-OADS,/arxiv_data1/oa_pdf/44/d1/rde-40-128.PMC4432255.pdf
"For the restorations with bulk-fill resin composites, the  http://dx.doi.org/10.5395/rde.2015.40.2.128",Non-OADS,/arxiv_data1/oa_pdf/44/d1/rde-40-128.PMC4432255.pdf
J Dent 2009;37:102-107. http://dx.doi.org/10.5395/rde.2015.40.2.128,Non-OADS,/arxiv_data1/oa_pdf/44/d1/rde-40-128.PMC4432255.pdf
"The Korean Academy of Conservative Dentistry.136This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Effects of endodontic tri-antibiotic paste on bond strengths of dentin adhesives to coronal dentin Objectives:  The aim of this study was to evaluate the effects of tri-antibiotic paste  (TAP) on microtensile bond strengths (MTBS) of dental adhesives to dentin.",Non-OADS,/arxiv_data1/oa_pdf/47/1d/rde-40-136.PMC4432256.pdf
"1Mirzakoucheki P; Mirsattari S,  Department of Restorative Dentistry, Khorasgan University of Medical Sciences, Isfahan, Iran 2Walter R, Department of Operative  Dentistry, University of North Carolina School of Dentistry, Chapel Hill, NC, USA 3Khalighinejad N, Dental Materials  Research Center, Isfahan University of Medical Sciences, Isfahan, Iran 4Jahromi MZ, Department of  Endodontics, Khorasgan University of Medical Sciences, Isfahan, Iran 5Akbarzadeh N, Case Western Reserve  University, Cleveland, OH, USA*Correspondence to Navid Khalighinejad, DDS.Researcher, Dental Materials Research Center, Isfahan University of Medical Sciences, Isfahan, IranTEL, +98-91-3211-5931; FAX, +98-31-1668-3637; E-mail, Navid.kh1@gmail.comResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.2.136",Non-OADS,/arxiv_data1/oa_pdf/47/1d/rde-40-136.PMC4432256.pdf
60 dentin  specimens30 specimens covered with saline  saturated cotton pellets (control) 30 specimens treated with  triantibiotic paste (TAP)Group A - One-step self-etch adhesive Filtek P90 (n  = 15) Group B - Two-step etch-and-rinse adhesive Adper Single Bond Plus (n  = 15) Group C - One-step self-etch adhesive Filtek P90 (n  = 15) Group D - Two-step etch-and-rinse adhesive Adper Single Bond Plus (n  = 15) http://dx.doi.org/10.5395/rde.2015.40.2.136,Non-OADS,/arxiv_data1/oa_pdf/47/1d/rde-40-136.PMC4432256.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.136,Non-OADS,/arxiv_data1/oa_pdf/47/1d/rde-40-136.PMC4432256.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.136,Non-OADS,/arxiv_data1/oa_pdf/47/1d/rde-40-136.PMC4432256.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.136,Non-OADS,/arxiv_data1/oa_pdf/47/1d/rde-40-136.PMC4432256.pdf
"Minabe M, Takeuchi K, Kumada H, Umemoto T. The  http://dx.doi.org/10.5395/rde.2015.40.2.136",OADS,/arxiv_data1/oa_pdf/47/1d/rde-40-136.PMC4432256.pdf
J Adv Res 2013;4:61-67.  http://dx.doi.org/10.5395/rde.2015.40.2.136,OADS,/arxiv_data1/oa_pdf/47/1d/rde-40-136.PMC4432256.pdf
"The Korean Academy of Conservative Dentistry.143This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Effect of three different irrigation solutions applied by passive ultrasonic irrigation Objectives:  This study evaluated the maximum depth and percentage of irrigant  penetration into dentinal tubules by passive ultrasonic irrigation (PUI).",Non-OADS,/arxiv_data1/oa_pdf/06/1d/rde-40-143.PMC4432257.pdf
"1Llena C, Forner L, Lozano A,  Department of Stomatology, Universitat de València, Valencia, Spain 2Cambralla R, Private practice,  ASISA Baleares, Pedro Martel St. 30, Palma de Mallorca, Spain*Correspondence to Carmen Llena, MD, DDS, PhD.Professor, Department of Stomatology, Universitat de València, C. Gascó Oliag Nº 1,46012 Valencia, SpainTEL, +34-963-86-41-75; FAX, +34-963-86-41-44; E-mail, llena@uv.esResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.2.143",Non-OADS,/arxiv_data1/oa_pdf/06/1d/rde-40-143.PMC4432257.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.143,Non-OADS,/arxiv_data1/oa_pdf/06/1d/rde-40-143.PMC4432257.pdf
"At 8 mm level, Group A had a significantly greater penetration depth than Group C (p  < 0.05), but it was not different from Group B.  Wilcoxon signed rank sum test showed a significantly lower penetration at 2 mm level than at 8 mm level in all groups  http://dx.doi.org/10.5395/rde.2015.40.2.143",Non-OADS,/arxiv_data1/oa_pdf/06/1d/rde-40-143.PMC4432257.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.143,Non-OADS,/arxiv_data1/oa_pdf/06/1d/rde-40-143.PMC4432257.pdf
"Baca P, Mendoza-Llamas ML, Arias-Moliz MT, González- http://dx.doi.org/10.5395/rde.2015.40.2.143",Non-OADS,/arxiv_data1/oa_pdf/06/1d/rde-40-143.PMC4432257.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.143,Non-OADS,/arxiv_data1/oa_pdf/06/1d/rde-40-143.PMC4432257.pdf
"The Korean Academy of Conservative Dentistry.149This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Evaluation of penetration depth of 2% chlorhexidine digluconate into root dentinal tubules using confocal laser scanning microscope Objectives:  This study evaluated the penetration depth of 2% chlorhexidine  digluconate (CHX) into root dentinal tubules and the influence of passive ultrasonic irrigation (PUI) using a confocal laser scanning microscope (CLSM).",Non-OADS,/arxiv_data1/oa_pdf/22/0c/rde-40-149.PMC4432258.pdf
"Vadhana S; Latha J; Velmurugan N, Department of Conservative  Dentistry and Endodontics, Meenakshi Ammal Dental College and Hospital, Meenakshi Academy of Higher Education and Research (MAHER), Tamil Nadu, India*Correspondence to Sekar Vadhana, BDS.Post graduate student, Department of Conservative Dentistry and Endodontics, Meenakshi Ammal Dental College and Hospital, Meenakshi Academy of Higher Education and Research (MAHER), Alapakkam Main Road, Maduravoyal, Chennai, 600 095, Tamil Nadu, IndiaTEL, +91-80-12259954; FAX, +91-44-23781631; E-mail, vadhansekar@gmail.comResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.2.149",Non-OADS,/arxiv_data1/oa_pdf/22/0c/rde-40-149.PMC4432258.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.149,Non-OADS,/arxiv_data1/oa_pdf/22/0c/rde-40-149.PMC4432258.pdf
(a) (b) (c) (d) (e) (f) http://dx.doi.org/10.5395/rde.2015.40.2.149,Non-OADS,/arxiv_data1/oa_pdf/22/0c/rde-40-149.PMC4432258.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.149,Non-OADS,/arxiv_data1/oa_pdf/22/0c/rde-40-149.PMC4432258.pdf
"Boutsioukis C, Lambrianidis T, Verhaagen B, Versluis M, Penetration depth of 2% CHX http://dx.doi.org/10.5395/rde.2015.40.2.149",Non-OADS,/arxiv_data1/oa_pdf/22/0c/rde-40-149.PMC4432258.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.149,Non-OADS,/arxiv_data1/oa_pdf/22/0c/rde-40-149.PMC4432258.pdf
"The Korean Academy of Conservative Dentistry.155This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.The success rate of bupivacaine and lidocaine as anesthetic agents in inferior alveolar nerve block in teeth with irreversible pulpitis without spontaneous pain Objectives:  Achieving adequate anesthesia with inferior alveolar nerve blocks (IANB)  is of great importance during dental procedures.",Non-OADS,/arxiv_data1/oa_pdf/e3/60/rde-40-155.PMC4432259.pdf
"1Parirokh M, Oral and Dental Diseases  Research Center, School of Dentistry, Kerman University of Medical Sciences, Kerman, Iran 2Yosefi MH, Endodontic Department,  School of Dentistry, Yazd University of Medical Sciences, Yazd, Iran 3Nakhaee N, Neuroscience Research  Center, Kerman University of Medical Sciences, Kerman, Iran 4Abbott PV, School of Dentistry, University  of Western Australia, Perth, Australia 5Manochehrifar H, Endodontology  Research Center, School of Dentistry, Kerman University of Medical Sciences, Kerman, Iran*Correspondence to Hamed Manochehrifar, DMD, MS.Assistant Professor, Endodontology Research Center, School of Dentistry, Kerman University of Medical Sciences, Kerman, IranTEL, +98-914-315-4323; FAX, +98-913- 211-8073; E-mail, h.manochehrifar@kmu.ac.ir, hamed_man61@yahoo.comResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.2.155",Non-OADS,/arxiv_data1/oa_pdf/e3/60/rde-40-155.PMC4432259.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.155,Non-OADS,/arxiv_data1/oa_pdf/e3/60/rde-40-155.PMC4432259.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.155,Non-OADS,/arxiv_data1/oa_pdf/e3/60/rde-40-155.PMC4432259.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.155,Non-OADS,/arxiv_data1/oa_pdf/e3/60/rde-40-155.PMC4432259.pdf
A prospective randomized trial of different supplementary local  http://dx.doi.org/10.5395/rde.2015.40.2.155,Non-OADS,/arxiv_data1/oa_pdf/e3/60/rde-40-155.PMC4432259.pdf
Available from: http://www.nxtbook.com/nxtbooks/aae/endodonticglossary/index.php#/0 (updated 2015 Feb 16).,Non-OADS,/arxiv_data1/oa_pdf/e3/60/rde-40-155.PMC4432259.pdf
J Endod 2010;36:379-382. http://dx.doi.org/10.5395/rde.2015.40.2.155,OADS,/arxiv_data1/oa_pdf/e3/60/rde-40-155.PMC4432259.pdf
"The Korean Academy of Conservative Dentistry.161This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Use of cone-beam computed tomography and three-dimensional modeling for assessment of anomalous pulp canal configuration: a case report Three-dimensional (3D) reconstruction of cone-beam computed tomography (CBCT) scans appears to be a valuable method for assessing pulp canal configuration.",Non-OADS,/arxiv_data1/oa_pdf/e5/e2/rde-40-161.PMC4432260.pdf
"1Sinanoglu A, Department of Oral  and Maxillofacial Radiology, Faculty of Dentistry, Kocaeli University, Kocaeli, Turkey 2Helvacioglu-Yigit D, Department of  Endodontics, Faculty of Dentistry, Kocaeli University, Kocaeli, Turkey 3Mutlu I, Department of  Biomechanical Engineering, Faculty of Technology, Kocaeli University, Kocaeli, Turkey*Correspondence to Alper Sinanoglu, DDS, PhD.Assistant Professor, Department of Oral and Maxillofacial Radiology, Faculty of Dentistry, Kocaeli University, Yuvacık Yerle şkesi,  Başiskele, Kocaeli, Turkey 41190 TEL, +90 2623442222; FAX, +90 2623442109; E-mail, alpersinanoglu@yahoo.comCase report ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.2.161",Non-OADS,/arxiv_data1/oa_pdf/e5/e2/rde-40-161.PMC4432260.pdf
(b) (a) (d) (c) http://dx.doi.org/10.5395/rde.2015.40.2.161,Non-OADS,/arxiv_data1/oa_pdf/e5/e2/rde-40-161.PMC4432260.pdf
(a) (b) (c) http://dx.doi.org/10.5395/rde.2015.40.2.161,Non-OADS,/arxiv_data1/oa_pdf/e5/e2/rde-40-161.PMC4432260.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.161,Non-OADS,/arxiv_data1/oa_pdf/e5/e2/rde-40-161.PMC4432260.pdf
Available from: http://ec.europa.eu/energy/nuclear/radiation_protection/doc/publication/172.pdf (updated 2014 Nov 13).,Non-OADS,/arxiv_data1/oa_pdf/e5/e2/rde-40-161.PMC4432260.pdf
Available from: http://www.aae.org/colleagues/  (updated 2014 Nov 13).,OADS,/arxiv_data1/oa_pdf/e5/e2/rde-40-161.PMC4432260.pdf
3-D modeling of anomalous pulp configuration http://dx.doi.org/10.5395/rde.2015.40.2.161,Non-OADS,/arxiv_data1/oa_pdf/e5/e2/rde-40-161.PMC4432260.pdf
"The Korean Academy of Conservative Dentistry.166This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Surgical management with intentional replantation on a tooth with palato-radicular groove A palato-radicular groove (PRG) is a developmental anomaly primarily found in the maxillary lateral incisors.",Non-OADS,/arxiv_data1/oa_pdf/2b/b7/rde-40-166.PMC4432261.pdf
"Bogotá, ColombiaTEL, +57-300-3195998; FAX, +571 3165000; E-mail, jlninob@unal.edu.coCase report ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.2.166",Non-OADS,/arxiv_data1/oa_pdf/2b/b7/rde-40-166.PMC4432261.pdf
(a) (b) (c) http://dx.doi.org/10.5395/rde.2015.40.2.166,Non-OADS,/arxiv_data1/oa_pdf/2b/b7/rde-40-166.PMC4432261.pdf
(a) (b) http://dx.doi.org/10.5395/rde.2015.40.2.166,Non-OADS,/arxiv_data1/oa_pdf/2b/b7/rde-40-166.PMC4432261.pdf
(a) (b) http://dx.doi.org/10.5395/rde.2015.40.2.166,Non-OADS,/arxiv_data1/oa_pdf/2b/b7/rde-40-166.PMC4432261.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.166,Non-OADS,/arxiv_data1/oa_pdf/2b/b7/rde-40-166.PMC4432261.pdf
J Endod 2009;35:663-667. http://dx.doi.org/10.5395/rde.2015.40.2.166,OADS,/arxiv_data1/oa_pdf/2b/b7/rde-40-166.PMC4432261.pdf
"The Korean Academy of Conservative Dentistry.172This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Statistical notes for clinical researchers: post-hoc multiple comparisonsOpen lecture on statistics ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.2.172 For comparison of three or more group means we apply the analysis of variance  (ANOVA) method to decide if all means are equal or there is at least one mean which is different from others.",Non-OADS,/arxiv_data1/oa_pdf/0d/60/rde-40-172.PMC4432262.pdf
"appropriate for balanced or unbalanced design Gabriel Single-stepEquivalent to GF2 test for balanced one-way ANOVA.For unbalanced design, less conservative than GF2 Ryan-Einot-Gabriel-Walsch (REGW) Step-downModification of the SNK procedure (more strict control of family-wise α error) REGWF: based on F statistics (available only in SPSS)REGWQ: based on q statistics (maximum range distribution) Post-hoc error correctionFor a completely post-hoc analysis Scheffé Single-stepComplex comparisonMost stringent error control No control of errorInappropriate for control of family-wise error LSD (Least Significant Difference)Single-step No control of family-wise error α PC, α error level per comparison; αFW, family-wise α error level; k, number of comparisons.1 k http://dx.doi.org/10.5395/rde.2015.40.2.172",Non-OADS,/arxiv_data1/oa_pdf/0d/60/rde-40-172.PMC4432262.pdf
It shows more power  compared to the Bonferroni procedure.1 31k0.005   3 http://dx.doi.org/10.5395/rde.2015.40.2.172,Non-OADS,/arxiv_data1/oa_pdf/0d/60/rde-40-172.PMC4432262.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.172,Non-OADS,/arxiv_data1/oa_pdf/0d/60/rde-40-172.PMC4432262.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.172,Non-OADS,/arxiv_data1/oa_pdf/0d/60/rde-40-172.PMC4432262.pdf
"The Korean Academy of Conservative Dentistry.177This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Treatment after bleaching for optimal bondingReaders' forum ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2015.40.2.177 I am aware of sodium hydroxide treatment after walking bleaching.",Non-OADS,/arxiv_data1/oa_pdf/6d/8d/rde-40-177.PMC4432263.pdf
Clin Lab Res Dent 2014;20:4-9.  http://dx.doi.org/10.5395/rde.2015.40.2.177,Non-OADS,/arxiv_data1/oa_pdf/6d/8d/rde-40-177.PMC4432263.pdf
"The Korean Academy of Conservative Dentistry.97This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Antimicrobial effect of calcium hydroxide as an intracanal medicament in root canal treatment: a literature review - Part II.",Non-OADS,/arxiv_data1/oa_pdf/dc/1e/rde-40-97.PMC4432264.pdf
acReview article ISSN 2234-7658 (print) / ISSN 2234-7666 (online) http://dx.doi.org/10.5395/rde.2015.40.2.97,Non-OADS,/arxiv_data1/oa_pdf/dc/1e/rde-40-97.PMC4432264.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.97,Non-OADS,/arxiv_data1/oa_pdf/dc/1e/rde-40-97.PMC4432264.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.97,Non-OADS,/arxiv_data1/oa_pdf/dc/1e/rde-40-97.PMC4432264.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.97,Non-OADS,/arxiv_data1/oa_pdf/dc/1e/rde-40-97.PMC4432264.pdf
http://dx.doi.org/10.5395/rde.2015.40.2.97,Non-OADS,/arxiv_data1/oa_pdf/dc/1e/rde-40-97.PMC4432264.pdf
Endodontic therapy associated with calcium hydroxide  Kim D and Kim E http://dx.doi.org/10.5395/rde.2015.40.2.97,Non-OADS,/arxiv_data1/oa_pdf/dc/1e/rde-40-97.PMC4432264.pdf
Antimicrobial effect of calcium hydroxide - in vivo studies http://dx.doi.org/10.5395/rde.2015.40.2.97,Non-OADS,/arxiv_data1/oa_pdf/dc/1e/rde-40-97.PMC4432264.pdf
"Clin Chem Lab Med 2005; 43: 1276 –1277 26.http://www.hgmd.cf.ac.uk/ac/gene.php?gene=GLA (25 July 2012, date last accessed).",OADS,/arxiv_data1/oa_pdf/a2/92/sfs124.PMC4432429.pdf
"High incidence of later-onset fabry disease revealed by newborn screening.Am J Hum Genet 2006; 79: 31 –40 29.http://www.rostlab.org/services/snpdbe/dosearch.php?id=name &val=NP_000160&organism2=human&organism1 (25 July 2012, date last accessed).",OADS,/arxiv_data1/oa_pdf/a2/92/sfs124.PMC4432429.pdf
"Dalrymple J. http://www.mrcophth.com/ophthalmologyhallof fame/dalrymple.html (23 July 2012, date last accessed) 19.",Non-OADS,/arxiv_data1/oa_pdf/46/3f/sfs127.PMC4432430.pdf
I will share highlights of the  recent INCA/Novartis Global NET Patient Survey  (http://netcancerday.org/results‑ from‑first‑global‑  survey‑of‑neuroendocrine‑tumor‑net‑patients).,Non-OADS,/arxiv_data1/oa_pdf/59/6c/WJNM-14-15.PMC4432529.pdf
"Clinical transplant can also be classi ﬁ ed as Recieved:  June 2013 Accepted:  January 2015 Address for correspondence:   Dr. Deepika Nappalli,Department of Oral Medicine and Radiology, KVG Dental College and Hospital, Sullia - 574 327, Karnataka, India.E-mail:  deepsnappalli@ gmail.com Access this article online Website:  http://drj.mui.ac.ir/index.php/drj http://www.ncbi.nlm.nih.gov/pmc/journals/1480/",Non-OADS,/arxiv_data1/oa_pdf/15/82/DRJ-12-199.PMC4432601.pdf
[1] The etch-and-rinse approach  with phosphoric acid has become a standard procedure for the surface conditioning of enamel and dentin prior to adhesive resin application: The  Access this article online Website:  http://drj.mui.ac.ir/index.php/drj http://www.ncbi.nlm.nih.gov/pmc/journals/1480/,Non-OADS,/arxiv_data1/oa_pdf/c6/be/DRJ-12-209.PMC4432602.pdf
[1] This is  Access this article online Website:  http://drj.mui.ac.ir/index.php/drj http://www.ncbi.nlm.nih.gov/pmc/journals/1480/,Non-OADS,/arxiv_data1/oa_pdf/83/7a/DRJ-12-215.PMC4432603.pdf
"[3]Received:  December 2013 Accepted:  May 2014 Address for correspondence:   Dr. Bahareh Yousefipour,Department of Operative Dentistry, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.E-mail: ybahary@yahoo.com INTRODUCTION Resin-modi ﬁ ed glass-ionomers (RMGIs) were  introduced to overcome the drawbacks of conventional glass-ionomers by the addition of a small quantity of  Access this article online Website:  http://drj.mui.ac.ir/index.php/drj http://www.ncbi.nlm.nih.gov/pmc/journals/1480/",Non-OADS,/arxiv_data1/oa_pdf/b6/b4/DRJ-12-224.PMC4432604.pdf
"[6] Several studies have Received:  April 2014 Accepted:  May 2014 Address for correspondence: Dr. Alireza Haerian,Dental Students Research Center, School of Dentistry, Isfahan University of Medical Sciences, Isfahan 8174673461, Iran.E-mail:  haerian.alireza@ gmail.com Access this article online Website:  http://drj.mui.ac.ir/index.php/drj http://www.ncbi.nlm.nih.gov/pmc/journals/1480/",Non-OADS,/arxiv_data1/oa_pdf/06/20/DRJ-12-231.PMC4432605.pdf
"5-51-1-1, Chaitanyapuri, Beside Raghunatha Model High School, Dilsukhnagar, Hyderabad - 500 060, Andhra Pradesh, India.E-mail:  gangulashailaja@ gmail.com Access this article online Website:  http://drj.mui.ac.ir/index.php/drj http://www.ncbi.nlm.nih.gov/pmc/journals/1480/",Non-OADS,/arxiv_data1/oa_pdf/0c/a2/DRJ-12-235.PMC4432606.pdf
"[15]Received:  April 2014 Accepted:  March 2015 Address for correspondence: Dr. Elahe Rafiei,Department of Orthodontics, Dental Students Research Center, School of Dentistry, Isfahan University of Medical sciences, Isfahan 8174673461, Iran.E-mail:  rafiei@dnt.mui.ac.ir Access this article online Website:  http://drj.mui.ac.ir/index.php/drj http://www.ncbi.nlm.nih.gov/pmc/journals/1480/",Non-OADS,/arxiv_data1/oa_pdf/d3/f2/DRJ-12-243.PMC4432607.pdf
"[8,9] Furthermore, treating anxious patients Received:  December 2014 Accepted:  March 2015 Address for correspondence: Dr. Mansoureh Abtahi, School of Dentistry, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.E-mail:  mansooreh.abtahi@ yahoo.com Access this article online Website:  http://drj.mui.ac.ir/index.php/drj http://www.ncbi.nlm.nih.gov/pmc/journals/1480/",Non-OADS,/arxiv_data1/oa_pdf/2b/0b/DRJ-12-248.PMC4432608.pdf
"[5,6] Rotary  instrument is the contemporary technique to remove Recieved:  December 2013 Accepted:  March 2015 Address for correspondence:   Dr. Neda Joshan, Department of Orthodontics, School of Dentistry, Shahid Sadoughi University of Medical Sciences, Dahe Fajr Blvd, Imam Ave., PO Box 89195/165, Yazd, Iran.E-mail: neda.joshan@gmail.com Access this article online Website:  http://drj.mui.ac.ir/index.php/drj http://www.ncbi.nlm.nih.gov/pmc/journals/1480/",Non-OADS,/arxiv_data1/oa_pdf/22/80/DRJ-12-254.PMC4432609.pdf
E-mail:  rafiei@dnt.mui.ac.ir Access this article online Website:  http://drj.mui.ac.ir/index.php/drj http://www.ncbi.nlm.nih.gov/pmc/journals/1480/,Non-OADS,/arxiv_data1/oa_pdf/81/96/DRJ-12-260.PMC4432610.pdf
E-mail: m66.delavarian@gmail.com Access this article online Website:  http://drj.mui.ac.ir/index.php/drj http://www.ncbi.nlm.nih.gov/pmc/journals/1480/,Non-OADS,/arxiv_data1/oa_pdf/ca/d7/DRJ-12-265.PMC4432611.pdf
The most  Access this article online Website: http://drj.mui.ac.ir/index.php/drj http://www.ncbi.nlm.nih.gov/pmc/journals/1480/,Non-OADS,/arxiv_data1/oa_pdf/37/6f/DRJ-12-271.PMC4432612.pdf
"Although, KOT has particular histopathological features and clinical course, its developmental mechanisms and Recieved:  November 2014 Accepted:  March 2015 Address for correspondence:   Dr. Maryam Seyedmajidi, Oral and Maxillofacial Pathology Department, Dental Materials Research Center, Dental Faculty, Babol University of Medical Sciences, Babol, Iran.E-mail:  ms_majidi79@ yahoo.com Access this article online Website:  http://drj.mui.ac.ir/index.php/drj http://www.ncbi.nlm.nih.gov/pmc/journals/1480/",Non-OADS,/arxiv_data1/oa_pdf/bc/85/DRJ-12-278.PMC4432613.pdf
E-mail: prashanth.pedo@gmail.com Access this article online Website:  http://drj.mui.ac.ir/index.php/drj http://www.ncbi.nlm.nih.gov/pmc/journals/1480/,Non-OADS,/arxiv_data1/oa_pdf/7e/ad/DRJ-12-285.PMC4432614.pdf
"Although a cool NS irrigation is necessary during bone  drilling to prevent an increase of bone temperature, it  Access this article online Website:  http://drj.mui.ac.ir/index.php/drj http://www.ncbi.nlm.nih.gov/pmc/journals/1480/",Non-OADS,/arxiv_data1/oa_pdf/b6/be/DRJ-12-289.PMC4432615.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunicationsARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8057 6 NATURE COMMUNICATIONS | 6:7057 | DOI: 10.1038/ncomms8057 | www.nature.com/naturecommunications &2015 Macmillan Publishers Limited.,Non-OADS,/arxiv_data1/oa_pdf/ff/ee/ncomms8057.PMC4432626.pdf
"Reprints and permission information is available at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Mukhopadhyay, D. et al.",Non-OADS,/arxiv_data1/oa_pdf/ff/ee/ncomms8057.PMC4432626.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8057 ARTICLE NATURE COMMUNICATIONS | 6:7057 | DOI: 10.1038/ncomms8057 | www.nature.com/naturecommunications 7 &2015 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/ff/ee/ncomms8057.PMC4432626.pdf
http://www.wma.net/en/30publications/10policies/b3/index.html.,Non-OADS,/arxiv_data1/oa_pdf/bb/e0/e2014.00120.PMC4432720.pdf
http://www.euro.who.int/document/mediacentre/fs1305e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bb/e0/e2014.00120.PMC4432720.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/06/nihms688369.PMC4432840.pdf
Epub ahead of print http://dx.doi.org/10.1097/COC.,Non-OADS,/arxiv_data1/oa_pdf/ce/06/nihms688369.PMC4432840.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/57/e3/ceg-8-149.PMC4433044.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical and Experimental Gastroenterology 2015:8 149–157Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  149REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S5606 9web-based interventions for ulcerative colitis   and Crohn’s disease: systematic review   and future directions Colleen Stiles-Shields1 Laurie Keefer2,3 1Department of Preventive  Medicine and Center for Behavioral  intervention Technologies,  Northwestern University Feinberg  School of Medicine, Chicago, iL, USA;   2Division of Gastroenterology and  Hepatology,  3Center for Psychosocial  Research in Gi, Northwestern  University Feinberg School of  Medicine, Chicago, iL, USA Correspondence: Laurie Keefer   Department of Medicine- Gastroenterology and Hepatology,  Northwestern University Feinberg School  of Medicine,  676 N St Clair, Suite  1400,  Chicago, iL  60611, USA   Email laurie.keefer@northwestern.ed uAbstract:  Behavioral intervention technologies (BITs), the application of psychological and  behavioral interventions through the use of technology, provide the opportunity for clinicians  to deliver care through a means that overcomes a number of treatment barriers.",Non-OADS,/arxiv_data1/oa_pdf/57/e3/ceg-8-149.PMC4433044.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/57/e3/ceg-8-149.PMC4433044.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/57/e3/ceg-8-149.PMC4433044.pdf
Available from: http://www.lialda.com/ulcerative-colitis- websites.aspx.,Non-OADS,/arxiv_data1/oa_pdf/57/e3/ceg-8-149.PMC4433044.pdf
Available from: http://www.everydayhealth.com/forums/ digestive-health.html.,Non-OADS,/arxiv_data1/oa_pdf/57/e3/ceg-8-149.PMC4433044.pdf
Available from: http://www.ccfacom - munity.org/chatseries.aspx.,Non-OADS,/arxiv_data1/oa_pdf/57/e3/ceg-8-149.PMC4433044.pdf
Available from: http://www.ibdetermined.org /.,Non-OADS,/arxiv_data1/oa_pdf/57/e3/ceg-8-149.PMC4433044.pdf
Available  from: https://developer.imshealth.com/Content/pdf/IIHI_Patient_Apps_ Report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/57/e3/ceg-8-149.PMC4433044.pdf
Available from: https://gibuddy.ibdetermined.org /.,Non-OADS,/arxiv_data1/oa_pdf/57/e3/ceg-8-149.PMC4433044.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e9/b9/cpaa-7-077.PMC4433045.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Pharmacology: Advances and Applications 2015:7 77–78Clinical Pharmacology: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  77Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/CPAA.S8098 6Pharmacodynamics and Pharmacokinetics of oral  factor Xa inhibitors Pontus B Persson Institute of Vegetative Physiology,   Berlin, Germany Correspondence: Pontus B Persson   Institut für Vegetative Physiologie,   Charitéplatz 1, 10117 Berlin, Germany   tel +49 30 450 528 162   email pontus.persson@charite.d eDear Editor Apixaban and rivaroxaban are oral factor Xa inhibitors.",Non-OADS,/arxiv_data1/oa_pdf/e9/b9/cpaa-7-077.PMC4433045.pdf
"Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-pharmacology-advances-and-applications-journa lClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/e9/b9/cpaa-7-077.PMC4433045.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e9/b9/cpaa-7-077.PMC4433045.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/66/ac/dddt-9-2599.PMC4433046.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2599–2608Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2599Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8101 3a quest to increase safety of anesthetics  by advancements in anesthesia monitoring:  scientometric analysis Kamen V Vlassakov igor Kissin Department of anesthesiology,   Perioperative and Pain Medicine,   Brigham and Women’s hospital,   harvard Medical school, Boston,   Ma, UsaAbstract:  The aim of this study was to assess progress in the field of anesthesia monitoring  over the past 40 years using scientometric analysis.",Non-OADS,/arxiv_data1/oa_pdf/66/ac/dddt-9-2599.PMC4433046.pdf
"For example, accord - ing to one of the studies in this field, the mortality solely attributable to anesthesia  decreased from 357 (95% confidence interval [CI]: 324–394) per million (pre-1970s) correspondence: igor Kissin Department of anesthesiology, Brigham  and Women’s hospital, 75 Francis street,  Boston, Ma 02115, Usa Tel +1 617 732 5052 Fax +1 617 734 0682 email kissin@zeus.bwh.harvard.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Vlassakov and Kissin Running head recto: Scientometrics of advancements in anesthesia monitoring DOI: http://dx.doi.org/10.2147/DDDT.S81013",Non-OADS,/arxiv_data1/oa_pdf/66/ac/dddt-9-2599.PMC4433046.pdf
The articles were counted using the National Library of  Medicine’s PubMed Web site ( http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/66/ac/dddt-9-2599.PMC4433046.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/66/ac/dddt-9-2599.PMC4433046.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/ac/dddt-9-2599.PMC4433046.pdf
"Available from: https://www.acep.org/uploadedFiles/ACEP/ Membership/ACEP_chapters/chapter_services/chapter_membership_   marketing/ABMS%202012.pd f. Accessed September 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/66/ac/dddt-9-2599.PMC4433046.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d2/4b/opth-9-833.PMC4433047.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 833–841Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  833Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S5349 0Selective laser trabeculoplasty: current  perspectives Kate e Leahy1 Andrew JR white1–3 1westmead Hospital, westmead,   NSw , Australia; 2Centre for vision  Research, westmead Millennium  institute, University of Sydney, Sydney,   NSw , Australia; 3Save Sight institute,   University of Sydney, Sydney, NSw ,   AustraliaAbstract:  Selective laser trabeculoplasty (SLT) has been used in the treatment of glaucoma  for just over a decade.",Non-OADS,/arxiv_data1/oa_pdf/d2/4b/opth-9-833.PMC4433047.pdf
"In 1974, Q-switched ruby laser goniopuncture of the anterior  chamber angle was used to reduce IOP in 50 of 52 eyes by an average of 8.3 mmHg,  with the effect lasting for a period of 3 months.5Correspondence: Kate Leahy Sydney eye Hospital, GPO Box 1614,  Sydney, NSw 2001, Australia Tel +61 422 943 761 email kate.leahy@uon.edu.a u Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Leahy and White Running head recto: Selective laser trabeculoplasty DOI: http://dx.doi.org/10.2147/OPTH.S53490",Non-OADS,/arxiv_data1/oa_pdf/d2/4b/opth-9-833.PMC4433047.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/d2/4b/opth-9-833.PMC4433047.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d2/4b/opth-9-833.PMC4433047.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/99/25/cia-10-849.PMC4433048.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 849–858Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  849RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7495 1The role of perioperative oral nutritional  supplementation in elderly patients after  hip surgery Ming Liu1,* Jing Yang2,* Xi Yu3 Xiao Huang1 Sushan vaidya1 Fuguo Huang1 Zhou Xiang1 1Department of Orthopedics, west  China Hospital, Sichuan University,   Chengdu, Sichuan Province,   2Department of Pain, Xiamen No 2  Hospital, Xiamen, Fujian Province,   3west China School of Medicine,   Sichuan University, Chengdu, Sichuan  Province, People’s Republic of China *These authors contributed equally  to this workBackground: The effect of perioperative oral nutritional supplementation (ONS) on elderly  patients after hip surgery remains controversial.",Non-OADS,/arxiv_data1/oa_pdf/99/25/cia-10-849.PMC4433048.pdf
"Furthermore, ONS is more economical and practical than parenteral  nutritional supplementation.15,16 One multicenter, randomized controlled trial (RCT), Correspondence: Zhou Xiang  Department of Orthopedics, west China  Hospital, Sichuan University, Chengdu,  610041 Sichuan Province, People’s  Republic of China email xiangzhou15@hotmail.co m Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Liu et al Running head recto: ONS for elderly patients after hip surgery DOI: http://dx.doi.org/10.2147/CIA.S74951",Non-OADS,/arxiv_data1/oa_pdf/99/25/cia-10-849.PMC4433048.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/99/25/cia-10-849.PMC4433048.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/99/25/cia-10-849.PMC4433048.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d6/1c/dddt-9-2565.PMC4433049.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2565–2579Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2565Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7942 5skin regeneration in deep second-degree scald  injuries either by infusion pumping or topical  appli cation of recombinant human erythropoietin gel  Priya giri1  sabine ebert1  Ulf-Dietrich Braumann2  Mathias Kremer3  shibashish giri1  hans-günther Machens4  augustinus Bader1 1Department of cell Techniques and  applied stem cell Biology, center  for Biotechnology and Biomedicine  (BBZ), Faculty of Medicine,   University of leipzig, leipzig,   germany; 2interdisciplinary center  for Bioinformatics ( iZBi), University  of leipzig, leipzig, germany;   3Department of Plastic and hand  surgery, University of lübeck, lübeck,   germany; 4Department of Plastic  and hand surgery, Technical University  of Munich, Munich, germany Abstract:  Large doses of recombinant growth factors formulated in solution form directly  injected into the body is usual clinical practice in treating second-degree scald injuries, with  promising results, but this approach creates side effects; furthermore, it may not allow appropriate  levels of the factor to be sensed by the target injured tissue/organ in the specific time frame, owing  to complications arising from regeneration.",Non-OADS,/arxiv_data1/oa_pdf/d6/1c/dddt-9-2565.PMC4433049.pdf
"Keywords:  re-epithelialization, scald wound, skin regeneration, neovascularization, vascular - ization, segmentation Introduction Scald injuries ranked in the top 15 leading causes of the burden of disease worldwide,1  and annual deaths from scalds injuries are approximately 300,000 worldwide.2 Scald  injuries are also among the most expensive traumatic injuries because of the long  recovery period.3 Annually, approximately six million patients seek medical treat - ment for scalds worldwide, but the majority are often treated in outpatient clinics.4 correspondence: shibashish giri;  augustinus Bader Department of cell Techniques and  applied stem cell Biology, center for  Biotechnology and Biomedicine (BBZ),  Faculty of Medicine, University of  leipzig, Deutscher Platz 5, 04103  leipzig, germany Tel +49 341 973 1353 Fax +49 341 973 1329 email shibashish.giri@bbz.uni-leipzig.d e;  augustinus.bader@bbz.uni-leipzig.d e Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Giri et al Running head recto: Skin regeneration in second-degree scald injuries  DOI: http://dx.doi.org/10.2147/DDDT.S79425",Non-OADS,/arxiv_data1/oa_pdf/d6/1c/dddt-9-2565.PMC4433049.pdf
The analysis  software used in the present study can be downloaded free  at http://rsb.info.nih.gov/i j.,Non-OADS,/arxiv_data1/oa_pdf/d6/1c/dddt-9-2565.PMC4433049.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d6/1c/dddt-9-2565.PMC4433049.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/1c/dddt-9-2565.PMC4433049.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/8e/ccid-8-249.PMC4433050.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 249–255Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  249RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S5594 2Nalfurafine hydrochloride to treat   pruritus: a review Shigeki Inui Department of Regenerative  Dermatology, Osaka University  Graduate School of Medicine,    Osaka, Japan Correspondence: Shigeki Inui   Department of Regenerative  Dermatology, Osaka University Graduate  School of Medicine,  2-2, G2, Yamadaoka,  Suita-shi, Osaka  5650871, Japan   Tel +81 6 6879 3960  email inui@r-derma.med.osaka-u.ac.j pAbstract:  Uremic pruritus has a great negative influence on quality of life in hemodialysis (HD)  patients and, importantly, negatively affects mortality risk.",Non-OADS,/arxiv_data1/oa_pdf/8a/8e/ccid-8-249.PMC4433050.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/8a/8e/ccid-8-249.PMC4433050.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/8e/ccid-8-249.PMC4433050.pdf
"NIH  Evidence-Based Methodology Workshop on  Polycystic Ovary Syndrome: executive sum - mary, 2012. https://prevention.nih.gov/docs/ programs/pcos/FinalReport.pdf.",Non-OADS,/arxiv_data1/oa_pdf/a7/ba/116.PMC4433074.pdf
Available from https://www.women - shealth.gov/publications/our-publications/ fact-sheet/polycystic-ovary-syndrome.pdf  Accessed 23 February 2015 18.,Non-OADS,/arxiv_data1/oa_pdf/a7/ba/116.PMC4433074.pdf
Available from  http://professional.diabetes.org/Abstracts_ Display.aspx?TYP=1&CID=86570.,Non-OADS,/arxiv_data1/oa_pdf/d4/82/121.PMC4433075.pdf
Available from http://www.medscape.com/ viewarticle/504227.,Non-OADS,/arxiv_data1/oa_pdf/d4/82/121.PMC4433075.pdf
Available from  http://www.medicalnewstoday.com/arti - cles/257891.php.,Non-OADS,/arxiv_data1/oa_pdf/d4/82/121.PMC4433075.pdf
Available  from http://minorityhealth.hhs.gov/   templates/content.aspx?lvl=3&lvlID   =5&ID=3017.,OADS,/arxiv_data1/oa_pdf/5d/44/106.PMC4433078.pdf
Available from http://www.cdc.gov/diabetes/ statistics/preventive/tNewDEduRace.htm.,Non-OADS,/arxiv_data1/oa_pdf/5d/44/106.PMC4433078.pdf
Available from http://www.dshs.,Non-OADS,/arxiv_data1/oa_pdf/5d/44/106.PMC4433078.pdf
Available from http://www.dshs.state.tx.us/chs/cfs/2009/2009-Health-Facts- Profiles-for-Texas.,Non-OADS,/arxiv_data1/oa_pdf/5d/44/106.PMC4433078.pdf
Available from  http://factfinder2.census.gov/faces/nav/ jsf/pages/searchresults.xhtml?refresh=t.,OADS,/arxiv_data1/oa_pdf/5d/44/106.PMC4433078.pdf
Available from  http://factfinder2.census.gov/faces/nav/jsf/ pages/index.xhtml.,OADS,/arxiv_data1/oa_pdf/5d/44/106.PMC4433078.pdf
Available from http://www.cdc.gov/hrqol/ hrqol14_measure.htm .,OADS,/arxiv_data1/oa_pdf/5d/44/106.PMC4433078.pdf
Available from http://www.cdc.gov/ media/pressrel/2010/r101022.html.,OADS,/arxiv_data1/oa_pdf/d4/d6/83.PMC4433079.pdf
Available  from http://www.who.int/goe/publications/ ehealth_series_vol3/en.,Non-OADS,/arxiv_data1/oa_pdf/d4/d6/83.PMC4433079.pdf
Available from  http://pewinternet.org/Reports/2012/Cell- Activities.aspx.,OADS,/arxiv_data1/oa_pdf/d4/d6/83.PMC4433079.pdf
Available  from http://www.pewinternet.org/PPF/r/213/ report_display.asp.,Non-OADS,/arxiv_data1/oa_pdf/d4/d6/83.PMC4433079.pdf
Available  from http://professional.diabetes.org/ ResourcesForProfessionals.aspx?cid=84160.,Non-OADS,/arxiv_data1/oa_pdf/d4/d6/83.PMC4433079.pdf
"VOLUME 28, NUMBER 2, SPRING 2015  91 c a p o z z a  e t a l.http://www.pwc.com/en_GX/gx/healthcare/ mhealth/assets/pwc-emerging-mhealth-full.",Non-OADS,/arxiv_data1/oa_pdf/d4/d6/83.PMC4433079.pdf
Available from http://www.cms.,Non-OADS,/arxiv_data1/oa_pdf/d4/d6/83.PMC4433079.pdf
Avail- able from http://mobihealthnews.com/   23026/welldocs-bluestar-secures-first-  mobile-health-reimbursement.,Non-OADS,/arxiv_data1/oa_pdf/d4/d6/83.PMC4433079.pdf
Available from http://www.queri.research.,Non-OADS,/arxiv_data1/oa_pdf/25/57/99.PMC4433080.pdf
Available from  http://www.cdc.gov/diabetes/pubs/stats   report14/national-diabetes-report-web.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c6/11/141.PMC4433081.pdf
Available from http://www.united   healthgroup.com/~/media/UHG/PDF/2010/ UNH-Working-Paper-5.ashx.,Non-OADS,/arxiv_data1/oa_pdf/c6/11/141.PMC4433081.pdf
Available from http://report.nih.gov/categorical_spending.aspx.,OADS,/arxiv_data1/oa_pdf/c6/11/141.PMC4433081.pdf
Available from http://www.cspinet.org/ new/201309271.html.,Non-OADS,/arxiv_data1/oa_pdf/c6/11/141.PMC4433081.pdf
Available from http://www.ncqa.,Non-OADS,/arxiv_data1/oa_pdf/c6/f4/132.PMC4433082.pdf
"She delivered the  address in June 2014 at the association’s  74th Annual Meeting and Scientific Sessions  in San Francisco, Calif. A webcast of this  speech is available for viewing at the ADA  website (http://professional.diabetes.org/ Presentations_Details.aspx?session=4514).",Non-OADS,/arxiv_data1/oa_pdf/c2/9d/146.PMC4433083.pdf
http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/ce/79/txd-1-0e7.PMC4433175.pdf
"Protein Expression, Purification, Crystallography, and Interaction Analysis For binding, structural, and interaction analysis see Figure S1 (SDC, http://links.lww.com/TXD/A0).",Non-OADS,/arxiv_data1/oa_pdf/ce/79/txd-1-0e7.PMC4433175.pdf
"For crystal- lographic data collection and refinement statistics, see Table S1 (SDC, http://links.lww.com/TXD/A0).",OADS,/arxiv_data1/oa_pdf/ce/79/txd-1-0e7.PMC4433175.pdf
Other reason to be cautious in relation to the available data in the literature about the mixture of iodinated contrast agent or http://dx.doi.org/10.1590/0100-3984.2015.48.2e1,Non-OADS,/arxiv_data1/oa_pdf/1f/74/rb-48-02-000V.PMC4433293.pdf
"Studies show that the delimitation of many intra-articu- lar structures, the visualization of the normal articularYvana Lopes Pinheiro da Silva1, Rita Zanlorensi Visneck Costa2, Kátia Elisa Prus Pinho3, Ricardo Rabello Ferreira4, Sueliton Miyamoto Schuindt5 http://dx.doi.org/10.1590/0100-3984.2013.0002",OADS,/arxiv_data1/oa_pdf/e8/64/rb-48-02-0069.PMC4433294.pdf
"Five-year survival for patientsRicardo Hoelz de Oliveira Barros1, Thiago José Penachim1, Daniel Lahan Martins1, Nelson Adami Andreollo2, Nelson Marcio Gomes Caserta3 http://dx.doi.org/10.1590/0100-3984.2014.0021de Universitária Zeferino Vaz.",Non-OADS,/arxiv_data1/oa_pdf/94/c0/rb-48-02-0074.PMC4433295.pdf
"The affected individuals require long-term assistance and follow-up and, considering that they are in the most produc-Marli Batista Fernandes Vermelho1, Ademir Silva Correia1, Tânia Cibele de Almeida Michailowsky1, Elizete Kazumi Kuniyoshi Suzart1, Aline Santos Ibanês2, Lanamar Aparecida Almeida3, Zarifa Khoury4, Mário Flores Barba5 http://dx.doi.org/10.1590/0100-3984.2013.0025INTRODUCTION Paracoccidioidomycosis (PCM), Lutz disease or South American blastomycosis is a systemic fungal infection caused by the primary pathogenic, thermally dimorphic, saprophyticfungus Paracoccidioides brasiliensis  discovered in 1908 (1–6).",Non-OADS,/arxiv_data1/oa_pdf/65/37/rb-48-02-0081.PMC4433296.pdf
"Iniquities to be overcome apart, it is important to high-Vanessa Cristina Felippe Lopes Villar1, Marismary Horsth De Seta2, Carla Lourenço Tavares de Andrade2, Elizabete Vianna Delamarque3, Ana Cecília Pedrosa de Azevedo4 http://dx.doi.org/10.1590/0100-3984.2014.0047INTRODUCTION Breast cancer represents a severe public health problem and, in Brazil, deficiencies in the diagnosis and treatment ofthis disease are pointed out, with huge disparities in outcomesresulting from disparities in geography, social, ethnic and Mailing Address: Vanessa Cristina Felippe Lopes Villar.",Non-OADS,/arxiv_data1/oa_pdf/86/a5/rb-48-02-0086.PMC4433297.pdf
Disponível em: http://www.ibge.gov.br/home/estatistica/populacao/panorama_saude_brasil_2003_2008/default.shtm .,Non-OADS,/arxiv_data1/oa_pdf/86/a5/rb-48-02-0086.PMC4433297.pdf
[acessado em 1º de setembro de 2014].Disponível em: http://www2.inca.gov.br/wps/wcm/connect/acoes_programas/site/home/nobrasil/programa_controle_cancer_mama/controle_garantia_qualidade_mamografia .,OADS,/arxiv_data1/oa_pdf/86/a5/rb-48-02-0086.PMC4433297.pdf
"Both images are generally acquiredwith a conventional clinical gradient echo (GE) sequenceJeam Haroldo Oliveira Barbosa1, Antonio Carlos Santos2, Carlos Ernesto Garrido Salmon3 http://dx.doi.org/10.1590/0100-3984.2014.0010INTRODUCTION In the clinical practice, the most frequently utilized mag- netic resonance imaging modality is fundamentally weightedby relaxation time of tissues.",Non-OADS,/arxiv_data1/oa_pdf/dc/a3/rb-48-02-0093.PMC4433298.pdf
http://dx.doi.org/10.1590/0100-3984.2015.48.2e3,Non-OADS,/arxiv_data1/oa_pdf/e4/ef/rb-48-02-00IX.PMC4433299.pdf
"Magnetic http://dx.doi.org/10.1590/0100-3984.2015.48.2qdUnicamp), Campinas, SP , Brazil.",OADS,/arxiv_data1/oa_pdf/64/b3/rb-48-02-00XI.PMC4433300.pdf
"Accepted after revision February 7, 2014.Luiz Henrique Costa Garcia1, Bruna Cortez Ferreira2 http://dx.doi.org/10.1590/0100-3984.2013.1846INTRODUCTION Cranial computed tomography (CT) is an extremely useful and common imaging method, particularly in theintensive care environment and at emergency departmentsin most hospitals both in Brazil and worldwide.",Non-OADS,/arxiv_data1/oa_pdf/51/a7/rb-48-02-0101.PMC4433301.pdf
[acessado em 25 de junho de 2013].Disponível em: http://accessmedicine.mhmedical.com/content.aspx?bookid=348&Sectionid=40381742.,OADS,/arxiv_data1/oa_pdf/51/a7/rb-48-02-0101.PMC4433301.pdf
"Besidesassessment of cancer in children, WBMRI stands out in theinvestigation of inflammatory and/or infectious processes (5,6),Sara Reis Teixeira1, Jorge Elias Junior2, Marcello Henrique Nogueira-Barbosa3, Marcos Duarte Guimarães4, Edson Marchiori5, Marcel Koenigkam Santos1 http://dx.doi.org/10.1590/0100-3984.2014.0005INTRODUCTION Until recently, whole-body imaging in children was performed only with plain radiography, scintigraphy andpositron-emission tomography (PET), either in combinationor not with computed tomography (CT).",Non-OADS,/arxiv_data1/oa_pdf/68/68/rb-48-02-0111.PMC4433302.pdf
"MRI is considered the most relevantEric Mendonça Bimbato1, Amanda Gontijo Carvalho2, Fabiano Reis3 http://dx.doi.org/10.1590/0100-3984.2013.1923INTRODUCTION Toxic-metabolic diseases constitute a group of condi- tions that, by different pathophysiological changes, lead toacute or chronic central nervous system (CNS) functional disorders.",Non-OADS,/arxiv_data1/oa_pdf/7e/8a/rb-48-02-0121.PMC4433303.pdf
http://dx.doi.org/10.1590/0100-3984.2014.0035 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/9c/df/rb-48-02-0126.PMC4433304.pdf
http://dx.doi.org/10.1590/0100-3984.2014.0035 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/57/5f/rb-48-02-0127.PMC4433305.pdf
http://dx.doi.org/10.1590/0100-3984.2014.0073causing abdominal distension upstream due to fecal buildup (Fig- ure 1B).,Non-OADS,/arxiv_data1/oa_pdf/57/5f/rb-48-02-0127.PMC4433305.pdf
http://dx.doi.org/10.1590/0100-3984.2014.0073causing abdominal distension upstream due to fecal buildup (Fig- ure 1B).,Non-OADS,/arxiv_data1/oa_pdf/00/65/rb-48-02-0128.PMC4433306.pdf
http://dx.doi.org/10.1590/0100-3984.2014.0067Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/00/65/rb-48-02-0128.PMC4433306.pdf
http://dx.doi.org/10.1590/0100-3984.2013.0020 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/2c/5c/rb-48-02-0130.PMC4433307.pdf
Diagnóstico da esteatose hepá- http://dx.doi.org/10.1590/0100-3984.2015.48.2e2,OADS,/arxiv_data1/oa_pdf/9d/64/rb-48-02-0VII.PMC4433308.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/ad/amiajnl-2013-002481.PMC4433357.pdf
MATERIALS AND METHODS Data and genomic knowledge Normalized multi-omics datasets in ovarian cancer were retrieved from the TCGA data portal ( http://tcga-data.nci.nih.,OADS,/arxiv_data1/oa_pdf/e3/ad/amiajnl-2013-002481.PMC4433357.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/94/amiajnl-2013-002491.PMC4433358.pdf
2013. http://www.medicare.gov/ hospitalcompare/ (accessed 24 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/f7/94/amiajnl-2013-002491.PMC4433358.pdf
2013. http://www.qualityindica tors.ahrq.gov/icd10/ (accessed 15 Jan 2014).,OADS,/arxiv_data1/oa_pdf/f7/94/amiajnl-2013-002491.PMC4433358.pdf
"2013. http://himss.files.cms-plus.com/HIMSSBRIEF COMMUNICATIONBoyd AD, et al.",OADS,/arxiv_data1/oa_pdf/f7/94/amiajnl-2013-002491.PMC4433358.pdf
"2013. http://www.qualityindicators.ahrq.gov/Downloads/Resources/Publications/2013/ICD-10%20Report%2007-15-2013.pdf(accessed 3 Nov 2013), HHSA290201200001C.21.",Non-OADS,/arxiv_data1/oa_pdf/f7/94/amiajnl-2013-002491.PMC4433358.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/2f/amiajnl-2013-002511.PMC4433359.pdf
http://www.oecd.org/uni tedstates/HealthSpendingInUSA_HealthData2012.pdf (ac- cessed 29 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/cf/2f/amiajnl-2013-002511.PMC4433359.pdf
https://www.cia.,Non-OADS,/arxiv_data1/oa_pdf/cf/2f/amiajnl-2013-002511.PMC4433359.pdf
http://blogs.hbr.org/2013/09/why-health-care-is- stuck-and-how-to-fix-it/ (accessed 29 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/cf/2f/amiajnl-2013-002511.PMC4433359.pdf
http://dashboard.healthit.gov/ HITAdoption (accessed 1 Oct 2013).,OADS,/arxiv_data1/oa_pdf/cf/2f/amiajnl-2013-002511.PMC4433359.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/be/amiajnl-2013-002544.PMC4433360.pdf
The ShARe project guidelines relevant to Task 1 are available at: https://physionet.org/works/ ShAReCLEFeHealth2013/files/Task1ShAReGuidelines2013.pdfand https://sites.google.com/site/shareclefehealth/data .,Non-OADS,/arxiv_data1/oa_pdf/3c/be/amiajnl-2013-002544.PMC4433360.pdf
The website to the ShARe/CLEF lab is located at https://sites.google.com/site/shareclefehealth/ Evaluation We used the following evaluation criteria: •Task 1a —Correctness in identification of the character spans of disorders.,Non-OADS,/arxiv_data1/oa_pdf/3c/be/amiajnl-2013-002544.PMC4433360.pdf
http://sharpn.org 12.,Non-OADS,/arxiv_data1/oa_pdf/3c/be/amiajnl-2013-002544.PMC4433360.pdf
http://en.wikipedia.org/ wiki/SemEval 23.,Non-OADS,/arxiv_data1/oa_pdf/3c/be/amiajnl-2013-002544.PMC4433360.pdf
http://compbio.ucdenver.edu/BioNLP2013 24.,Non-OADS,/arxiv_data1/oa_pdf/3c/be/amiajnl-2013-002544.PMC4433360.pdf
http://www.biocreative.org/ 25. i2b2 Shared Tasks.,OADS,/arxiv_data1/oa_pdf/3c/be/amiajnl-2013-002544.PMC4433360.pdf
https://www.i2b2.org/NLP/Relations/ 26.,Non-OADS,/arxiv_data1/oa_pdf/3c/be/amiajnl-2013-002544.PMC4433360.pdf
http://www.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/3c/be/amiajnl-2013-002544.PMC4433360.pdf
http://www.nlm.nih.gov/research/ umls 29.,Non-OADS,/arxiv_data1/oa_pdf/3c/be/amiajnl-2013-002544.PMC4433360.pdf
http://www.nicta.com.au/ pub?id=7264 30.,Non-OADS,/arxiv_data1/oa_pdf/3c/be/amiajnl-2013-002544.PMC4433360.pdf
http://www.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/3c/be/amiajnl-2013-002544.PMC4433360.pdf
https://www.nlm.nih.gov/research/umls/rxnorm/ 32.,Non-OADS,/arxiv_data1/oa_pdf/3c/be/amiajnl-2013-002544.PMC4433360.pdf
http://www.aclweb.org/anthology/ W12-2411 39.,Non-OADS,/arxiv_data1/oa_pdf/3c/be/amiajnl-2013-002544.PMC4433360.pdf
http://mimic.physionet.org/ 42.,Non-OADS,/arxiv_data1/oa_pdf/3c/be/amiajnl-2013-002544.PMC4433360.pdf
http://www.acl web.org/anthology/W13-3516 47.,Non-OADS,/arxiv_data1/oa_pdf/3c/be/amiajnl-2013-002544.PMC4433360.pdf
https://code.google.com/p/clearnlp/ 55.,Non-OADS,/arxiv_data1/oa_pdf/3c/be/amiajnl-2013-002544.PMC4433360.pdf
"http://factorie.cs.umass.edu/ AUTHOR AFFILIATIONS............................................................................................................................... ..................... 1Boston Children’s Hospital and Harvard Medical School, Boston, Massachusetts, USA 2Columbia University, New York, New York, USA 3University of Utah, Salt Lake City, Utah, USA4The University of Melbourne, Australia 5NICTA, The Australian National University, and University of Canberra, Canberra, Australian Capital Territory, Australia RESEARCH AND APPLICATIONSPradhan S, et al.",Non-OADS,/arxiv_data1/oa_pdf/3c/be/amiajnl-2013-002544.PMC4433360.pdf
"All the software can be downloaded as a MOLGENIS open source app from http://www.github.com/molgenis , with a demo available at http://www.biobankcon nect.org .",Non-OADS,/arxiv_data1/oa_pdf/17/8e/amiajnl-2013-002577.PMC4433361.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/8e/amiajnl-2013-002577.PMC4433361.pdf
A demonstration and the open source software are available at http://www.biobankconnect.org .,Non-OADS,/arxiv_data1/oa_pdf/17/8e/amiajnl-2013-002577.PMC4433361.pdf
"DATA SHARING STATEMENT All data and software are available as open source from thedemo application ( http://www.biobankconnect.org ) and source code repository ( http://github.com/molgenis ), respectively.",OADS,/arxiv_data1/oa_pdf/17/8e/amiajnl-2013-002577.PMC4433361.pdf
2005. http://www.p3gobservatory.org 22.,Non-OADS,/arxiv_data1/oa_pdf/17/8e/amiajnl-2013-002577.PMC4433361.pdf
Agenda 2006;2009. http://lucene.apache.org/ .,Non-OADS,/arxiv_data1/oa_pdf/17/8e/amiajnl-2013-002577.PMC4433361.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/20/amiajnl-2014-002649.PMC4433365.pdf
2009. http://www.naac cr.org/LinkClick.aspx?fileticket=RD1FxWlmC24%3D& tabid=130&mid=470 (accessed 5 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/d1/20/amiajnl-2014-002649.PMC4433365.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/08/amiajnl-2014-002726.PMC4433367.pdf
http://www.medscape.com/ viewarticle/820101 (accessed 6 Feb 2014).,Non-OADS,/arxiv_data1/oa_pdf/1f/08/amiajnl-2014-002726.PMC4433367.pdf
http://www.ama-assn.org/ama/pub/physician-re- sources/solutions-managing-your-practice/coding-billing-insurance/cpt.page (accessed 28 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/1f/08/amiajnl-2014-002726.PMC4433367.pdf
2013. http://www.cdc.gov/nchs/fastats/diabe tes.htm (accessed 22 Oct 2013).,OADS,/arxiv_data1/oa_pdf/1f/08/amiajnl-2014-002726.PMC4433367.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/9e/amiajnl-2014-002768.PMC4433368.pdf
2014. http://www.joint commission.org/specifications_manual_for_national_hospital_inpatient_quality_measures.aspx (accessed 11 Feb 2014).,Non-OADS,/arxiv_data1/oa_pdf/1e/9e/amiajnl-2014-002768.PMC4433368.pdf
2012 February 15. http://cran.r-project.org/web/ packages/tm/tm.pdf (accessed 14 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/1e/9e/amiajnl-2014-002768.PMC4433368.pdf
"Vienna, Austria: Technische Universita ¨t, Department of Statistics, 14 February 2012. http://cran.r-project.org/web/ packages/e1071/e1071.pdf (accessed 14 Apr 2013).",Non-OADS,/arxiv_data1/oa_pdf/1e/9e/amiajnl-2014-002768.PMC4433368.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/14/amiajnl-2014-002871.PMC4433374.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/ea/amiajnl-2014-002887.PMC4433376.pdf
SUPPLEMENTARY MATERIAL Supplementary material is available online at http://jamia.ox fordjournals.org/ .,Non-OADS,/arxiv_data1/oa_pdf/4c/ea/amiajnl-2014-002887.PMC4433376.pdf
2013. http://trec.nist.,Non-OADS,/arxiv_data1/oa_pdf/4c/ea/amiajnl-2014-002887.PMC4433376.pdf
The twentith Text REtrieval Conference Proceedings(TREC); 2011. http://trec.nist.gov/pubs/trec20/papers/ Fraunhofer-SCAI.med.update.pdf (accessed 17 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/4c/ea/amiajnl-2014-002887.PMC4433376.pdf
The twentith Text REtrieval Conference Proceedings (TREC) 2011. http://trec.nist.gov/pubs/trec20/ papers/Cengage.medical.update.pdf (accessed 17 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/4c/ea/amiajnl-2014-002887.PMC4433376.pdf
The twentith Text REtrieval Conference Proceedings(TREC) 2011. http://trec.nist.gov/pubs/trec20/papers/uog Tr.crowd.microblog.web.update4-20.pdf (accessed 17 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/4c/ea/amiajnl-2014-002887.PMC4433376.pdf
A knowledge-based approach to medical records retrieval.The twentith Text REtrieval Conference Proceedings (TREC)2011. http://trec.nist.gov/pubs/trec20/papers/NLM.medi cal.pdf (accessed 17 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/4c/ea/amiajnl-2014-002887.PMC4433376.pdf
The twentith firstText REtrieval Conference Proceedings (TREC) 2012. http://trec.nist.gov/ pubs/trec21/papers/udel_fang.medical.nb.pdf (accessed 17 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/4c/ea/amiajnl-2014-002887.PMC4433376.pdf
Thetwentith first Text REtrieval Conference Proceedings (TREC);2012. http://trec.nist.gov/pubs/trec21/papers/uogTr.medi cal.microblog.web.final.pdf (accessed 17 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/4c/ea/amiajnl-2014-002887.PMC4433376.pdf
The twenty first Text REtrieval ConferenceProceedings (TREC); 2012. http://trec.nist.gov/pubs/trec21/ papers/sennamed.medical.final.pdf (accessed 17 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/4c/ea/amiajnl-2014-002887.PMC4433376.pdf
The twenty first Text REtrieval ConferenceProceedings (TREC); 2012. http://trec.nist.gov/pubs/trec21/ papers/udel.medical.final.pdf (accessed 17 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/4c/ea/amiajnl-2014-002887.PMC4433376.pdf
2013. http://www.nlm.nih.gov/research/umls/ (accessed 17 April 2014).,OADS,/arxiv_data1/oa_pdf/4c/ea/amiajnl-2014-002887.PMC4433376.pdf
2013. http://www.ihtsdo.org/snomed-ct/ (accessed 17 April 2014).,OADS,/arxiv_data1/oa_pdf/4c/ea/amiajnl-2014-002887.PMC4433376.pdf
2013. https://www.nlm.nih.gov/research/umls/ rxnorm/ (accessed 17 April 2014).,OADS,/arxiv_data1/oa_pdf/4c/ea/amiajnl-2014-002887.PMC4433376.pdf
2013. http://lucene.apache.org/ (accessed 17 April 2014).,OADS,/arxiv_data1/oa_pdf/4c/ea/amiajnl-2014-002887.PMC4433376.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/ac/amiajnl-2014-002902.PMC4433377.pdf
SUPPLEMENTARY MATERIAL Supplementary material is available online at http://jamia.ox fordjournals.org/ .,Non-OADS,/arxiv_data1/oa_pdf/9c/ac/amiajnl-2014-002902.PMC4433377.pdf
http://www.schattauer.de/en/ magazine/subject-areas/journals-a-z/imia-yearbook/imia-yearbook-2008/issue/840/manuscript/9830.html 31.,Non-OADS,/arxiv_data1/oa_pdf/9c/ac/amiajnl-2014-002902.PMC4433377.pdf
Unitex: http://www-igm.univ-mlv.fr/~unitex/ 39.,Non-OADS,/arxiv_data1/oa_pdf/9c/ac/amiajnl-2014-002902.PMC4433377.pdf
Health Fidelity: http://healthfidelity.com/health-fidelity-an nounces-research-program-support-advanced-use-unstructured-clinical-data 47.,Non-OADS,/arxiv_data1/oa_pdf/9c/ac/amiajnl-2014-002902.PMC4433377.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
6 March 2008.http://resources.sei.cmu.edu/asset_files/presentation/2008_017_001_23733.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
1 March 2011. http://blogs.hbr.org/2011/03/ searching-for-health-cares-ent/ 6.,Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
http://www.iom.edu/bestcare 9.,Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
http://www.nejm.org/doi/pdf/ 10.1056/NEJMp1006304 11.,Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
2014. http://www.per sonalizedmedicinecoalition.org/Userfiles/PMC-Corporate/file/pmc_case_for_personalized_medicine.pdf 12.,Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
2011. http://www.healthit.gov/sites/default/ files/utility/final-federal-health-it-strategic-plan-0911.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
2014. http://healthit.gov/sites/default/ files/ONC10yearInteroperabilityConceptPaper.pdf14.,OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
"OECD Publishing, 2013. http://www.oecd.org/els/health-systems/ Health-at-a-Glance-2013.pdf 17.",Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
"New York: The Commonwealth Fund, 2012. http://www.common- wealthfund.org/~/media/Files/News/News%20Releases/2012/Apr/SquiresOECDRelease_FINAL_5312wolink.pdf 18.",Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
http://news.medi cine.duke.edu/wp-content/uploads/2013/08/Eliminating-Waste-in-US-Healthcare-Berwick.pdf 19.,Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
http://www.nejm.org/doi/full/10.1056/ NEJMsa022615 20.,Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
2012.http://iom.edu/~/media/Files/Activity%20Files/Quality/ VSRT/Core%20Documents/LearningHealthSystem.pdf 22.,Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
"National Academies Press, 2007. http://www.iom.edu/ Reports/2007/The-Learning-Healthcare-System-Workshop-Summary.aspx 23.",Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
USA Today 12 October 2004. http://usatoday30.usatoday.com/news/ health/2004–10-12-vioxx-cover_x.htm 24.,Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
Presented at ECRI Institute AnnualConference: Data BIG and Small: What Healthcare DecisionMakers are Using Now; November 2013. https://www.ecri.,Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
"July 2014: Volume 33, Issue 7. http://content.healthaffairs.org/con tent/33/7.toc 28.",Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
http://content.healthaffairs.,Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
"Inc. November 1, 2012.http://www.inc.com/leigh-buchanan/big-ideas/jim-collins-big-hairy-audacious-goals.html 31.",Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
1 September 2011. http://www.tech nologyreview.com/news/425298/the-rise-of-electronic-medicine/ 32.,Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
06 Nov. 2013. http://www.asco.org/ quality-guidelines/cancerlinq 37.,Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
http://www.learn inghealth.org/corevalues/39.,Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
http://www.trans formproject.eu/ 40.,Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
"Austin, TX, 2013. http://www.cdisc.org/lhs 41.",Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
Ecol Soc 2005;10:6. http://www.ecologyandsoci ety.org/vol10/iss2/art6/ES-2005-1360.pdf 43.,OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
"21 December 2013. https://www.kevinjsullivan.com/ blog/%5B%20node%3Acreated%3Acustom%3AY%5D/12/21/cyber-social-ecosystems AUTHOR AFFILIATIONS............................................................................................................................... ..................... 1University of Michigan, Ann Arbor, Michigan, USA 2Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA 3Vanderbilt University, Nashville, Tennessee, USA 4National Library of Medicine, Bethesda, Maryland, USA5George Washington University, Washington, District of Columbia, USA 6University of Illinois, Urbana-Champaign, Illinois, USA 7Stanford University, Stanford, California, USA 8University of Virginia, Charlottesville, Virginia, USA RESEARCH AND APPLICATIONSFriedman C, et al.",Non-OADS,/arxiv_data1/oa_pdf/0f/ab/amiajnl-2014-002977.PMC4433378.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/88/amiajnl-2014-003043.PMC4433380.pdf
SUPPLEMENTARY MATERIAL Supplementary material is available online at http://jamia.ox fordjournals.org/ .,Non-OADS,/arxiv_data1/oa_pdf/d0/88/amiajnl-2014-003043.PMC4433380.pdf
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-07-088.html 9.,Non-OADS,/arxiv_data1/oa_pdf/d0/88/amiajnl-2014-003043.PMC4433380.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/af/d6/10.1177_2058460115580878.PMC4433477.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommerci al 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distribution, and reproductio n in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2015, 4: 28165 - http://dx.doi.org/10.3402/jev.v4.28165",Non-OADS,/arxiv_data1/oa_pdf/42/7c/JEV-4-28165.PMC4433486.pdf
"Inflammasome and sterile inflammation Xuan Li, Sarah Thome and Ziad Mallat Cardiovascular Division, Department of Medicine, University of Cambridge, Robinson Way, Cambridge, UKAbstracts 2 Citation: Journal of Extracellular Vesicles 2015, 4: 28165 - http://dx.doi.org/10.3402/jev.v4.28165",Non-OADS,/arxiv_data1/oa_pdf/42/7c/JEV-4-28165.PMC4433486.pdf
"Funding This work was supported by the Russian Science Foundation 14- 24-00086.UK-Russia Workshop Citation: Journal of Extracellular Vesicles 2015, 4: 28165 - http://dx.doi.org/10.3402/jev.v4.28165 3",Non-OADS,/arxiv_data1/oa_pdf/42/7c/JEV-4-28165.PMC4433486.pdf
"Several cancer modelsAbstracts 4 Citation: Journal of Extracellular Vesicles 2015, 4: 28165 - http://dx.doi.org/10.3402/jev.v4.28165",Non-OADS,/arxiv_data1/oa_pdf/42/7c/JEV-4-28165.PMC4433486.pdf
"This work was supported by the Russian Foundation for Basic Research (grant number 13-04-00169a).UK-Russia Workshop Citation: Journal of Extracellular Vesicles 2015, 4: 28165 - http://dx.doi.org/10.3402/jev.v4.28165 5",OADS,/arxiv_data1/oa_pdf/42/7c/JEV-4-28165.PMC4433486.pdf
"This work was funded by Russian Ministry of Science and Education project No 14.610.21.0001.Abstracts 6 Citation: Journal of Extracellular Vesicles 2015, 4: 28165 - http://dx.doi.org/10.3402/jev.v4.28165",OADS,/arxiv_data1/oa_pdf/42/7c/JEV-4-28165.PMC4433486.pdf
"XL1 as a new effective antimicrobial preparation.UK-Russia Workshop Citation: Journal of Extracellular Vesicles 2015, 4: 28165 - http://dx.doi.org/10.3402/jev.v4.28165 7",Non-OADS,/arxiv_data1/oa_pdf/42/7c/JEV-4-28165.PMC4433486.pdf
"These pieces ofevidence point to the possible use of strains JS1 and FM3 for furtherexploration of various types of biogenesis of EVs in the bacteria-producers of biologically active substances and subsequent estima- tion of their biotechnological potential.Abstracts 8 Citation: Journal of Extracellular Vesicles 2015, 4: 28165 - http://dx.doi.org/10.3402/jev.v4.28165",Non-OADS,/arxiv_data1/oa_pdf/42/7c/JEV-4-28165.PMC4433486.pdf
"This fact makes identifying factors thatmodulate exosomal release and constitution key priorities for futurework and may reveal potential therapeutic targets for the treatmentUK-Russia Workshop Citation: Journal of Extracellular Vesicles 2015, 4: 28165 - http://dx.doi.org/10.3402/jev.v4.28165 9",Non-OADS,/arxiv_data1/oa_pdf/42/7c/JEV-4-28165.PMC4433486.pdf
"This work is supported by grant of Russian Science Foundation #14-24-00086.Abstracts 10 Citation: Journal of Extracellular Vesicles 2015, 4: 28165 - http://dx.doi.org/10.3402/jev.v4.28165",OADS,/arxiv_data1/oa_pdf/42/7c/JEV-4-28165.PMC4433486.pdf
"Nanoparticle tracking analysis: theory, applications for exosomes research and tips and tricks Evgeniy G. Evtushenko Laboratory of Postgenomic Chemistry, Lomonosov Moscow State University, Moscow, RussiaUK-Russia Workshop Citation: Journal of Extracellular Vesicles 2015, 4: 28165 - http://dx.doi.org/10.3402/jev.v4.28165 11",OADS,/arxiv_data1/oa_pdf/42/7c/JEV-4-28165.PMC4433486.pdf
"The aim of the study was to identify possible ways ofinternalization and localization of new lipophilic complexes of aAbstracts 12 Citation: Journal of Extracellular Vesicles 2015, 4: 28165 - http://dx.doi.org/10.3402/jev.v4.28165",OADS,/arxiv_data1/oa_pdf/42/7c/JEV-4-28165.PMC4433486.pdf
"Acknowledgements The work was performed in the framework of the Program for Basic Research of State Academies of Sciences for 2013 /C12020.UK-Russia Workshop Citation: Journal of Extracellular Vesicles 2015, 4: 28165 - http://dx.doi.org/10.3402/jev.v4.28165 13",OADS,/arxiv_data1/oa_pdf/42/7c/JEV-4-28165.PMC4433486.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2015, 4: 28094 - http://dx.doi.org/10.3402/jev.v4.28094 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/75/36/JEV-4-28094.PMC4433487.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 28094 - http://dx.doi.org/10.3402/jev.v4.28094",OADS,/arxiv_data1/oa_pdf/75/36/JEV-4-28094.PMC4433487.pdf
"J Extracell Vesicles.2013;2:20389, doi: http://dx.doi.org/10.3402/jev.v2i0.20389 2.",OADS,/arxiv_data1/oa_pdf/75/36/JEV-4-28094.PMC4433487.pdf
"2014;3:26913, doi: http://dx.doi.org/10.3402/ jev.v3.26913UK/C1Russia Researcher Links Workshop Citation: Journal of Extracellular Vesicles 2015, 4: 28094 - http://dx.doi.org/10.3402/jev.v4.28094 3 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/75/36/JEV-4-28094.PMC4433487.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"EE /C30early endosome; MVB /C30multi-vesicular body; ILV/C30intraluminal vesicles; N /C30Nucleus; OM /C30outer membrane; Pp /C30periplasm; IM /C30inner membrane; n /C30nucleoid; F /C30ﬂagella.Biological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"Moreover, surface glycosylation patterns may be important for the EV uptake by recipient cells (37,50,62), which has been shown to be dependent on heparin sulphate proteoglycans (65) so that it can be inhibited by heparin addition (30).Biological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"However, sugars do not seem to play a significant role in the EV interaction and their uptake,Biological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"Interleukin 1 b(IL-1 b) Secreted not only by fusion of secretory lysosomes with the plasma membrane but also by EVs(138/C1140) Interleukin 1 a(IL-1 a) Endothelial cell-derived apoptotic bodies, both in precursor and mature forms(141) Interleukin 18 (IL-18) Associated with EVs shed from the surface of macrophages (142) Macrophage migration inhibitory factor (MIF) Associated with EVs that are transferred to spermatozoa during the epididymal transit(143) Interleukin 32 Released from intestinal epithelial cells in EVs (144) Membrane-bound tumour necrosis factor (TNF) Detected on EVs produced by synovial fibroblasts of patients with rheumatoid arthritis(145) Interleukin 6 (IL-6) Released in EVs by mast cells upon IL-1 stimulation (146) Vascular endothelial growth factor (VEGF) Secreted in EVs by platelets (147) Interleukin 8 (CXCL8) In association with tumour-derived EVs (149)Fractalkine (CX3CL1) Released from apoptotic lymphocytes in EVs (150)CCL2, CCL3, CCL4, CCL5 and CCL20 Associated with EVs from heat-stressed tumour cells (151)Transforming growth factor b(TGF b) Associated with thymus-derived EVs, tumour-derived EVs (152 /C1155)Biological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"DNA content of EVs In contrast to RNA, the presence of DNA in EVs has so far been less explored despite the early concept of theBiological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 11 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"12 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"Both types had an unusual lipid composition, with high levels ofsphingomyelin, cholesterol and glycosphingolipids(333) Plasma/ Homo sapiens TLC Microparticles from plasma contained a high level of phosphatidylcholine (59%), sphingomyelin (21%) and phosphatidylethanolamine (9%)(699)Biological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 13 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"14 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"Furthermore, a mammalian nuclearBiological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 15 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"16 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"However, it is now known thatBiological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 17 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"18 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"Similarly, they have been shown to contain AQP1, indicating that extracellular osmotic conditions can induce release of this protein and suggesting a role for its releaseBiological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 19 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"20 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"DC /C30dendritic cell; NK /C30natural killer; NKG2D /C30natural killer group 2D; HSP /C30heat shock protein.Biological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 21 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"22 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"APC /C30antigen-presenting cell; Treg /C30regulatory T cell; NK /C30natural killer; MHC /C30major histocompatibility complex.Biological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 23 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"24 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"DC /C30dendritic cell; NK /C30 natural killer.Biological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 25 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"26 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"Prostasomes are thought to interact with sperm cells in the female reproductive tract to facilitate them reaching the oocyte.Biological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 27 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"28 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"The resident liver tissue macrophages (Kupffer cells), NK cells,Biological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 29 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"30 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"In addition, H. polygyrus derived miRNAs and Y RNAs were shown to be transported into mammalian host cellsBiological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 31 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"32 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"Moreover, GP63 delivery by EVs was alsoBiological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 33 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"34 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"The membrane of the vesicle is derived from the outer membrane and the lumen contains proteins and other biomolecules from theperiplasma.Biological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 35 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"36 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"(711)Biological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 37 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"38 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"[Figure adapted from (714,715)].Biological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 39 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2013;2:20389, doi: http://dx.doi.org/10.3402/jev.v2i0.2038925.",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2013;2:20384, doi: http://dx.doi.org/10.3402/jev.v2i0.20384 36.",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2012;1:18374, doi:http://dx.doi.org/10.3402/jev.v1i0.18374 37.",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"40 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2014;3: 24692, doi: http://dx.doi.org/10.3402/jev.v3.24692 44.",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2013;2:20360, doi: http://dx.doi.org/10.3402/jev.v2i0.20360 47.",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2013;2:20424, doi: http://dx.doi.org/10.3402/jev.v2i0.20424 49.",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2010;70:1668 /C178.Biological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 41 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"42 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"CX3CL1/fractalkine is released fromBiological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 43 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2014;3:23743, doi: http://dx.doi.org/10.3402/jev.v3.23743 170.",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2014;3:24783, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"44 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2013;2:20167, doi: http://dx.doi.org/10.3402/jev.v2i0.20167 191.",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2012;1:18389, doi: http://dx.doi.org/10.3402/jev.v1i0.18389 206.",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2014;9:e114627.Biological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 45 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"46 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2010;126:1032 /C140, 40 e1-4.Biological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 47 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"J Extracell Vesicles.2013;2:22859, doi: http://dx.doi.org/10.3402/jev.v2i0.22859 318.",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"48 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2014;3:24214, doi: http://dx.doi.org/10.3402/jev.v3.24214 328.",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2002;88:415 /C120.Biological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 49 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2012;1:18396, doi: http://dx.doi.org/10.3402/jev.v1i0.18396 380.",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"50 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2013;13:102 /C16.Biological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 51 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"52 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"Extracellular membrane vesicles fromBiological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 53 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2013;2:21927, doi: http://dx.doi.org/10.3402/jev.v2i0.21927 497.",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"54 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2012;1821:124 /C136.Biological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 55 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2014;3:24722, doi: http://dx.doi.org/10.3402/jev.v3.24722 586.",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"56 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2014;3:25040, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"J Extracell Vesicles.2014;3:24214, doi: http://dx.doi.org/10.3402/jev.v3.24214 614.",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"Malaria-infected erythrocyte-derivedmicrovesicles mediate cellular communication within theBiological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 57 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"2013;2:22484, doi:http://dx.doi.org/10.3402/jev.v2i0.22484 642.",Non-OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"58 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"Effect of Porphyromonas gingivalis outer membrane vesicles on gingipain-mediated detachment ofBiological properties of EVs and their physiological functions Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066 59 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
"60 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27066 - http://dx.doi.org/10.3402/jev.v4.27066",OADS,/arxiv_data1/oa_pdf/df/22/JEV-4-27066.PMC4433489.pdf
Available from: http://opinionator.blogs.nytimes.com/2013/ 02/06/malawis-leader-makes-safe-childbirth-her-mission/.,Non-OADS,/arxiv_data1/oa_pdf/fe/fa/tmi0020-0617.PMC4433497.pdf
Available from: http://politicsofpoverty.oxfamamerica.org/2014/04/ with-us-support-malawi-is-reducing-maternal-mortality/.,Non-OADS,/arxiv_data1/oa_pdf/fe/fa/tmi0020-0617.PMC4433497.pdf
Available from: http://repos-itory.uneca.org/handle/10855/15543.,Non-OADS,/arxiv_data1/oa_pdf/fe/fa/tmi0020-0617.PMC4433497.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/c1/57/10.1177_2058460115579121.PMC4433626.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/a7/a8/jpts-27-1001.PMC4433963.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c0/1f/jpts-27-1005.PMC4433964.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/86/5d/jpts-27-1009.PMC4433965.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/3c/4f/jpts-27-1013.PMC4433966.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/e4/ac/jpts-27-1019.PMC4433967.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d6/8a/jpts-27-1023.PMC4433968.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/44/54/jpts-27-1029.PMC4433969.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/3d/6c/jpts-27-1033.PMC4433970.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/4e/ab/jpts-27-1037.PMC4433971.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c8/c0/jpts-27-1041.PMC4433972.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/58/15/jpts-27-1045.PMC4433973.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/77/56/jpts-27-1049.PMC4433974.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/65/f1/jpts-27-1053.PMC4433975.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/95/78/jpts-27-1055.PMC4433976.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/70/0f/jpts-27-1059.PMC4433977.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/25/e8/jpts-27-1063.PMC4433978.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/bb/5b/jpts-27-1067.PMC4433979.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/60/9e/jpts-27-1071.PMC4433980.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/50/40/jpts-27-1075.PMC4433981.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/86/6a/jpts-27-1079.PMC4433982.pdf
"[Medline]   [CrossRef] 12) http://www.ncmedical.com/wp-ntent/uploads/2011/07/Touch-Test- Senso - ry-Evaluator_11_web.pdf (Accessed Jan, 2.",Non-OADS,/arxiv_data1/oa_pdf/86/6a/jpts-27-1079.PMC4433982.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/a8/0a/jpts-27-1083.PMC4433983.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/e9/2e/jpts-27-1087.PMC4433984.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/04/3f/jpts-27-1091.PMC4433985.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/ea/0f/jpts-27-1097.PMC4433986.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/50/8d/jpts-27-1103.PMC4433987.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c3/94/jpts-27-1107.PMC4433988.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f1/8a/jpts-27-1113.PMC4433989.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/41/00/jpts-27-1117.PMC4433990.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/15/02/jpts-27-1121.PMC4433991.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/55/c2/jpts-27-1125.PMC4433992.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/02/00/jpts-27-1129.PMC4433993.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/2f/b7/jpts-27-1133.PMC4433994.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/cb/1a/jpts-27-1137.PMC4433995.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/50/a0/jpts-27-1141.PMC4433996.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/10/59/jpts-27-1145.PMC4433997.pdf
"[Medline]   [Cross - Ref] 3) The Internet Stroke Center: Stroke Statistics http://www.strokecenter.org/ patients/about-stroke/stroke-statistics (Accessed Aug. 7, 2014) 4) Asplund K, Stegmayr B, Peltonen M: From the twentieth to the twenty-first  century: a public health perspective on stroke.",Non-OADS,/arxiv_data1/oa_pdf/10/59/jpts-27-1145.PMC4433997.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/83/5c/jpts-27-1153.PMC4433998.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/83/4e/jpts-27-1157.PMC4433999.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d3/be/jpts-27-1161.PMC4434000.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/9f/ba/jpts-27-1165.PMC4434001.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/cd/e2/jpts-27-1169.PMC4434002.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/8b/77/jpts-27-1173.PMC4434003.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d8/64/jpts-27-1177.PMC4434004.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/6d/6c/jpts-27-1181.PMC4434005.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/c8/39/jpts-27-1187.PMC4434006.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/8e/a9/jpts-27-1191.PMC4434007.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/15/10/jpts-27-1195.PMC4434008.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/1d/3a/jpts-27-1199.PMC4434009.pdf
"March 2000. http://www.srs.org/professionals/ glossary/SRS revised_glossary_of_terms.htm (Accessed Oct. 20, 2012) 14) Lenke LG, Bridwell KH, Baldus C, et al.",Non-OADS,/arxiv_data1/oa_pdf/1d/3a/jpts-27-1199.PMC4434009.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/30/8e/jpts-27-1203.PMC4434010.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/0e/dd/jpts-27-1207.PMC4434011.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/a7/61/jpts-27-1211.PMC4434012.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/38/d5/jpts-27-1215.PMC4434013.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/db/4f/jpts-27-1219.PMC4434014.pdf
http://dx.doi.org/.,Non-OADS,/arxiv_data1/oa_pdf/db/4f/jpts-27-1219.PMC4434014.pdf
"[Cross - Ref] 15) Intermed: Manual of Neuronic 32, 2010. http://www.intermed.co.kr/eng/ com01.html (Accessed Dec. 10, 2014) 16) Heck SA: The effect of purposeful activity on pain tolerance.",Non-OADS,/arxiv_data1/oa_pdf/db/4f/jpts-27-1219.PMC4434014.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/b8/fd/jpts-27-1223.PMC4434015.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/b3/c4/jpts-27-1227.PMC4434016.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/db/ef/jpts-27-1233.PMC4434017.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/9f/5b/jpts-27-1239.PMC4434018.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/47/ce/jpts-27-1243.PMC4434019.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/f6/3b/jpts-27-1247.PMC4434020.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/40/8a/jpts-27-1251.PMC4434021.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/40/2b/jpts-27-1257.PMC4434022.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/41/d2/jpts-27-1261.PMC4434023.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/9c/20/jpts-27-1267.PMC4434024.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Review,Non-OADS,/arxiv_data1/oa_pdf/c1/74/jpts-27-1271.PMC4434025.pdf
http://www.pedro.org.au.,Non-OADS,/arxiv_data1/oa_pdf/c1/74/jpts-27-1271.PMC4434025.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Case	Study,Non-OADS,/arxiv_data1/oa_pdf/a0/11/jpts-27-1277.PMC4434026.pdf
[Medline] 7)	 http://www.rmingenierie.net/stabilite-posture.,Non-OADS,/arxiv_data1/oa_pdf/a0/11/jpts-27-1277.PMC4434026.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Case Study,Non-OADS,/arxiv_data1/oa_pdf/69/6c/jpts-27-1279.PMC4434027.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/4e/3f/jpts-27-981.PMC4434028.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/8c/d8/jpts-27-985.PMC4434029.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/da/48/jpts-27-989.PMC4434030.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/db/06/jpts-27-993.PMC4434031.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/68/35/jpts-27-997.PMC4434032.pdf
"2015 April;21(2):102-110.  http://dx.doi.org/10.4258/hir.2015.21.2.102pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: January 10, 2015Revised: 1st, March 11, 2015; 2nd, April 14, 2015Accepted: April 25, 2015 Corresponding Author  Sooyoung Yoo, PhDCenter for Medical Informatics, Seoul National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 463-707, Korea.",Non-OADS,/arxiv_data1/oa_pdf/ca/cf/hir-21-102.PMC4434058.pdf
"Tel: +82-31-787-1151, Fax: +82-31-787-4004, E-mail: yoosoo0@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/cf/hir-21-102.PMC4434058.pdf
104 www.e-hir.orgSungyoung Oh et al http://dx.doi.org/10.4258/hir.2015.21.2.102 •	Only	authorized	 users	should	be	able	to	access	the	SaaS	 service.,Non-OADS,/arxiv_data1/oa_pdf/ca/cf/hir-21-102.PMC4434058.pdf
106 www.e-hir.orgSungyoung Oh et al http://dx.doi.org/10.4258/hir.2015.21.2.102framework for exposing business services to web services.,OADS,/arxiv_data1/oa_pdf/ca/cf/hir-21-102.PMC4434058.pdf
108 www.e-hir.orgSungyoung Oh et al http://dx.doi.org/10.4258/hir.2015.21.2.102Figure 5.,OADS,/arxiv_data1/oa_pdf/ca/cf/hir-21-102.PMC4434058.pdf
110 www.e-hir.orgSungyoung Oh et al http://dx.doi.org/10.4258/hir.2015.21.2.102ical healthcare solutions.,Non-OADS,/arxiv_data1/oa_pdf/ca/cf/hir-21-102.PMC4434058.pdf
Available from: http://www.himssanalytics.org/emram/scoreTrends.aspx.,Non-OADS,/arxiv_data1/oa_pdf/ca/cf/hir-21-102.PMC4434058.pdf
Available from: http://www.healthit.gov/sites/default/files/clinicaldecisionsup-port_tipsheet.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ca/cf/hir-21-102.PMC4434058.pdf
Available from: http://www.hl7.org/documentcenter/public/wg/dss/Infobutton - DSS IG - 08-12-2010.docx.,Non-OADS,/arxiv_data1/oa_pdf/ca/cf/hir-21-102.PMC4434058.pdf
Available from: http://www.hl7.org/implement/standards/product_brief.cfm?product_id=12.,OADS,/arxiv_data1/oa_pdf/ca/cf/hir-21-102.PMC4434058.pdf
Available from: https://www.forrester.com/The+Forrester+Wave+PlatformAsAService+For+App+Dev+And+Delivery+Professionals+Q2+2011/fulltext/-/E-RES56710?objectid=RES56710.,OADS,/arxiv_data1/oa_pdf/ca/cf/hir-21-102.PMC4434058.pdf
"2015 April;21(2):111-117.  http://dx.doi.org/10.4258/hir.2015.21.2.111pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: March 25, 2015Revised: April 16, 2015Accepted: April 24, 2015 Corresponding Author  Jae Mok Ahn, PhDDepartment of Electronics Engineering, College of Information and Electronics Engineering, Hallym University, 1 Hallymdaehak-gil, Chuncheon 200-702 Korea.",Non-OADS,/arxiv_data1/oa_pdf/8e/81/hir-21-111.PMC4434059.pdf
"Tel: +82-33-248-2347, Fax: +82-33-241-4183, E-mail: ajm@hallym.ac.kr This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/81/hir-21-111.PMC4434059.pdf
112 www.e-hir.orgJae Mok Ahn http://dx.doi.org/10.4258/hir.2015.21.2.111shapes of the PPG must be mathematically differentiated  from one heartbeat to another to clarify the wave inflection providing information on the vascular status.,Non-OADS,/arxiv_data1/oa_pdf/8e/81/hir-21-111.PMC4434059.pdf
114 www.e-hir.orgJae Mok Ahn http://dx.doi.org/10.4258/hir.2015.21.2.111tive waves of the original PPG signal were determined to  facilitate wave detection during the phase of the inflections.,OADS,/arxiv_data1/oa_pdf/8e/81/hir-21-111.PMC4434059.pdf
116 www.e-hir.orgJae Mok Ahn http://dx.doi.org/10.4258/hir.2015.21.2.111terquartile range.,Non-OADS,/arxiv_data1/oa_pdf/8e/81/hir-21-111.PMC4434059.pdf
"2015 April;21(2):118-124.  http://dx.doi.org/10.4258/hir.2015.21.2.118pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: March 11, 2015Revised: April 16, 2015Accepted: April 22, 2015 Corresponding Author  Jinhyung Lee, PhDDepartment of Economics, Sungkyunkwan University, 25-2, Sung - kyunkwan-ro, Jongno-gu, Seoul 110-745, Korea.",Non-OADS,/arxiv_data1/oa_pdf/0c/b5/hir-21-118.PMC4434060.pdf
"Tel: +82-2-760-0263, Fax: +82-2-760-0946, E-mail: leejinh@skku.edu This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/b5/hir-21-118.PMC4434060.pdf
The survey is conducted to maximize accuracy and participation (see detailed process in http://www.ahadataviewer.com/about/data/).,Non-OADS,/arxiv_data1/oa_pdf/0c/b5/hir-21-118.PMC4434060.pdf
120 www.e-hir.orgHye Yeong Kim and Jinhyung Lee http://dx.doi.org/10.4258/hir.2015.21.2.118Teaching status was a dummy variable indicating Council of  Teaching Hospitals (COTH) membership.,Non-OADS,/arxiv_data1/oa_pdf/0c/b5/hir-21-118.PMC4434060.pdf
122 www.e-hir.orgHye Yeong Kim and Jinhyung Lee http://dx.doi.org/10.4258/hir.2015.21.2.118tentially be directly prevented by features available in EHRs.,Non-OADS,/arxiv_data1/oa_pdf/0c/b5/hir-21-118.PMC4434060.pdf
Available from: http://www.texmed.org/Template.aspx?id=6188.,OADS,/arxiv_data1/oa_pdf/0c/b5/hir-21-118.PMC4434060.pdf
Available from: http://mmicgroup.com/pdf/EHR_Application.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/0c/b5/hir-21-118.PMC4434060.pdf
Avail-able from: http://www.netdoc.com/Physician-Practice-Articles/General-Medical-Practice/Can-Electronic-Medical-Records-Help-to-Decrease-Malpractice-,Non-OADS,/arxiv_data1/oa_pdf/0c/b5/hir-21-118.PMC4434060.pdf
124 www.e-hir.orgHye Yeong Kim and Jinhyung Lee http://dx.doi.org/10.4258/hir.2015.21.2.118Insurance-Costs?/.,Non-OADS,/arxiv_data1/oa_pdf/0c/b5/hir-21-118.PMC4434060.pdf
Available from: http://www.oshpd.ca.gov/HID/Products/PatDischarge - Data/CaseMixIndex/.,OADS,/arxiv_data1/oa_pdf/0c/b5/hir-21-118.PMC4434060.pdf
Available from: http://www.kevinmd.com/blog/2009/12/electronic-medical-records-decrease-liability-risk.html.,Non-OADS,/arxiv_data1/oa_pdf/0c/b5/hir-21-118.PMC4434060.pdf
"2015 April;21(2):125-133.  http://dx.doi.org/10.4258/hir.2015.21.2.125pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: March 30, 2015Accepted: April 22, 2015 Corresponding Author  Myung Kyung Lee, RN, PhDResearch Institute of Nursing Science, College of Nursing, Kyung-pook National University, 680 Gukchabosangro, Jung-gu, Daegu 700-842, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4f/4c/hir-21-125.PMC4434061.pdf
"Tel: +82-53-200-4792, Fax: +82-53-425-1258, E-mail: mlee@knu.ac.kr This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/4c/hir-21-125.PMC4434061.pdf
"126 www.e-hir.orgMyung Kyung Lee http://dx.doi.org/10.4258/hir.2015.21.2.125experience cognitive conflicts through comprehensive dis- cussion, expand their cognitive capacity through negotiation with others, recognize the existence of others, and experience collaborative learning through interaction with others [1].",Non-OADS,/arxiv_data1/oa_pdf/4f/4c/hir-21-125.PMC4434061.pdf
"128 www.e-hir.orgMyung Kyung Lee http://dx.doi.org/10.4258/hir.2015.21.2.125about trying to do so”), clear goals (e.g., “I knew clearly what  I wanted to do”), unambiguous feedback (e.g., “It was really clear to me that I was doing well”), concentration on the task at hand (e.g., “My attention was focused entirely on what I was doing”), sense of control (e.g., “I felt in total control of what I was doing”), loss of self-consciousness (e.g., “I was not concerned with what others may have been thinking of me”), transformation of time (e.g., “It felt like time stopped while I was performing”), and autotelic experience (e.g., “I found the experience extremely rewarding”).",Non-OADS,/arxiv_data1/oa_pdf/4f/4c/hir-21-125.PMC4434061.pdf
130 www.e-hir.orgMyung Kyung Lee http://dx.doi.org/10.4258/hir.2015.21.2.125IV.,Non-OADS,/arxiv_data1/oa_pdf/4f/4c/hir-21-125.PMC4434061.pdf
132 www.e-hir.orgMyung Kyung Lee http://dx.doi.org/10.4258/hir.2015.21.2.125Conflict of Interest No potential conflict of interest relevant to this article was  reported.,Non-OADS,/arxiv_data1/oa_pdf/4f/4c/hir-21-125.PMC4434061.pdf
"2015 April;21(2):134-137.  http://dx.doi.org/10.4258/hir.2015.21.2.134pISSN 2093-3681  •  eISSN 2093-369X  Case Report Submitted: March 28, 2015Revised: April 21, 2015Accepted: April 25, 2015 Corresponding Author  Myung-Chul Chang, MD, PhDDepartment of Surgery, Dankook University College of Medicine, 119 Dandae-ro, Dongnam-gu, Cheonan 330-714, Korea.",Non-OADS,/arxiv_data1/oa_pdf/80/31/hir-21-134.PMC4434062.pdf
"Tel: +82-41-550-3930, Fax: +82-41-550-7006, E-mail: changmc@dankook.ac.kr This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/31/hir-21-134.PMC4434062.pdf
136 www.e-hir.orgMyung-Chul Chang http://dx.doi.org/10.4258/hir.2015.21.2.134variate were input for the calculation of survival rate (Figure 4).,OADS,/arxiv_data1/oa_pdf/80/31/hir-21-134.PMC4434062.pdf
"Online (http://www.adjuvantonline.com), the PREDICT tool (http://www.predict.nhs.uk), the Finprog study (http://fin-prog.primed.info), and CancerMath (http://www.lifemath.net/cancer/).",Non-OADS,/arxiv_data1/oa_pdf/80/31/hir-21-134.PMC4434062.pdf
"2015 April;21(2):138-140. http://dx.doi.org/10.4258/hir.2015.21.2.138pISSN 2093-3681  •  eISSN 2093-369X  Book Review This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/69/hir-21-138.PMC4434063.pdf
"With a mission to spread social media use in health, he actively runs a Y ouTube channel (The Medi - cal Futurist, http://www.youtube.com/user/medicalfuturist) as well as a blog (http://themedicalfuturist.com).",Non-OADS,/arxiv_data1/oa_pdf/f7/69/hir-21-138.PMC4434063.pdf
Available from: http://en.wikipedia.org/wiki/Health_2.0.,Non-OADS,/arxiv_data1/oa_pdf/f7/69/hir-21-138.PMC4434063.pdf
Available from: http://getreferralmd.com/2013/09/healthcare-social-media-statistics.,OADS,/arxiv_data1/oa_pdf/f7/69/hir-21-138.PMC4434063.pdf
Available from: http://ssl.gstatic.com/think/docs/the-digital-journey-to-wellness-hospital-selection_research-studies.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f7/69/hir-21-138.PMC4434063.pdf
140 www.e-hir.orgMona Choi http://dx.doi.org/10.4258/hir.2015.21.2.138Healthc Inform Res 2015;21(1):10-20.,Non-OADS,/arxiv_data1/oa_pdf/f7/69/hir-21-138.PMC4434063.pdf
Available from: http://tedxnijmegen.nl/2013/04/bertalan-mesko/.,Non-OADS,/arxiv_data1/oa_pdf/f7/69/hir-21-138.PMC4434063.pdf
Available from: http://thecourse.webicina.com.,Non-OADS,/arxiv_data1/oa_pdf/f7/69/hir-21-138.PMC4434063.pdf
"2015 April;21(2):63-66.  http://dx.doi.org/10.4258/hir.2015.21.2.63pISSN 2093-3681  •  eISSN 2093-369X  Editorial This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/3e/hir-21-63.PMC4434064.pdf
"64 www.e-hir.orgIl Kon Kim http://dx.doi.org/10.4258/hir.2015.21.2.63Among those efforts, one good example is Hesel [5].",Non-OADS,/arxiv_data1/oa_pdf/9f/3e/hir-21-63.PMC4434064.pdf
Available from: http://www.who.int/governance/eb/who_consti-tution_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9f/3e/hir-21-63.PMC4434064.pdf
Available from: http://www.iso.org/iso/home/standards_development/list_of_iso_technical_committees/iso_technical_committee.htm?commid=54960.,Non-OADS,/arxiv_data1/oa_pdf/9f/3e/hir-21-63.PMC4434064.pdf
Available from: http://www.hesel.org/.,Non-OADS,/arxiv_data1/oa_pdf/9f/3e/hir-21-63.PMC4434064.pdf
66 www.e-hir.orgIl Kon Kim http://dx.doi.org/10.4258/hir.2015.21.2.63PHR applications and health information exchange.,OADS,/arxiv_data1/oa_pdf/9f/3e/hir-21-63.PMC4434064.pdf
Available from: http://www.healthit.gov/patients-families/blue-button/about-blue-button.,Non-OADS,/arxiv_data1/oa_pdf/9f/3e/hir-21-63.PMC4434064.pdf
Available from: http://www.healthit.gov/buzz-blog/consumer/introducing-blue-button/.,Non-OADS,/arxiv_data1/oa_pdf/9f/3e/hir-21-63.PMC4434064.pdf
Available from: http://www.hrsa.gov/healthit/meaningfuluse/stage1clinicalquality/whatis.html.,OADS,/arxiv_data1/oa_pdf/9f/3e/hir-21-63.PMC4434064.pdf
"2015 April;21(2):67-73.  http://dx.doi.org/10.4258/hir.2015.21.2.67pISSN 2093-3681  •  eISSN 2093-369X  Review Article Submitted: March 30, 2015Accepted: April 21, 2015 Corresponding Author  Luis Fernández Luque, PhDNorthern Research Institute, Tromso Science Park, Sykehusvn 21, Tromso, Norway.",Non-OADS,/arxiv_data1/oa_pdf/7a/9e/hir-21-67.PMC4434065.pdf
"Tel: +47-934-21-287, Fax: +47-776-29-401, E-mail: luis.luque@norut.no This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/9e/hir-21-67.PMC4434065.pdf
68 www.e-hir.orgLuis Fernández-Luque and Teresa Bau http://dx.doi.org/10.4258/hir.2015.21.2.67published by The Lancet described “WhatsAppitis” [2] as the  wrist pain a young women had as a result of sending mes-sages on their phones.,Non-OADS,/arxiv_data1/oa_pdf/7a/9e/hir-21-67.PMC4434065.pdf
70 www.e-hir.orgLuis Fernández-Luque and Teresa Bau http://dx.doi.org/10.4258/hir.2015.21.2.67health social networking and level of diabetes management.,Non-OADS,/arxiv_data1/oa_pdf/7a/9e/hir-21-67.PMC4434065.pdf
72 www.e-hir.orgLuis Fernández-Luque and Teresa Bau http://dx.doi.org/10.4258/hir.2015.21.2.67out during the Ebola crisis.,Non-OADS,/arxiv_data1/oa_pdf/7a/9e/hir-21-67.PMC4434065.pdf
Available from: http://isis.kisa.or.kr.,Non-OADS,/arxiv_data1/oa_pdf/7a/9e/hir-21-67.PMC4434065.pdf
Available from: http://mhealtheconomics.com.,Non-OADS,/arxiv_data1/oa_pdf/7a/9e/hir-21-67.PMC4434065.pdf
Avail-able from: http://www.alexa.com/topsites.,Non-OADS,/arxiv_data1/oa_pdf/7a/9e/hir-21-67.PMC4434065.pdf
Available from: http://p2pfoundation.net/Apo-mediation.,Non-OADS,/arxiv_data1/oa_pdf/7a/9e/hir-21-67.PMC4434065.pdf
Available from: http://www.tudiabetes.org/forum/topics/tuanalyze-is-here.,Non-OADS,/arxiv_data1/oa_pdf/7a/9e/hir-21-67.PMC4434065.pdf
Available from: http://www.who.int/fea-tures/factfiles/diabetes/facts/en/.,Non-OADS,/arxiv_data1/oa_pdf/7a/9e/hir-21-67.PMC4434065.pdf
Available from: http://www.telemed.no/diabetes-and-self-manage-ment.4982935-162159.html.,Non-OADS,/arxiv_data1/oa_pdf/7a/9e/hir-21-67.PMC4434065.pdf
Available from: https://myglu.org/articles/big-blue-test-results.,Non-OADS,/arxiv_data1/oa_pdf/7a/9e/hir-21-67.PMC4434065.pdf
Available from: https://play.google.com/store/apps/details?id=com.github.browep.thinspo.,Non-OADS,/arxiv_data1/oa_pdf/7a/9e/hir-21-67.PMC4434065.pdf
Available from: http://www.nvic.org/.,Non-OADS,/arxiv_data1/oa_pdf/7a/9e/hir-21-67.PMC4434065.pdf
Available from: http://knowledge.amia.org/56638-amia-1.1540970/t-004-1.1544972/f-004-1.1544973/a-227-1.1544992/an-227-1.1544993?qr=1.,OADS,/arxiv_data1/oa_pdf/7a/9e/hir-21-67.PMC4434065.pdf
Available from: http://www.vaccine-confidence.org/.,Non-OADS,/arxiv_data1/oa_pdf/7a/9e/hir-21-67.PMC4434065.pdf
Available from: http://www.vaccineconfidence.org/about/#partners.,Non-OADS,/arxiv_data1/oa_pdf/7a/9e/hir-21-67.PMC4434065.pdf
Available from: http://www.healthmap.org/.,Non-OADS,/arxiv_data1/oa_pdf/7a/9e/hir-21-67.PMC4434065.pdf
Available from: http://www.bbc.com/news/technol-ogy-29610865.,Non-OADS,/arxiv_data1/oa_pdf/7a/9e/hir-21-67.PMC4434065.pdf
"2015 April;21(2):74-82.  http://dx.doi.org/10.4258/hir.2015.21.2.74pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: December 18, 2013Revised: June 11, 2014Accepted: July 17, 2014 Corresponding Author  Hyeoun-Ae Park, PhD, FAAN, RNCollege of Nursing, Seoul National University, 103 Daehak-ro, Jong-no-gu, Seoul 110-799, Korea.",Non-OADS,/arxiv_data1/oa_pdf/bc/b1/hir-21-74.PMC4434066.pdf
"Tel: +82-2-740-8827, Fax: +82-2-765-4103, E-mail: hapark@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/b1/hir-21-74.PMC4434066.pdf
"76 www.e-hir.orgEunjoo Jeon and Hyeoun-Ae Park http://dx.doi.org/10.4258/hir.2015.21.2.74degree to which a person believes that using a particular IS  would be free from effort, and PU is defined as the degree to which a person believes that using a particular IS would enhance his or her job performance.",Non-OADS,/arxiv_data1/oa_pdf/bc/b1/hir-21-74.PMC4434066.pdf
78 www.e-hir.orgEunjoo Jeon and Hyeoun-Ae Park http://dx.doi.org/10.4258/hir.2015.21.2.742.,Non-OADS,/arxiv_data1/oa_pdf/bc/b1/hir-21-74.PMC4434066.pdf
80 www.e-hir.orgEunjoo Jeon and Hyeoun-Ae Park http://dx.doi.org/10.4258/hir.2015.21.2.7439 years.,Non-OADS,/arxiv_data1/oa_pdf/bc/b1/hir-21-74.PMC4434066.pdf
82 www.e-hir.orgEunjoo Jeon and Hyeoun-Ae Park http://dx.doi.org/10.4258/hir.2015.21.2.74patients.,Non-OADS,/arxiv_data1/oa_pdf/bc/b1/hir-21-74.PMC4434066.pdf
"2015 April;21(2):83-94.  http://dx.doi.org/10.4258/hir.2015.21.2.83pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: March 24, 2015Revised: April 17, 2015Accepted: April 22, 2015 Corresponding Author  Hwa Sun Kim, RN, PhDDepartment of Medical information Technology, Daegu Haany University, 1 Hanuidae-ro, Gyeongsan 712-715, Korea.",Non-OADS,/arxiv_data1/oa_pdf/9e/84/hir-21-83.PMC4434067.pdf
"Tel: +82-53-819-1591, Fax: +82-53-819-1271, E-mail: pulala@paran.com This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/84/hir-21-83.PMC4434067.pdf
84 www.e-hir.orgHyun Sang Park et al http://dx.doi.org/10.4258/hir.2015.21.2.83and it is reported that the prevalence in adults at 30 years of  age and older in 2011 was 12.4% [4].,OADS,/arxiv_data1/oa_pdf/9e/84/hir-21-83.PMC4434067.pdf
"86 www.e-hir.orgHyun Sang Park et al http://dx.doi.org/10.4258/hir.2015.21.2.83IEEE 11073 Manager is a component that implements an op- timized exchange protocol and device specializations from an ISO/IEEE 11073 protocol stack, and the data communi-cation with a glucometer linked through the Bluetooth HDP Connector is processed with the Medical Device Encoding Rule (MDER).",OADS,/arxiv_data1/oa_pdf/9e/84/hir-21-83.PMC4434067.pdf
88 www.e-hir.orgHyun Sang Park et al http://dx.doi.org/10.4258/hir.2015.21.2.83the agent.,OADS,/arxiv_data1/oa_pdf/9e/84/hir-21-83.PMC4434067.pdf
90 www.e-hir.orgHyun Sang Park et al http://dx.doi.org/10.4258/hir.2015.21.2.83decode() method from the ClinicalDocument element class  as a parameter.,OADS,/arxiv_data1/oa_pdf/9e/84/hir-21-83.PMC4434067.pdf
"92 www.e-hir.orgHyun Sang Park et al http://dx.doi.org/10.4258/hir.2015.21.2.83displays fasting and postprandial selection for blood glucose  measurement, levels, date and time of measurement; a start and end button, which limit the blood glucose levels to be displayed in a list and a chart; a delete button to delete the selected level; and a chart button, which displays the current list of levels into a bar chart (Figure 6G).",OADS,/arxiv_data1/oa_pdf/9e/84/hir-21-83.PMC4434067.pdf
94 www.e-hir.orgHyun Sang Park et al http://dx.doi.org/10.4258/hir.2015.21.2.83the development and progression of long-term compli- cations in insulin-dependent diabetes mellitus.,OADS,/arxiv_data1/oa_pdf/9e/84/hir-21-83.PMC4434067.pdf
Available from: https://www.ope-nit.co.kr/business/medicalHealth/healthup.,Non-OADS,/arxiv_data1/oa_pdf/9e/84/hir-21-83.PMC4434067.pdf
Avail-able from: http://www.myfitnesscompanion.com/.,Non-OADS,/arxiv_data1/oa_pdf/9e/84/hir-21-83.PMC4434067.pdf
Available from: http://www.foracare.com/Blood-Pressure-D40.html.,Non-OADS,/arxiv_data1/oa_pdf/9e/84/hir-21-83.PMC4434067.pdf
"2015 April;21(2):95-101.  http://dx.doi.org/10.4258/hir.2015.21.2.95pISSN 2093-3681  •  eISSN 2093-369X  Original Article Submitted: February 9, 2015Revised: 1st, March 20, 2015;  2nd April 1, 2015Accepted: April 5, 2015 Corresponding Author  Seung Hyun Chung, MD, PhDRehabilitation Clinic & Information Technology Team, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 410-769, Korea.",Non-OADS,/arxiv_data1/oa_pdf/f9/ce/hir-21-95.PMC4434068.pdf
"Tel: +82-31-920-1747, Fax: +82-31-920-1929, E-mail: shchung@ncc.re.kr This is an Open Access article distributed under the terms of the Creative Com-mons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduc-tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/ce/hir-21-95.PMC4434068.pdf
"96 www.e-hir.orgHyo Soung Cha et al http://dx.doi.org/10.4258/hir.2015.21.2.95to the latest information and communications technology,  such as mobile and individually customized services [1].",Non-OADS,/arxiv_data1/oa_pdf/f9/ce/hir-21-95.PMC4434068.pdf
98 www.e-hir.orgHyo Soung Cha et al http://dx.doi.org/10.4258/hir.2015.21.2.953.,Non-OADS,/arxiv_data1/oa_pdf/f9/ce/hir-21-95.PMC4434068.pdf
100 www.e-hir.orgHyo Soung Cha et al http://dx.doi.org/10.4258/hir.2015.21.2.95| t | < because it showed 0.0001); HERS efficiency could be  noted.,OADS,/arxiv_data1/oa_pdf/f9/ce/hir-21-95.PMC4434068.pdf
Avail-able from: http://kosis.kr/statHtml/statHtml.do?orgId=101&tblId=DT_1SS14HE111R&vw_cd=MT_OTITLE&list_id=MT_CTITLE_gE_2014&scrId=&seqNo=&lang_mode=ko&obj_var_id=&itm_id=&conn_path=E1.,OADS,/arxiv_data1/oa_pdf/f9/ce/hir-21-95.PMC4434068.pdf
The patient has undergone http://dx.doi.org/10.1016/j.gore.2014.09.003 2352-5789/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/47/38/main.PMC4434143.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/38/main.PMC4434143.pdf
"However, the median number of concurrent radiation and gemcitabine/ cisplatin chemotherapy cycles in the study was 5, with a range of 1 –6 cycles ( Duenas-Gonzalez et al., 2011 ), 54.6% of patients experienced at least one dose reduction in gemcitabine, and 90.4% omitted at least one dose of gemcitabine (data on ﬁle).DOI of original article: http://dx.doi.org/10.1016/j.ygyno.2012.08.002 , http://dx.doi.org/10.1016/j.ygyno.2013.05.024 http://dx.doi.org/10.1016/j.gore.2014.09.002 2352-5789/© 2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/8a/b7/main.PMC4434144.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/b7/main.PMC4434144.pdf
http://dx.doi.org/10.1016/j.gore.2014.07.003 2352-5789/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/25/46/main.PMC4434145.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/46/main.PMC4434145.pdf
Peritoneal http://dx.doi.org/10.1016/j.gore.2014.07.005 2352-5789/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/24/main.PMC4434146.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/24/main.PMC4434146.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2014.10.002 2352-5789/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/28/main.PMC4434147.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/28/main.PMC4434147.pdf
Dissection of the tumor from the surrounding tissue was more http://dx.doi.org/10.1016/j.gore.2014.07.001 2352-5789/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/83/main.PMC4434148.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/83/main.PMC4434148.pdf
http://dx.doi.org/10.1016/j.gore.2014.09.001 2352-5789/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/01/67/main.PMC4434149.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/67/main.PMC4434149.pdf
"1 to 3 ), because the epineural end to end tension free anastomosis was not possible.Gynecologic Oncology Reports 10 (2014) 16 –18 http://dx.doi.org/10.1016/j.gore.2014.08.001 2352-5789/© 2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c5/fd/main.PMC4434150.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).⁎Corresponding author at: Rua Capote Valente, 432- conjunto 103, São Paulo- S.P.- Brazil.",Non-OADS,/arxiv_data1/oa_pdf/c5/fd/main.PMC4434150.pdf
http://dx.doi.org/10.1016/j.gore.2014.10.001 2352-5789/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/3c/main.PMC4434151.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).cytoreductive surgery and intraperitoneal chemotherapy (IPC) have been increasingly used as a potentially valuable therapeutic intervention in women with PMP.,Non-OADS,/arxiv_data1/oa_pdf/d6/3c/main.PMC4434151.pdf
Treatment consisted of Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2014.07.004 2352-5789/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/b4/cb/main.PMC4434152.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/cb/main.PMC4434152.pdf
Sections from the uterine endometrium showed features of moderately differentiated endometrioid adenocarcinoma (International http://dx.doi.org/10.1016/j.gore.2014.08.003 2352-5789/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/43/85/main.PMC4434153.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/85/main.PMC4434153.pdf
"Patients in the conventional-start group received ovarian stimulation on day two or three of their men- strual cycles; when the lead follicle measured ≥14 mm, GnRH antago- nist 0.25 mg (Cetrotide, EMD-Serono) was administered to prevent http://dx.doi.org/10.1016/j.gore.2014.08.002 2352-5789/© 2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c9/94/main.PMC4434154.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/94/main.PMC4434154.pdf
Available at http://www.cancer.org .,Non-OADS,/arxiv_data1/oa_pdf/c9/94/main.PMC4434154.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/3c/main.PMC4434155.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2014.12.003 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/3c/main.PMC4434155.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/3c/main.PMC4434155.pdf
Prospective randomized comparison of monthly ﬂuorouracil and cisplatin versus weekly cisplatinGynecologic Oncology Reports 11 (2015) 38 –40 http://dx.doi.org/10.1016/j.gore.2014.10.006 2352-5789/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/de/99/main.PMC4434156.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/99/main.PMC4434156.pdf
http://www.nih.gov/news/pr/feb99/nci-22.htm ).,Non-OADS,/arxiv_data1/oa_pdf/de/99/main.PMC4434156.pdf
http://dx.doi.org/10.1016/j.gore.2014.07.002 2352-5789/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/52/main.PMC4434157.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/52/main.PMC4434157.pdf
Immunohistochem- istry con ﬁrmed the endometrial stromal nature of the tumor by its http://dx.doi.org/10.1016/j.gore.2014.11.003 2352-5789/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/17/main.PMC4434158.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/17/main.PMC4434158.pdf
"At this point the decision was made to perform debulking surgery with total abdominal hysterectomy, bilateral salpingo-oophorectomy, infracolic omentectomy, and resection of Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2014.11.002 2352-5789/© 2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/76/8a/main.PMC4434159.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/8a/main.PMC4434159.pdf
"National Cancer Institute, Bethesda, MD (Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/ , based on November 2013 SEER data submis- sion, posted to the SEER web site, April 2014).",OADS,/arxiv_data1/oa_pdf/76/8a/main.PMC4434159.pdf
http://dx.doi.org/10.1016/j.gore.2014.11.001 2352-5789/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/a2/main.PMC4434160.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/a2/main.PMC4434160.pdf
An extraction of Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.01.001 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/47/main.PMC4434161.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/47/main.PMC4434161.pdf
Discussion Our case illustrates that a single incision using a harmonic scalpel could potentially lead to ESS dissemination which has been similarly Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2014.10.003 2352-5789/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/13/main.PMC4434162.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/13/main.PMC4434162.pdf
Microscopically the tumor was composed of cytologically http://dx.doi.org/10.1016/j.gore.2014.10.004 2352-5789/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/06/0e/main.PMC4434163.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/06/0e/main.PMC4434163.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/25/main.PMC4434164.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2014.12.002 2352-5789/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/25/main.PMC4434164.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/25/main.PMC4434164.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/34/main.PMC4434165.pdf
http://dx.doi.org/10.1016/j.gore.2015.01.002 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/34/main.PMC4434165.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/34/main.PMC4434165.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/2b/main.PMC4434166.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.01.003 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/2b/main.PMC4434166.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/2b/main.PMC4434166.pdf
"Rs763035 was not reported as an expression quantitative trait locus (eQTL) for skin in a Genotype-Tissue Expressionsearch of skin (http://commonfund.nih.gov/GTex/index,accessed on 25 November 2013).",OADS,/arxiv_data1/oa_pdf/63/51/jid201553a.PMC4434179.pdf
HapMap was used tointerrogate allele frequencies in individuals of European ancestry.GeneMANIA (http://geneMANIA.org) was used to search for geneinteractions in the signi ﬁcant SNP.,OADS,/arxiv_data1/oa_pdf/63/51/jid201553a.PMC4434179.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ALS Chang et al.",Non-OADS,/arxiv_data1/oa_pdf/63/51/jid201553a.PMC4434179.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
192Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.04.004 2213-2317/ &2015 The Authors.,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: ALS, amyotrophic lateral sclerosis; AD, Alzheimer's disease; AP1, activator protein 1; BOAA, β-N-oxalylamino-L-alanine; DAXX, death-associated receptor; GCL, ganglion cell layer; Grx, glutaredoxin; GSH, glutathione (reduced); GSR, glutathione reductase; GSSG, glutathione disulphide (oxidised glu tathione); GST, glutathione-S- transferase; L-DOPA, L-3,4-dihydroxyphenylalanine; mGluR, metabotropic glutamate receptor; MMP, mitochondrial membrane potential; MPP þ, 1-methyl-4-phenylpyr- idinium; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NF- ΚB, nuclear factor- ΚB; NGF, nerve growth factor; NMDA, N-methyl- D-aspartate; NRF2, nuclear factor (erythroid-derived 2)-like 2; NTG, normal tension glaucoma; POAG, primary open angle glaucoma; PD, Parkinson ’s disease; Prx, peroxiredoxin; SOD1, superoxide dismutase 1; Trx, thioredoxin; TrxR, thioredoxin receptor; TxNIP, thioredoxin inhibitory protein; xCT, functional subunit of the x c/C0cystine –glutamate exchanger nCorrespondence to: UCD School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Bel ﬁeld, Dublin 4, Ireland.",Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1016/j.cbpa.2008.07.028 18804173 .,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1039/b719986d 18493649 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1016/j.jprot.2013.06.019 23796488 .,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
"[7] S. Fernandez-Fernandez, A. Almeida, J.P. Bolaños, Antioxidant and bioener- getic coupling between neurons and astrocytes, Biochemical Journal 443 (1)(2012) 3 –11.http://dx.doi.org/10.1042/BJ20111943 22417747 .",Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1038/ncb1881 19448625 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1016/j.biochi.2011.09.013 21964032 .,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.3233/JAD-132756 24844688 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1016/j.neuint.2006.09.014 17095121 .,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/ 10.1111/j.1471-4159.1993.tb09802.x 8228986 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1038/sj.,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1007/s00726-011-0867-5 21409388 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1124/ pr.110.003889 22759795 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/ 10.1523/JNEUROSCI.1007-05.2005 16000629 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1002/glia.21113 21192095 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/ 10.1167/iovs.03-1355 15326101 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
"Soria, P. Villoslada, A. Rodríguez-Antigüedad, C. Matute, Increased expression of cystine/glutamate antiporter in multiplesclerosis, Journal of Neuroin ﬂammation 8 (2011) 63. http://dx.doi.org/ 10.1186/1742-2094-8-63 21639880 .",Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1042/ BJ20111148 21943374 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1042/ BJ20090424 19715555 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
"Hutchinson, In vivo assessment of high-grade glioma biochemistry using microdialysis: a study of energy-related molecules, growth factors and cytokines, Journal of Neuro-Oncology97 (1) (2010) 11 –23.http://dx.doi.org/10.1007/s11060-009-9990-5 19714445 .",Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1038/nm1772 18469825 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1038/sj.leu.2402238 11587223 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
"Pedersen, J. Wang, P.Ø Enger, Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptakethrough system xc /C0, leading to glutathione depletion, Oncogene (2015) , http://dx.doi.org/10.1038/onc.2015.60 , epub ahead of print].",Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1523/JNEUROSCI.5186-05.2006 16554485 .G.J.,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
"Lobsiger, S. Millecamps, C. Escartin, D. Seilhean, H. Sato, M. Mallat, S. Boillée, System xc- is a mediator of microglial function and itsdeletion slows symptoms in amyotrophic lateral sclerosis mice, Brain 138 (1)(2015) 53 –68.http://dx.doi.org/10.1093/brain/awu312 25384799 .",Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1016/j.neuroscience.2010.12.036 21187126 .,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/ 10.1167/iovs.14-15207 25370512 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
"[39] M. Aslan, S. Dogan, E. Kucuksayan, Oxidative stress and potential applica- tions of free radical scavengers in glaucoma, Redox Report 18 (2) (2013)76–87.http://dx.doi.org/10.1179/1351000212Y.0000000033 23485101 .",Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1097/ ICU.0b013e3280895aea 17301611 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/ 10.1016/j.exer.2009.02.005 19233171 .,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1016/j.febs- let.2013.05.020 23684651 .,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.4103/2008-322X.143378 25667739 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
"[45] E. Ganea, J.J. Harding, Glutathione-related enzymes and the eye, Current Eye Research 31 (1) (2006) 1 –11.http://dx.doi.org/10.1080/02713680500477347 16421014 .",Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/ 10.1016/j.freeradbiomed.2008.04.026 18489911 .,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/ 10.1016/j.freeradbiomed.2004.06.001 15384194 .,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1167/iovs.04-0777 15728543 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1167/iovs.12-11256 23599328 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
"Fiorile, A. Primavera, M. Lo Bello, Glutathione transferases and neurodegenerative diseases, Neurochemistry International 82 (2015) 10–18.http://dx.doi.org/10.1016/j.neuint.2015.01.008 .",Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
"[52] A. Bagnis, A. Izzotti, M. Centofanti, S.C. Saccá, Aqueous humor oxidative stress proteomic levels in primary open angle glaucoma, Experimental Eye Research 103 (2012) 55 –62.http://dx.doi.org/10.1016/j.exer.2012.07.011 22974818 .",Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/ 10.1001/archopht.1996.01100130295012 8600890 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1007/s00441-005- 0116-x 16609915 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1089/ars.2012.4644 22530666 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1089/ ars.2011.4501 22369136 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/ 10.1089/ars.2011.4119 22066468 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/ 10.1016/j.neulet.2013.05.045 23742763 .,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1096/fj.02-0771fje 12594173 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
"Kenchappa, J. Annepu, V. Ravindranath, Downregulation of glutaredoxin but not glutathione loss leads to mitochondrial dysfunction infemale mice CNS: implications in excitotoxicity, Neurochemistry Interna-tional 51 (1) (2007) 37 –46.http://dx.doi.org/10.1016/j.neuint.2007.03.008 17512091 .",Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1089/ARS.2009.2489 19290777 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
"Koumar, V. Ravindranath, Constitutive expression and functional characterization of mitochondrial glutaredoxin (Grx2) in mouse and human brain, Brain Research 1185 (2007) 8–17.http://dx.doi.org/10.1016/j.brainres.2007.09.019 1796 1515 .",Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1371/journal.pone.0002459 18560520 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1093/hmg/ddq383 20829229 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
"Outten, Redox properties of the dis- ulﬁde bond of human Cu,Zn superoxide dismutase and the effects of human glutaredoxin 1, Biochemical Journal 446 (1) (2012) 59 –67.http://dx.doi.org/ 10.1042/BJ20120075 22651090 .",Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1016/j.redox.2014.04.010 24936441 .,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1038/sj.,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1021/bi9018658 20141169 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1385/MN:29:3:229 15181236 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1016/j.free- radbiomed.2012.09.019 23010496 .,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/ 10.1016/j.bbrc.2010.03.083 20494123 .,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1146/annurev.bi.54.070185.001321 3896121 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1089/ars.2007.9.25 17115886 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1073/ pnas.94.8.3633 9108029 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1161/ATV- BAHA.110.218982 21212402 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1016/j.neures.2010.04.002 20385180 .,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/ 10.1016/j.freeradbiomed.2010.02.024 20202476 .,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1093/toxsci/k ﬂ125 17018646 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/ 10.1016/j.toxlet.2009.08.024 19735704 .,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
"Wang, J. Bai, The role of thioredoxin-1 in suppression of endoplasmic reticulum stress in Parkinson disease, Free Radical Biology and Medicine 67 (2014) 10 –18.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/ 10.1074/jbc.M700937200 17301052 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
"Grif ﬁths, Healthy ageing and depletion of intracellular glutathione in ﬂuences T cell membrane thioredoxin-1 levels and cytokine secretion, Chemistry Central Journal 7 (1) (2013) 150. http://dx.doi.org/10.1186/1752-153X-7-150 24007191 .",Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.3233/JAD-131814 24270206 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1007/978-1- 4020-6051-9_17 18084903 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/ 10.1016/j.mcn.2007.03.013 17490890 .,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1074/jbc.M113.539213 24719319 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1073/ pnas.0705904104 18003920 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.3109/ 10715762.2013.833330 23937564 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1007/s12035-013- 8479-6 23771816 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.4589-10.2011 21209210 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1093/hmg/ ddu542 25355420 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/ 10.1007/s00401-008-0373-3 18386021 .,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
http://dx.doi.org/10.1016/j.neurobiolaging.2007.06.012 17688973 .G.J.,OADS,/arxiv_data1/oa_pdf/bd/d0/main.PMC4434181.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
Most analytical techniques rely on aContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.04.006 2213-2317/ &2015 The Authors.,OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
Supporting material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2015.04.,OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
Bio- chemical Journal 401 (1) (2007) 1 –11.http://dx.doi.org/10.1042/BJ20061131 17150040 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
"Bollineni, R. Hoffmann, Protein carbonylation as a major hallmark of oxidative damage: update of analytical strategies, Mass Spectro-metry Reviews 33 (2) (2014) 79 –97.http://dx.doi.org/10.1002/mas.21381 23832618 .",Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1046/j.1471- 4159.2002.01103.x 12354300 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.2337/diacare.21.10.1736 9773740 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1046/j.1471- 4159.1998.70010268.x 9422371 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
"[8] I. Dalle-Donne, R. Rossi, D. Giustarini, A. Milzani, R. Colombo, Protein carbonyl groups as biomarkers of oxidative stress, Clinica Chimica Acta 329 (1 –2) (2003) 23 –38.http://dx.doi.org/10.1016/S0009-8981(03)00003-2 12589963 .",Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1089/ ars.2009.2887 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1046/j.1471-4159.1998.71010302.x 9648879 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/ 10.1111/j.1582-4934.2006.tb00407.x 16796807 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/ 10.1016/j.freeradbiomed.2011.10.481 22080084 .,OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/ 10.1016/j.jchromb.2010.08.004 20732835 .,OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1007/s11095- 014-1496-y 25182973 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1016/0003-2697(86)90133-8 2937341 .,OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1021/ac302356z 23186270 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/ 10.1021/pr500324y 25010493 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1006/exnr.1994.1150 7925846 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1007/s00216-011-4725-9 21327623 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1007/s00216-008- 2187-5 18548236 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/ 10.1016/j.freeradbiomed.2005.11.023 16631520 .,OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/ 10.1016/j.freeradbiomed.2006.11.029 17320760 .,OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
"[27] I. Milic, M. Fedorova, Derivatization and detection of small aliphatic and lipid- bound carbonylated lipid peroxidation products by ESI-MS, Methods inMolecular Biology 1208 (2015) 3 –20.http://dx.doi.org/10.1007/978-1-4939- 1441-8_1 25323495 .",Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1172/JCI118853 8698873 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1073/ pnas.96.11.6353 10339591 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1194/jlr.,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1265/ehpm.2002.89 21432289 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1016/0014-5793(91) 81186-C 1959661 .,OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
"[36] M. Tsukamoto, Y. Tampo, M. Sawada, M. Yonaha, Paraquat-induced oxidative stress and dysfunction of the glutathione redox cycle in pulmonary micro- vascular endothelial cells, Toxicology and Applied Pharmacology 178 (2) (2002) 82 –92.http://dx.doi.org/10.1006/taap.2001.9325 11814328 .",Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1016/j.legalmed.2009.01.082 19261533 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.3892/ijmm_00000487 20818484 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
"Hill, Oxidized lipids activate autophagy in a JNK-dependent manner by stimulating the endoplasmic reticulum stress response, RedoxBiology 1 (2013) 56 –64.http://dx.doi.org/10.1016/j.redox.2012.10.003 24024137 .",Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1248/cpb.48.1702 11086899 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.4103/ 0973-029X.102496 23248474 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/ 10.1371/journal.pone.0041026 22808290 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/ 10.1016/j.freeradbiomed.2012.02.030 22387198 .,OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1177/002215540305100608 .,Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1016/j.redox.2013.12.029 24563857 .,OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1016/j.redox.2013.12.008 25460724 .,OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
"Ozer, T. Grune, Age-related loss of stress-induced nuclear proteasome activation is due to low PARP-1 activity, Free Radical Biology and Medicine 50 (1) (2011) 86–92.http://dx.doi.org/10.1016/j.freeradbiomed.2010.10.700 20977936 .",Non-OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
http://dx.doi.org/10.1016/j.free- radbiomed.2013.10.807 24145121 .,OADS,/arxiv_data1/oa_pdf/c8/37/main.PMC4434198.pdf
"Additional integrated modulesContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.04.010 2213-2317/ &2015 Published by Elsevier B.V.Abbreviations: ALS, autophagy lysosome system; becn1, beclin-1; ctsl, cathepsin- L; ctsd, cathepsin-D; CLU, apolipoprotein J/Clusterin; ER, endoplasmic reticulum;hdac6, histone deacetylase 6; HDFs, human diploid ﬁbroblasts; hsf1, heat shock transcription factor-1; hsp, heat shock protein; Keap1, Kelch-like ECH-associated protein 1; Nqo1, NAD(P)H dehydrogenase, quinone 1; Nrf2, NF-E2-related factor 2; PDR, proteome damage responses; PN, proteostasis network; ROS, reactive oxygenspecies; Sqstm1, sequestosome 1; Txnrd1, thioredoxin reductase 1; UPS, ubiquitinproteasome system nCorresponding author.Redox Biology 5 (2015) 205 –215",OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
Primers were designed using the primer-BLAST tool (http://www.ncbi.nlm.nih.gov/tools/primer-blast/ ) and are descri- bed in Supplemental data.,OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
Supplementary Information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2015.04.010 .,OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Skaltsounis, Natural com- pounds with anti-ageing activity, Nature Product Reports 30 (11) (2013) 1412 –1437, http://dx.doi.org/10.1039/c3np70031c 24056714 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Blasco, L. Partridge, M. Serrano, G. Kroemer, The hallmarks of aging, Cell 153 (6) (2013) 1194 –1217, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Gorgoulis, Non-enzymatic post-transla- tional protein modi ﬁcations and proteostasis network deregulation in carci- nogenesis, Journal of Proteomics 92 (2013) 274 –298, http://dx.doi.org/10.1016/ j.jprot.2013.02.024 23500136 .",OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"[4] R.I. Morimoto, Proteotoxic stress and inducible chaperone networks in neu- rodegenerative disease and aging, Genes Development 22 (11) (2008) 1427 –1438, http://dx.doi.org/10.1101/gad.1657108 18519635 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Trougakos, Molecular chaperones and pro- teostasis regulation during redox imbalance, Redox Biology 2 (2014) 323 –332, http://dx.doi.org/10.1016/j.redox.2014.01.017 24563850 .",OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Taylor, A. Dillin, Aging as an event of proteostasis collapse, Cold Spring Harbor Perspectives in Biology 3 (5) (2011) , http://dx.doi.org/10.1101/ cshperspect.a004440 21441594 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Narendra, Mechanisms of mitophagy, Nature Reviews Molecular Cell Biology 12 (1) (2011) 9 –14,http://dx.doi.org/10.1038/nrm3028 21179058 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Glickman, A. Ciechanover, The ubiquitin-proteasome proteolytic path- way: destruction for the sake of construction, Physiology Reviews 82 (2) (2002) 373 –428, http://dx.doi.org/10.1152/physrev.00027.2001 11917093 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Gonos, Protein damage, repair and proteolysis, Molecular Aspects of Medicine 35 (2014) 1 –71,http://dx.doi.org/10.1016/j.mam.2012.09.001 23107776 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Trougakos, The amazing ubiquitin-proteasome system: struc- tural components and implication in aging, International Review of Cell andMolecular Biology 314 (2015) 171 –237, http://dx.doi.org/10.1016/bs.",OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Rivett, E. S. Gonos, Central role of the proteasome in senescence and survival of humanﬁbroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation, Journal of Biological Chemistry 278 (30) (2003) 28026 –28037, http://dx.doi.org/10.1074/jbc.M301048200 12736271 .",OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Papassideri, T. Grune, I. P. Trougakos, Diet-derived advanced glycation end products or lipofuscindisrupts proteostasis and reduces life span in Drosophila melanogaster , Free Radical Biology and Medicine 65 (2013) 1155 –1163, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Davies, B. J. Halliday, Peptides from live yeast cell derivative stimulate wound healing, Archives of Surgery 125 (5) (1990) 641 –646, http://dx.doi.org/10.1001/arch- surg.1990.01410170089019 1691911 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Keller, Medicinal yeast extracts, Cell Stress Chaperones 4 (3) (1999) 171 –176, http://dx.doi.org/ 10.1379/1466-1268(1999)004 o0171:MYE 42.3.CO;2 10547066 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Keller, Topical application of yeast extract accelerates the wound healing of diabetic mice, Journal of Burn Care and Rehabiliation 20 (2) (1999) 155 –162, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"[20] V. Frei, E. Perrier, I. Orly, A. Huc, C. Augustin, O. Damour, Activation of ﬁbro- blast metabolism in a dermal and skin equivalent model: a screening test for activity of peptides, International Journal of Cosmetic Science 20 (3) (1998)159 –173, http://dx.doi.org/10.1046/j.1467-2494.1998.171748.x 18505500 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"[21] F. Debacq-Chainiaux, T. Pascal, E. Boilan, C. Bastin, E. Bauwens, O. Toussaint, Screening of senescence-associated genes with speci ﬁc DNA array reveals the role of IGFBP-3 in premature senescence of human diploid ﬁbroblasts, Free Radical Biology and Medicine 44 (10) (2008) 1817 –1832, http://dx.doi.org/ 10.1016/j.freeradbiomed.2008.02.001 18329388 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Erusalimsky, J. Campisi, O. Toussaint, Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a bio- marker of senescent cells in culture and in vivo, Nature Protocol 4 (12) (2009) 1798 –1806, http://dx.doi.org/10.1038/nprot.2009.191 20010931 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Gorgoulis, D. Bohmann, I. P. Trougakos, Differential regulation of proteasome functionality in repro- ductive vs. somatic tissues of Drosophila during aging or oxidative stress, The FASEB Journal 27 (6) (2013) 2407 –2420, http://dx.doi.org/10.1096/fj.12- 221408 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Davies, Protein oxidation and degradation during postmitotic senescence, Free Radical Biology and Medicine 39 (9) (2005) 1208 –1215, http://dx.doi.org/10.1016/j.free- radbiomed.2005.06.009 16214036 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Guan, In vitro scratch assay: a convenient and inex- pensive method for analysis of cell migration in vitro , Nature Protocol 2 (2) (2007) 329 –333, http://dx.doi.org/10.1038/nprot.2007.30 17406593 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Davies, Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and “aggre- somes ”during oxidative stress, aging, and disease, International Journal of Biochemistry and Cell Biology 36 (12) (2004) 2519 –2530, http://dx.doi.org/ 10.1016/j.biocel.2004.04.020 15325589 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"[29] J. Campisi, Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors, Cell 120 (4) (2005) 513 –522, http://dx.doi.org/ 10.1016/j.cell.2005.02.003 15734683 .A.D.",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"[30] J. Campisi, F. d ’Adda di Fagagna, Cellular senescence: when bad things happen to good cells, Nature Reviews Molecular Cell Biology 8 (9) (2007) 729 –740, http://dx.doi.org/10.1038/nrm2233 17667954 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Blasco, M. Serrano, Cellular senescence in cancer and aging, Cell 130 (2) (2007) 223 –233, http://dx.doi.org/10.1016/j.cell.2007.07.003 17662938 .",OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"1) (2014) S33 –S38, http://dx.doi.org/10.1093/gerona/glu049 24833584 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Blackwell, TOR sig- naling and rapamycin in ﬂuence longevity by regulating SKN-1/Nrf and DAF- 16/FoxO, Cell Metabolism 15 (5) (2012) 713 –724, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Gonos, Anti-ageing and rejuvenating effects of quercetin, Experimental Gerontology 45 (10) (2010) 763 –771, http://dx.doi.org/10.1016/j.exger.2010.07.001 20619334 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Shen, Icariin and its derivative icariside II extend healthspan via insulin/IGF-1 pathway in C. elegans , PLoS One 6 (12) (2011) e28835, http://dx.doi.org/10.1371/journal.",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Gonos, The olive con- stituent oleuropein exhibits proteasome stimulatory properties in vitro and confers life span extension of human embryonic ﬁbroblasts, Rejuvenation Research 10 (2) (2007) 157 –172, http://dx.doi.org/10.1089/rej.2006.0513 17518699 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Parkinson, Increased secretion of tissue inhi-bitors of metalloproteinases 1 and 2 (TIMPs /C01 and /C02) in ﬁbroblasts are early indicators of oral sub-mucous ﬁbrosis and ageing, Journal of Oral Pathology and Medicine 41 (6) (2012) 454 – 462, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Pimentel, LLLT improves tendon healing through increase of MMP activity and collagen synthesis, Lasers in Medical Science 28 (5) (2013) 1281 –1288, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Kim, Resveratrol induces MMP-9 and cell migration via the p38 kinase and PI /C03K pathways in HT1080 human ﬁbrosarcoma cells, Oncology Reports 29 (2) (2013) 826 –834, http://dx.doi.org/10.3892/or.2012.2151 23229870 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Seyer, R. Raghow, A.H. Kang, Regulation of extracellular matrix production by chemically synthesized subfragments of type I collagen carboxy propeptide, Biochemistry 30 (29) (1991) 7097 –7104, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Rattan, Molecular gerontology: from homeodynamics to hormesis, Current Pharmaceutical Design 20 (18) (2014) 3036 –3039, http://dx.doi.org/10.2174/ 13816128113196660708 24079765 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
"Balch, R.I. Morimoto, Small- molecule proteostasis regulators for protein conformational diseases, Nature Chemical Biology 8 (2) (2012) 185 –196, http://dx.doi.org/10.1038/nchem- bio.763 22198733 .A.D.",OADS,/arxiv_data1/oa_pdf/1c/ca/main.PMC4434199.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/be/main.PMC4434204.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.04.026 2049-0801/ ©2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/4f/be/main.PMC4434204.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ca/65/main.PMC4434206.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.04.021 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/65/main.PMC4434206.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/4b/main.PMC4434207.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.04.005 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/4b/main.PMC4434207.pdf
"Accessed, http://www.medpac.",Non-OADS,/arxiv_data1/oa_pdf/e0/4b/main.PMC4434207.pdf
[7] Health and social care information centre http://www.hscic.gov.uk/catalogue/ PUB11200 .,Non-OADS,/arxiv_data1/oa_pdf/e0/4b/main.PMC4434207.pdf
http://www.chi.nhs.uk .,Non-OADS,/arxiv_data1/oa_pdf/e0/4b/main.PMC4434207.pdf
http://cvquality.acc.,Non-OADS,/arxiv_data1/oa_pdf/e0/4b/main.PMC4434207.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/9d/main.PMC4434208.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.04.004 2049-0801/Crown Copyright ©2015 Published by Elsevier Ltd on behalf of IJS Publishing Group Limited.,Non-OADS,/arxiv_data1/oa_pdf/73/9d/main.PMC4434208.pdf
http://www.biomedcentral.com/1471- 2288/13/72 .,Non-OADS,/arxiv_data1/oa_pdf/73/9d/main.PMC4434208.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/81/main.PMC4434209.pdf
URL:http://www.merfmk.com Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.04.002 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/81/main.PMC4434209.pdf
"Mohan, S. Kulkarni, Rubella virus and birth defects: molecular insights into the viral teratogenesis at the cellular level, Birth Defects Res Part a Clin Mol Teratol 70 (7) (2004) 431 e437, http://dx.doi.org/10.1002/ bdra.20045 .",Non-OADS,/arxiv_data1/oa_pdf/2f/81/main.PMC4434209.pdf
Graphical Abstract ©2015 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/09/emss-63292.PMC4434221.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, three figures, and three tables and can be found with this  article online at http://dx.doi.org/10.1016/j.celrep.2014.12.004 .Europe PMC Funders Group Author Manuscript Cell Rep .",Non-OADS,/arxiv_data1/oa_pdf/36/09/emss-63292.PMC4434221.pdf
(2012) and are available at http://panzea.org/db/gateway?,Non-OADS,/arxiv_data1/oa_pdf/e7/f6/hdy2014123a.PMC4434247.pdf
Phenotype mean values and linkage map informationand scores are available at http://www.panzea.org/db/gateway?,OADS,/arxiv_data1/oa_pdf/e7/f6/hdy2014123a.PMC4434247.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Heredity website (http://www.nature.com/hdy)Joint-multiple family and single-family QTL analysis FO g u t et al 563 Heredity",Non-OADS,/arxiv_data1/oa_pdf/e7/f6/hdy2014123a.PMC4434247.pdf
"Comparative mapping and estimates of recombination rates SNP marker positions were determined in the Salix purpurea (Subgenus: Vetrix) genome assembly v 1.0, (DOE-JGI, http://phytozome.jgi.doe.gov/pz/ portal.html#!info?alias =Org_Spurpurea), in the Salix suchowensis genome assembly (Dai et al.",OADS,/arxiv_data1/oa_pdf/96/64/hdy2014125a.PMC4434249.pdf
", 2014) and in the P. trichocarpa genome assembly v. 3 (http://www.phytozome.net/poplar.php; Tuskan et al.",OADS,/arxiv_data1/oa_pdf/96/64/hdy2014125a.PMC4434249.pdf
Gene models located within the genomic interval were retrieved from the genome browser at http://phytozome.jgi.doe.gov/pz/portal.html#!info?alias = Org_Spurpurea.,OADS,/arxiv_data1/oa_pdf/96/64/hdy2014125a.PMC4434249.pdf
"The linkage map, the genotype data and the phenotype data have been deposited on Dryad at http://datadryad.org underdoi:10.5061/dryad.1qh3k.",OADS,/arxiv_data1/oa_pdf/96/64/hdy2014125a.PMC4434249.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Heredity website (http://www.nature.com/hdy)Sex determination in S. viminalis PP u c h o l t et al 583 Heredity",Non-OADS,/arxiv_data1/oa_pdf/96/64/hdy2014125a.PMC4434249.pdf
"Repetitive DNA content was estimated using RepeatMasker(version 4.0.5, http://www.repeatmasker.org) against the REPBASE repeat database (20140131).",OADS,/arxiv_data1/oa_pdf/3c/63/hdy20153a.PMC4434252.pdf
Multiple alignments of protein sequences with known intron locations and lengths were used to analyze intron evolution using Malinsoftware (http://www.iro.umontreal.ca/ ~ csuros/introns/malin/).,OADS,/arxiv_data1/oa_pdf/3c/63/hdy20153a.PMC4434252.pdf
Sequence comparison and analysis Sequences of complementary DNA for each gene were veri ﬁed and annotated through Basic Local Alignment Search Tool X (BLASTX) search against NCBI-NR database (http://blast.ncbi.nlm.nih.gov) and Ensembl zebra ﬁsh DRE protein database (http://uswest.ensembl.org/Tools/Blast?db =core).,OADS,/arxiv_data1/oa_pdf/3c/63/hdy20153a.PMC4434252.pdf
(http://www.genomesize.com) which could be associated with the proportion of retroelements (Table 3).,OADS,/arxiv_data1/oa_pdf/3c/63/hdy20153a.PMC4434252.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Heredity website (http://www.nature.com/hdy)Genomics of ﬁsh hybrids JW a n g et al 609 Heredity",Non-OADS,/arxiv_data1/oa_pdf/3c/63/hdy20153a.PMC4434252.pdf
http://dx.doi.org/10.1016/j.aju.2013.08.012,OADS,/arxiv_data1/oa_pdf/11/85/main.PMC4434421.pdf
"(modiﬁed from British Association of UrologicalSurgeons webpage, ‘Career path of a Urologist’: http://www.baus.org.uk/EducationAndTraining/urology- careers ).",Non-OADS,/arxiv_data1/oa_pdf/11/85/main.PMC4434421.pdf
http://dx.doi.org/10.1016/j.aju.2014.01.004,OADS,/arxiv_data1/oa_pdf/ab/5f/main.PMC4434433.pdf
http://dx.doi.org/10.1016/j.aju.2014.02.001,OADS,/arxiv_data1/oa_pdf/2d/0f/main.PMC4434434.pdf
http://dx.doi.org/10.1016/j.aju.2013.09.002,OADS,/arxiv_data1/oa_pdf/41/3c/main.PMC4434435.pdf
http://dx.doi.org/10.1016/j.aju.2013.08.003,OADS,/arxiv_data1/oa_pdf/d8/b7/main.PMC4434436.pdf
It is also possible to use a spec-ialised medical information service like http://f1000.com orhttp://www.biomedexperts.com .,Non-OADS,/arxiv_data1/oa_pdf/d8/b7/main.PMC4434436.pdf
http://dx.doi.org/10.1016/j.aju.2013.11.001,OADS,/arxiv_data1/oa_pdf/63/a0/main.PMC4434437.pdf
"Available online at: http://www.britishmuseum.org/ explore/highlights/highlight_objects/pd/a/mantegna,_calumny_of_apelles.aspx .",Non-OADS,/arxiv_data1/oa_pdf/63/a0/main.PMC4434437.pdf
"The term has been generally applied to(biological) systems and processes, which continuously regenerate the network of processes that produced them(http://www.media-ecology.org/publications/MEA_pro- ceedings/v10/13_varela_maturanda.pdf ) and has been extended in the ﬁelds of biology and cognition by others,not without controversy.",Non-OADS,/arxiv_data1/oa_pdf/63/a0/main.PMC4434437.pdf
"Heutagogy: A study of self-determined learning, a term coined by Hase and Kenyon ( http://en.wikipe- dia.org/wiki/Heutagogy ).",Non-OADS,/arxiv_data1/oa_pdf/63/a0/main.PMC4434437.pdf
Available online at: < http://mail.stei.itb.,Non-OADS,/arxiv_data1/oa_pdf/63/a0/main.PMC4434437.pdf
"Slate Magazine Essay 2013 Available online at: < http://www.slate.com/articles/ health_and_science/medical_ examiner/./poetry_and_medi cine_ rafael_campo_and_why_doctors_need_the_humanities.html >, 2013 [accessed 19.07.13].",Non-OADS,/arxiv_data1/oa_pdf/63/a0/main.PMC4434437.pdf
Available online at: <http://www.sccs.swarthmore.edu/users/00/pwillen1/lit/ aids.htm > [accessed 3.09.13].,Non-OADS,/arxiv_data1/oa_pdf/63/a0/main.PMC4434437.pdf
Available onlineat: < http://eur-lex.europa.eu/LexUri Serv/LexUriServ.do?uri=COM.,Non-OADS,/arxiv_data1/oa_pdf/63/a0/main.PMC4434437.pdf
"< http://en.wikipedia.org/ wiki/Heutagogy >, 2013 [accessed 3.09.13].94 Talati",Non-OADS,/arxiv_data1/oa_pdf/63/a0/main.PMC4434437.pdf
"Available online at: <http://www.bridg- emanart.com/asset/209275/Botticelli-Sandro-14445–1510/ Calumny- of-Apelles-1497–98-oil-on-panel>, 2013 [accessed 6.08.13].",Non-OADS,/arxiv_data1/oa_pdf/63/a0/main.PMC4434437.pdf
"Available online at: < http://www.ford- ham.edu/halsall/ancient/hamcode.asp >, 2013 [accessed 2.09.13].",Non-OADS,/arxiv_data1/oa_pdf/63/a0/main.PMC4434437.pdf
"Available online at: < http://infed.org/mobi/life- long-learning/ >, 2013 [accessed 7.11.13].",Non-OADS,/arxiv_data1/oa_pdf/63/a0/main.PMC4434437.pdf
Available onlineat: < http://unesdoc.unesco.or g/images/0000/000018/001801e.,Non-OADS,/arxiv_data1/oa_pdf/63/a0/main.PMC4434437.pdf
"UNESCO Institute of Education,2001 Available online at: < http://www.unesco.org/education/uie/ pdf/revisitingLLL.pdf >, 2013 [accessed 7.06.13].",Non-OADS,/arxiv_data1/oa_pdf/63/a0/main.PMC4434437.pdf
"Available online at: < http://www.chebucto.ns.ca/CommunitySupport/NCC/ SCDEFJE.html >, 2013 [accessed 27.08.13].",Non-OADS,/arxiv_data1/oa_pdf/63/a0/main.PMC4434437.pdf
"Available at <http://en.wikipedia.org/wiki/science_and_invention_in_birming- ham#cite_note-telegraph-2 >, 2013 [accessed 27.08.13].",Non-OADS,/arxiv_data1/oa_pdf/63/a0/main.PMC4434437.pdf
"Available at < http://epubs.sur- rey.ac.uk/691/ >, 2013 [accessed 25.08.13].",Non-OADS,/arxiv_data1/oa_pdf/63/a0/main.PMC4434437.pdf
Available online at: < http://www.hanze.,Non-OADS,/arxiv_data1/oa_pdf/63/a0/main.PMC4434437.pdf
"2001 Available online at: <http://www.architectureweek.com/./0124/culture_1–1.html>, 2013 [accessed 6.08.13].Lifelong learning: Established concepts and evolving values 95",Non-OADS,/arxiv_data1/oa_pdf/63/a0/main.PMC4434437.pdf
http://dx.doi.org/10.1016/j.aju.2013.09.005,OADS,/arxiv_data1/oa_pdf/40/06/main.PMC4434438.pdf
http://dx.doi.org/10.1016/j.aju.2013.10.006,OADS,/arxiv_data1/oa_pdf/9e/ac/main.PMC4434439.pdf
http://dx.doi.org/10.1016/j.aju.2013.08.010,OADS,/arxiv_data1/oa_pdf/3e/95/main.PMC4434440.pdf
Available from < http://www.cebm.net/index.aspx?o=1025 >.,OADS,/arxiv_data1/oa_pdf/3e/95/main.PMC4434440.pdf
Available from: http://www.polioeradication.,Non-OADS,/arxiv_data1/oa_pdf/54/94/ABR-4-99.PMC4434443.pdf
Available from: http://www.hpsc.ie.,Non-OADS,/arxiv_data1/oa_pdf/54/94/ABR-4-99.PMC4434443.pdf
Available from: http://www.drmodarreslab.ir/index.php [Last  accessed on 2013 July 7].,OADS,/arxiv_data1/oa_pdf/0f/17/ABR-4-80.PMC4434455.pdf
"Surgical Neurology International Editor Antonio A. F. DeSalles,  MD University of California,  Los Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Stereotactic, a supplement to Surgical Neurology InternationalS249Radiosurgery for symptomatic cavernous malformations:  A multi‑institutional retrospective study in Japan Y oshihisa Kida, Toshinori Hasegawa1, Y oshiyasu Iwai2, Takashi Shuto3, Manabu Satoh4,   Takeshi Kondoh5, Motohiro Hayashi6 Departments of Neurosurgery, General Kamiiida Daiichi Hospital, 1Komaki City Hospital, 2Osaka General Medical Center, 3Yokohama Rosai Hospital, 4Rakusai  Shimizu Hospital, 5Shinsuma General Hospital, 6T okyo Women’s Medical University, Scientific Committee of Japanese Gamma Knife Society, Japan E‑mail: *Yoshihisa Kida ‑ yoshihisa_kida@mac.com; T oshinori Hasegawa ‑ h‑toshi@aa.cyberhome.ne.jp; Yoshiyasu Iwai ‑ y‑iwai@rc5.so‑net.ne.jp;   Takashi Shuto ‑ shuto@yokohamah.rofuku.go.jp; Manabu Satoh ‑ rakusimi@atlas.plala.or.jp; Takeshi Kondoh ‑ comopark1958@gmail.com;   Motohiro Hayashi ‑gkrmoto@gmail.com   *Corresponding author Received: 28 May 14  Accepted: 29 October 14  Published: 14 May 15 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.157071  Quick Response Code: Abstract Background: A group study for symptomatic cavernous malformation (CM) treated  with gamma knife (GK) surgery was performed.",Non-OADS,/arxiv_data1/oa_pdf/42/ff/SNI-6-249.PMC4434491.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/6/249/157071 Copyright: © 2015 Kida Y.,Non-OADS,/arxiv_data1/oa_pdf/42/ff/SNI-6-249.PMC4434491.pdf
"International Journal of Preventive Medicine 2015, 6:40 http://www.ijpvmjournal.net/content/6/1/40Baby‑friendly Hospital and more than 1300 hospitals in  India have been certified as Baby‑friendly.",Non-OADS,/arxiv_data1/oa_pdf/b4/ae/IJPVM-6-40.PMC4434492.pdf
"International Journal of Preventive Medicine 2015, 6:40 http://www.ijpvmjournal.net/content/6/1/40among medical students, few had much more than  the average level of knowledge as found from the wide  variability and outliers [Figure 1].",Non-OADS,/arxiv_data1/oa_pdf/b4/ae/IJPVM-6-40.PMC4434492.pdf
"International Journal of Preventive Medicine 2015, 6:40 http://www.ijpvmjournal.net/content/6/1/40When the knowledge about the individual steps was  assessed in medical and nursing students, it revealed that  the least understood steps were 1 (policy) (15.7%, 15.6%),  3 (pre‑ and post‑natal information) (27.5%, 29.2%), 8  (cues) (10.8%, 24%) and 10 (community support) (8.8%,  11.5%) respectively.",Non-OADS,/arxiv_data1/oa_pdf/b4/ae/IJPVM-6-40.PMC4434492.pdf
"International Journal of Preventive Medicine 2015, 6:40 http://www.ijpvmjournal.net/content/6/1/40is, advise about not to use supplements,[6] and artificial  teats,[11] and the need for training was well understood  by majority of them [Table 2].",Non-OADS,/arxiv_data1/oa_pdf/b4/ae/IJPVM-6-40.PMC4434492.pdf
"International Journal of Preventive Medicine 2015, 6:40 http://www.ijpvmjournal.net/content/6/1/40Received:  08 May 14 Accepted:  25 Sep 2014   Published:  11 may 15 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/b4/ae/IJPVM-6-40.PMC4434492.pdf
Available from: http://www.unicef.org/nutrition/files/BFHI_2009_s1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b4/ae/IJPVM-6-40.PMC4434492.pdf
Available from:  http://www.unicef.org/nutrition/files/BFHI_2009_s3.1and2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b4/ae/IJPVM-6-40.PMC4434492.pdf
"Available from: http://www.who, int/topics/brest  feeding/en/.",Non-OADS,/arxiv_data1/oa_pdf/b4/ae/IJPVM-6-40.PMC4434492.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditorial The Dumbest Mistake I Ever Made O. Howard Reichman Department of Neurological Surgery, Loyola University Medical Center, Maywood, Illinois, USA  E‑mail: *O. Howard Reichman   *Corresponding author Received: 17 February 15   Accepted: 17 February 15  Published: 14 May 15 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.156635  Quick Response Code: Abstract Life as a Neurological Surgeon is a foreboding responsibility and a gratifying  opportunity.",Non-OADS,/arxiv_data1/oa_pdf/82/bc/SNI-6-78.PMC4434493.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/78/156635 Copyright: © 2015 Reichman OH.,Non-OADS,/arxiv_data1/oa_pdf/82/bc/SNI-6-78.PMC4434493.pdf
"Surgical Neurology International 2015, 6:78  http://www.surgicalneurologyint.com/content/6/1/78Fulton, Missouri in May 1947 and attended Northwestern  University Medical School (1947-1952).",Non-OADS,/arxiv_data1/oa_pdf/82/bc/SNI-6-78.PMC4434493.pdf
"Surgical Neurology International 2015, 6:78  http://www.surgicalneurologyint.com/content/6/1/78carotid and vertebral arteries.",Non-OADS,/arxiv_data1/oa_pdf/82/bc/SNI-6-78.PMC4434493.pdf
"Surgical Neurology International 2015, 6:78  http://www.surgicalneurologyint.com/content/6/1/78surgery.",Non-OADS,/arxiv_data1/oa_pdf/82/bc/SNI-6-78.PMC4434493.pdf
"Surgical Neurology International 2015, 6:78  http://www.surgicalneurologyint.com/content/6/1/78In his community there was no kindergarten, so he  began first grade in 1970 at age 6.",Non-OADS,/arxiv_data1/oa_pdf/82/bc/SNI-6-78.PMC4434493.pdf
"Surgical Neurology International 2015, 6:78  http://www.surgicalneurologyint.com/content/6/1/78without much relief.",Non-OADS,/arxiv_data1/oa_pdf/82/bc/SNI-6-78.PMC4434493.pdf
"Surgical Neurology International 2015, 6:78  http://www.surgicalneurologyint.com/content/6/1/78Inc.",Non-OADS,/arxiv_data1/oa_pdf/82/bc/SNI-6-78.PMC4434493.pdf
"Surgical Neurology International 2015, 6:78  http://www.surgicalneurologyint.com/content/6/1/78Author Queries???",Non-OADS,/arxiv_data1/oa_pdf/82/bc/SNI-6-78.PMC4434493.pdf
"Surgical Neurology International 2015, 6:78  http://www.surgicalneurologyint.com/content/6/1/78On September 16, 2014 during a telephone conversation,  his situation continues with important activities, but not  with employment consistent with his level of talent.",Non-OADS,/arxiv_data1/oa_pdf/82/bc/SNI-6-78.PMC4434493.pdf
"Surgical Neurology International 2015, 6:78  http://www.surgicalneurologyint.com/content/6/1/78Postoperatively, she began immediately to experience  neurological improvement, but because of previous  radiation and scar tissue the wound developed some  spinal fluid drainage and required wire closure of  the dehiscence for longer healing.",Non-OADS,/arxiv_data1/oa_pdf/82/bc/SNI-6-78.PMC4434493.pdf
"International Journal of Preventive Medicine 2015, 6:41 http://www.ijpvmjournal.net/content/6/1/41variations which defines as appearance of physical signs  of sexual development in a child prior to the earliest  accepted age of sexual maturation, 7 years in girls and  9 years in boys.",Non-OADS,/arxiv_data1/oa_pdf/1d/10/IJPVM-6-41.PMC4434494.pdf
"International Journal of Preventive Medicine 2015, 6:41 http://www.ijpvmjournal.net/content/6/1/41EXON 2 F: CAGATCCTGTGCCTGACCT EXON 2 R: TTGCAACAACCCACTTGCT EXON 3 F: GTGTTGCAAAGCCATCTTTC EXON 3 R: TCTTTTATTGCCTCGGGTTG In this study, all PCR reactions were performed in a  25 μl reaction containing 1.5 mM MgCl2, 200 mM  of each dNTPs, I U of Taq DNA polymerase (Feldan,  Germany) 150 ng DNA and 25 pmol of each primers.",Non-OADS,/arxiv_data1/oa_pdf/1d/10/IJPVM-6-41.PMC4434494.pdf
"International Journal of Preventive Medicine 2015, 6:41 http://www.ijpvmjournal.net/content/6/1/41In this study, we identified four polymorphisms among  9 patients with ICPP .",Non-OADS,/arxiv_data1/oa_pdf/1d/10/IJPVM-6-41.PMC4434494.pdf
"International Journal of Preventive Medicine 2015, 6:41 http://www.ijpvmjournal.net/content/6/1/41further studies with consideration of familial history of  the disease and parental consanguinity are recommended.",Non-OADS,/arxiv_data1/oa_pdf/1d/10/IJPVM-6-41.PMC4434494.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Lateral orbitotomy approach for removing hyperostosing en  plaque sphenoid wing meningiomas.",Non-OADS,/arxiv_data1/oa_pdf/17/60/SNI-6-79.PMC4434495.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/79/157074 Copyright: © 2015 Amirjamshidi A.,Non-OADS,/arxiv_data1/oa_pdf/17/60/SNI-6-79.PMC4434495.pdf
"Surgical Neurology International 2015, 6:79  http://www.surgicalneurologyint.com/content/6/1/79INTRODUCTION Sphenoid wing (SW) en plaque meningioma (ePM)  is a subgroup of meningiomas defined by its specific  character presenting with a rather thin sheath of soft  tumor tissue accompanied by disproportionate and  extensive bone hyperostosis.",Non-OADS,/arxiv_data1/oa_pdf/17/60/SNI-6-79.PMC4434495.pdf
"Surgical Neurology International 2015, 6:79  http://www.surgicalneurologyint.com/content/6/1/79Infiltration and enhancement of the periorbita, dura  mater of the temporal fossa, cavernous sinus, and the  extra‑calvarial soft tissue were assessed on postcontrast  MR images, while osseous extension was assessed on CT  scans before and after contrast enhancement.",Non-OADS,/arxiv_data1/oa_pdf/17/60/SNI-6-79.PMC4434495.pdf
"Surgical Neurology International 2015, 6:79  http://www.surgicalneurologyint.com/content/6/1/79the sphenoid.",Non-OADS,/arxiv_data1/oa_pdf/17/60/SNI-6-79.PMC4434495.pdf
"Surgical Neurology International 2015, 6:79  http://www.surgicalneurologyint.com/content/6/1/79looking boundary of the tumor in all directions.",Non-OADS,/arxiv_data1/oa_pdf/17/60/SNI-6-79.PMC4434495.pdf
"Surgical Neurology International 2015, 6:79  http://www.surgicalneurologyint.com/content/6/1/79optic nerve sheath was exposed in the latero‑superior  aspect.",Non-OADS,/arxiv_data1/oa_pdf/17/60/SNI-6-79.PMC4434495.pdf
"Surgical Neurology International 2015, 6:79  http://www.surgicalneurologyint.com/content/6/1/79enhanced CT scans.",Non-OADS,/arxiv_data1/oa_pdf/17/60/SNI-6-79.PMC4434495.pdf
"Surgical Neurology International 2015, 6:79  http://www.surgicalneurologyint.com/content/6/1/79Among those who had a poor quality of vision, two  improved and one became almost blind after operation  with no further improvement.",Non-OADS,/arxiv_data1/oa_pdf/17/60/SNI-6-79.PMC4434495.pdf
"Surgical Neurology International 2015, 6:79  http://www.surgicalneurologyint.com/content/6/1/79in group C had pain, while that was experienced  by 25 cases (32.9%) in group LO ( P = 0.53).",Non-OADS,/arxiv_data1/oa_pdf/17/60/SNI-6-79.PMC4434495.pdf
"Surgical Neurology International 2015, 6:79  http://www.surgicalneurologyint.com/content/6/1/79T umor growth after the operation correlated positively  with tumor invasion to bone ( P < 0.001), as it occurred  in 50.9% and 17.1% of cases with and without tumor  invasion to bone according to the histopathological  reports, respectively.",Non-OADS,/arxiv_data1/oa_pdf/17/60/SNI-6-79.PMC4434495.pdf
"Surgical Neurology International 2015, 6:79  http://www.surgicalneurologyint.com/content/6/1/79irreducible, and painless.",Non-OADS,/arxiv_data1/oa_pdf/17/60/SNI-6-79.PMC4434495.pdf
"Surgical Neurology International 2015, 6:79  http://www.surgicalneurologyint.com/content/6/1/79within the dural leaflets of SOF in any one of our cases.",Non-OADS,/arxiv_data1/oa_pdf/17/60/SNI-6-79.PMC4434495.pdf
"Surgical Neurology International 2015, 6:79  http://www.surgicalneurologyint.com/content/6/1/79but it can be a reactive sclerosing bone (27%) • This surgical technique is certainly not advised in  cases with a large, carpet like dural tumor growth  extending over the convexity or passing midline in  the skull base region • It is suggested that the RIePM should be excluded  from the standard grading system of SOMs (ePM)  in future classifications of mid skull base  meningiomas.",Non-OADS,/arxiv_data1/oa_pdf/17/60/SNI-6-79.PMC4434495.pdf
"International Journal of Preventive Medicine 2015, 6:38  http://www.ijpvmjournal.net/content/6/1/38call for updated valid evidences to monitor, prevent,  and control of obesity.",Non-OADS,/arxiv_data1/oa_pdf/19/c1/IJPVM-6-38.PMC4434496.pdf
"International Journal of Preventive Medicine 2015, 6:38  http://www.ijpvmjournal.net/content/6/1/38 Figure 1:  The time trend of obesity/overweight publication by Middle  East countries, 1990–2013 Figure 2: The time trend of citations of obesity/overweight publication by Middle East countries, 1990–2013 Table  2: P‑trends of total number of papers and total number of citations of Middle East’s countries obesity/overweight  related papers, 1990‑2013 No Countries Total number of papers P‑trend* Total number of citations P‑trend* 1 Bahrain 198 Significant 1431 Significant 2 Cyprus 184 Significant 2622 Significant 3 Egypt 1205 Significant 8554 Significant 4 Iran 3331 Significant 20010 Significant 5 Iraq 144 Significant 721 Significant 6 Israel 4778 Significant 180079 Significant 7 Jordan 326 Significant 2919 Significant 8 Kuwait 396 Significant 3405 Significant 9 Lebanon 670 Significant 11257 Significant 10 Oman 218 Significant 2088 Significant 11 Palestine 85 Significant 572 Significant 12 Qatar 194 Significant 1487 Significant 13 Saudi Arabia 1311 Significant 10006 Significant 14 Syria 139 Significant 1628 Significant 15 Turkey 6229 Significant 52436 Significant 16 United Arab Emirates 369 Significant 4965 Significant 17 Yemen 55 Significant 330 Significant *P value<0.001  was considered  as statistically  significanttime trends in their obesity/overweight publications’  citations  (P = 0.000).",Non-OADS,/arxiv_data1/oa_pdf/19/c1/IJPVM-6-38.PMC4434496.pdf
"International Journal of Preventive Medicine 2015, 6:38  http://www.ijpvmjournal.net/content/6/1/38partnership between the countries in their publication.",Non-OADS,/arxiv_data1/oa_pdf/19/c1/IJPVM-6-38.PMC4434496.pdf
"International Journal of Preventive Medicine 2015, 6:38  http://www.ijpvmjournal.net/content/6/1/38 Figure 4: Contribution of national universities/scientific institutes  in publication of obesity/overweight papers, 1990–2013 Figure 5:  The national distribution of article type Figure 3: The distribution of subject area of obesity/overweight publication at national, regional and global levels articles  (4%) and letters  (2%) set on next levels.",Non-OADS,/arxiv_data1/oa_pdf/19/c1/IJPVM-6-38.PMC4434496.pdf
"International Journal of Preventive Medicine 2015, 6:38  http://www.ijpvmjournal.net/content/6/1/38DISCUSSION The results of the present study verify Iran’s position in  obesity/overweight publications between other Middle East countries’.",Non-OADS,/arxiv_data1/oa_pdf/19/c1/IJPVM-6-38.PMC4434496.pdf
"International Journal of Preventive Medicine 2015, 6:38  http://www.ijpvmjournal.net/content/6/1/38Source of Support: Nil, Conflict of Interest:  None declared.7.",Non-OADS,/arxiv_data1/oa_pdf/19/c1/IJPVM-6-38.PMC4434496.pdf
Available  from: http://www.science ‑metrix.com/30 years ‑Paper.pdf.,Non-OADS,/arxiv_data1/oa_pdf/19/c1/IJPVM-6-38.PMC4434496.pdf
"International Journal of Preventive Medicine 2015, 6:39 http://www.ijpvmjournal.net/content/6/1/39One of the important determinants of childhood OBO  is socioeconomic disparity, which is often observed in  high‑income countries, both in adults and children.",Non-OADS,/arxiv_data1/oa_pdf/24/ad/IJPVM-6-39.PMC4434497.pdf
"International Journal of Preventive Medicine 2015, 6:39 http://www.ijpvmjournal.net/content/6/1/39Portugal, Italy, France and Kosovo.",Non-OADS,/arxiv_data1/oa_pdf/24/ad/IJPVM-6-39.PMC4434497.pdf
Statistical analysis Statistical analysis was performed using Stata™ 10.0  (http://www.stata.com/) and Spotfire™ S + 9.1 for  Windows (http://spotfire.tibco.com/).,OADS,/arxiv_data1/oa_pdf/24/ad/IJPVM-6-39.PMC4434497.pdf
"International Journal of Preventive Medicine 2015, 6:39 http://www.ijpvmjournal.net/content/6/1/39mothers in higher socioeconomic classes (leaders and  senior executives), displayed the lowest prevalence  of overweight and obesity, compared to the other socioeconomic classes ( P < 0.001) with prevalence  rates of 8.3% and 1.5%, respectively.",Non-OADS,/arxiv_data1/oa_pdf/24/ad/IJPVM-6-39.PMC4434497.pdf
"International Journal of Preventive Medicine 2015, 6:39 http://www.ijpvmjournal.net/content/6/1/39SES (adjusted OR = 4.21; 95% CI: 2.83–6.25) in fifth  grade.",Non-OADS,/arxiv_data1/oa_pdf/24/ad/IJPVM-6-39.PMC4434497.pdf
"[12] Comparing our findings, regarding the prevalence of  overweight and obesity, to those reported in other Swiss  cantons (data PSCH, http://www.gesundheitsfoerderung.",Non-OADS,/arxiv_data1/oa_pdf/24/ad/IJPVM-6-39.PMC4434497.pdf
"International Journal of Preventive Medicine 2015, 6:39 http://www.ijpvmjournal.net/content/6/1/39obesity than children from the more northern regions.",Non-OADS,/arxiv_data1/oa_pdf/24/ad/IJPVM-6-39.PMC4434497.pdf
"International Journal of Preventive Medicine 2015, 6:39 http://www.ijpvmjournal.net/content/6/1/39CONCLUSIONS This study shows the age related trends in OBO for  children aged 5–12 years in Geneva.",Non-OADS,/arxiv_data1/oa_pdf/24/ad/IJPVM-6-39.PMC4434497.pdf
"International Journal of Preventive Medicine 2015, 6:39 http://www.ijpvmjournal.net/content/6/1/39of more than 94,000 school‑age children in the city of Basel (Switzerland).",Non-OADS,/arxiv_data1/oa_pdf/24/ad/IJPVM-6-39.PMC4434497.pdf
http://dx.doi.org/10.1016/j.aju.2013.12.002,OADS,/arxiv_data1/oa_pdf/7e/a8/main.PMC4434498.pdf
London Deanery; 2008 Available from: http://www.faculty.londondeanery.ac.uk/profes- sional-development-framework-for-supervisors .,Non-OADS,/arxiv_data1/oa_pdf/7e/a8/main.PMC4434498.pdf
http://dx.doi.org/10.1016/j.aju.2013.07.002,OADS,/arxiv_data1/oa_pdf/41/12/main.PMC4434499.pdf
http://dx.doi.org/10.1016/j.aju.2013.11.006,OADS,/arxiv_data1/oa_pdf/98/36/main.PMC4434500.pdf
http://dx.doi.org/10.1016/j.aju.2013.08.004,OADS,/arxiv_data1/oa_pdf/40/56/main.PMC4434501.pdf
http://dx.doi.org/10.1016/j.aju.2013.06.001,OADS,/arxiv_data1/oa_pdf/af/11/main.PMC4434502.pdf
"Coordinators and mentors should encourage residents to participate in programmes like those offered by the European Asso- ciation of Urology ( http://www.endourology.org/fellow- ship/fellowship.php ), Socie ´te´Internationale d’Urologie (http://www.siu-urology.org/training-scholarships.aspx ), or the Endourological Society ( http://www.endourology.",Non-OADS,/arxiv_data1/oa_pdf/af/11/main.PMC4434502.pdf
http://dx.doi.org/10.1016/j.aju.2013.10.001,OADS,/arxiv_data1/oa_pdf/db/22/main.PMC4434503.pdf
http://dx.doi.org/10.1016/j.aju.2013.10.005,OADS,/arxiv_data1/oa_pdf/62/ed/main.PMC4434504.pdf
http://dx.doi.org/10.1016/j.aju.2013.08.006,OADS,/arxiv_data1/oa_pdf/fa/d1/main.PMC4434509.pdf
Available from:<http://eur-lex.europa.eu/LexUriServ/ LexUriServ.do?uri=OJ:L:2011:311:0001:0193:EN:PDF >.,Non-OADS,/arxiv_data1/oa_pdf/a5/cb/main.PMC4434510.pdf
"[2] The Intercollegiate Surgical Curriculum, General Surgery, 2013; Available from: < http://www.gmc-uk.org/General_Surgery_ Curriculum_August_2013.pdf_51331157.pdf >.",Non-OADS,/arxiv_data1/oa_pdf/a5/cb/main.PMC4434510.pdf
Available from: < http://homepage.psy.utexas.edu/homepage/ group/helmreichlab/publications/pubﬁles/pub262.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/a5/cb/main.PMC4434510.pdf
http://dx.doi.org/10.1016/j.aju.2013.08.011,OADS,/arxiv_data1/oa_pdf/7c/24/main.PMC4434512.pdf
Available from:<http://eur-lex.europa.eu/LexUriServ/ LexUriServ.do?uri=OJ:L:2011:311:0001:0193:EN:PDF >.,Non-OADS,/arxiv_data1/oa_pdf/7c/24/main.PMC4434512.pdf
"[2] The Intercollegiate Surgical Curriculum, General Surgery, 2013; Available from: < http://www.gmc-uk.org/General_Surgery_ Curriculum_August_2013.pdf_51331157.pdf >.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/main.PMC4434512.pdf
Available from: < http://homepage.psy.utexas.edu/homepage/ group/helmreichlab/publications/pubﬁles/pub262.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/7c/24/main.PMC4434512.pdf
http://dx.doi.org/10.1016/j.aju.2013.07.001,OADS,/arxiv_data1/oa_pdf/bf/ac/main.PMC4434515.pdf
http://dx.doi.org/10.1016/j.aju.2013.08.007,OADS,/arxiv_data1/oa_pdf/29/51/main.PMC4434536.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/51/omv035.PMC4434574.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/89/omv037.PMC4434575.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/29/06/omv036.PMC4434576.pdf
http://dx.doi.org/10.1016/j.aju.2013.08.002,OADS,/arxiv_data1/oa_pdf/95/0f/main.PMC4434578.pdf
http://dx.doi.org/10.1016/j.aju.2013.11.004,OADS,/arxiv_data1/oa_pdf/16/d5/main.PMC4434579.pdf
http://dx.doi.org/10.1016/j.aju.2013.11.003,OADS,/arxiv_data1/oa_pdf/19/dc/main.PMC4434582.pdf
http://dx.doi.org/10.1016/j.aju.2013.08.015,OADS,/arxiv_data1/oa_pdf/65/6f/main.PMC4434583.pdf
http://dx.doi.org/10.1016/j.aju.2013.11.002,OADS,/arxiv_data1/oa_pdf/bb/d9/main.PMC4434606.pdf
http://dx.doi.org/10.1016/j.aju.2013.12.001,OADS,/arxiv_data1/oa_pdf/86/02/main.PMC4434607.pdf
http://dx.doi.org/10.1016/j.aju.2013.11.005,OADS,/arxiv_data1/oa_pdf/c4/34/main.PMC4434608.pdf
http://dx.doi.org/10.1016/j.aju.2013.06.005,OADS,/arxiv_data1/oa_pdf/64/5e/main.PMC4434609.pdf
[6] < http://wiki.answers.com/Q/What_are_the_Duties_of_a_family_ practitioner >.,Non-OADS,/arxiv_data1/oa_pdf/64/5e/main.PMC4434609.pdf
http://dx.doi.org/10.1016/j.aju.2014.01.001,OADS,/arxiv_data1/oa_pdf/56/70/main.PMC4434610.pdf
Available at: < http://www.gmc-uk.org/ news/23578.asp >; 2013 [accessed 03.12.13].,Non-OADS,/arxiv_data1/oa_pdf/56/70/main.PMC4434610.pdf
Available at:<http://www.revalidationsupport.nhs.uk/news_media/news- article.php?id=19 >.Revalidation: A world ﬁrst in medical regulation 85,Non-OADS,/arxiv_data1/oa_pdf/56/70/main.PMC4434610.pdf
http://dx.doi.org/10.1016/j.aju.2013.10.003,OADS,/arxiv_data1/oa_pdf/a5/0e/main.PMC4434612.pdf
http://dx.doi.org/10.1016/j.aju.2014.01.003,OADS,/arxiv_data1/oa_pdf/08/8d/main.PMC4434682.pdf
http://dx.doi.org/10.1016/j.aju.2014.01.002,OADS,/arxiv_data1/oa_pdf/b3/96/main.PMC4434685.pdf
http://dx.doi.org/10.1016/j.aju.2013.10.004,OADS,/arxiv_data1/oa_pdf/0a/80/main.PMC4434779.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/02/main.PMC4434780.pdf
"Production and hosting by ElsevierArab Journal of Urology (2015) 13,5 3–56 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2015.02.002 2090-598X Published by Elsevier B.V. on behalf of Arab Association of Urology.This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/68/02/main.PMC4434780.pdf
"Production and hosting by ElsevierArab Journal of Urology (2014) 12, 256–261 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2014.09.006 2090-598X ª2014 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/a0/bd/main.PMC4434800.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a0/bd/main.PMC4434800.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/35/fiv027.PMC4434801.pdf
Isotig sequence information and putative annotations are available from the Paxillus EST database: http://mbio-serv2.mbioekol.lu.se/Paxillus/Hybrid/ (add ‘paxillus ’ to the isotig ID when searching).,OADS,/arxiv_data1/oa_pdf/9e/35/fiv027.PMC4434801.pdf
Annotations of transcripts encoding en- zymes active on carbohydrates (CAZymes) and those of aux- iliary redox activities/enzymes (AAs) were retrieved from the Carbohydrate-Active Enzymes Database ( http://www.cazy.org/ ) (Cantarel et al.2009; Levasseur et al.2013).,OADS,/arxiv_data1/oa_pdf/9e/35/fiv027.PMC4434801.pdf
Relevant genemodelswereusedasqueriestoidentifyputativehomologs using the blastp tools available at the JGI P. involutus genome database ( http://genome.jgi.doe.gov/Paxin1/Paxin1.home.html ).,OADS,/arxiv_data1/oa_pdf/9e/35/fiv027.PMC4434801.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/40/main.PMC4434834.pdf
"Production and hosting by ElsevierArab Journal of Urology (2015) 13,2 7–31 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2014.12.006 2090-598X ª2015 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/c9/40/main.PMC4434834.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/40/main.PMC4434834.pdf
"BJU Int 2015. http://dx.doi.org/10.1111/bju.12679 , in press.",OADS,/arxiv_data1/oa_pdf/c9/40/main.PMC4434834.pdf
"Production and hosting by ElsevierArab Journal of Urology (2015) 13,6 0–63 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2014.11.006 2090-598X ª2015 Production and hosting by Elsevier B.V. on behalf of Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/36/c2/main.PMC4434879.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/c2/main.PMC4434879.pdf
"Production and hosting by ElsevierArab Journal of Urology (2014) 12, 290–293 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2014.08.001 2090-598X ª2014 Production and hosting by Elsevier B.V. on behalf of Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/f2/a7/main.PMC4434880.pdf
[10] < http://www.un.org/en/aboutun/languages.shtml >.,Non-OADS,/arxiv_data1/oa_pdf/f2/a7/main.PMC4434880.pdf
http://dx.doi.org/10.1016/j.aju.2014.04.004,OADS,/arxiv_data1/oa_pdf/e4/4e/main.PMC4434883.pdf
"Production and hosting by ElsevierArab Journal of Urology (2014) 12, 304–308 Arab Journal of Urology (Ofﬁcial Journal of the Arab Association of Urology) www.sciencedirect.com http://dx.doi.org/10.1016/j.aju.2014.09.005 2090-598X ª2014 Arab Association of Urology.",Non-OADS,/arxiv_data1/oa_pdf/be/b5/main.PMC4434884.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/b5/main.PMC4434884.pdf
6 http://repository.academyhealth.org/egems/vol3/iss1/6 DOI: 10.13063/2327-9214.1122,Non-OADS,/arxiv_data1/oa_pdf/8f/5e/egems1122.PMC4434917.pdf
6 http://repository.academyhealth.org/egems/vol3/iss1/6 DOI: 10.13063/2327-9214.1122,Non-OADS,/arxiv_data1/oa_pdf/8f/5e/egems1122.PMC4434917.pdf
6 http://repository.academyhealth.org/egems/vol3/iss1/6 DOI: 10.13063/2327-9214.1122,Non-OADS,/arxiv_data1/oa_pdf/8f/5e/egems1122.PMC4434917.pdf
6 http://repository.academyhealth.org/egems/vol3/iss1/6 DOI: 10.13063/2327-9214.1122,Non-OADS,/arxiv_data1/oa_pdf/8f/5e/egems1122.PMC4434917.pdf
Website: http://www.pcori.org/content/pcornet-nation-al-patient-centered-clinical-research-network (Accessed: 01/06/2015) 7.,Non-OADS,/arxiv_data1/oa_pdf/8f/5e/egems1122.PMC4434917.pdf
http://www.myopennotes.org/(accessed  01/07/2015) 15.,Non-OADS,/arxiv_data1/oa_pdf/8f/5e/egems1122.PMC4434917.pdf
6 http://repository.academyhealth.org/egems/vol3/iss1/6 DOI: 10.13063/2327-9214.1122,Non-OADS,/arxiv_data1/oa_pdf/8f/5e/egems1122.PMC4434917.pdf
10 http://repository.academyhealth.org/egems/vol3/iss1/10 DOI: 10.13063/2327-9214.1116,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/egems1116.PMC4434976.pdf
10 http://repository.academyhealth.org/egems/vol3/iss1/10 DOI: 10.13063/2327-9214.1116,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/egems1116.PMC4434976.pdf
10 http://repository.academyhealth.org/egems/vol3/iss1/10 DOI: 10.13063/2327-9214.1116,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/egems1116.PMC4434976.pdf
10 http://repository.academyhealth.org/egems/vol3/iss1/10 DOI: 10.13063/2327-9214.1116,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/egems1116.PMC4434976.pdf
2013 [cited 2013 July 29]; Available from: https://www.psoppc.org/web/patientsafety.,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/egems1116.PMC4434976.pdf
The use of the  WHO-UMC system for standardised case causality assess-ment [cited 2013 August 21]; Available from: http://www.who-umc.org/Graphics/24734.pdf.,OADS,/arxiv_data1/oa_pdf/9c/b1/egems1116.PMC4434976.pdf
10 http://repository.academyhealth.org/egems/vol3/iss1/10 DOI: 10.13063/2327-9214.1116,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/egems1116.PMC4434976.pdf
10 http://repository.academyhealth.org/egems/vol3/iss1/10 DOI: 10.13063/2327-9214.1116,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/egems1116.PMC4434976.pdf
10 http://repository.academyhealth.org/egems/vol3/iss1/10 DOI: 10.13063/2327-9214.1116,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/egems1116.PMC4434976.pdf
10 http://repository.academyhealth.org/egems/vol3/iss1/10 DOI: 10.13063/2327-9214.1116,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/egems1116.PMC4434976.pdf
10 http://repository.academyhealth.org/egems/vol3/iss1/10 DOI: 10.13063/2327-9214.1116,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/egems1116.PMC4434976.pdf
10 http://repository.academyhealth.org/egems/vol3/iss1/10 DOI: 10.13063/2327-9214.1116,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/egems1116.PMC4434976.pdf
10 http://repository.academyhealth.org/egems/vol3/iss1/10 DOI: 10.13063/2327-9214.1116,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/egems1116.PMC4434976.pdf
10 http://repository.academyhealth.org/egems/vol3/iss1/10 DOI: 10.13063/2327-9214.1116,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/egems1116.PMC4434976.pdf
10 http://repository.academyhealth.org/egems/vol3/iss1/10 DOI: 10.13063/2327-9214.1116,Non-OADS,/arxiv_data1/oa_pdf/9c/b1/egems1116.PMC4434976.pdf
7 http://repository.academyhealth.org/egems/vol3/iss1/7 DOI: 10.13063/2327-9214.1052,Non-OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
7 http://repository.academyhealth.org/egems/vol3/iss1/7 DOI: 10.13063/2327-9214.1052,Non-OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
7 http://repository.academyhealth.org/egems/vol3/iss1/7 DOI: 10.13063/2327-9214.1052,Non-OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
7 http://repository.academyhealth.org/egems/vol3/iss1/7 DOI: 10.13063/2327-9214.1052,Non-OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
Available from: http://www.nejm.org/doi/full/10.1056/nejmp1109407 5.,OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
Available from: http://reposi-tory.academyhealth.org/egems/vol2/iss1/2 22.,Non-OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
Available from: http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-13-012.html 23.,Non-OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
2012; Available from: http://repository.academyhealth.org/edm_briefs/2/ 26.,Non-OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
2007; Available from: http://www.nap.edu/openbook.,Non-OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
7 http://repository.academyhealth.org/egems/vol3/iss1/7 DOI: 10.13063/2327-9214.1052,Non-OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
Available from: http://www.cihi.ca/CIHI-ext-portal/pdf/inter-net/DATA_QUALITY_FRAMEWORK_2009_EN 38.,OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
Available from: http://www.cochrane.org 42.,OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
Available from: http://mitiq.mit.edu/ICIQ/Documents/IQ%20Conference%202005/Papers/AFormalDefinitionofD-QProblems.pdf45.,Non-OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
Available  from: http://www.dmreview.com/portals/portalarticle.cfm?ar- ticleId=1056199&topicId=230005 48.,Non-OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
Available from: http://www.gbif.org/or-c/?doc_id=1229 49.,Non-OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
Available from: http://www.healthit.gov/sites/default/files/rtc_adoption_and_exchange9302014.pdf 59.,Non-OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
Available from: http://www.experian.co.uk/assets/marketing-services/white-papers/wp-qas-the-da-ta-advantage.pdf 60.,Non-OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
"Washington, DC: National Academy Press; 1999. xii, 76 p. p. Available from: http://books.nap.edu/catalog/9623.html 69.",Non-OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
20; Available from: http://www.mini-sentinel.org/work_prod-ucts/About_Us/Mini-Sentinel_SO P_Data-Quality-Check- ing-and-Profiling.pdf72.,OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
Available from: http://omop.fnih.org/OSCAR 73.,Non-OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
Available from: http://omop.fnih.org/GROUCH 74.,Non-OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
7 http://repository.academyhealth.org/egems/vol3/iss1/7 DOI: 10.13063/2327-9214.1052,Non-OADS,/arxiv_data1/oa_pdf/4d/24/egems1052.PMC4434997.pdf
5 http://repository.academyhealth.org/egems/vol3/iss1/5 DOI: 10.13063/2327-9214.1127,Non-OADS,/arxiv_data1/oa_pdf/14/40/egems1127.PMC4435001.pdf
5 http://repository.academyhealth.org/egems/vol3/iss1/5 DOI: 10.13063/2327-9214.1127,Non-OADS,/arxiv_data1/oa_pdf/14/40/egems1127.PMC4435001.pdf
5 http://repository.academyhealth.org/egems/vol3/iss1/5 DOI: 10.13063/2327-9214.1127,Non-OADS,/arxiv_data1/oa_pdf/14/40/egems1127.PMC4435001.pdf
5 http://repository.academyhealth.org/egems/vol3/iss1/5 DOI: 10.13063/2327-9214.1127,Non-OADS,/arxiv_data1/oa_pdf/14/40/egems1127.PMC4435001.pdf
5 http://repository.academyhealth.org/egems/vol3/iss1/5 DOI: 10.13063/2327-9214.1127,Non-OADS,/arxiv_data1/oa_pdf/14/40/egems1127.PMC4435001.pdf
Available from: http://appliedresearch.cancer.gov/seermedi-care/.,Non-OADS,/arxiv_data1/oa_pdf/14/40/egems1127.PMC4435001.pdf
5 http://repository.academyhealth.org/egems/vol3/iss1/5 DOI: 10.13063/2327-9214.1127,Non-OADS,/arxiv_data1/oa_pdf/14/40/egems1127.PMC4435001.pdf
9 http://repository.academyhealth.org/egems/vol3/iss1/9 DOI: 10.13063/2327-9214.1119,Non-OADS,/arxiv_data1/oa_pdf/bb/9f/egems1119.PMC4435002.pdf
9 http://repository.academyhealth.org/egems/vol3/iss1/9 DOI: 10.13063/2327-9214.1119,Non-OADS,/arxiv_data1/oa_pdf/bb/9f/egems1119.PMC4435002.pdf
9 http://repository.academyhealth.org/egems/vol3/iss1/9 DOI: 10.13063/2327-9214.1119,Non-OADS,/arxiv_data1/oa_pdf/bb/9f/egems1119.PMC4435002.pdf
http://www.carecontinu- umalliance.org.,Non-OADS,/arxiv_data1/oa_pdf/bb/9f/egems1119.PMC4435002.pdf
2004. http://www.partnership-forsolutions.org/DMS/files/chronicbook2004.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bb/9f/egems1119.PMC4435002.pdf
2008. http://www.ahrq.gov/professionals/systems/long-term-care/resources/hcbs/medicaidmgmt/index.html.,OADS,/arxiv_data1/oa_pdf/bb/9f/egems1119.PMC4435002.pdf
2013. http://www.effectivehealthcare.ahrq.gov/search-for-guides-re-views-and-reports/?pageaction=displayproduct&produc- tID=1677.,Non-OADS,/arxiv_data1/oa_pdf/bb/9f/egems1119.PMC4435002.pdf
http://www.incose.org/practice/whatissys- temseng.aspx.,Non-OADS,/arxiv_data1/oa_pdf/bb/9f/egems1119.PMC4435002.pdf
2012. http://www.effectivehealthcare.ahrq.,Non-OADS,/arxiv_data1/oa_pdf/bb/9f/egems1119.PMC4435002.pdf
2013. http://www.pcori.org/assets/2013/11/PCO-RI-Methodology-Report.pdf.,OADS,/arxiv_data1/oa_pdf/bb/9f/egems1119.PMC4435002.pdf
1998. http://www.fda.gov/downloads/drugs/guidance complianceregulatoryin- formation/guidances/ucm073137.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bb/9f/egems1119.PMC4435002.pdf
2012. http://www.aplu.org/document.doc?id=3652.,Non-OADS,/arxiv_data1/oa_pdf/bb/9f/egems1119.PMC4435002.pdf
"Rockville, MD: Agency for Healthcare Research and Quality; 2009. http://www.ncbi.nlm.nih.gov/books/NBK44088/.",Non-OADS,/arxiv_data1/oa_pdf/bb/9f/egems1119.PMC4435002.pdf
9 http://repository.academyhealth.org/egems/vol3/iss1/9 DOI: 10.13063/2327-9214.1119,Non-OADS,/arxiv_data1/oa_pdf/bb/9f/egems1119.PMC4435002.pdf
"Sao Paulo 57(2):93-103, March-April, 2015 http://dx.doi.org/10.1590/S0036-46652015000200001 (1) Laboratorio de Biologıa Celular, CA Biomedicina de Enfermedades Infecciosas y Parasitarias, Centro de Investigaciones Regionales, Centro de Investigaciones Regionales “Hideyo  Noguchi”, Universidad Autonoma de Yucatan, Avenida Itzaes 490, 97000 Merida, Yucatan, Mexico.",Non-OADS,/arxiv_data1/oa_pdf/ad/72/0036-4665-rimtsp-57-02-0093.PMC4435006.pdf
"Sao Paulo 57(2):105-110, March-April, 2015 http://dx.doi.org/10.1590/S0036-46652015000200002 (1) Secondary Immunodeficiencies Outpatient Clinic, Dermatology Department, São Paulo University Medical School, S. Paulo, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/4a/00/0036-4665-rimtsp-57-02-0105.PMC4435007.pdf
Brasília: Ministério da Saúde; 2012.  http://www.aids.gov.br/sites/default/files/anexos/publicacao/2011/50652/boletim_ aids_2011_final_m_pdf_26659.pdf,Non-OADS,/arxiv_data1/oa_pdf/4a/00/0036-4665-rimtsp-57-02-0105.PMC4435007.pdf
Available from: http://www.unaids.org/AIDSreporting  40.,Non-OADS,/arxiv_data1/oa_pdf/4a/00/0036-4665-rimtsp-57-02-0105.PMC4435007.pdf
"Sao Paulo 57(2):111-120, March-April, 2015 http://dx.doi.org/10.1590/S0036-46652015000200003 (1) Gynecologist and Obstetrics of Cassiano Antonio Moraes University Hospital, Health Sciences Centre, Federal University of Espírito Santo.",Non-OADS,/arxiv_data1/oa_pdf/e2/e3/0036-4665-rimtsp-57-02-0111.PMC4435008.pdf
Available from: http://www.vitoria.,Non-OADS,/arxiv_data1/oa_pdf/e2/e3/0036-4665-rimtsp-57-02-0111.PMC4435008.pdf
"Sao Paulo 57(2):121-127, March-April, 2015 http://dx.doi.org/10.1590/S0036-46652015000200004 (1) Public Health and Tropical Pathology Institute, Federal University of Goiás, Rua 235 s/n, Setor Universitário, 74605-050 Goiânia, Goiás, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/ba/0a/0036-4665-rimtsp-57-02-0121.PMC4435009.pdf
"Sao Paulo 57(2):129-132, March-April, 2015 http://dx.doi.org/10.1590/S0036-46652015000200005 (1) Laboratorio de Enfermedades Infecciosas y Parasitarias I. Facultad de Medicina.",Non-OADS,/arxiv_data1/oa_pdf/1f/41/0036-4665-rimtsp-57-02-0129.PMC4435010.pdf
"Sao Paulo 57(2):133-138, March-April, 2015 http://dx.doi.org/10.1590/S0036-46652015000200006 (1) Instituto Nacional de Epidemiología “Juan H. Jara”, ANLIS Malbrán.",Non-OADS,/arxiv_data1/oa_pdf/c1/ba/0036-4665-rimtsp-57-02-0133.PMC4435011.pdf
Available from: http://www.indec.mecon.gob.ar/   8.,Non-OADS,/arxiv_data1/oa_pdf/c1/ba/0036-4665-rimtsp-57-02-0133.PMC4435011.pdf
Available from:http://www.satscan.,Non-OADS,/arxiv_data1/oa_pdf/c1/ba/0036-4665-rimtsp-57-02-0133.PMC4435011.pdf
Available from:  http://ais.paho.org/ phip/viz/ed_flu.asp  17.,Non-OADS,/arxiv_data1/oa_pdf/c1/ba/0036-4665-rimtsp-57-02-0133.PMC4435011.pdf
"Sao Paulo 57(2):145-152, March-April, 2015 http://dx.doi.org/10.1590/S0036-46652015000200008 (1) Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal do Ceará, Fortaleza, Ceará, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/e0/32/0036-4665-rimtsp-57-02-0145.PMC4435013.pdf
Available from: http://www.census.gov/ipc/prod/ib98-2.pdf   33.,OADS,/arxiv_data1/oa_pdf/e0/32/0036-4665-rimtsp-57-02-0145.PMC4435013.pdf
Available from: http://www.who.int/bloodproducts/ref_materials/WHO_Report_1st_ Chagas_BRP_consultation_7-2007_final.pdf   64.,Non-OADS,/arxiv_data1/oa_pdf/e0/32/0036-4665-rimtsp-57-02-0145.PMC4435013.pdf
"Sao Paulo 57(2):153-163, March-April, 2015 http://dx.doi.org/10.1590/S0036-46652015000200009 (1) Faculdade de Medicina, Univ.",Non-OADS,/arxiv_data1/oa_pdf/00/e6/0036-4665-rimtsp-57-02-0153.PMC4435014.pdf
"Sao Paulo 57(2):164, March-April, 2015 http://dx.doi.org/10.1590/S0036-46652015000200010 TRIBUTE LUIZ HILDEBRANDO PEREIRA DA SILVA (1928-2014) Luiz Hildebrando Pereira da Silva (1928-2014) graduated from the  University of São Paulo Medical School in 1953 and shortly thereafter  joined the Department of Parasitology, then chaired by Professor Samuel  Pessoa, a leading Brazilian parasitologist.",Non-OADS,/arxiv_data1/oa_pdf/7b/0d/0036-4665-rimtsp-57-02-0164.PMC4435015.pdf
"Sao Paulo 57(2):165-167, March-April, 2015 http://dx.doi.org/10.1590/S0036-46652015000200011 (1) Grupo de Química de Materiais Avançados (GQMAT), Departamento de Química Analítica e Físico-Química, Universidade Federal do Ceará-UFC, Campus do Pici, CP 12100, 60451-970  Fortaleza, CE, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/00/24/0036-4665-rimtsp-57-02-0165.PMC4435016.pdf
"Sao Paulo 57(2):169-174, March-April, 2015 http://dx.doi.org/10.1590/S0036-46652015000200012 (1) Department of Clinical Analysis and Biomedicine, State University of Maringá, Paraná, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/ef/e5/0036-4665-rimtsp-57-02-0169.PMC4435017.pdf
Available from: http://www.cdc.gov.,OADS,/arxiv_data1/oa_pdf/ef/e5/0036-4665-rimtsp-57-02-0169.PMC4435017.pdf
"Sao Paulo 57(2):175-176, March-April, 2015 http://dx.doi.org/10.1590/S0036-46652015000200013 (1) Universidad Miguel Hernández de Elche, Alicante, Spain.",Non-OADS,/arxiv_data1/oa_pdf/00/7f/0036-4665-rimtsp-57-02-0175.PMC4435018.pdf
"Sao Paulo 57(2):177-180, March-April, 2015 http://dx.doi.org/10.1590/S0036-46652015000200014 (1) Estação Ecológica de Taiamã, Instituto Chico Mendes de Conservação da Biodiversidade (ICMBio), Av.",Non-OADS,/arxiv_data1/oa_pdf/d7/6e/0036-4665-rimtsp-57-02-0177.PMC4435019.pdf
"Sao Paulo 57(2):181-183, March-April, 2015 http://dx.doi.org/10.1590/S0036-46652015000200015 (1) Museo de Zoología “Alfonso L. Herrera”, Departamento de Biología Evolutiva, Facultad de Ciencias, Universidad Nacional Autónoma de México, Distrito Federal, México.",Non-OADS,/arxiv_data1/oa_pdf/d5/fb/0036-4665-rimtsp-57-02-0181.PMC4435020.pdf
"Sao Paulo 57(2):184, March-April, 2015 http://dx.doi.org/10.1590/S0036-46652015000200016 CORRESPONDENCE FALSE-NEGATIVE DENGUE CASES September 24, 2014 Dear Editor, we would like to discuss on the recent publication on false-negative dengue cases1.",Non-OADS,/arxiv_data1/oa_pdf/10/5a/0036-4665-rimtsp-57-02-0184.PMC4435021.pdf
8 http://repository.academyhealth.org/egems/vol3/iss1/8 DOI: 10.13063/2327-9214.1173,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/egems1173.PMC4435025.pdf
Accessed online at http://www.gpo.gov/fdsys/pkg/FR-2012-09-04/pdf/2012-21050.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/egems1173.PMC4435025.pdf
Accessed online at http://healthit.gov/patients-families/your-health-data 3.,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/egems1173.PMC4435025.pdf
Accessed online December 2013 http://www.healthit.gov/sites/default/files/pghi_tep_finalreport121713.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/egems1173.PMC4435025.pdf
"8, 2014), Accessed online http://iom.edu/Reports/2014/Capturing Social and Behavioral Domains in Electronic Health Records Phase 1.aspx?utm_medium=etmail&utm_source=Insti-tute%20of%20Medicine&utm_campaign=04.08.14+New+Re-port+ +EHR+1&utm_content=&utm_term=.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/egems1173.PMC4435025.pdf
We decided to address the kinase annotation   by screening the PKIS across over 200 kinase inhibition as- says and making the data readily available at ChEMBL  (https://www.ebi.ac.uk/chembl/) [9].,OADS,/arxiv_data1/oa_pdf/14/f6/CTMC-14-340.PMC4435035.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4f/c3/cia-10-859.PMC4435046.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Interventions in Aging 2015:10 859–869Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  859RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5584 2Prevention and optimal management of sarcopenia:  a review of combined exercise and nutrition  interventions to improve muscle outcomes in  older people Hayley J Denison1 Cyrus Cooper1,2 Avan Aihie Sayer1,2 Sian M Robinson1,2 1MRC Lifecourse epidemiology  Unit, University of Southampton,   Southampton General Hospital,   Southampton, UK; 2National Institute  for Health Research Southampton  Biomedical Research Centre,   University of Southampton and  University Hospital Southampton  NHS Foundation Trust,   Southampton,  UKAbstract:  The growing recognition of sarcopenia, the age-related loss of skeletal muscle mass  and function, has highlighted the need to understand more about its etiology.",Non-OADS,/arxiv_data1/oa_pdf/4f/c3/cia-10-859.PMC4435046.pdf
"Keywords:  sarcopenia, diet, exercise, intervention Introduction The importance of sarcopenia, the age-related loss of skeletal muscle mass and func - tion, is now widely recognized.1 The decline in muscle mass between 40 and 80 years  is estimated to be between 30% and 50%, with reported losses in functional capacity  amounting to as much as 3% each year beyond the age of 60.2 Sarcopenia is a major  clinical problem for older people as it is common (with estimates of prevalence as high  as 33% in community-dwelling older adults)2–4 and is clearly associated with poorer  health consequences, including obesity, osteoporosis, and type 2 diabetes.5–7 It is a  major cause of frailty6 and, importantly, predicts future mortality in middle-aged as  well as older adults.7,8 The estimated direct health care cost attributable to sarcopenia  in the United States in 2000 was $18.5 billion.9Correspondence: Avan Aihie Sayer MRC Lifecourse epidemiology Unit,  University of Southampton, Southampton  General Hospital, Tremona Road,  Southampton SO16 6YD, UK Tel +44 23 8076 4050 Fax +44 23 8070 4021 email aas@mrc.soton.ac.u k Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Denison et al Running head recto: Exercise and diet interventions for sarcopenia DOI: http://dx.doi.org/10.2147/CIA.S55842",Non-OADS,/arxiv_data1/oa_pdf/4f/c3/cia-10-859.PMC4435046.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/4f/c3/cia-10-859.PMC4435046.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/4f/c3/cia-10-859.PMC4435046.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/95/dhps-7-077.PMC4435047.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug, Healthcare and Patient Safety 2015:7 77–85Drug, Healthcare and Patient Safety Dove press submit your manuscript | www.dovepress.co m Dove press  77Original reSearcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DHPS.S8086 4Determinant factors of tobacco use among   ever-married men in Bangladesh Md Shafiur rahman1,2 Md nazrul islam Mondal2 Md rafiqul islam2 Md Mizanur rahman2 M nazrul Hoque3 Md Shamsher alam4 1Department of Public Health, First  capital University of Bangladesh,   chuadanga, Bangladesh; 2Department  of Population Science and Human  resource Development, University of  rajshahi, rajshahi, Bangladesh; 3Hobby  center for Public Policy, University of  Houston, Houston, TX, USa; 4Faculty  of ecology, Peoples’ Friendship  University of russia, Moscow, russia correspondence: Md nazrul islam  Mondal   Department of Population Science  and Human resource Development,  University of rajshahi, rajshahi 6205,  Bangladesh   Tel +880 721 751 217   Fax +880 721 750 064   email nazrulupm@gmail.co mBackground:  The burden of tobacco use is shifting from developed to developing countries.",Non-OADS,/arxiv_data1/oa_pdf/71/95/dhps-7-077.PMC4435047.pdf
Available from: http://www.who.int/tobacco/surveillance/en_tfi_ china_gats_factsheet_2010.pdf?ua =1.,Non-OADS,/arxiv_data1/oa_pdf/71/95/dhps-7-077.PMC4435047.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-healthcare-and-patient-safety-journa lDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare  continuum from diagnostic and screening interventions through to treat - ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/71/95/dhps-7-077.PMC4435047.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/95/dhps-7-077.PMC4435047.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/9d/ppa-9-649.PMC4435048.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Preference and Adherence 2015:9 649–658Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  649OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8202 2Behavioral economics survey of patients with type 1  and type 2 diabetes naoya emoto1 Fumitaka Okajima1 hitoshi sugihara2 rei goto3,4 1Division of endocrinology,   Department of Medicine, nippon  Medical school chiba hokusoh  hospital, chiba, 2Department  of endocrinology, Diabetes and  Metabolism, graduate school of  Medicine, nippon Medical school,   T okyo, 3hakubi center of Advanced  research, Kyoto University, Kyoto,   4graduate school of economics,   Kyoto University, Kyoto, JapanBackground:  Adherence to treatment and the metabolic control of diabetes are challenging  in many patients with diabetes.",Non-OADS,/arxiv_data1/oa_pdf/80/9d/ppa-9-649.PMC4435048.pdf
"Type 2 diabetes is initially caused by insulin resistance, which is closely related to the  accumulation of abdominal fat resulting from overeating, the lack of exercise, relative  insulin deficiency, first phase insulin defect, and incretin deficiency.2 The standard  treatment for type 2 diabetes is dietary therapy and appropriate exercise, followed  by sequential addition of oral antihyperglycemic agents, GLP-1 receptor agonists, or  insulin injection (basal and/or mealtime).3 Large prospective clinical studies show a correspondence: naoya emoto Division of endocrinology, Department  of Medicine, nippon Medical school  chiba hokusoh hospital, 1715 Kamagari,  inzai-shi, chiba 270-1694, Japan email n-emoto@nms.ac.j p Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Emoto et al Running head recto: Behavioral economics survey of diabetic patients DOI: http://dx.doi.org/10.2147/PPA.S82022",Non-OADS,/arxiv_data1/oa_pdf/80/9d/ppa-9-649.PMC4435048.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/80/9d/ppa-9-649.PMC4435048.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/19/3f/opth-9-853.PMC4435049.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 853–858Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  853Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S8102 0Detection of cytomegalovirus in an  immunocompetent adult presenting with acute  retinal necrosis due to varicella-zoster virus:  a case report tomoko Nakamura1 tohru Daikoku2 Kimiyasu shiraki2 atsushi Hayashi1 1Department of Ophthalmology,   2Department of Virology, Graduate  school of Medicine and pharmaceutical  sciences, University of toyama, toyama,  JapanBackground:  To report a case of simultaneous detection of cytomegalovirus (CMV) in acute  retinal necrosis (ARN) due to varicella-zoster virus (VZV) in an immunocompetent adult.",Non-OADS,/arxiv_data1/oa_pdf/19/3f/opth-9-853.PMC4435049.pdf
"The left eye showed inflammation in the anterior chamber Correspondence: atsushi Hayashi Department of Ophthalmology, Graduate  school of Medicine and pharmaceutical  sciences, University of toyama, 2630  sugitani, toyama 930-0194, Japan tel +81 76 434 7363 Fax +81 76 434 5037 email ahayashi@med.u-toyama.ac.j p Journal name: Clinical Ophthalmology Article Designation: Case report Y ear: 2015 Volume: 9 Running head verso: Nakamura et al Running head recto: Detection of cytomegalovirus in acute retinal necrosis due to varicella-zoster virus DOI: http://dx.doi.org/10.2147/OPTH.S81020",Non-OADS,/arxiv_data1/oa_pdf/19/3f/opth-9-853.PMC4435049.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/19/3f/opth-9-853.PMC4435049.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/19/3f/opth-9-853.PMC4435049.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/32/15/ott-8-1017.PMC4435050.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 1017–1024OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1017Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8216 8gcDFP-15, ar, and her-2 as biomarkers for  primary ductal adenocarcinoma of the lacrimal  gland: a chinese case and literature review Miao-Miao Zhu1 hong-guang cui1 Xiao-Dong T eng2 1Department of Ophthalmology,   2Department of Pathology, The  First affiliated hospital, school  of Medicine, Zhejiang University,   hangzhou, People’s republic of chinaPurpose:  Primary ductal adenocarcinoma (PDA) of the lacrimal gland is a rare malignant  epithelial tumor, and its clinicopathological characteristics are still unclear.",Non-OADS,/arxiv_data1/oa_pdf/32/15/ott-8-1017.PMC4435050.pdf
"In this study, we aimed to report a novel case of  PDA of the lacrimal gland in the People’s Republic of China, and we also determined  its immunohistochemical characteristics to support its early diagnosis.correspondence: hong-guang cui Department of Ophthalmology, The First  Affiliated Hospital, School of Medicine,  Zhejiang University, 79 Qingchun road,  hangzhou 310003, People’s republic  of china Tel +86 571 8723 6790 Fax +86 571 8723 6393 email dr_chg@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Zhu et al Running head recto: Biomarkers for primary ductal adenocarcinoma of the lacrimal gland DOI: http://dx.doi.org/10.2147/OTT.S82168",Non-OADS,/arxiv_data1/oa_pdf/32/15/ott-8-1017.PMC4435050.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/32/15/ott-8-1017.PMC4435050.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/15/ott-8-1017.PMC4435050.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/96/62/ccid-8-257.PMC4435051.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 257–265Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  257RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S6912 7The diagnosis and treatment of dermatitis  herpetiformis emiliano Antiga Marzia Caproni Department of Surgery and  Translational Medicine, Section of  Dermatology, University of Florence,   Florence, Italy Correspondence: emiliano Antiga   Department of Surgery and Translational  Medicine, Section of Dermatology,  University of Florence, viale Michelangelo  41, 50125 Florence, Italy   Tel +39 055 6939 664   Fax +39 055 6939 598   email emiliano.antiga@unifi.i tAbstract:  Dermatitis herpetiformis (DH) is an inflammatory cutaneous disease with a chronic  relapsing course, pruritic polymorphic lesions, and typical histopathological and immunop - athological findings.",Non-OADS,/arxiv_data1/oa_pdf/96/62/ccid-8-257.PMC4435051.pdf
"Available from: https://www.orpha.net/data/patho/ GB/uk-DermatitisHerpetiformis.pd f. Accessed December 12, 2014.",Non-OADS,/arxiv_data1/oa_pdf/96/62/ccid-8-257.PMC4435051.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/96/62/ccid-8-257.PMC4435051.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/96/62/ccid-8-257.PMC4435051.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/18/b5/ceor-7-257.PMC4435053.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 257–266ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  257ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S8393 2application of a validated algorithm to estimate  the effectiveness and cost of biologics   for rheumatoid arthritis in the Us pharmacy   benefit manager context ning Wu1 sharvari Bhurke1 neel shah2 David J harrison2 1health Economics and Epidemiology,  Evidera, lexington, M a, Usa;  2amgen  inc., Thousand Oaks, Ca, Usa Correspondence: sharvari Bhurke   health Economics and Epidemiology,  Evidera,  430 Bedford street,   suite 300, Lexington Office Park,  lexington, Ma  02420, Usa   Tel +1 781 960 0349  Email sharvari.bhurke@evidera.co mBackground:  Several biologic medicines are available to treat rheumatoid arthritis (RA), and  they differ in administration method (subcutaneous or intravenous [IV]).",Non-OADS,/arxiv_data1/oa_pdf/18/b5/ceor-7-257.PMC4435053.pdf
Available from: http://www.effectivehealthcare.ahrq.,Non-OADS,/arxiv_data1/oa_pdf/18/b5/ceor-7-257.PMC4435053.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/18/b5/ceor-7-257.PMC4435053.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/b5/ceor-7-257.PMC4435053.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/be/0e/dddt-9-2617.PMC4435054.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2617–2625Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2617Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8033 8Fixed-combination treatments for intraocular  hypertension in Chinese patients – focus  on bimatoprost-timolol Yuan Fang1,* Zhihong Ling1,* Xinghuai Sun1–4 1Department of Ophthalmology  and visual Science, eye, ear, Nose  and Throat Hospital, Shanghai Medical  College, Fudan University, 2Shanghai  Key Laboratory of visual impairment  and Restoration, 3Key Laboratory of  Myopia, Ministry of Health, 4State Key  Laboratory of Medical Neurobiology,   institutes of Brain Science, Fudan  University, Shanghai, People’s  Republic of China *These authors contributed equally  to this workAbstract:  Glaucoma is a common eye disease that can lead to irreversible vision loss if left  untreated.",Non-OADS,/arxiv_data1/oa_pdf/be/0e/dddt-9-2617.PMC4435054.pdf
"The medical expense of treating glaucoma in the People’s  Republic of China is about 4.8 billion USD annually; accordingly, the prevention and Correspondence: Xinghuai Sun Department of Ophthalmology  and visual Science, eye, ear,  Nose and Throat Hospital, Shanghai  Medical College, Fudan University,  83 Fenyang Road, Shanghai 200031,  People’s Republic of China Tel +86 21 6437 7134 Fax +86 21 6437 7151 email xhsun@shmu.edu.c n Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Fang et al Running head recto: Bimatoprost-timolol for intraocular hypertension in Chinese patients DOI: http://dx.doi.org/10.2147/DDDT.S80338",Non-OADS,/arxiv_data1/oa_pdf/be/0e/dddt-9-2617.PMC4435054.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/be/0e/dddt-9-2617.PMC4435054.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/0e/dddt-9-2617.PMC4435054.pdf
"http://www.drugbank.ca/drugs/  DB00485 (accessed September 15, 2013).",Non-OADS,/arxiv_data1/oa_pdf/ae/40/CDM-15-581.PMC4435065.pdf
"http://www.drugbank.ca/drugs/DB01060  (accessed September 15, 2013).",Non-OADS,/arxiv_data1/oa_pdf/ae/40/CDM-15-581.PMC4435065.pdf
"http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_Product_Information/human/000637/WC 500036049.pdf (accessed September 25, 2013).",Non-OADS,/arxiv_data1/oa_pdf/ae/40/CDM-15-581.PMC4435065.pdf
"http://www.drugbank.ca/drugs/DB00330 (accessed February 13, 2014).",Non-OADS,/arxiv_data1/oa_pdf/ae/40/CDM-15-581.PMC4435065.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6a/80/opth-9-843.PMC4435077.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 843–852Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  843Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8316 2Antibacterial efficacy of prophylactic besifloxacin  0.6% and moxifloxacin 0.5% in patients undergoing  cataract surgery Frank a Bucci Jr1 ruth e evans1 loretta M amico1 Timothy W Morris2 angel T Fluet1 Christine M sanfilippo3 heleen h DeCory3 Timothy l Comstock3 1Bucci laser Vision institute, Wilkes- Barre, P a, Usa; 2Microbiology and  sterilization sciences, Bausch and  lomb, rochester, nY, Usa; 3Medical  affairs, Bausch and lomb, rochester,   nY, UsaBackground:  The purpose of this study was to investigate the ocular bacterial flora in patients  scheduled to undergo cataract surgery and compare the antibacterial effects of besifloxacin  ophthalmic suspension 0.6% and moxifloxacin ophthalmic solution 0.5% in these patients.",Non-OADS,/arxiv_data1/oa_pdf/6a/80/opth-9-843.PMC4435077.pdf
"Keywords:  besifloxacin, moxifloxacin, prophylaxis, cataract patients, coagulase-negative  staphylococci Introduction Bacterial endophthalmitis is a rare but potentially vision-threatening complication of  cataract surgery.1 The most common causes of bacterial endophthalmitis are gram- positive organisms, often originating from resident bacterial flora on the conjunctiva  and/or eyelids, which penetrate the eye during surgery or following surgery through  the incision.2,3 Accordingly, the most frequently isolated organisms from culture- proven cases of postoperative endophthalmitis are coagulase-negative staphylococci  (CoNS), most notably Staphylococcus epidermidis ,3–9 also the most prevalent organ - ism of the ocular flora in these patients.10–12 While the previously published European  Society of Cataract and Refractive Surgeons (ESCRS) study established the efficacy of  intraoperative, intracameral antibiotics in the prophylaxis against infection following Correspondence: Frank a Bucci Jr Bucci laser Vision institute,   158 Wilkes-Barre Township Boulevard,  Wilkes-Barre, Pa 18702, Usa Tel +1 570 825 5949 Fax +1 570 825 2645 email b uccivision@aol.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Bucci et al Running head recto: Besifloxacin and moxifloxacin prophylaxis in cataract patients DOI: http://dx.doi.org/10.2147/OPTH.S83162",Non-OADS,/arxiv_data1/oa_pdf/6a/80/opth-9-843.PMC4435077.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/6a/80/opth-9-843.PMC4435077.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/80/opth-9-843.PMC4435077.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/19/56/copd-10-909.PMC4435078.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2015:10 909–915International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  909OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8308 2Lower 30-day readmission rates with roflumilast  treatment among patients hospitalized for chronic  obstructive pulmonary disease alex Z Fu1 shawn X sun2 Xingyue huang2 alpesh n amin3 1georgetown University Medical  Center, Washington, DC, 2health  economics and Outcomes research,   Forest laboratories, llC, an affiliate  of actavis, Inc., Jersey City, nJ,  3Department of Medicine, University  of California, Irvine, C a, UsaBackground:  Few data exist related to the impact of roflumilast on health care utilization.",Non-OADS,/arxiv_data1/oa_pdf/19/56/copd-10-909.PMC4435078.pdf
"Keywords:  chronic obstructive pulmonary disease, roflumilast, health care utilization, hospital  readmission Introduction COPD is a progressive lung condition characterized by persistent airflow limitation,  chronic and progressive dyspnea, cough, and sputum production, and is often compli - cated by exacerbations.1 COPD affects approximately 24 million US adults, including   12 million diagnosed patients and 12 million undiagnosed,2 and is the third leading cause of  death in the USA.3 The annual cost of COPD was estimated at $49.9 billion in 2010, with  $29.5 billion attributable to direct health care costs, in which hospital care cost accounted  for the largest share of the total.2Correspondence: alex Z Fu georgetown University Medical Center,  3300 Whitehaven street, nW, suite 4100,   Washington, DC 20007, Usa email zf54@georgetown.ed u Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Fu et al Running head recto: Roflumilast associated with fewer 30-day readmissions for COPD DOI: http://dx.doi.org/10.2147/COPD.S83082",Non-OADS,/arxiv_data1/oa_pdf/19/56/copd-10-909.PMC4435078.pdf
Available from: http://www.goldcopd.org/guidelines- global-strategy-for-diagnosis-management.html.,Non-OADS,/arxiv_data1/oa_pdf/19/56/copd-10-909.PMC4435078.pdf
Available at:  https://www.nhlbi.nih.gov/files/docs/research/2012_ChartBook_508.,Non-OADS,/arxiv_data1/oa_pdf/19/56/copd-10-909.PMC4435078.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/19/56/copd-10-909.PMC4435078.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/19/56/copd-10-909.PMC4435078.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/42/98/ceor-7-249.PMC4435086.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 249–256ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  249ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S8219 4nab-paclitaxel, docetaxel, or solvent-based  paclitaxel in metastatic breast cancer: a cost-utility  analysis from a Chinese health care perspective george Dranitsaris1 Bo Yu2 Jennifer King3 satyin Kaura3 adams Zhang3 1augmentium Pharma Consulting  inc., Toronto, On , Canada;  2Fudan  University shanghai Cancer Center,   shanghai, People’s Republic of China;   3Celgene Corporation, summit, nJ,  Usa Correspondence: george Dranitsaris   augmentium Pharma Consulting inc.,  283 Danforth ave, suite  448,   Toronto, On, M4K  1n2, Canada   Tel +1 416 461 2720  Fax +1 416 461 4735  Email george@augmentium.co mBackground:  Paclitaxel and docetaxel are commonly used for metastatic breast cancer in the  People’ s Republic of China.",Non-OADS,/arxiv_data1/oa_pdf/42/98/ceor-7-249.PMC4435086.pdf
"Available from: http://hdr.undp.org/en/media/ Lets-Talk-HD-HDI_2010.pd f. Accessed April  26, 2015.",Non-OADS,/arxiv_data1/oa_pdf/42/98/ceor-7-249.PMC4435086.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/42/98/ceor-7-249.PMC4435086.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/42/98/ceor-7-249.PMC4435086.pdf
Available from: https://www.cancer.ca/~/media/cancer.ca/ CW/cancer%20information/cancer%20101/Canadian%20cancer%20 statistics/Canadian-Cancer-Statistics-2008-EN.pdf .,Non-OADS,/arxiv_data1/oa_pdf/42/98/ceor-7-249.PMC4435086.pdf
Available from: http://service2.bjpc.gov.cn/bjpc/mediprice/  MedicalService2.js p).,Non-OADS,/arxiv_data1/oa_pdf/42/98/ceor-7-249.PMC4435086.pdf
Available  from: https://research.tufts-nemc.org/cear4/AboutUs/WhoisCEVR.,OADS,/arxiv_data1/oa_pdf/42/98/ceor-7-249.PMC4435086.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1a/64/dddt-9-2627.PMC4435087.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2627–2634Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2627Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7970 9Prevalence of the CYP2D6*10  (c100T),  *4 (g1846a), and *14 (g1758a) alleles among  iranians of different ethnicities ali Bagheri1 Behnam Kamalidehghan2 Maryam haghshenas3 Parisa azadfar4 leila akbari4 Mohammad hossein  sangtarash1 Faramarz Vejdandoust5 Fatemeh ahmadipour2 goh Y ong Meng6 Massoud houshmand7,8 1Department of Biology, University  of sistan and Baluchestan, Zahedan,   iran; 2Department of Pharmacy,   Faculty of Medicine, University  of Malaya, Kuala lumpur, Malaysia;   3Department of Biology, Pardis  international Unit, University  of guilan, rasht, iran; 4Department  of Biology, science and research  Branch, azad University, T ehran,   iran; 5Department of Biology,   azad University, ashkezar Branch,   Yazd, iran; 6Department of animal  science, Faculty of Veterinary  Medicine, Universiti Putra Malaysia,   serdang, Malaysia; 7Medical genetics  Department, special Medical center,   8Medical genetics Department,   national institute for genetic  engineering and Biotechnology  (nigeB), T ehran, iranAbstract:  The presence of polymorphisms in the CYP2D6  gene may modulate enzyme level  and activity, thereby affecting individual responses to pharmacological treatment.",Non-OADS,/arxiv_data1/oa_pdf/1a/64/dddt-9-2627.PMC4435087.pdf
"Liver and small  intestine microsomal enzymes metabolize the majority of drugs, in which the activity  of drugs are determined based on their interaction with enzymatic activity of the  cytochrome P450 (CYP) system.1 More than 50 human CYP isozymes have been identified to date,2 and more  than 20 are functionally encoded by polymorphic CYP2A6 , CYP2C9 , CYP2C19 , correspondence: Massoud houshmand national institute for genetic engineering  and Biotechnology (nigeB), PO Box  14965/161 Tehran, iran  Tel +98 21 4458 0390 Fax +98 21 4458 0399 email massoudh@nigeb.ac.i r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Bagheri et al Running head recto: CYP2D6*10 , *4, and *14 alleles in the Iranian population  DOI: http://dx.doi.org/10.2147/DDDT.S79709",Non-OADS,/arxiv_data1/oa_pdf/1a/64/dddt-9-2627.PMC4435087.pdf
Available from: https://circle.ubc.ca/bitstream/2429/15602/1/ubc_2004- 0519.pd f  7.,OADS,/arxiv_data1/oa_pdf/1a/64/dddt-9-2627.PMC4435087.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/1a/64/dddt-9-2627.PMC4435087.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/64/dddt-9-2627.PMC4435087.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/f0/tcrm-11-713.PMC4435088.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 713–729Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  713Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S6813 0Update on the management of chemotherapy- induced nausea and vomiting – focus on  palonosetron Michelle Zhou Marko Popovic Mark Pasetka Natalie Pulenzas Soha Ahrari edward Chow Carlo DeAngelis Department of Pharmacy, Odette  Cancer Center, Sunnybrook  Health Sciences Center, University  of T oronto, T oronto, ON, CanadaPurpose:  Nausea and vomiting are major adverse effects of chemotherapy and can greatly  impact patients’ quality of life.",Non-OADS,/arxiv_data1/oa_pdf/fe/f0/tcrm-11-713.PMC4435088.pdf
"Keywords:  chemotherapy-induced nausea and vomiting, palonosetron, efficacy, safety, phar - macology, patient-reported outcomes Introduction Chemotherapy-induced nausea and vomiting (CINV) is considered a major adverse  effect of cytotoxic chemotherapy and can greatly impact patients’ quality of life.1–3   As a result, CINV is one of the major reasons for disruption or delay in treatment, which  is often due to patient noncompliance.3 The administration of a safe and efficacious  prophylactic antiemetic regimen is thus important for current and future patients at  risk for CINV.4 In antiemetic clinical trials, there are five common endpoints that are  employed for comparison: complete response (CR), defined as no emesis and no use Correspondence: Carlo DeAngelis Department of Pharmacy, Odette Cancer  Center, Sunnybrook Health Sciences  Center, University of Toronto, 2075  Bayview Avenue, Toronto M4N 3M5,  ON, Canada Tel +1 416 480 6100 ext 1085 email carlo.deangelis@sunnybrook.c a Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Zhou et al Running head recto: Management of CINV with palonosetron DOI: http://dx.doi.org/10.2147/TCRM.S68130",Non-OADS,/arxiv_data1/oa_pdf/fe/f0/tcrm-11-713.PMC4435088.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/fe/f0/tcrm-11-713.PMC4435088.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/f0/tcrm-11-713.PMC4435088.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/af/83/dddt-9-2609.PMC4435089.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2609–2616Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2609Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8006 6a pharmacokinetic comparison of two voriconazole  formulations and the effect of cYP2c19  polymorphism on their pharmacokinetic profiles hyewon chung1,* howard lee1,2,* hyeKyung han1 hyungmi an1 Kyoung soo lim1,3 Y ongJin lee4 Joo-Y oun cho1 seo hyun Y oon1 in-Jin Jang1 Kyung-sang Yu1 1Department of clinical Pharmacology  and Therapeutics, seoul national  University college of Medicine, seoul  national University hospital, seoul,   republic of Korea; 2Department of  Transdisciplinary studies, graduate  school of convergence science  and Technology, seoul national  University, seoul, republic of Korea;   3Department of clinical Pharmacology  and Therapeutics, cha  University  school of Medicine and cha  Bundang Medical center, seongnam,   republic of Korea; 4Medical and  regulatory affairs Team, samyang  Biopharmaceuticals corporation,   seoul, republic of Korea *These authors contributed equally  to this workPurpose:  SYP-1018 is a lyophilized polymeric nanoparticle formulation of voriconazole that  is under development for intravenous dosing.",Non-OADS,/arxiv_data1/oa_pdf/af/83/dddt-9-2609.PMC4435089.pdf
"The *2 and *3 alleles are deficient alleles,3,4 correspondence: Kyung-sang Yu Department of clinical Pharmacology  and Therapeutics, seoul national  University college of Medicine, seoul  national University hospital, 101  Daehak-ro, Jongno-gu, seoul 110-744,  republic of Korea Tel +82 2 2072 1920 Fax +82 2 742 9252 email ksyu@snu.ac.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Chung et al Running head recto: Comparative pharmacokinetics of two voriconazoles and CYP2C19 DOI: http://dx.doi.org/10.2147/DDDT.S80066",Non-OADS,/arxiv_data1/oa_pdf/af/83/dddt-9-2609.PMC4435089.pdf
Available from: http://labeling.pfizer.com/ShowLabeling.aspx?id =618.,Non-OADS,/arxiv_data1/oa_pdf/af/83/dddt-9-2609.PMC4435089.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/af/83/dddt-9-2609.PMC4435089.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/83/dddt-9-2609.PMC4435089.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e0/4e/ott-8-1031.PMC4435090.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 1031–1038OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1031Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6579 4lung cancer drug therapy in hungary –   3-year experience Judit Moldvay1 györgy rokszin2 Zsolt abonyi-Tóth2 lajos Katona3 Katalin Fábián4 gábor Kovács5 1Department of T umor Biology,  national Korányi institute of  Pulmonology, semmelweis University,  Budapest, hungary; 2rxTarget company  ltd, szolnok, hungary; 3Department  of Psychiatry and Psychotherapy,  semmelweis University, Budapest,  hungary; 4Department of Pulmonology,  semmelweis University, Budapest,  hungary; 5national Korányi institute  of Pulmonology and T uberculosis,  Budapest, hungary correspondence: Katalin Fábián   Department of T umor Biology, national  Korányi institute of Pulmonology,  semmelweis University, Diósárok 1/c,  Budapest 1125, hungary   Tel +36 30 388 5443   Fax +36 1 214 2498   email drfabian.katalin@gmail.co mAbstract:  Hungary is a world leader in lung cancer deaths, so it is of crucial importance that  patients have access to modern treatments.",Non-OADS,/arxiv_data1/oa_pdf/e0/4e/ott-8-1031.PMC4435090.pdf
"Note:  adapted from cancer research UK, http://www.cancerresearchuk.org/ cancer-info/cancerstats/types/lung/mortality /.",Non-OADS,/arxiv_data1/oa_pdf/e0/4e/ott-8-1031.PMC4435090.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e0/4e/ott-8-1031.PMC4435090.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/4e/ott-8-1031.PMC4435090.pdf
"Available  from: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/ lung/mortalit y. Accessed January 3, 2014.",Non-OADS,/arxiv_data1/oa_pdf/e0/4e/ott-8-1031.PMC4435090.pdf
"Available  from: http://www.koranyi.hu/tartalom/bulletin/Evkonyv2012.pd f.  Accessed September 26, 2014.",Non-OADS,/arxiv_data1/oa_pdf/e0/4e/ott-8-1031.PMC4435090.pdf
"Available from: http://www.oncol.hu/rakreg/stat2/nrr_2010.htm l.  Accessed September 26, 2014.",OADS,/arxiv_data1/oa_pdf/e0/4e/ott-8-1031.PMC4435090.pdf
"Available from: http://www.nccn.org/professionals/physician_gls/pdf/ nscl.pd f. Accessed September 26, 2014.",Non-OADS,/arxiv_data1/oa_pdf/e0/4e/ott-8-1031.PMC4435090.pdf
"Available from: http://www.nccn.org/professionals/physician_gls/pdf/ sclc.pd f. Accessed September 26, 2014.",Non-OADS,/arxiv_data1/oa_pdf/e0/4e/ott-8-1031.PMC4435090.pdf
"sourceforge.net) and Xpose (version 4.4.0, http://xpose.sourceforge.net).",OADS,/arxiv_data1/oa_pdf/2c/46/jcsm0006-0045.PMC4435096.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/01/c8/hiv-7-145.PMC4435239.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pHIV/AIDS – Research and Palliative Care 2015:7 145–155HIV/AIDS – Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  145ORIg InAl ReSeARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S7852 3Dyslipidemia and cardiovascular disease risk  profiles of patients attending an HIV treatment  clinic in Harare, Zimbabwe Danai Tavonga Zhou1,2 Vitaris Kodogo1 Kudzai Fortunate Vongai  Chokuona1 exnevia gomo1 Olav Oektedalen3 Babill Stray-Pedersen2 1Department of Medical Laboratory  Sciences, College of Health Sciences,   University of Zimbabwe, Avondale,   Zimbabwe; 2Institute of Clinical  Medicine, University in Oslo, Oslo  University Hospital, Oslo, norway;   3Department of Infectious Diseases,   Oslo University Hospital, Oslo,   norway Correspondence: Danai Tavonga Zhou   Department of Medical Laboratory  Sciences, College of Health Sciences,  University of Zimbabwe, Parirenyatwa  Group of Hospitals Grounds, Mazowe  Street, Avondale, Harare, Zimbabwe   Tel +263 77 256 6214   email danaitz@medisin.uio.n oAbstract:  The chronic inflammation induced by human immunodeficiency virus (HIV) contrib - utes to increased risk of coronary heart disease (CHD) in HIV -infected individuals.",Non-OADS,/arxiv_data1/oa_pdf/01/c8/hiv-7-145.PMC4435239.pdf
"Available  at http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pd f.  Accessed January 15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/01/c8/hiv-7-145.PMC4435239.pdf
"Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/ l13_c_met_lipids.pd f. Accessed January 25, 2015.",OADS,/arxiv_data1/oa_pdf/01/c8/hiv-7-145.PMC4435239.pdf
Available from: http://apps.who.int/bmi/ index.jsp?introPage =intro_3.,OADS,/arxiv_data1/oa_pdf/01/c8/hiv-7-145.PMC4435239.pdf
Available from: http://cvdrisk.nhlbi.nih.gov /.,Non-OADS,/arxiv_data1/oa_pdf/01/c8/hiv-7-145.PMC4435239.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/01/c8/hiv-7-145.PMC4435239.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/01/c8/hiv-7-145.PMC4435239.pdf
"Available from:  http://www.centerforaids.org/pdfs/rita0613.pd f. Accessed January 25,  2015.",Non-OADS,/arxiv_data1/oa_pdf/01/c8/hiv-7-145.PMC4435239.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ scientificreports CONFLICT OF INTEREST: Authors declare no competing financial interest.,Non-OADS,/arxiv_data1/oa_pdf/fa/06/srep09862.PMC4435243.pdf
"• Tel: (822) 3010-4355  • Fax: (822) 476-0090 • E-mail: seojb@amc.seoul.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/7c/kjr-16-632.PMC4435244.pdf
"Korean J Radiol 2015;16(3):632-640http://dx.doi.org/10.3348/kjr.2015.16.3.632 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Thoracic Imaging INTRODUCTION Asthma is a common chronic disorder of the airways  that involves a complex interaction of airflow obstruction,  bronchial hyper-responsiveness, and an underlying  inflammation (1).",Non-OADS,/arxiv_data1/oa_pdf/75/7c/kjr-16-632.PMC4435244.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ee/40/ijwh-7-527.PMC4435247.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2015:7 527–529International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  527Case reportopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IJWH.S8233 9transfundal puncture of a large ovarian cyst  with hysteroscopic and ultrasonographic guidance piotr Zolnierczyk Krzysztof Cendrowski Wlodzimierz sawicki Department of obstetrics,   Gynecology and oncology, 2nd  Faculty of Medicine, Medical  University of Warsaw, Warsaw, polandAbstract:  This paper describes the case of an 83-year-old patient with hypertension, diabetes,  obesity (body mass index – 38), congestive heart failure, and history of cardiac surgery, who was  referred for a diagnostic–therapeutic decompression of a large, symptomatic ovarian cyst.",Non-OADS,/arxiv_data1/oa_pdf/ee/40/ijwh-7-527.PMC4435247.pdf
"Kondratowicza 8, 03-242 Warsaw tel +48 60 130 1773 email pzolnier@wp.p l Journal name: International Journal of Women’s Health Article Designation: Case report Y ear: 2015 Volume: 7 Running head verso: Zolnierczyk et al Running head recto: Transfundal puncture of a large ovarian cyst DOI: http://dx.doi.org/10.2147/IJWH.S82339",Non-OADS,/arxiv_data1/oa_pdf/ee/40/ijwh-7-527.PMC4435247.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/ee/40/ijwh-7-527.PMC4435247.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/40/ijwh-7-527.PMC4435247.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ae/44/jbm-6-151.PMC4435248.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Blood Medicine 2015:6 151–156Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  151Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JBM.S8242 3The neutrophil to lymphocyte ratio is associated  with severity of rheumatic mitral valve stenosis erkan Baysal1 cengiz Burak2 serkan cay2 T olga aksu3 Bernas Altıntaş1 Barış Yaylak1 Utkan sevük4 Önder Bilge1 1Department of cardiology,  Diyarbakır Gazi Yaşargil Education  and Research Hospital, Diyarbakır,  Turkey;  2Department of cardiology,  Ankara Yüksek İhtisas education  and research hospital, ankara,  Turkey;  3Department of cardiology,  Kocaeli Derince education and  research hospital, Kocaeli, Turkey;   4Department of cardiovascular  Surgery, Diyarbakır Gazi Yaşargil  education and research hospital,  Diyarbakır, Turkey correspondence: erkan Baysal   Fabrika Mahallesi 813. sokak no:1,  Altınpark sitesi C blok no:21 yenişehir,  21090, Diyarbakır, Turkey   Tel +90 53 1790 6499  email dr.erkan.baysal@hotmail.co mBackground:  Rheumatic heart disease (RHD) is a serious health concern in developing   countries.",Non-OADS,/arxiv_data1/oa_pdf/ae/44/jbm-6-151.PMC4435248.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/ae/44/jbm-6-151.PMC4435248.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/44/jbm-6-151.PMC4435248.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/b5/ndt-11-1175.PMC4435249.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1175–1180Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1175OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7706 0Wearing-off in Parkinson’s disease:  neuropsychological differences between  on and off periods Fabiane caillava-santos1,2 regina Margis2 carlos roberto de Mello  rieder2–4 1Psychology Department,   Universidade da região da campanha,   Bagé, rs, Brazil; 2curso de Pós- graduaç ão em Medicina, ciências  Médicas da Universidade Federal do  rio grande do sul, Porto alegre, rs,   Brazil; 3Movement Disorders center,   Division of Neurology, Universidade  Federal de ciências da saúde de  Porto alegre, Porto alegre, rs, Brazil;   4Movement Disorder clinic, Division  of Neurology, hospital de clínicas de  Porto alegre, Universidade Federal  do rio grande do sul, Porto alegre,   rs, BrazilBackground:  Levodopa-associated motor fluctuations are common complications observed  in Parkinson’s disease (PD) patients.",Non-OADS,/arxiv_data1/oa_pdf/8a/b5/ndt-11-1175.PMC4435249.pdf
"It has been suggested that all patients with motor fluctuations associated with the  levodopa therapy experience nonmotor fluctuations simultaneously.2 Sleep disorder,  neuropsychiatric manifestations such as depression and anxiety, as well as autonomic, correspondence: Fabiane caillava-santos Mostardeiro, 5 – conj 1004   independencia – Porto alegre,   rs, ceP 90.430-001, Brazil email fabicaillava@icloud.co mJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Caillava-Santos et al Running head recto: Parkinson’s disease and non-motor fluctuations DOI: http://dx.doi.org/10.2147/NDT.S77060",Non-OADS,/arxiv_data1/oa_pdf/8a/b5/ndt-11-1175.PMC4435249.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/8a/b5/ndt-11-1175.PMC4435249.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/b5/ndt-11-1175.PMC4435249.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/f5/ijwh-7-517.PMC4435250.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 517–525International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  517OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S7739 8relationship power, communication, and violence  among couples: results of a cluster-randomized  HIV prevention study in a south african township alexandra M Minnis1,2 Irene a Doherty1,3 Tracy l Kline1 William a Zule1 Bronwyn Myers4,5 Tara carney4 Wendee M Wechsberg1,3,6,7 1rTI International, research Triangle  Park, nc, 2school of Public Health,   University of california, Berkeley, ca,   3University of north carolina, chapel  Hill, nc, Usa; 4alcohol, T obacco and  Other Drug research Unit, south  african Medical research council,   5Department of Psychiatry and Mental  Health, University of cape T own,   cape T own, south africa; 6north  carolina state University, raleigh,   7Duke University school of Medicine,   Durham, nc, UsaBackground:  Inequitable gender-based power in relationships and intimate partner violence  contribute to persistently high rates of HIV infection among South African women.",Non-OADS,/arxiv_data1/oa_pdf/70/f5/ijwh-7-517.PMC4435250.pdf
"Indeed, gender norms and strategies  adopted to express masculinity are shaped by historical disempowerment and the  legacies of colonization and apartheid, which restricted opportunities to achieve  traditional milestones of adulthood.2 There are multiple pathways whereby gender correspondence: alexandra M Minnis Women’s global Health Imperative, rTI  International, 351 california street, suite  500, san Francisco, ca 94104, Usa Tel +1 415 848 1323 email aminnis@rti.or g Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2015 Volume: 7 Running head verso: Minnis et al Running head recto: Effects of couples-based HIV prevention on relationship-based risk DOI: http://dx.doi.org/10.2147/IJWH.S77398",Non-OADS,/arxiv_data1/oa_pdf/70/f5/ijwh-7-517.PMC4435250.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/70/f5/ijwh-7-517.PMC4435250.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/f5/ijwh-7-517.PMC4435250.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8f/ba/ijn-10-3475.PMC4435251.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2015:10 3475–3488International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3475OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8258 7Delivery of micro rNa-146a with polyethylenimine  nanoparticles inhibits renal fibrosis in vivo Y oshiyuki Morishita1 T oshimi Imai1 hiromichi Y oshizawa1 Minami Watanabe1 Kenichi Ishibashi2 shigeaki Muto1 Daisuke Nagata1 1Division of Nephrology, Department  of Medicine, Jichi Medical University,   T ochigi, 2Department of Medical  Physiology, Meiji Pharmaceutical  University, T okyo, JapanAbstract:  Renal fibrosis is the final common pathway leading to end-stage renal disease.",Non-OADS,/arxiv_data1/oa_pdf/8f/ba/ijn-10-3475.PMC4435251.pdf
"Numerous studies have demonstrated that the transforming growth factor beta 1   (TGF-β1)–Smad signaling pathway plays a central role in the development of renal  fibrosis.4–6 TGF-β1 receptor-activated Smad3 combines with a common Smad,  Smad4, and this complex is translocated to the nucleus, where it binds to DNA ele - ments to promote the transcription of various pro-fibrotic genes.4–6 Smad4 knockout  in the kidney was found to enhance inflammation, as evidenced by leukocyte and  macrophage infiltration.6 Unresolved inflammation characterized by macrophage  infiltration has also been reported to promote progressive renal fibrosis.7–9 Infiltration  by macrophages is invariably observed at sites of renal fibrosis, with the degree of  infiltration correlated with the extent of fibrosis.10,11 Nuclear factor kappa B (NF- κB)  is a major signaling pathway that activates and promotes macrophage infiltration.12,13  Blocking NF- κB signaling can suppress renal injury, whereas enhancing this pathway correspondence: Yoshiyuki Morishita Division of Nephrology, Department  of Medicine, Jichi Medical University,  3311-1 Yakushiji, shimotsuke, Tochigi  329-0498, Japan Tel +81 285 44 7346 Fax +81 285 44 4869 email ymori@jichi.ac.j p Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Morishita et al Running head recto: MicroRNA-146a and renal fibrosis DOI: http://dx.doi.org/10.2147/IJN.S82587",Non-OADS,/arxiv_data1/oa_pdf/8f/ba/ijn-10-3475.PMC4435251.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/8f/ba/ijn-10-3475.PMC4435251.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8f/ba/ijn-10-3475.PMC4435251.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/73/e4/ijn-10-3499.PMC4435252.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 3499–3518International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3499OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7828 4Nanofabrication of methylglyoxal with chitosan  biopolymer: a potential tool for enhancement  of its anticancer effect aparajita Pal1,* Dipa Talukdar1,* anirban roy1 subhankar ray2 asish Mallick3 chitra Mandal3 Manju ray1 1Department of Biophysics, Bose  Institute, Kolkata, India; 2Department  of Biochemistry, University of  calcutta, Kolkata, India; 3cancer  Biology and Inflammatory Disorder  Division, council of scientific and  Industrial research (csIr)-Indian  Institute of chemical Biology,   Kolkata,  India *These authors contributed equally  to this workPurpose:  The normal metabolite methylglyoxal (MG) specifically kills cancer cells by inhibiting  glycolysis and mitochondrial respiration without much adverse effect upon normal cells.",Non-OADS,/arxiv_data1/oa_pdf/73/e4/ijn-10-3499.PMC4435252.pdf
"Keywords:  nano-methylglyoxal, anticancer agent, C2C12, HBL-100, A549, EAC, sarcoma- 180, apoptosiscorrespondence: Manju ray Department of Biophysics, Bose Institute,  P 1/12, cIT road, scheme VIIM,  Kolkata 700 054, West Bengal, India email manjuray@jcbose.ac.i n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Pal et al Running head recto: Methylglyoxal-conjugated chitosan nanoparticles as a potent anticancer agent DOI: http://dx.doi.org/10.2147/IJN.S78284",Non-OADS,/arxiv_data1/oa_pdf/73/e4/ijn-10-3499.PMC4435252.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/73/e4/ijn-10-3499.PMC4435252.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/73/e4/ijn-10-3499.PMC4435252.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/31/69/crj-01-007.PMC4435254.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/31/69/crj-01-007.PMC4435254.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/d0/b1/crj-01-016.PMC4435255.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/d0/b1/crj-01-016.PMC4435255.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/95/45/crj-01-047.PMC4435256.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/95/45/crj-01-047.PMC4435256.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/59/38/crj-01-055.PMC4435257.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/59/38/crj-01-055.PMC4435257.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/3a/25/crj-01-064.PMC4435259.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/3a/25/crj-01-064.PMC4435259.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/1c/d5/crj-01-058.PMC4435260.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/1c/d5/crj-01-058.PMC4435260.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/aa/18/crj-01-013.PMC4435261.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/aa/18/crj-01-013.PMC4435261.pdf
http://www.who.int/vmnis/database/anaemia/ anaemia_status_summary/en/index.html.,OADS,/arxiv_data1/oa_pdf/aa/18/crj-01-013.PMC4435261.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/88/d5/crj-01-051.PMC4435262.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/88/d5/crj-01-051.PMC4435262.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/cc/e8/crj-01-019.PMC4435263.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/cc/e8/crj-01-019.PMC4435263.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/90/0e/crj-01-040-b.PMC4435264.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/90/0e/crj-01-040-b.PMC4435264.pdf
Please view video at http://acgcasereports.gi.org/?p=329.,Non-OADS,/arxiv_data1/oa_pdf/d0/37/crj-01-003.PMC4435265.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/e3/32/crj-01-004.PMC4435266.pdf
